0001144204-15-060400.txt : 20151022 0001144204-15-060400.hdr.sgml : 20151022 20151022153050 ACCESSION NUMBER: 0001144204-15-060400 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151022 DATE AS OF CHANGE: 20151022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroMetrix, Inc. CENTRAL INDEX KEY: 0001289850 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043308180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33351 FILM NUMBER: 151170144 BUSINESS ADDRESS: STREET 1: 62 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 890-9989 MAIL ADDRESS: STREET 1: 62 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 10-Q 1 v422003_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____

Commission File Number 001-33351

NEUROMETRIX, INC.

(Exact name of registrant as specified in its charter)

Delaware	04-3308180
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

1000 Winter Street, Waltham, Massachusetts	02451
(Address of principal executive offices)	(Zip Code)

(781) 890-9989

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):

Large accelerated filer ¨	Accelerated filer ¨	Non-accelerated filer ¨	Smaller reporting company x
		(Do not check if a smaller
		reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

13,785,239 shares of common stock, par value $0.0001 per share, were outstanding as of October 21, 2015.

NeuroMetrix, Inc.

Form 10-Q

Quarterly Period Ended September 30, 2015

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements:

	Balance Sheets (unaudited) as of September 30, 2015 and December 31, 2014	2

	Statements of Operations (unaudited) for the quarters and nine months ended September 30, 2015 and 2014	3

	Statements of Cash Flows (unaudited) for the nine months ended September 30, 2015 and 2014	4

	Notes to Unaudited Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21

Item 4.	Controls and Procedures	22

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	22

Item 1A.	Risk Factors	22

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23

Item 3.	Defaults Upon Senior Securities	23

Item 4.	Mine Safety Disclosures	23

Item 5.	Other Information	23

Item 6.	Exhibits	23

Signatures		24

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

NeuroMetrix, Inc.

Balance Sheets

(Unaudited)

	September 30, 2015			December 31, 2014

Assets
Current assets:
Cash and cash equivalents	$	9,116,806		$	9,221,985
Accounts receivable, net		901,895			580,240
Inventories		1,072,162			679,740
Prepaid expenses and other current assets		878,533			608,160
Total current assets		11,969,396			11,090,125

Fixed assets, net		745,133			311,520
Other long-term assets		214,275			585
Total assets	$	12,928,804		$	11,402,230

Liabilities and Stockholders’ Equity
Current liabilities:

Accounts payable	$	946,146		$	522,871
Accrued compensation		766,557			885,353
Accrued expenses		1,132,863			1,264,876
Current portion of deferred revenue		692,244			25,048
Total current liabilities		3,537,810			2,698,148

Deferred revenue, net of current portion		10,433			9,635
Common stock warrants		890,105			5,307,332
Total liabilities		4,438,348			8,015,115

Commitments and contingencies (Note 6)

Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized at September 30, 2015 and December 31, 2014; no shares issued and outstanding at September 30, 2015 and December 31, 2014		—			—
Series A convertible preferred stock, 11,083 shares designated at September 30, 2015 and December 31, 2014, and zero and 3,614.357 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively		—			4
Series B convertible preferred stock, 147,000 and zero shares designated at September 30, 2015 and December 31, 2014, respectively, and 94,146 and zero shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively		94			—
Common stock, $0.0001 par value; 50,000,000 shares authorized; 13,785,239 and 8,152,746 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively		1,379			815
Additional paid-in capital		169,345,497			157,764,598
Accumulated deficit		(160,856,514	)		(154,378,302	)
Total stockholders’ equity		8,490,456			3,387,115
Total liabilities and stockholders’ equity	$	12,928,804		$	11,402,230

The accompanying notes are an integral part of these interim financial statements.

NeuroMetrix, Inc.

Statements of Operations

(Unaudited)

	Quarters Ended September 30,						Nine months Ended September 30,
	2015			2014			2015			2014

Revenues	$	2,054,432		$	1,427,828		$	4,562,379		$	4,103,135

Cost of revenues		1,119,186			639,025			2,351,479			1,909,443

Gross profit		935,246			788,803			2,210,900			2,193,692

Operating expenses:
Research and development		940,794			945,349			2,825,589			3,273,900
Sales and marketing		1,965,627			537,785			5,183,595			1,678,665
General and administrative		1,386,170			1,310,012			4,157,082			3,605,047

Total operating expenses		4,292,591			2,793,146			12,166,266			8,557,612

Loss from operations		(3,357,345	)		(2,004,343	)		(9,955,366	)		(6,363,920	)

Interest income		1,761			1,336			3,350			3,362
Warrants offering costs		—			(23,256	)		—			(50,874	)
Change in fair value of warrant liability		151,806			564,550			3,473,804			1,554,411

Net loss	$	(3,203,778	)	$	(1,461,713	)	$	(6,478,212	)	$	(4,857,021	)

Net loss per common share applicable to common stockholders, basic and diluted (See Note 3, Net Loss per Common Share)	$	(0.26	)	$	(0.19	)	$	(1.02	)	$	(1.18	)
Weighted average number of common shares outstanding, basic and diluted		12,133,984			7,853,292			9,879,905			6,602,626

The accompanying notes are an integral part of these interim financial statements.

NeuroMetrix, Inc.

Statements of Cash Flows

(Unaudited)

	Nine months Ended September 30,
	2015			2014
Cash flows from operating activities:
Net loss	$	(6,478,212	)	$	(4,857,021	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		160,993			103,250
Stock-based compensation		246,406			208,358
Warrant offering cost		—			50,874
Change in fair value of warrant liability		(3,473,804	)		(1,554,411	)
Changes in operating assets and liabilities:
Accounts receivable		(321,655	)		(220,868	)
Inventories		(392,422	)		(67,200	)
Prepaid expenses and other current and long-term assets		(484,063	)		(26,476	)
Accounts payable		423,275			199,818
Accrued expenses and compensation		30,948			841,317
Deferred revenue		667,994			(32,570	)
Net cash used in operating activities		(9,620,540	)		(5,354,929	)

Cash flows from investing activities:
Purchases of fixed assets		(594,606	)		(71,982	)
Net cash used in investing activities		(594,606	)		(71,982	)

Cash flows from financing activities:
Net proceeds from issuance of stock and warrants		13,316,324			7,918,179
Repurchase of Series A-4 preferred stock and warrants		(3,206,357	)		—
Net cash provided by financing activities		10,109,967			7,918,179

Net (decrease) increase in cash and cash equivalents		(105,179	)		2,491,268
Cash and cash equivalents, beginning of period		9,221,985			9,195,753
Cash and cash equivalents, end of period	$	9,116,806		$	11,687,021
Supplemental disclosure of cash flow information:
Common stock issued to settle employee incentive compensation obligation	$	281,757		$	104,405
Warrants issued under Securities Purchase Agreement recorded as a non-current liability	$	—		$	4,418,824

The accompanying notes are an integral part of these interim financial statements.

NeuroMetrix, Inc.

Notes to Unaudited Financial Statements

September 30, 2015

Business and Basis of Presentation

Our Business-An Overview

NeuroMetrix, Inc., or the Company, a Delaware corporation, was founded in June 1996. The Company develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The Company markets Quell^®and SENSUS^® which are wearable therapeutic devices designed for relief of chronic, intractable pain. Quell was commercially launched in the United States during the second quarter of 2015. The Company also markets DPNCheck^®, which is a quantitative nerve conduction test that is used by physicians and health care professionals to evaluate systemic neuropathies such as diabetic peripheral neuropathy, or DPN. The Company’s historical neurodiagnostic business is based on the ADVANCE^TM System which is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures and which is primarily used in physician offices and clinics.

The accompanying financial statements have been prepared on a basis which assumes that the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The Company has suffered recurring losses from operations and negative cash flows from operating activities. The Company held cash and cash equivalents of $9.1 million as of September 30, 2015. The Company believes that these resources and the cash to be generated from expected product sales will be sufficient to meet its projected operating requirements into the second quarter of 2016. The Company continues to face significant challenges and uncertainties and, as a result, the Company’s available capital resources may be consumed more rapidly than currently expected due to (a) decreases in sales of the Company’s products and the uncertainty of future revenues from new products; (b) changes the Company may make to the business that affect ongoing operating expenses; (c) changes the Company may make in its business strategy; (d) regulatory developments affecting the Company’s existing products and delays in the FDA approval process for products under development; (e) changes the Company may make in its research and development spending plans; and (f) other items affecting the Company’s forecasted level of expenditures and use of cash resources. Accordingly, the Company will need to raise additional funds to support its operating and capital needs in the second quarter of 2016 and beyond. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company intends to obtain additional funding through public or private financing, collaborative arrangements with strategic partners, or through additional credit lines or other debt financing sources to increase the funds available to fund operations. However, the Company may not be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity or debt securities to raise additional funds, its existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of the Company’s existing stockholders. If the Company raises additional funds through collaboration, licensing or other similar arrangements, it may be necessary to relinquish valuable rights to its potential products or proprietary technologies, or grant licenses on terms that are not favorable to the Company. Without additional funds, the Company may be forced to delay, scale back or eliminate some of its sales and marketing efforts, research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue its operations. If any of these events occurs, the Company’s ability to achieve its development and commercialization goals would be adversely affected.

Unaudited Interim Financial Statements

The accompanying unaudited balance sheet as of September 30, 2015, unaudited statements of operations for the quarters and nine months ended September 30, 2015 and 2014 and the unaudited statements of cash flows for the nine months ended September 30, 2015 and 2014 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the financial statements include all normal and recurring adjustments considered necessary for a fair statement of the Company’s financial position and operating results. Operating results for the quarter ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other period. These financial statements and notes should be read in conjunction with the financial statements for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, or the SEC, on February 25, 2015 (File No. 001-33351), or the Company’s 2014 Form 10-K. The accompanying balance sheet as of December 31, 2014 has been derived from audited financial statements prepared at that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

Revenues

The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists, delivery has occurred and risk of loss has passed, the seller’s price to the buyer is fixed or determinable, and collection is reasonably assured.

Revenues associated with the Company’s medical devices and consumables, including single use nerve specific electrodes and other accessories are generally recognized upon shipment, assuming all other revenue criteria have been met. For the Company’s newest product, Quell, launched in June 2015, there was insufficient data available at September 30, 2015 to reasonably estimate product returns. Accordingly, approximately $680,000 of Quell revenue and approximately $425,000 of costs of Quell revenue have been deferred until sufficient product return history has been obtained or the right of return has lapsed. Deferred costs of Quell revenue have been recorded in prepaid expenses and other current assets on the balance sheet.

Revenue recognition involves judgments, including assessments of expected returns and expected customer relationship periods. The Company analyzes various factors, including a review of specific transactions, its historical returns, average customer relationship periods, customer usage, customer balances, and market and economic conditions. Changes in judgments or estimates on these factors could materially impact the timing and amount of revenues and costs recognized. Should market or economic conditions deteriorate, the Company’s actual return or bad debt experience could exceed its estimate.

Product sales are made with a specified right of return ranging from 30 to 60 days. Since the Company can reasonably estimate future returns for products other than Quell, it recognizes revenues associated with such product sales that contain a right of return upon shipment and at the same time it records a sales return reserve, which reduces revenue and accounts receivable by the amount of estimated returns.

One customer accounted for 11% and 16% of total revenues during the quarter and nine months ended September 30, 2015, respectively. Two customers accounted for a combined 51% of gross accounts receivables as of September 30, 2015. In comparison, during the quarter and nine months ended September 30, 2014, two customers accounted for a combined 31% and 22% of total revenue, respectively. At December 31, 2014, one customer accounted for 30% of accounts receivables.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.

Recent Accounting Pronouncements

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (ASU 2014-15). ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016, with early adoption permitted. We are currently evaluating the provisions of ASU 2014-15 and assessing the impact, if any, it may have on our financial position, results of operations or cash flows.

In May 2014, the FASB and the International Accounting Standards Board ("IASB") jointly issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance. The objective of ASU 2014-09 is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is effective for public entities for annual and interim periods beginning after December 15, 2017. An entity can elect to adopt ASU 2014-09 using one of two methods, either full retrospective adoption to each prior reporting period, or recognizing the cumulative effect of adoption at the date of initial application. The Company is in the process of evaluating the new standard and does not know the effect, if any, ASU 2014-09 will have on the Consolidated Financial Statements or which adoption method will be used.

Comprehensive Loss

For the quarters and nine months ended September 30, 2015 and 2014, the Company had no components of other comprehensive income or loss other than net loss itself.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic net income per share. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period plus the dilutive effect of the weighted average number of outstanding instruments such as options, warrants, and restricted stock. Because the Company has reported a net loss for all periods presented, diluted loss per common share is the same as basic loss per common share, as the effect of utilizing the fully diluted share count would have reduced the net loss per common share. Therefore, in calculating net loss per share amounts, shares underlying the following potentially weighted average dilutive number of common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive for each of the periods presented:

	Quarters Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Options		867,135		576,746		822,769		406,540
Warrants		18,889,103		4,978,892		11,771,953		2,436,336
Unvested restricted stock		—		15,493		405		16,512
Convertible preferred stock		10,923,802		1,971,744		6,777,980		693,361
Total		30,680,040		7,542,875		19,373,107		3,552,749

The Beneficial Conversion Feature, or BCF, recorded in both the 2015 Offering and 2014 Offering was recognized as a deemed dividend attributable to the Preferred Stock and is reflected as an adjustment in the calculation of earnings per share. In May 2015, a BCF was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature, and is reflected as an adjustment in the calculation of earnings per share. See Note 9, Stockholders’ Equity, for further details.

	Quarters Ended September 30,						Nine months Ended September 30,
	2015			2014			2015			2014
Net loss	$	(3,203,778	)	$	(1,461,713	)	$	(6,478,212	)	$	(4,857,021	)
Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features		—			—			(4,140,446	)		(2,955,668	)
Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature		—			—			589,751			—
Net loss applicable to common stockholders	$	(3,203,778	)	$	(1,461,713	)	$	(10,028,907	)	$	(7,812,689	)
Net loss per common share applicable to common stockholders, basic and diluted	$	(0.26	)	$	(0.19	)	$	(1.02	)	$	(1.18	)
Weighted average number of common shares outstanding, basic and diluted		12,133,984			7,853,292			9,879,905			6,602,626

Inventories

Inventories consist of the following:

	September 30, 2015		December 31, 2014

Purchased components	$	502,952	$	209,426
Finished goods		569,210		470,314
	$	1,072,162	$	679,740

Included in finished goods is $64,477 and zero of consigned inventory held by a third party as of September 30, 2015 and December 31, 2014, respectively.

Accrued Compensation and Expenses

The following table provides a rollforward of the liability balance for severance obligations which was recorded as research and development expense in the Company’s Statement of Operations for the year ended December 31, 2014. The severance obligations were fully paid as of June 30, 2015.

	September 30, 2015
Balance - beginning	$	148,921
Accrual for severance		—
Severance payments made		(148,921	)
Balance - ending	$	—

Accrued expenses consist of the following:

	September 30, 2015		December 31, 2014

Technology fees	$	450,000	$	450,000
Professional services		229,189		257,024
Sales taxes		122,901		34,206
Consulting fees		67,200		173,759
Personnel related obligations		64,543		37,761
Clinical study obligations		34,085		74,000
Federal excise tax		26,289		25,989
Other		138,656		212,137
	$	1,132,863	$	1,264,876

Commitments and Contingencies

Operating Lease

In August 2014, the Company entered into a 5-year operating lease agreement with one 5-year extension option for manufacturing and order fulfillment facilities in Woburn, Massachusetts (the “Woburn Lease”). The Woburn Lease commenced December 15, 2014 and has a monthly base rent of $7,350. In September 2014, the Company entered into a 7-year operating lease agreement with one 5-year extension option for its corporate office and product development activities in Waltham, Massachusetts (the “Waltham Lease”). The term of the Waltham Lease commenced on February 20, 2015 and includes fixed payment obligations that escalate over the initial lease term. Average monthly base rent under the 7-year lease is approximately $37,792. These payment obligations were accrued and recognized over the term of occupancy. Under the Waltham Lease, the landlord was responsible for making certain improvements to the leased space at an agreed upon cost to the landlord. Total costs for the landlord improvements exceeded the agreed upon cost by $275,000. The landlord billed that excess cost to the Company as additional rent, which has been included in other long term assets at September 30, 2015. This additional rent has been included in the net calculation of lease payments, so that rent expense is recognized on a straight-line basis over the term of occupancy.

Fair Value Measurements

The Fair Value Measurements and Disclosures Topic of the Codification defines fair value, establishes a framework for measuring fair value in applying generally accepted accounting principles, and expands disclosures about fair value measurements. This Codification topic identifies two kinds of inputs that are used to determine the fair value of assets and liabilities: observable and unobservable. Observable inputs are based on market data or independent sources while unobservable inputs are based on the Company’s own market assumptions. Once inputs have been characterized, this Codification topic requires companies to prioritize the inputs used to measure fair value into one of three broad levels. Fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values identified by Level 2 inputs utilize observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. Fair values identified by Level 3 inputs are unobservable data points and are used to measure fair value to the extent that observable inputs are not available. Unobservable inputs reflect the Company’s own assumptions about the assumptions that market participants would use at pricing the asset or liability.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis for the periods presented and indicates the fair value hierarchy of the valuation techniques it utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

			Fair Value Measurements at September 30, 2015 Using
	September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	5,028,053	$	5,028,053	$	—	$	—
Total	$	5,028,053	$	5,028,053	$	—		—

Liabilities:
Common stock warrants	$	890,105	$	—	$	—	$	890,105
Total	$	890,105	$	—	$	—	$	890,105

Due to the lack of market quotes relating to our common stock warrants issued in the 2014 Offering and a 2013 financing (see Note 9), the fair value of the common stock warrants was determined at September 30, 2015 using the Black-Scholes model, which is based on Level 3 inputs. As of September 30, 2015, inputs used in the Black-Scholes model are presented below. The assumptions used may change as the underlying sources of these assumptions and market conditions change. Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $0.9 million at September 30, 2015. In May 2015, 1,571,744 warrants were repurchased by the Company. These warrants were adjusted to their fair value of $943,423 at the date of repurchase.

	Black-Scholes Inputs to Warrant Liability Valuation at September 30, 2015
Warrants:	Stock Price		Exercise Price		Expected Volatility			Risk-Free Interest			Expected Term	Dividends
2014 Offering	$	0.88	$	2.04		72.03	%		1.09	%	3yr 9mo	none
2013 Offering	$	0.88	$	2.00		72.80	%		0.82	%	2yr 8mo	none

The following table provides a summary of changes in the fair value of the Company’s Level 3 financial liabilities between December 31, 2014 and September 30, 2015.

	2014 Offering			2013 Offering			Total
Balance at December 31, 2014	$	4,233,729		$	1,073,603		$	5,307,332
Repurchase of warrants in conjunction with public offering		(943,423	)		—			(943,423	)
Change in fair value of warrant liability		(2,625,305	)		(848,499	)		(3,473,804	)
Balance at September 30, 2015	$	665,001		$	225,104		$	890,105

			Fair Value Measurements at December 31, 2014 Using
	December 31, 2014		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	4,107,478	$	4,107,478	$	—	$	—
Total	$	4,107,478	$	4,107,478	$	—	$	—

Liabilities:
Common stock warrants	$	5,307,332	$	—	$	—	$	5,307,332
Total	$	5,307,332	$	—	$	—	$	5,307,332

Due to the lack of market quotes relating to our common stock warrants then outstanding, the fair value of the common stock warrants was determined at December 31, 2014 using the Black-Scholes model, which is based on Level 3 inputs. As of December 31, 2014, inputs used in the Black-Scholes model are presented below. The assumptions used may change as the underlying sources of these assumptions and market conditions change. Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $5.3 million at December 31, 2014.

	Black-Scholes Inputs to Warrant Liability Valuation at December 31, 2014
Warrants:	Stock Price		Exercise Price		Expected Volatility			Risk-Free Interest			Expected Term	Dividends
2014 Offering	$	1.95	$	2.04		71.11	%		1.51	%	4yr 6mo	none
2013 Offering	$	1.95	$	2.00		75.71	%		1.24	%	3yr 5mo	none

Credit Facility

The Company is party to a Loan and Security Agreement, or the Credit Facility, with a bank. As of September 30, 2015 the Credit Facility permitted the Company to borrow up to $2.5 million on a revolving basis. The Credit Facility was amended on January 23, 2015 and expires on January 15, 2016. Amounts borrowed under the Credit Facility will bear interest equal to the prime rate plus 0.5%. Any borrowings under the Credit Facility will be collateralized by the Company’s cash, accounts receivable, inventory, and equipment. The Credit Facility includes traditional lending and reporting covenants. As of September 30, 2015, the Company was in compliance with these covenants and had not borrowed any funds under the Credit Facility. However, $226,731 of the amount available under the Credit Facility is restricted to support letters of credit issued in favor of the Company’s landlords for its premises leased in September 2014 for its corporate offices. Consequently, the amount available for borrowing under the Credit Facility as of September 30, 2015 was $2.3 million.

Stockholders’ Equity

Public Offerings of Common Stock and Warrants

In May 2015, the Company completed an underwritten public offering (the “2015 Offering”) of (i) 147,000 shares of Series B Preferred Stock (the “Series B Preferred Stock”) at a price of $100 per share, and (ii) five year warrants to purchase up to 14,553,000 shares of common stock with an exercise price of $1.25 per share. The 2015 Offering resulted in approximately $14.7 million in gross proceeds, before deducting underwriting discounts and commission and expenses. In conjunction with the 2015 Offering, approximately $3.2 million of the proceeds were used to repurchase the outstanding Series A-4 preferred shares from the 2014 Offering (described below). Net proceeds from the 2015 Offering, after deducting underwriting discount and commissions and offering expenses and repurchase of outstanding Series A-4 preferred shares, were approximately $10.1 million.

Each share of Series B Preferred Stock had a stated value of $100 and is convertible at the option of the holder into the number of shares of common stock determined by dividing the stated value by the conversion price of $1.0101, which is subject to adjustment as provided in the Certificate of Designation for the Series B Preferred Stock. The Series B Preferred Stock has no dividend rights, liquidation preference or other preferences over common stock and has no voting rights except as provided in the Certificate of Designation for the Series B Preferred Stock and as required by law.

The Series B Preferred Stock is convertible into an aggregate of 14,553,000 shares of common stock. During the second quarter of 2015, 24,684 shares of the Series B Preferred Stock were converted into a total of 2,443,716 shares of common stock. During the third quarter of 2015, 28,170 shares of the Series B Preferred Stock were converted into a total of 2,788,830 shares of common stock. As of September 30, 2015, 94,146 shares of the Series B Preferred Stock were outstanding.

The terms and conditions of the Series B Preferred Stock were evaluated based on the guidance of the Derivatives and Hedging topic of the Codification to determine if the conversion feature was an embedded derivative requiring bifurcation. It was concluded that bifurcation was not required because the conversion feature was clearly and closely related to the Series B Preferred Stock. The conversion price at which shares of Series B Preferred Stock were convertible into shares of common stock was determined to be lower than the fair value of common stock at the date of entering into the agreement with the underwriter. This “in-the-money” beneficial conversion feature, or BCF, required separate recognition and measurement of its intrinsic value (i.e., the amount of the increase in value that holders of Series B Preferred Stock would realize upon conversion based on the value of the conversion shares on the date of the underwriting agreement). Because there was not a stated redemption date for the shares of Series B Preferred Stock, the BCF was recognized as a deemed dividend attributable to the Series B Preferred Stock and reflected as an adjustment in the calculation of earnings per share. The amount of the BCF totaled $4,140,446 for the 2015 Offering.

The Company determined that equity classification was appropriate for the warrants in the 2015 Offering following guidance in the Derivatives and Hedging topic of the Codification. In making this equity classification determination, the Company noted the warrants had no requirements to be settled in registered shares when exercised, and the Company is not required to pay cash in the event it does not make timely filings with the SEC. The fair value of the warrants issued in connection with the 2015 Offering was estimated to be $3.2 million on the offering date using utilizing quoted prices (unadjusted) in active markets. The relative fair value was recorded as equity.

In June 2014, the Company entered into a securities purchase agreement (the “2014 Offering”) for the issuance of (i) 664,600 shares of common stock at a price of $2.04 per share, (ii) 2,621.859 shares of Series A-3 Preferred Stock (the “Series A-3 Preferred Stock”) at a price of $1,000 per share, (iii) 4,022.357 shares of Series A-4 Preferred Stock (the “Series A-4 Preferred Stock,” and together with the Series A-3 Preferred Stock, the “Preferred Stock”) at a price of $1,000 per share, and (iv) five year warrants to purchase up to 3,921,569 shares of common stock with an exercise price of $2.04 per share. The 2014 Offering resulted in approximately $8.0 million in gross proceeds, before deducting expenses. Net proceeds from the 2014 Offering were approximately $7.9 million.

In the 2014 Offering, each share of Preferred Stock had a stated value of $1,000 and was convertible at the option of the holder into the number of shares of common stock determined by dividing the stated value by the conversion price of $2.04, which is subject to adjustment as provided in each applicable Certificate of Designation for the Preferred Stock. The Preferred Stock had no dividend rights, liquidation preference or other preferences over common stock and had no voting rights except as provided in each applicable Certificate of Designation for the Preferred Stock and as required by law. The 2014 Offering BCF measurement was limited by the transaction proceeds which had been allocated to the Preferred Stock. The BCF was recognized as a deemed dividend attributable to the Preferred Stock and reflected as an adjustment in the calculation of earnings per share in the quarter ended September 30, 2014. The amount of the BCF totaled $2,955,668 for the 2014 Offering.

The Series A-3 Preferred Stock was convertible into an aggregate of 1,285,225 shares of common stock and the Series A-4 Preferred Stock was convertible into an aggregate of 1,971,744 shares of common stock. During June 2014, 204 shares of the Series A-3 Preferred Stock were converted into a total of 100,000 shares of common stock. During July 2014, the remaining 2,417.859 shares of the Series A-3 Preferred Stock were converted into 1,185,225 shares of common stock. During October 2014, 408 shares of the Series A-4 Preferred Stock were converted into a total of 200,000 shares of common stock. During February 2015, 408 shares of the Series A-4 Preferred Stock were converted into a total of 200,000 shares of common stock. During May 2015, the remaining 3,206.357 shares of the Series A-4 Preferred Stock were repurchased by the Company at a price of $1,000 per share. Total consideration of $3.2 million for the repurchase of the Series A-4 convertible preferred stock and warrants was allocated to the convertible preferred stock and warrants based on their relative fair value. A BCF totalling $589,751 was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature. This BCF was reflected as an adjustment in the calculation of earnings per share in the quarter ended June 30, 2015.

The Company continues to revalue unexercised warrants from the 2014 Offering at each reporting period over the life of the warrants using the Black-Scholes model and the changes in the fair value of the warrants were recognized in the Company's statement of operations. The warrants issued in connection with the 2014 Offering were within the scope of the Derivatives and Hedging topic of the Codification. This Codification topic requires issuers to classify as liabilities (or assets under certain circumstances) financial instruments which require an issuer to settle in registered shares. As the warrants are required to be settled in registered shares when exercised, and since the Company is required to pay cash in the event it does not make timely filings with the SEC, the Company reflected the warrants as a liability in the balance sheet.

The fair value of the warrants issued in connection with the 2014 Offering was estimated to be $4.4 million on the offering date using a Black-Scholes model with the following assumptions: stock price of $2.00, exercise price of $2.04, expected volatility of 67.48%, risk free interest rate of 1.64%, expected term of five years, and no dividends. At September 30, 2015 2,349,825 warrants remain outstanding. They were revalued at September 30, 2015 in the amount of $0.7 million using the Black-Scholes model (see Note 7) and the liability was reflected in the September 30, 2015 balance sheet. The Company also continues to revalue warrants from its 2013 offering. At September 30, 2015, 1,057,323 warrants from its 2013 offering remain outstanding. They were revalued at September 30, 2015 in the amount of $0.2 million using the Black-Scholes model (see Note 7) and the liability was reflected in the September 30, 2015 balance sheet.

In 2015 and 2014, the Company issued shares of fully vested common stock in partial settlement of management incentive compensation. In March 2015, the Company issued an aggregate of 166,405 shares of fully vested common stock with a value of $281,700 in partial settlement of 2014 management incentive compensation. The shares issued reflected the $1.69 closing price of the Company’s common stock as reported on the NASDAQ Capital Market on March 12, 2015. The 2014 issuance to settle the 2013 management incentive compensation totaled 42,615 shares with a value of $104,405 reflecting the $2.45 NASDAQ Capital Market closing price on February 25, 2014.

Total compensation cost related to nonvested awards not yet recognized at September 30, 2015 was $346,000. The total compensation cost is expected to be recognized over a weighted-average period of 2.3 years.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of our financial condition and results of operations in conjunction with our financial statements and the accompanying notes to those financial statements included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. For a description of factors that may cause our actual results to differ materially from those anticipated in these forward-looking statements, please refer to the below section of this Quarterly Report on Form 10-Q titled “Cautionary Note Regarding Forward-Looking Statements.” Unless the context otherwise requires, all references to “we”, “us”, the “Company”, or “NeuroMetrix” in this Quarterly Report on Form 10-Q refer to NeuroMetrix, Inc.

Overview

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. Our business is fully integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. We derive revenues from the sale of medical devices and after-market consumable products and accessories. Our products are sold in the United States and selected overseas markets, and are cleared by the U.S. Food and Drug Administration, or FDA, and regulators in foreign jurisdictions where appropriate. We have two principal product lines:

· Wearable neuro-stimulation therapeutic devices

· Point-of-care neuropathy diagnostic tests

Our core expertise in biomedical engineering has been refined over nearly two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. We created the market for point-of-care nerve testing and were first to market with sophisticated, wearable technology for management of chronic pain. We have an experienced management team and Board of Directors.

Chronic pain is a significant public health problem. It is defined by the National Institutes of Health as any pain lasting more than 12 weeks in contrast to acute pain which is a normal bodily response to injury or trauma. Chronic pain conditions include painful diabetic neuropathy, or PDN, arthritis, fibromyalgia, sciatica, musculoskeletal pain, cancer pain and many others. Chronic pain may be triggered by an injury or there may be an ongoing cause such as disease or illness. There may also be no clear cause. Pain signals continue to be transmitted in the nervous system over extended periods of time often leading to other health problems. These can include fatigue, sleep disturbance, decreased appetite, and mood changes which cause difficulty in carrying out important activities and contributing to disability and despair. In general, chronic pain cannot be cured. Treatment of chronic pain is focused on reducing pain and improving function. The goal is effective pain management.

Chronic pain is widespread. It affects over 100 million adults in the United States and more than 1.5 billion people worldwide. The global market for pain management drugs and devices alone was valued at $35 billion in 2012. The estimated incremental impact of chronic pain on health care costs in the United States is over $250 billion per year and lost productivity is estimated to exceed $300 billion per year.

The most common approach to chronic pain is pain medication. This includes over-the-counter drugs (such as Advil and Motrin), and prescription drugs including anti-convulsants (such as Lyrica and Neurontin) and anti-depressants (such as Cymbalta and Elavil). Topical creams may also be used (such as Zostrix and Bengay). With severe pain, narcotic pain medications may be prescribed (such as codeine, fentanyl, morphine, and oxycodone). The approach to treatment is individualized, drug combinations may be employed, and the results are often hit or miss. Side effects and the potential for addiction are real and the risks are substantial.

Reflecting the difficulty in treating chronic pain, we believe that inadequate relief leads 25 to 50% of pain sufferers to turn to the over-the-counter market for supplements or alternatives to prescription pain medications. These include non-prescription medications, topical creams, lotions, electrical stimulators, dietary products, braces, sleeves, pads and other items. In total they account for over $4 billion in annual spending in the United States on pain relief products.

High frequency nerve stimulation is an established treatment for chronic pain supported by numerous clinical studies demonstrating efficacy. In simplified outline, the mechanism of action involves intensive nerve stimulation to activate the body’s central pain inhibition system resulting in widespread analgesia, or pain relief. The nerve stimulation activates brainstem pain centers leading to the release of endogenous opioids that act primarily through the delta opioid receptor to reduce pain signal transmission through the central nervous system. This therapeutic approach is available through deep brain stimulation and through implantable spinal cord stimulation, both of which require surgery and have attendant risks. Non-invasive approaches to neuro-stimulation (transcutaneous electrical nerve stimulation, or TENS) have achieved limited efficacy in practice due to device limitations, ineffective dosing and low patient compliance.

Quell, our OTC wearable device for pain relief, was unveiled at the January 2015 Consumer Electronics Show (CES) and made commercially available in the United States during the second quarter of 2015. Following commercial launch through the end of the third quarter of 2015, approximately 7,000 Quell devices plus electrodes and accessories were shipped to consumers with a total invoiced value of $1.6 million. Quell utilizes OptiTherapy™, our proprietary non-invasive neuro-stimulation technology to provide relief from chronic intractable pain, such as nerve pain due to diabetes, fibromyalgia, arthritic pain, and lower back and leg pain. This advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic intractable pain without a doctor’s prescription. Users of the device have the option of using their smartphones to automatically track and personalize their pain therapy. Quell was launched through two distribution channels: a professional channel using a direct sales force to target podiatrists, pain physicians, primary care physicians, and chiropractors who resell the product, and a direct-to-consumer channel using online marketing and lead generation. After establishing the professional and direct to consumer channels, we expanded distribution to include Amazon e-commerce sales and QVC direct response TV, or DRTV, sales. We are developing other distribution channels for broader access to the retail markets. We believe there are significant opportunities to market Quell outside of the United States, particularly in Western Europe, Japan and China; however, we do not intend to approach those markets until we have established a solid presence in the United States.

DPNCheck, our diagnostic test for peripheral neuropathies, was made commercially available in the fourth quarter of 2011. DPNCheck revenues for 2014 and 2013 were approximately $1.8 million and $1.3 million, respectively. Our U.S. sales efforts focus on Medicare Advantage providers who assume financial responsibility and the associated risks for the health care costs of their patients. We believe that DPNCheck presents an attractive clinical case with early detection of neuropathy allowing for earlier clinical intervention to help mitigate the effects of neuropathy on both patient quality of life and cost of care. Also, the diagnosis and documentation of neuropathy provided by DPNCheck helps clarify the patient health profile which, in turn, may have a direct, positive effect on the Medicare Advantage premium received by the provider. We believe that attractive opportunities exist outside the United States, including Japan where we received regulatory approval and launched DPNCheck with our distribution partner Omron Healthcare in the third quarter of 2014; in China where we are also working with Omron Healthcare on the regulatory process and anticipate commercial launch in 2016; and in Mexico where our distributor Scienta Farma received regulatory approval and plans to launch in late-2015 or early 2016.

Our products consist of a medical device used in conjunction with a consumable electrode or biosensor. Other accessories and consumables are also available to customers. Our goal for these devices is to build an installed base of active customer accounts and distributors that regularly order aftermarket products to meet their needs. We successfully implemented this model when we started our business with the NC-stat system and applied it to subsequent product generations including ADVANCE. Our recent products, Quell, SENSUS and DPNCheck, conform to this model. Other products in our development pipeline are based on the device plus consumables business model.

Results of Operations

Comparison of Quarters Ended September 30, 2015 and 2014

Revenues

The following table summarizes our revenues:

	Quarters Ended September 30,
	2015		2014		Change		% Change
	(in thousands)
Revenues	$	2,054.4	$	1,427.8	$	626.6		43.9	%

Revenues include sales from Quell and SENSUS, our wearable therapeutic devices for relief of chronic intractable pain; DPNCheck, our diagnostic test for diabetic peripheral neuropathy, or DPN; and our legacy ADVANCE neurodiagnostics business.

During the third quarter of 2015, our first full quarter following the commercial launch of Quell, we shipped approximately 4,500 Quell devices and 5,500 electrode packs with a total invoiced value of approximately $985,000. During the third quarter of 2015, we recognized approximately $767,000 of revenue related to Quell shipments. As of September 30, 2015, we have recorded $680,000 to deferred revenue. Deferred revenue on Quell shipments will be recorded within revenue as customer rights of return expire or we develop sufficient return experience to reasonably estimate return rates. SENSUS, our prescription wearable device, posted shipments of about 465 devices and 3,800 electrode packs with total revenue of approximately $97,000. This is in comparison with approximately 950 SENSUS devices and 4,700 electrode packs and total revenue of approximately $164,000 in the third quarter in 2014. The decline in SENSUS revenue reflects pricing pressure of the durable medical equipment distribution channel from the Medicare competitive bidding initiative, as well as sales encroachment from our own launch of Quell. There were approximately 255 DPNCheck devices plus 39,500 electrodes shipped in the third quarter of 2015 with revenue of approximately $621,000 compared to approximately 335 DPN devices and 35,800 electrodes with approximately $611,000 in revenue in the third quarter in 2014. Revenues also include sales from our ADVANCE neurodiagnostic products totaling $570,000 in the third quarter of 2015, compared to $653,000 in the third quarter of 2014.

Cost of Revenues and Gross Profit

The following table summarizes our cost of revenues and gross profit:

	Quarters Ended September 30,
	2015		2014		Change		% Change
	(in thousands)
Cost of revenues	$	1,119.2	$	639.0	$	480.2		75.1	%

Gross profit	$	935.2	$	788.8	$	146.4		18.6	%

Our cost of revenues increased to $1,119,200 in the third quarter of 2015, compared to $639,000 in the third quarter of 2014, primarily due to the increase in shipment volumes and revenues during the comparable periods. Gross margin decreased to 45.5% in the third quarter of 2015 compared to 55.2% in the third quarter of 2014. The contraction in gross margin reflected the introduction of our new product Quell and our efforts to build a Quell installed base of customers who will purchase electrodes in the future. Early Quell sales are weighted more heavily to lower margin devices and, as the product line matures, we expect that the weighting of sales will shift toward higher margin electrodes.

Operating Expenses

The following table presents a breakdown of our operating expenses:

	Quarters Ended September 30,
	2015		2014		Change			% Change
	(in thousands)
Operating expenses:
Research and development	$	940.8	$	945.3	$	(4.5	)		(0.5	)%
Sales and marketing		1,965.6		537.8		1,427.8			265.5	%
General and administrative		1,386.2		1,310.0		76.2			5.8	%
Total operating expenses	$	4,292.6	$	2,793.1	$	1,499.5			53.7	%

Research and Development

Research and development expenses were consistent for the quarters ended September 30, 2015 and 2014 at $940,800 and $945,300, respectively.

Sales and Marketing

Sales and marketing expenses increased to $1,965,600 for the quarter ended September 30, 2015 from $537,800 for the quarter ended September 30, 2014. The increase of $1,427,800 included incremental advertising and marketing costs of approximately $665,000 to support the Quell launch with a strong investment in direct-to-consumer and physician online advertising, paid search, market research and public relations expenses. An increase of $432,000 versus the same quarter last year is attributed to the addition of 12 new employees hired specifically to support the commercialization of Quell, which included a new marketing team, a field sales force, and expansion of the customer care function.

General and Administrative

General and administrative expenses increased by $76,200 to $1,386,200 for the quarter ended September 30, 2015 compared to the prior year quarter. This increase was attributable to an increase of $105,000 in consulting services related to information technology and temporary support services.

Interest Income

Interest income was approximately $1,800 and $1,300 during the quarter ended September 30, 2015 and 2014, respectively. Interest income was earned from investments in cash equivalents.

Change in fair value of warrant liability

The change in fair value of warrant liability of $151,800 relates to the revaluation of warrants from $1,041,900 at June 30, 2015 to $890,100 at September 30, 2015. The lower fair value at September 30, 2015 reflects our lower stock price at September 30, 2015 compared to June 30, 2015, as well as the shorter remaining term of the warrants. The change in the fair value of the warrant liability in the third quarter of 2014 was $564,600.

Comparison of Nine Months Ended September 30, 2015 and 2014

Revenues

The following table summarizes our revenues:

	Nine Months Ended September 30,
	2015		2014		Change		% Change
	(in thousands)
Revenues	$	4,562.4	$	4,103.1	$	459.3		11.2	%

During the nine months ended September 30, 2015 we shipped approximately 7,100 Quell devices and 8,100 electrode packs with a total invoiced value of approximately $1,587,000. During the nine months ended September 30, 2015, we recognized approximately $791,000 of revenue related to Quell shipments. As of September 30, 2015, we have recorded $680,000 to deferred revenue.. Deferred revenue on Quell shipments will be recorded within revenue as customer rights of return expire or we develop sufficient return experience to reasonably estimate return rates. SENSUS, our prescription wearable device, posted shipments of about 2,100 devices and 15,200 electrode packs with total revenue of approximately $422,000. This is in comparison with approximately 4,100 SENSUS devices and 11,300 electrode packs and total revenue of approximately $615,000 in the same period in 2014. The decline in SENSUS revenue reflects pricing pressure of the durable medical equipment distribution channel from the Medicare competitive bidding initiative, as well as sales encroachment from our own launch of Quell. There were approximately 480 DPNCheck devices plus 104,700 electrodes shipped in the nine months ended September 30, 2015 with revenue of approximately $1,541,000 compared to approximately 440 DPN devices and 781,200 electrodes with approximately $1,249,000 in revenue in the same period of 2014. Revenues also include sales from our ADVANCE neurodiagnostic products totaling $1,809,000 in the nine months ended September 30, 2015, compared to $2,240,000 in the same period of 2014.

Cost of Revenues and Gross Profit

The following table summarizes our cost of revenues and gross profit:

	Nine Months Ended September 30,
	2015		2014		Change		% Change
	(in thousands)
Cost of revenues	$	2,351.5	$	1,909.4	$	442.1		23.2	%

Gross profit	$	2,210.9	$	2,193.7	$	17.2		0.8	%

Our cost of revenues increased to $2,351,500 in the nine months ended September 30, 2015, compared to $1,909,400 in the same period of 2014, primarily due to the increase in orders and shipment volumes during the comparable periods. Gross margin decreased to 48.5% in the nine months ended September 30, 2015 compared to 53.5% in the same period of 2014. The contraction in gross margin reflected the introduction of our new product Quell and our efforts to build a Quell installed base of customers who will purchase electrodes in the future. Early Quell sales are weighted more heavily to lower margin devices and, as the product line matures, we expect that the weighting of sales will shift toward higher margin electrodes.

Operating Expenses

The following table presents a breakdown of our operating expenses:

	Nine Months Ended September 30,
	2015		2014		Change			% Change
	(in thousands)
Operating expenses:
Research and development	$	2,825.6	$	3,273.9	$	(448.3	)		(13.7	)%
Sales and marketing		5,183.6		1,678.7		3,504.9			208.8	%
General and administrative		4,157.1		3,605.0		552.1			15.3	%
Total operating expenses	$	12,166.3	$	8,557.6	$	3,608.7			42.2	%

Research and Development

Research and development expenses for the nine months ended September 30, 2015 and 2014 were $2,825,600 and $3,273,900, respectively. The decrease of $448,300 primarily reflects decreased spending of $456,000 in personnel costs, as we completed development of Quell for launch in June 2015 and transitioned the engineering focus to Quell enhancements and eventually the next product generation.

Sales and Marketing

Sales and marketing expenses increased to $5,183,600 for the nine months ended September 30, 2015 from $1,678,700 for the same period of 2014. The increase of $3,504,900 included incremental advertising and marketing costs of approximately $1,548,000 to support the Quell launch with a strong investment in direct-to-consumer and physician online advertising, paid search, market research and public relations expenses. An increase of $1,363,000 versus same period last year is attributed to the addition of 12 new employees hired specifically to support the commercialization of Quell, which included a new marketing team, a field sales force, and expansion of the customer care function.

General and Administrative

General and administrative expenses increased by $552,100 to $4,157,100 for the nine months ended September 30, 2015 compared to $3,605,000 for the same period in the prior year. This increase reflected $400,000 in incremental temporary staffing and consulting services and recruiting fees of $93,000 related to staff turnover in accounting and information technology as well as costs related to relocating the company’s corporate offices and production to two new facilities in the first quarter of 2015.

Interest Income

Interest income was approximately $3,400 during the nine months ended September 30, 2015 and 2014. Interest income was earned from investments in cash equivalents.

Change in fair value of warrant liability

The change in fair value of warrant liability of $3,473,800 for the nine months ended September 30, 2015 relates to the revaluation of warrants from $5,307,300 at December 31, 2014 to $890,100 at September 30, 2015, plus the effects of the forfeiture of warrants during the second quarter of 2015 in connection with the repurchase of Series A-4 preferred stock (see Note 9 to the financial statements). The lower fair value at September 30, 2015 reflects our lower stock price at September 30, 2015 compared to December 31, 2014, as well as the shorter remaining term of the warrants. The change in the fair value of the warrant liability in the nine months ended September 30, 2014 was $1,554,000.

Liquidity and Capital Resources

Our principal source of liquidity is our cash and cash equivalents. As of September 30, 2015, cash and cash equivalents totaled $9.1 million. Our ability to generate revenue to fund our operations will largely depend on the success of our wearable therapeutic products for chronic pain and our diagnostic products for neuropathy. A low level of market interest in Quell or DPNCheck, an accelerated decline in our neurodiagnostics consumables sales, or unanticipated increases in our operating costs would have an adverse effect on our liquidity and cash generated from operations. The following table sets forth information relating to our cash and cash equivalents:

	September 30, 2015		December 31, 2014		Change			% Change
	($ in thousands)

Cash and cash equivalents	$	9,116.8	$	9,222.0	$	(105.2	)		(11.4	)%

In order to supplement our access to capital, we are party to an amended Loan and Security Agreement, with a bank which provides us with a credit facility in the amount of $2.5 million, or the Credit Facility. This Credit Facility was amended in January 2015 and will expire on January 15, 2016. As of September 30, 2015 the Credit Facility permitted us to borrow up to $2.5 million on a revolving basis. The Credit Facility was subsequently amended and extended until January 15, 2016. Amounts borrowed under the Credit Facility will bear interest equal to the prime rate plus 0.5%. Any borrowings under the Credit Facility will be collateralized by our cash, accounts receivable, inventory, and equipment. The Credit Facility includes traditional lending and reporting covenants. These include certain financial covenants applicable to liquidity that we are required to maintain. As of September 30, 2015, we were in compliance with these covenants and had not borrowed any funds under the Credit Facility. However, $226,731 of the amount available under the Credit Facility is restricted to support letters of credit issued in favor of our landlords for our premises leased in September 2014 for our corporate offices. Consequently, the amount available for borrowing under the Credit Facility as of September 30, 2015 was $2.3 million.

During the nine months ended September 30, 2015, our cash and cash equivalents decreased by $0.1 million reflecting the offsetting effects of $10.1 million in net proceeds from an underwritten public offering completed during May 2015 and the ongoing net cash usage for business operations which totaled $10.2 million during the nine month period.

In managing our working capital, we monitor days sales outstanding, or DSO, and inventory turnover rate, which are presented in the table below:

	Quarters Ended September 30,				Year Ended December 31,
	2015		2014		2014

Days sales outstanding (days)		25		36		38
Inventory turnover rate (times per year)		5.4		4.1		4.0

Days sales outstanding have improved with the launch of Quell where a significant proportion of sales are e-commerce with payment made at the point of order. The improvement in inventory turnover rate reflects increased attention to managing inventory levels following an initial surge to support Quell launch.

The following table sets forth information relating to the sources and uses of our cash:

	Nine Months Ended September 30,
	2015			2014
	(in thousands)
Net cash used in operating activities	$	(9,620.5	)	$	(5,354.9	)
Net cash used in investing activities		(594.6	)		(72.0	)
Net cash provided by financing activities		10,110.0			7,918.2

Our operating activities used $9.6 million in the nine months ended September 30, 2015. The primary driver for the use of cash in our operating activities during the nine months ended September 30, 2015 was our net loss of $6.5 million, which included non-cash charges of $407,000, for stock-based compensation and for depreciation and amortization, plus non-cash credits of $3.5 million for revaluing outstanding warrants at fair value.

We believe that our cash and cash equivalents at September 30, 2015 and the cash to be generated from expected product sales will be sufficient to meet our projected operating requirements into the second quarter of 2016. We continue to face significant challenges and uncertainties and, as a result, our available capital resources may be consumed more rapidly than currently expected due to (a) decreases in sales of our products and the uncertainty of future revenues from new products; (b) changes we may make to the business that affect ongoing operating expenses; (c) changes we may make in our business strategy; (d) regulatory developments affecting our existing products and delays in the FDA approval process for products under development; (e) changes we may make in our research and development spending plans; and (f) other items affecting our forecasted level of expenditures and use of cash resources. Accordingly, we will need to raise additional funds to support our operating and capital needs in the second quarter of 2016 and beyond. These factors raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. We will attempt to obtain additional funding through public or private financing, collaborative arrangements with strategic partners, or through additional credit lines or other debt financing sources to increase the funds available to fund operations. However, we may not be able to secure such financing in a timely manner or on favorable terms, if at all. We maintain a shelf registration statement on Form S-3 with the SEC covering shares of our common stock and other securities for sale, giving us the opportunity to raise funding when needed or otherwise considered appropriate at prices and on terms to be determined at the time of any such offerings. However, pursuant to the instructions to Form S-3, we only have the ability to sell shares under the shelf registration statement, during any 12-month period, in an amount less than or equal to one-third of the aggregate market value of our common stock held by non-affiliates. If we raise additional funds by issuing equity or debt securities, either through the sale of securities pursuant to a registration statement or by other means, our existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of our existing stockholders. If we raise additional funds through collaboration, licensing or other similar arrangements, it may be necessary to relinquish valuable rights to our potential products or proprietary technologies, or grant licenses on terms that are not favorable to us. Without additional funds, we may be forced to delay, scale back or eliminate some of our sales and marketing efforts, research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue our operations. If any of these events occurs, our ability to achieve our development and commercialization goals would be adversely affected.

Our common stock is quoted on the NASDAQ Capital Market under the symbol “NURO.” The closing bid price of our common stock on the NASDAQ Global Market was $0.86 on October 21, 2015.

On July 16, 2015, we received a notice from the Listing Qualifications Department of the NASDAQ Stock Market indicating that, for the last 30 consecutive business days, the bid price for our common stock had closed below the minimum $1.00 per share required for continued inclusion on The NASDAQ Capital Market under NASDAQ Listing Rule 5550(a)(2). The notification letter states that pursuant to NASDAQ Listing Rule 5810(c)(3)(A) the Company will be afforded 180 calendar days, or until January 12, 2016, to regain compliance with the minimum bid price requirement. In order to regain compliance, shares of the Company’s common stock must maintain a minimum bid closing price of at least $1.00 per share for a minimum of ten consecutive business days. If we do not regain compliance by January 12, 2016, NASDAQ will provide written notification to us that our common stock will be delisted. At that time, we may appeal NASDAQ’s delisting determination to a NASDAQ Listing Qualifications Panel. Alternatively, we may be eligible for an additional 180 day grace period if we satisfy all of the requirements, other than the minimum bid price requirement, for listing on The NASDAQ Capital Market set forth in NASDAQ Listing Rule 5505. The notification letter has no effect at this time on the listing of our common stock on The NASDAQ Capital Market.

We intend to take appropriate steps to maintain our listing on The NASDAQ Capital Market. These steps include keeping investors informed of developments with our newest product, Quell, while actively monitoring the bid price for our common stock between now and January 12, 2016. In addition, we are seeking shareholder approval to effect a reverse stock split of our common stock, at a ratio in the range of 1:2 to 1:4, if, in the judgement of our Board of Directors, such action could be instrumental in returning the Company to compliance with NASDAQ listing requirements.

Off-Balance Sheet Arrangements, Contractual Obligation and Contingent Liabilities and Commitments

As of September 30, 2015, we did not have any off-balance sheet financing arrangements.

See Note 6, Commitments and Contingencies, of our Notes to Unaudited Financial Statements for information regarding commitments and contingencies.

Recent Accounting Pronouncements

In May 2014, the FASB and the International Accounting Standards Board ("IASB") jointly issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance. The objective of ASU 2014-09 is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is effective for public entities for annual and interim periods beginning after December 15, 2017. An entity can elect to adopt ASU 2014-09 using one of two methods, either full retrospective adoption to each prior reporting period, or recognizing the cumulative effect of adoption at the date of initial application. We are in the process of evaluating the new standard and do not know the effect, if any, ASU 2014-09 will have on the Consolidated Financial Statements or which adoption method will be used.

Cautionary Note Regarding Forward-Looking Statements

The statements contained in this Quarterly Report on Form 10-Q, including under the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other sections of this Quarterly Report, include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, including, without limitation, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future; such as our estimates regarding anticipated operating losses, future revenues and projected expenses, particularly as they relate to Quell; our future liquidity and our expectations regarding our needs for and ability to raise additional capital; our ability to manage our expenses effectively and raise the funds needed to continue our business; our belief that there are unmet needs in the treatment of chronic pain and our expectations surrounding Quell and our currently marketed products; our expectation that Quell has the potential to be the largest contributor to 2015 revenues of our marketed products; our belief that controlled, personalized neuro-stimulation to suppress pain provides an important complement to existing pain medications and treatments and that we are well positioned to make neuro-stimulation widely available to chronic pain sufferers; our ability to execute our goal to build an installed base of active customer accounts and distributors for our marketed products; our plan to conduct Quell clinical studies to support our marketing and business plans and our hope that these studies will support future adoption of both Quell; our ability to obtain and maintain regulatory approval of our existing products and any future products we may develop; regulatory and legislative developments in the United States and foreign countries, including developments related to third-party reimbursement; our expectation that we will continue to manufacture our current marketed products as well as Quell; our belief that our manufacturing relationships minimize our capital investment, provide us with manufacturing expertise, and help control costs; our ability to obtain and maintain intellectual property protection for our products; the successful development of our sales and marketing capabilities; the size and growth of the potential domestic and international markets for our products and our ability to serve those markets; our belief that there are significant opportunities to market Quell outside of the United States and our plan to evaluate additional U.S. retail distribution opportunities after commercial launch of Quell; the rate and degree of market acceptance of any future products, including Quell; our reliance on key scientific management or personnel; and other factors discussed elsewhere in this Quarterly Report on Form 10-Q. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this quarterly report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section titled “Risk Factors” below and in our Annual Report on Form 10-K. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We do not use derivative financial instruments in our investment portfolio and have no foreign exchange contracts. Our financial instruments consist of cash and cash equivalents. We consider investments that, when purchased, have a remaining maturity of 90 days or less to be cash equivalents. The primary objectives of our investment strategy are to preserve principal, maintain proper liquidity to meet operating needs, and maximize yields. To minimize our exposure to an adverse shift in interest rates, we invest mainly in cash equivalents and short-term investments with a maturity of twelve months or less and maintain an average maturity of twelve months or less. We do not believe that a notional or hypothetical 10% change in interest rate percentages would have a material impact on the fair value of our investment portfolio or our interest income.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. Our principal executive officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2015, have concluded that, based on such evaluation, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Controls. There were no changes in our internal control over financial reporting, identified in connection with the evaluation of such internal control that occurred during the quarter ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

While we are not currently a party to any material legal proceedings, we could become subject to legal proceedings in the ordinary course of business. We do not expect any such potential items to have a significant impact on our financial position.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014, which could materially affect our business, financial condition, or results of operations. The risks described in our Annual Report on Form 10-K are not the only risks that we face. In addition, risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or results of operations. Other than the addition of the following risk factors, there have been no material changes in or additions to the risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2014 and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2015.

On September 17, 2015, our board approved, subject to approval by our stockholders, a reverse stock split within a range of 1:2 to 1:4, which we refer to as the reverse stock split range. If we effect a reverse stock split within the reverse stock split range, the reverse stock split may not result in a proportionate increase in the price of our common stock, in which case we may not be able to satisfy the continued listing requirements of The NASDAQ Capital Market.

On September 17, 2015, our board of directors approved, subject to approval by our stockholders, a reverse stock split within a range of 1:2 to 1:4, or the “reverse stock split range”. If our stockholders approve the reverse stock split, our board of directors will be authorized to effect a reverse stock split within the reverse stock split range in the event our board of directors determines that such reverse stock split is in the best interest of our stockholders and us. While our board of directors has not determined to effect a reverse stock split, it may determine that effecting a reverse stock split is necessary in connection with our ability to satisfy the continued listing requirements of The NASDAQ Capital Market. However, the effect of a reverse stock split upon the market price of our common stock cannot be predicted with certainty, and the results of reverse stock splits by companies in similar circumstances have been varied. It is possible that the market price of our common stock following such a reverse stock split will not increase sufficiently for us to be in compliance with the minimum bid price requirement. If we are unable meet the minimum bid price requirement, we may be unable to continue to list our shares of common stock or other securities on The NASDAQ Capital Market.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

See the Exhibit Index on the page immediately preceding the exhibits for a list of exhibits filed as part of this quarterly report, which Exhibit Index is incorporated herein by this reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		NEUROMETRIX, INC.


Date: October 22, 2015	/s/	SHAI N. GOZANI, M.D., PH. D.
		Shai N. Gozani, M.D., Ph. D.
		Chairman, President and Chief Executive Officer


Date: October 22, 2015	/s/	THOMAS T. HIGGINS
		Thomas T. Higgins
		Senior Vice President, Chief Financial Officer and Treasurer

EXHIBIT INDEX

Exhibit No.		Description

31.1		Certification of Principal Executive Officer Under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002. Filed herewith.

31.2		Certification of Principal Financial Officer Required Under Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Filed herewith.

32		Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350. Furnished herewith.

101		The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) Balance Sheets at September 30, 2015 and December 31, 2014, (ii) Statements of Operations for the quarters and nine months ended September 30, 2015 and 2014, (iii) Statements of Cash Flows for the nine months ended September 30, 2015 and 2014, and (iv) Notes to Financial Statements.

EX-31.1 2 v422003_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION

I, Shai N. Gozani, M.D., Ph.D., certify that:

I have reviewed this Quarterly Report on Form 10-Q of NeuroMetrix, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 22, 2015	/s/ SHAI N. GOZANI, M.D., PH.D.
	Shai N. Gozani, M.D., Ph.D.
	Chairman, President and Chief Executive Officer

EX-31.2 3 v422003_ex31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION

I, Thomas T. Higgins, certify that:

I have reviewed this Quarterly Report on Form 10-Q of NeuroMetrix, Inc.;

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 22, 2015	/s/ THOMAS T. HIGGINS
	Thomas T. Higgins
	Senior Vice President, Chief Financial Officer and Treasurer

EX-32 4 v422003_ex32.htm EXHIBIT 32

EXHIBIT 32

CERTIFICATION

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of NeuroMetrix, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended September 30, 2015 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ SHAI N. GOZANI, M.D., PH.D.
	Shai N. Gozani, M.D., Ph.D.
	Chairman, President and Chief Executive Officer

	/s/ THOMAS T. HIGGINS
	Thomas T. Higgins
	Senior Vice President, Chief Financial Officer and Treasurer

October 22, 2015

This certification is being furnished and not filed, and shall not be incorporated into any document for any purpose, under the Securities Exchange Act of 1934 or the Securities Act of 1933.

EX-101.INS 5 nuro-20150930.xml XBRL INSTANCE DOCUMENT 0001289850 2014-01-01 2014-09-30 0001289850 2015-01-01 2015-09-30 0001289850 2015-05-01 2015-05-31 0001289850 2014-07-01 2014-09-30 0001289850 2015-07-01 2015-09-30 0001289850 2015-09-30 0001289850 2015-10-21 0001289850 2014-12-31 0001289850 2013-12-31 0001289850 2014-09-30 0001289850 nuro:SeriesConvertiblePreferredStockMember 2015-09-30 0001289850 nuro:SeriesConvertiblePreferredStockMember 2014-12-31 0001289850 nuro:SeriesBConvertiblePreferredStockMember 2015-09-30 0001289850 nuro:SeriesBConvertiblePreferredStockMember 2014-12-31 0001289850 us-gaap:SalesRevenueNetMember nuro:CustomerOneMember 2015-07-01 2015-09-30 0001289850 us-gaap:SalesRevenueNetMember nuro:CustomerOneMember 2015-01-01 2015-09-30 0001289850 nuro:FiveYearOperatingLeaseAgreementMember 2014-08-01 2014-08-31 0001289850 nuro:SevenYearOperatingLeaseAgreementMember 2014-09-01 2014-09-30 0001289850 us-gaap:OtherNoncurrentAssetsMember 2015-01-01 2015-09-30 0001289850 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0001289850 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0001289850 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0001289850 us-gaap:FairValueInputsLevel1Member 2015-09-30 0001289850 us-gaap:FairValueInputsLevel2Member 2015-09-30 0001289850 us-gaap:FairValueInputsLevel3Member 2015-09-30 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndFourteenOfferingMember 2014-12-31 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndThirteenOfferingMember 2014-12-31 0001289850 us-gaap:WarrantMember 2014-12-31 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndFourteenOfferingMember 2015-01-01 2015-09-30 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndThirteenOfferingMember 2015-01-01 2015-09-30 0001289850 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndFourteenOfferingMember 2015-09-30 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndThirteenOfferingMember 2015-09-30 0001289850 us-gaap:WarrantMember 2015-09-30 0001289850 nuro:TwoThousandFourteenOfferingWarrantsMember 2015-09-30 0001289850 nuro:TwoThousandThirteenOfferingWarrantsMember 2015-09-30 0001289850 nuro:TwoThousandFourteenOfferingWarrantsMember 2015-01-01 2015-09-30 0001289850 nuro:TwoThousandThirteenOfferingWarrantsMember 2015-01-01 2015-09-30 0001289850 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001289850 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001289850 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001289850 us-gaap:FairValueInputsLevel1Member 2014-12-31 0001289850 us-gaap:FairValueInputsLevel2Member 2014-12-31 0001289850 us-gaap:FairValueInputsLevel3Member 2014-12-31 0001289850 nuro:TwoThousandFourteenOfferingWarrantsMember 2014-12-31 0001289850 nuro:TwoThousandThirteenOfferingWarrantsMember 2014-12-31 0001289850 nuro:TwoThousandFourteenOfferingWarrantsMember 2014-01-01 2014-12-31 0001289850 nuro:TwoThousandThirteenOfferingWarrantsMember 2014-01-01 2014-12-31 0001289850 us-gaap:PrimeRateMember 2015-01-01 2015-09-30 0001289850 nuro:TwoThousandAndFifteenOfferingMember us-gaap:SeriesBPreferredStockMember 2015-05-01 2015-05-31 0001289850 nuro:TwoThousandAndFifteenOfferingMember us-gaap:SeriesBPreferredStockMember 2015-05-31 0001289850 nuro:TwoThousandAndFifteenOfferingMember 2015-05-31 0001289850 nuro:TwoThousandAndFifteenOfferingMember 2015-05-01 2015-05-31 0001289850 us-gaap:SeriesBPreferredStockMember 2015-05-01 2015-05-31 0001289850 us-gaap:CommonStockMember 2015-06-30 0001289850 us-gaap:CommonStockMember 2015-05-31 0001289850 us-gaap:SeriesBPreferredStockMember 2015-04-01 2015-06-30 0001289850 nuro:TwoThousandAndFourteenOfferingMember nuro:SeriesA4PreferredStockMember 2015-05-01 2015-05-31 0001289850 nuro:TwoThousandAndFourteenIssuanceMember nuro:TwoThousandThirteenManagementIncentiveCompensationMember 2014-01-01 2014-12-31 0001289850 nuro:TwoThousandAndFifteenIssuanceMember nuro:TwoThousandFourteenManagementIncentiveCompensationMember 2015-03-01 2015-03-31 0001289850 nuro:TwoThousandThirteenManagementIncentiveCompensationMember 2014-02-25 0001289850 nuro:TwoThousandFourteenManagementIncentiveCompensationMember 2015-03-12 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndFourteenOfferingMember 2015-09-30 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndFourteenOfferingMember 2014-09-30 0001289850 us-gaap:WarrantMember nuro:TwoThousandAndFourteenOfferingMember 2015-01-01 2015-09-30 0001289850 nuro:TwoThousandAndThirteenOfferingMember 2015-09-30 0001289850 nuro:TwoThousandAndFourteenOfferingMember 2015-09-30 0001289850 nuro:TwoThousandAndFourteenOfferingMember 2014-06-01 2014-06-30 0001289850 nuro:TwoThousandAndFourteenOfferingMember 2014-06-30 0001289850 nuro:SeriesThreeConvertiblePreferredStockMember 2014-06-30 0001289850 nuro:SeriesFourConvertiblePreferredStockMember 2014-06-30 0001289850 nuro:SeriesA4PreferredStockMember nuro:TwoThousandAndFourteenOfferingMember 2014-06-01 2014-06-30 0001289850 nuro:TwoThousandAndFourteenOfferingMember 2014-09-30 0001289850 nuro:SeriesThreeConvertiblePreferredStockMember 2015-07-01 2015-09-30 0001289850 us-gaap:CommonStockMember 2014-06-30 0001289850 us-gaap:CommonStockMember 2014-07-31 0001289850 nuro:SeriesThreeConvertiblePreferredStockMember 2014-06-01 2014-06-30 0001289850 nuro:SeriesA4PreferredStockMember 2014-10-01 2014-10-31 0001289850 us-gaap:CommonStockMember 2014-10-31 0001289850 nuro:SeriesA4PreferredStockMember 2015-02-01 2015-02-28 0001289850 us-gaap:CommonStockMember 2015-02-28 0001289850 nuro:SeriesA4PreferredStockMember 2015-05-31 0001289850 us-gaap:SeriesBPreferredStockMember 2015-07-01 2015-09-30 0001289850 nuro:TwoThousandAndFifteenOfferingMember 2015-09-30 0001289850 nuro:SeriesFourConvertiblePreferredStockMember 2014-06-01 2014-06-30 0001289850 nuro:SeriesThreeConvertiblePreferredStockMember 2014-07-01 2014-07-31 0001289850 nuro:SeriesA4PreferredStockMember 2015-05-01 2015-05-31 0001289850 nuro:TwoCustomersMember us-gaap:AccountsReceivableMember 2015-01-01 2015-09-30 0001289850 nuro:TwoCustomersMember us-gaap:SalesRevenueNetMember 2014-07-01 2014-09-30 0001289850 nuro:TwoCustomersMember us-gaap:SalesRevenueNetMember 2014-01-01 2014-09-30 0001289850 us-gaap:AccountsReceivableMember nuro:CustomerOneMember 2014-01-01 2014-12-31 0001289850 us-gaap:CommonStockMember 2015-09-30 0001289850 us-gaap:SeriesBPreferredStockMember 2015-09-30 0001289850 nuro:SeriesFourConvertiblePreferredStockMember 2015-05-01 2015-05-31 0001289850 nuro:TwoThousandAndFourteenOfferingMember 2014-07-01 2014-09-30 0001289850 us-gaap:MinimumMember 2015-01-01 2015-09-30 0001289850 us-gaap:MaximumMember 2015-01-01 2015-09-30 0001289850 nuro:SeriesFourConvertiblePreferredStockMember 2015-07-01 2015-09-30 0001289850 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-09-30 0001289850 us-gaap:WarrantMember 2015-07-01 2015-09-30 0001289850 us-gaap:RestrictedStockMember 2015-07-01 2015-09-30 0001289850 us-gaap:ConvertiblePreferredStockMember 2015-07-01 2015-09-30 0001289850 us-gaap:EmployeeStockOptionMember 2014-07-01 2014-09-30 0001289850 us-gaap:WarrantMember 2014-07-01 2014-09-30 0001289850 us-gaap:RestrictedStockMember 2014-07-01 2014-09-30 0001289850 us-gaap:ConvertiblePreferredStockMember 2014-07-01 2014-09-30 0001289850 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0001289850 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001289850 us-gaap:RestrictedStockMember 2015-01-01 2015-09-30 0001289850 us-gaap:ConvertiblePreferredStockMember 2015-01-01 2015-09-30 0001289850 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0001289850 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001289850 us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0001289850 us-gaap:ConvertiblePreferredStockMember 2014-01-01 2014-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2015-09-30 2015 Q3 NeuroMetrix, Inc. 0001289850 --12-31 Smaller Reporting Company NURO 13785239

9116806

9221985

901895

580240

1072162

679740

878533

608160

11969396

11090125

745133

311520

214275

585

12928804

11402230

946146

522871

766557

885353

1132863

1264876

692244

25048

3537810

2698148

10433

9635

890105 5307332

4438348

8015115

1379

815

169345497

157764598

-160856514

-154378302

8490456

3387115

12928804

11402230

4103135

4562379

1427828

2054432

1909443

2351479

639025

1119186

2193692

2210900

788803

935246

3273900

2825589

945349

940794

1678665

5183595

537785

1965627

3605047

4157082

1310012

1386170

8557612

12166266

2793146

4292591

-6363920

-9955366

-2004343

-3357345

3362

3350

1336

1761

-1554411

-3473804

-564550

-151806

-4857021

-6478212

-1461713

-3203778

-1.18

-1.02

-0.19

-0.26

6602626

9879905

7853292

12133984

23256

50874

103250

160993

208358

246406

220868

321655

67200

392422

26476

484063

199818

423275

841317

30948

-32570

667994

-5354929

-9620540

71982

594606

-71982

-594606

2491268

-105179

9195753

11687021

-104405 -281757

-50874

13316324

7918179

3206357

10109967

7918179

0 4418824

680000

425000

0.11

0.16

-3203778

-1461713

-10028907

-7812689

0 0 4140446 2955668 0 0 589751 0

502952

209426

569210

470314

148921

450000 450000

229189

257024

34085 74000

122901

34206

138656

212137

64543 37761 26289 25989 67200 173759

7350

37792

275000

5028053

890105 0 0 890105

890105

4233729

1073603

5307332

-2625305

-848499

-3473804

665001

225104

890105

943423 0 943423 943423 1571744

0.88

0.7203

0.728

0.0109

0.0082

4107478

5307332 0 0 5307332

5307332

1.95

0.7111

0.7571

0.0151

0.0124

2500000

2016-01-15

0.005

226731

2300000

147000

100

14553000

1.25

14700000

10100000

100

1.0101

2443716

14553000

24684

3200000

42615

166405

2.45 1.69

104405

281700

P2Y3M18D

4400000

2.00

2.04

0.6748

0.0164

346000

1057323

200000

2349825

700000

664600

2.04

1000

3921569

2.04

8000000

7900000

1000

2955668

1285225

100000

1185225

204

408

200000

408

200000

1000

4140446

0.001

5000000

0.0001

50000000

13785239

8152746

3614.357

94146

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Revenues</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists, delivery has occurred and risk of loss has passed, the seller’s price to the buyer is fixed or determinable, and collection is reasonably assured.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Revenues associated with the Company’s medical devices and consumables, including single use nerve specific electrodes and other accessories are generally recognized upon shipment, assuming all other revenue criteria have been met. For the Company’s newest product, Quell, launched in June 2015, there was insufficient data available at September 30, 2015 to reasonably estimate product returns. Accordingly, approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">680,000</font> of Quell revenue and approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">425,000</font> of costs of Quell revenue have been deferred until sufficient product return history has been obtained or the right of return has lapsed. Deferred costs of Quell revenue have been recorded in prepaid expenses and other current assets on the balance sheet.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Revenue recognition involves judgments, including assessments of expected returns and expected customer relationship periods. The Company analyzes various factors, including a review of specific transactions, its historical returns, average customer relationship periods, customer usage, customer balances, and market and economic conditions. Changes in judgments or estimates on these factors could materially impact the timing and amount of revenues and costs recognized. Should market or economic conditions deteriorate, the Company’s actual return or bad debt experience could exceed its estimate.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Product sales are made with a specified right of return ranging from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">60</font> days. Since the Company can reasonably estimate future returns for products other than Quell, it recognizes revenues associated with such product sales that contain a right of return upon shipment and at the same time it records a sales return reserve, which reduces revenue and accounts receivable by the amount of estimated returns.</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> One customer accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16</font>% of total revenues during the quarter and nine months ended September 30, 2015, respectively. Two customers accounted for a combined <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% of gross accounts receivables as of September 30, 2015. In comparison, during the quarter and nine months ended September 30, 2014, two customers accounted for a combined <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 31</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 22</font>% of total revenue, respectively. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman','serif'">At December 31, 2014, one customer accounted for</font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 30</font>% of accounts receivables.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

28170

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Recent Accounting Pronouncements</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> In August 2014, the FASB issued Accounting Standards Update No. 2014-15, <i>Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern</i> (ASU 2014-15). ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016, with early adoption permitted. We are currently evaluating the provisions of ASU 2014-15 and assessing the impact, if any, it may have on our financial position, results of operations or cash flows.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> In May 2014, the FASB and the International Accounting Standards Board ("IASB") jointly issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance. The objective of ASU 2014-09 is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is effective for public entities for annual and interim periods beginning after December 15, 2017. An entity can elect to adopt ASU 2014-09 using one of two methods, either full retrospective adoption to each prior reporting period, or recognizing the cumulative effect of adoption at the date of initial application. The Company is in the process of evaluating the new standard and does not know the effect, if any, ASU 2014-09 will have on the Consolidated Financial Statements or which adoption method will be used.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

3200000

2621859

4022357

2417859

3206357

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-SIZE: 10pt"><strong>7.</strong></font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt"><strong>Fair Value Measurements</strong></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Fair Value Measurements and Disclosures Topic of the Codification defines fair value, establishes a framework for measuring fair value in applying generally accepted accounting principles, and expands disclosures about fair value measurements. This Codification topic identifies two kinds of inputs that are used to determine the fair value of assets and liabilities: observable and unobservable. Observable inputs are based on market data or independent sources while unobservable inputs are based on the Company’s own market assumptions. Once inputs have been characterized, this Codification topic requires companies to prioritize the inputs used to measure fair value into one of three broad levels. Fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values identified by Level 2 inputs utilize observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. Fair values identified by Level 3 inputs are unobservable data points and are used to measure fair value to the extent that observable inputs are not available. Unobservable inputs reflect the Company’s own assumptions about the assumptions that market participants would use at pricing the asset or liability.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis for the periods presented and indicates the fair value hierarchy of the valuation techniques it utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates, and yield curves. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%" colspan="8"> <div> Fair Value Measurements at September 30, 2015 Using</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30, 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Quoted Prices in<br/> Active Markets<br/> for Identical<br/> Assets (Level 1)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant Other<br/> Observable Inputs<br/> (Level 2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Cash equivalents</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,028,053</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,028,053</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,028,053</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,028,053</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Common stock warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>890,105</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>890,105</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>890,105</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>890,105</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Due to the lack of market quotes relating to our common stock warrants issued in the 2014 Offering and a 2013 financing (see Note 9), the fair value of the common stock warrants was determined at September 30, 2015 using the Black-Scholes model, which is based on Level 3 inputs. As of September 30, 2015, inputs used in the Black-Scholes model are presented below. The assumptions used may change as the underlying sources of these assumptions and market conditions change.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.9</font> million at September 30, 2015. In May 2015, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,571,744</font> warrants were repurchased by the Company. These warrants were adjusted to their fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">943,423</font> at the date of repurchase.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in 0in 0in 0.25in; WIDTH: 91%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="19%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="70%" colspan="16"> <div> Black-Scholes Inputs to Warrant Liability Valuation at September 30, 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="19%"> <div>Warrants:</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Stock Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Exercise Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Expected Volatility</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Risk-Free Interest</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>Expected Term</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>Dividends</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="19%"> <div>2014 Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.04</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>72.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.09</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3yr 9mo</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>none</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="19%"> <div>2013 Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>72.80</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.82</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2yr 8mo</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>none</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table provides a summary of changes in the fair value of the Company’s Level 3 financial liabilities between December 31, 2014 and September 30, 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014 Offering</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2013 Offering</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Balance at December 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,233,729</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,073,603</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Repurchase of warrants in conjunction with public offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(943,423)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(943,423)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Change in fair value of warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,625,305)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(848,499)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(3,473,804)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Balance at September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>665,001</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>225,104</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>890,105</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> </div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%" colspan="8"> <div> Fair Value Measurements at December 31, 2014 Using</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December 31,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Quoted Prices in<br/> Active Markets<br/> for Identical<br/> Assets (Level 1)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant Other<br/> Observable Inputs<br/> (Level 2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Cash equivalents</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Common stock warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Due to the lack of market quotes relating to our common stock warrants then outstanding, the fair value of the common stock warrants was determined at December 31, 2014 using the Black-Scholes model, which is based on Level 3 inputs. As of December 31, 2014, inputs used in the Black-Scholes model are presented below. The assumptions used may change as the underlying sources of these assumptions and market conditions change. Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.3</font> million at December 31, 2014.</div>  </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in 0in 0in 0.25in; WIDTH: 91%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="20%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="69%" colspan="15"> <div> Black-Scholes Inputs to Warrant Liability Valuation at December 31, 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="20%"> <div>Warrants:</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Stock Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Exercise Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Expected Volatility</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Risk-Free Interest</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>Expected Term</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>Dividends</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="20%"> <div>2014 Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.95</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.04</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>71.11</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.51</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4yr 6mo</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>none</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="20%"> <div>2013 Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.95</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>75.71</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.24</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3yr 5mo</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>none</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; WIDTH: 100%; BORDER-COLLAPSE: collapse; MARGIN: 0in" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="35%" colspan="8"> <div> Fair Value Measurements at September 30, 2015 Using</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>September 30, 2015</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Quoted Prices in<br/> Active Markets<br/> for Identical<br/> Assets (Level 1)</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Significant Other<br/> Observable Inputs<br/> (Level 2)</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Assets:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Cash equivalents</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>5,028,053</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>5,028,053</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>5,028,053</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>5,028,053</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Liabilities:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Common stock warrants</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>890,105</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>890,105</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>890,105</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>890,105</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> </div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%" colspan="8"> <div> Fair Value Measurements at December 31, 2014 Using</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December 31,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Quoted Prices in<br/> Active Markets<br/> for Identical<br/> Assets (Level 1)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant Other<br/> Observable Inputs<br/> (Level 2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Cash equivalents</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,107,478</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Common stock warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,307,332</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.9</font> million at September 30, 2015. In May 2015, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,571,744</font> warrants were repurchased by the Company. These warrants were adjusted to their fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">943,423</font> at the date of repurchase.</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; WIDTH: 91%; BORDER-COLLAPSE: collapse; MARGIN: 0in 0in 0in 0.25in" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="19%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="70%" colspan="16"> <div> Black-Scholes Inputs to Warrant Liability Valuation at September 30, 2015</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="19%"> <div>Warrants:</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Stock Price</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Exercise Price</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Expected Volatility</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Risk-Free Interest</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>Expected Term</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>Dividends</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="19%"> <div>2014 Offering</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>0.88</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>2.04</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>72.03</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>1.09</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>3yr 9mo</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>none</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="19%"> <div>2013 Offering</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>0.88</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>2.00</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>72.80</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>0.82</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>2yr 8mo</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>none</div> </td> <td style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> </div><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid; WIDTH: 91%; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 0px solid; MARGIN: 0in 0in 0in 0.25in; BORDER-LEFT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="20%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="69%" colspan="15"> <div> Black-Scholes Inputs to Warrant Liability Valuation at December 31, 2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="20%"> <div>Warrants:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Stock Price</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Exercise Price</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Expected Volatility</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>Risk-Free Interest</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>Expected Term</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>Dividends</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="20%"> <div>2014 Offering</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>1.95</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>2.04</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>71.11</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>1.51</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>4yr 6mo</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>none</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="20%"> <div>2013 Offering</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>1.95</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>2.00</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>75.71</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>1.24</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>3yr 5mo</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="10%"> <div>none</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

P2Y8M

P4Y6M

P3Y5M

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-SIZE: 10pt"><strong>5.</strong></font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt"><strong>Accrued Compensation and Expenses</strong></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table provides a rollforward of the liability balance for severance obligations which was recorded as research and development expense in the Company’s Statement of Operations for the year ended December 31, 2014. The severance obligations were fully paid as of June 30, 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 75%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="62%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>September 30,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="62%"> <div>Balance - beginning</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>148,921</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="62%"> <div>Accrual for severance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="62%"> <div>Severance payments made</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(148,921)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="62%"> <div>Balance - ending</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Accrued expenses consist of the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>September 30,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>December 31,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Technology fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>450,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>450,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Professional services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>229,189</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>257,024</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Sales taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>122,901</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,206</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Consulting fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>67,200</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>173,759</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Personnel related obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>64,543</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>37,761</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Clinical study obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>74,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Federal excise tax</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>26,289</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>25,989</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>138,656</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>212,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,132,863</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,264,876</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Accrued expenses consist of the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>September 30,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>December 31,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Technology fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>450,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>450,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Professional services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>229,189</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>257,024</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Sales taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>122,901</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,206</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Consulting fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>67,200</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>173,759</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Personnel related obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>64,543</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>37,761</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Clinical study obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>74,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Federal excise tax</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>26,289</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>25,989</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>138,656</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>212,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,132,863</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,264,876</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid; BORDER-BOTTOM: 0px solid; FONT: 10pt Times New Roman, Times, Serif; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify"> <td style="WIDTH: 0.25in; TEXT-ALIGN: left"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <strong>3.</strong></font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <strong>Net Loss Per Common Share</strong></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 22pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic net income per share. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period plus the dilutive effect of the weighted average number of outstanding instruments such as options, warrants, and restricted stock. Because the Company has reported a net loss for all periods presented, diluted loss per common share is the same as basic loss per common share, as the effect of utilizing the fully diluted share count would have reduced the net loss per common share. Therefore, in calculating net loss per share amounts, shares underlying <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>the following potentially weighted average dilutive number of common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive for each of the periods presented:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 22pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; WIDTH: 100%; BORDER-COLLAPSE: collapse; MARGIN: 0in" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="43%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>Quarters Ended September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>Nine Months Ended September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="43%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Options</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>867,135</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>576,746</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>822,769</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>406,540</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Warrants</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>18,889,103</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,978,892</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>11,771,953</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,436,336</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Unvested restricted stock</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>15,493</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>405</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>16,512</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Convertible preferred stock</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>10,923,802</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,971,744</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>6,777,980</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>693,361</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>30,680,040</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>7,542,875</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>19,373,107</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>3,552,749</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> The Beneficial Conversion Feature, or BCF, recorded in both the 2015 Offering and 2014 Offering was recognized as a deemed dividend attributable to the Preferred Stock and is reflected as an adjustment in the calculation of earnings per share. In May 2015, a BCF was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature, and is reflected as an adjustment in the calculation of earnings per share. See Note 9, Stockholders’ Equity, for further details. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; WIDTH: 100%; BORDER-COLLAPSE: collapse; MARGIN: 0in" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Quarters Ended<br/> September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Nine months Ended<br/> September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Net loss</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(3,203,778)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1,461,713)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(6,478,212)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(4,857,021)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div style="CLEAR:both;MARGIN-LEFT: 13px; TEXT-INDENT: -13px"> Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(4,140,446)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(2,955,668)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div style="CLEAR:both;MARGIN-LEFT: 13px; TEXT-INDENT: -13px"> Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>589,751</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Net loss applicable to common stockholders</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(3,203,778)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1,461,713)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(10,028,907)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(7,812,689)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Net loss per common share applicable to common stockholders, basic and diluted</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(0.26)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(0.19)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1.02)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1.18)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Weighted average number of common shares outstanding, basic and diluted</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>12,133,984</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>7,853,292</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>9,879,905</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>6,602,626</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> the following potentially weighted average dilutive number of common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive for each of the periods presented:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 22pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; WIDTH: 100%; BORDER-COLLAPSE: collapse; MARGIN: 0in" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="43%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>Quarters Ended September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>Nine Months Ended September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="43%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Options</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>867,135</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>576,746</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>822,769</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>406,540</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Warrants</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>18,889,103</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,978,892</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>11,771,953</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,436,336</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Unvested restricted stock</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>15,493</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>405</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>16,512</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Convertible preferred stock</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>10,923,802</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,971,744</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>6,777,980</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>693,361</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>30,680,040</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>7,542,875</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>19,373,107</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>3,552,749</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

0.51

0.31

0.22

0.3

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center"></div> <table style="MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid; BORDER-BOTTOM: 0px solid; FONT: 10pt Times New Roman, Times, Serif; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify"> <td style="WIDTH: 0px"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 0.25in; TEXT-ALIGN: left"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>1.</b></font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <b>Business and Basis of Presentation</b></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Our Business-An Overview</b></div> <div style="CLEAR:both;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, Serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </div> <div style="CLEAR:both;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, Serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> NeuroMetrix, Inc., or the Company, a Delaware corporation, was founded in June 1996. The Company develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The Company markets Quell<sup style="font-style:normal">®</sup> and SENSUS<sup style="font-style:normal">®</sup> which are wearable therapeutic devices designed for relief of chronic, intractable pain. Quell was commercially launched in the United States during the second quarter of 2015. The Company also markets DPNCheck<sup style="font-style:normal">®</sup>, which is a quantitative nerve conduction test that is used by physicians and health care professionals to evaluate systemic neuropathies such as diabetic peripheral neuropathy, or DPN. The Company’s historical neurodiagnostic business is based on the ADVANCE<sup style="font-style:normal">TM</sup> System which is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures and which is primarily used in physician offices and clinics.</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> The accompanying financial statements have been prepared on a basis which assumes that the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The Company has suffered recurring losses from operations and negative cash flows from operating activities. The Company held cash and cash equivalents of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9.1</font> million as of September 30, 2015. The Company believes that these resources and the cash to be generated from expected product sales will be sufficient to meet its projected operating requirements into the second quarter of 2016. The Company continues to face significant challenges and uncertainties and, as a result, the Company’s available capital resources may be consumed more rapidly than currently expected due to (a) decreases in sales of the Company’s products and the uncertainty of future revenues from new products; (b) changes the Company may make to the business that affect ongoing operating expenses; (c) changes the Company may make in its business strategy; (d) regulatory developments affecting the Company’s existing products and delays in the FDA approval process for products under development; (e) changes the Company may make in its research and development spending plans; and (f) other items affecting the Company’s forecasted level of expenditures and use of cash resources. Accordingly, the Company will need to raise additional funds to support its operating and capital needs in the second quarter of 2016 and beyond. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company intends to obtain additional funding through public or private financing, collaborative arrangements with strategic partners, or through additional credit lines or other debt financing sources to increase the funds available to fund operations. However, the Company may not be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity or debt securities to raise additional funds, its existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of the Company’s existing stockholders. If the Company raises additional funds through collaboration, licensing or other similar arrangements, it may be necessary to relinquish valuable rights to its potential products or proprietary technologies, or grant licenses on terms that are not favorable to the Company. Without additional funds, the Company may be forced to delay, scale back or eliminate some of its sales and marketing efforts, research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue its operations. If any of these events occurs, the Company’s ability to achieve its development and commercialization goals would be adversely affected.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Unaudited Interim Financial Statements</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> The accompanying unaudited balance sheet as of September 30, 2015, unaudited statements of operations for the quarters and nine months ended September 30, 2015 and 2014 and the unaudited statements of cash flows for the nine months ended September 30, 2015 and 2014 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the financial statements include all normal and recurring adjustments considered necessary for a fair statement of the Company’s financial position and operating results. Operating results for the quarter ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other period. These financial statements and notes should be read in conjunction with the financial statements for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, or the SEC, on February 25, 2015 (File No. 001-33351), or the Company’s 2014 Form 10-K. The accompanying balance sheet as of December 31, 2014 has been derived from audited financial statements prepared at that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0in 0px 0in 0in; TEXT-INDENT: 0in"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Revenues</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists, delivery has occurred and risk of loss has passed, the seller’s price to the buyer is fixed or determinable, and collection is reasonably assured.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Revenues associated with the Company’s medical devices and consumables, including single use nerve specific electrodes and other accessories are generally recognized upon shipment, assuming all other revenue criteria have been met. For the Company’s newest product, Quell, launched in June 2015, there was insufficient data available at September 30, 2015 to reasonably estimate product returns. Accordingly, approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">680,000</font> of Quell revenue and approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">425,000</font> of costs of Quell revenue have been deferred until sufficient product return history has been obtained or the right of return has lapsed. Deferred costs of Quell revenue have been recorded in prepaid expenses and other current assets on the balance sheet.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Revenue recognition involves judgments, including assessments of expected returns and expected customer relationship periods. The Company analyzes various factors, including a review of specific transactions, its historical returns, average customer relationship periods, customer usage, customer balances, and market and economic conditions. Changes in judgments or estimates on these factors could materially impact the timing and amount of revenues and costs recognized. Should market or economic conditions deteriorate, the Company’s actual return or bad debt experience could exceed its estimate.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> Product sales are made with a specified right of return ranging from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">60</font> days. Since the Company can reasonably estimate future returns for products other than Quell, it recognizes revenues associated with such product sales that contain a right of return upon shipment and at the same time it records a sales return reserve, which reduces revenue and accounts receivable by the amount of estimated returns.</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> One customer accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16</font>% of total revenues during the quarter and nine months ended September 30, 2015, respectively. Two customers accounted for a combined <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% of gross accounts receivables as of September 30, 2015. In comparison, during the quarter and nine months ended September 30, 2014, two customers accounted for a combined <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 31</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 22</font>% of total revenue, respectively. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman','serif'">At December 31, 2014, one customer accounted for</font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 30</font>% of accounts receivables.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> <b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px" align="justify"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Recent Accounting Pronouncements</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> In August 2014, the FASB issued Accounting Standards Update No. 2014-15, <i>Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern</i> (ASU 2014-15). ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016, with early adoption permitted. We are currently evaluating the provisions of ASU 2014-15 and assessing the impact, if any, it may have on our financial position, results of operations or cash flows.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.25in"> In May 2014, the FASB and the International Accounting Standards Board ("IASB") jointly issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance. The objective of ASU 2014-09 is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is effective for public entities for annual and interim periods beginning after December 15, 2017. An entity can elect to adopt ASU 2014-09 using one of two methods, either full retrospective adoption to each prior reporting period, or recognizing the cumulative effect of adoption at the date of initial application. The Company is in the process of evaluating the new standard and does not know the effect, if any, ASU 2014-09 will have on the Consolidated Financial Statements or which adoption method will be used.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

P3Y9M

2.04

2.00

2.04

2.00

2788830

94146

3200000

3206357

11083 11083 147000 0 2.04

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>4.</strong></font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <strong>Inventories</strong></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Inventories consist of the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September 30,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">December 31,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div style="CLEAR:both;CLEAR: both">Purchased components</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">502,952</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">209,426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div style="CLEAR:both;CLEAR: both">Finished goods</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">569,210</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">470,314</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,072,162</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">679,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Included in finished goods is $64,477 and zero of consigned inventory held by a third party as of September 30, 2015 and December 31, 2014, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

P30D P60D

64477

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> The Beneficial Conversion Feature, or BCF, recorded in both the 2015 Offering and 2014 Offering was recognized as a deemed dividend attributable to the Preferred Stock and is reflected as an adjustment in the calculation of earnings per share. In May 2015, a BCF was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature, and is reflected as an adjustment in the calculation of earnings per share. See Note 9, Stockholders’ Equity, for further details. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; WIDTH: 100%; BORDER-COLLAPSE: collapse; MARGIN: 0in" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Quarters Ended<br/> September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Nine months Ended<br/> September 30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="51%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Net loss</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(3,203,778)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1,461,713)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(6,478,212)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(4,857,021)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div style="CLEAR:both;MARGIN-LEFT: 13px; TEXT-INDENT: -13px"> Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(4,140,446)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(2,955,668)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div style="CLEAR:both;MARGIN-LEFT: 13px; TEXT-INDENT: -13px"> Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>589,751</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Net loss applicable to common stockholders</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(3,203,778)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1,461,713)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(10,028,907)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(7,812,689)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Net loss per common share applicable to common stockholders, basic and diluted</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(0.26)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(0.19)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1.02)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #cceeff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="10%"> <div>(1.18)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #cceeff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="51%"> <div>Weighted average number of common shares outstanding, basic and diluted</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>12,133,984</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>7,853,292</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>9,879,905</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 3px double; FONT-FAMILY: times new roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>6,602,626</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1971744

30680040

7542875

867135

18889103

10923802

576746

4978892

15493

1971744

19373107

3552749

822769

11771953

405

6777980

406540

2436336

16512

693361

EX-101.SCH 6 nuro-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 103 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 104 - Statement - Statements of Operations link:presentationLink link:definitionLink link:calculationLink 105 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Business and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Net Loss Per Common Share link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Accrued Compensation and Expenses link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Credit Facility link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Business and Basis of Presentation (Policies) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Net Loss Per Common Share (Tables) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Accrued Compensation and Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Business and Basis of Presentation - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Comprehensive Loss - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Anti-dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Income Per Common Share (Detail) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Determination of Net Loss Per Common Share (Detail) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Net Loss Per Common Share - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Inventories (Detail) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Inventories - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Rollforward of the Liability Balance for Severance (Detail) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Accrued Expenses (Detail) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Black-Scholes Inputs to Warrant Liability Valuation (Detail) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Summary of changes in fair value of company's level 3 financial liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Credit Facility - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 nuro-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 nuro-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 nuro-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Payables and Accruals [Abstract] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Compensation and Expenses Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Debt Disclosure [Abstract] Debt Disclosure [Text Block] Credit Facility Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Accounting Policies [Abstract] Business Description And Basis Of Presentation [Policy Text Block] Our Business-An Overview Business description and basis of presentation policy text block. Interim Disclosure [Policy Text Block] Unaudited Interim Financial Statements Interim disclosure policy text block. Revenue Recognition, Policy [Policy Text Block] Revenues Use Of Estimates, Policy [Policy Text Block] Use of Estimates New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Earnings Per Share [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Potentially Calculation of Diluted Net Income Per Common Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted Inventory Disclosure [Abstract] Schedule Of Inventory, Current [Table Text Block] Inventories Restructuring and Related Costs [Table Text Block] Accrued Liabilities Restructuring Actions Statement Of Financial Position [Abstract] Statement [Table] Class of Stock [Domain] Statement [Line Items] Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Accounts Receivable, Net, Current, Total Accounts receivable, net Inventory, Net, Total Inventories Inventories Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current, Total Total current assets Property, Plant and Equipment, Net, Total Fixed assets, net Prepaid Expense and Other Assets, Noncurrent Other long-term assets Assets, Total Total assets Assets [Abstract] Assets Accounts Payable, Current Accounts payable Employee-Related Liabilities, Current Accrued compensation Accrued Liabilities, Current Accrued expenses Accrued expenses Deferred Revenue Current Current portion of deferred revenue Liabilities, Current, Total Total current liabilities Deferred Revenue Noncurrent Deferred revenue, net of current portion Common Stock Warrants Common stock warrants Common stock warrants. Liabilities, Total Total liabilities Liabilities, Current [Abstract] Current liabilities: Commitments and Contingencies Commitments and contingencies (Note 6) Preferred Stock Value Preferred stock value Common Stock Value Common stock, $0.0001 par value; 50,000,000 shares authorized; 13,785,239 and 8,152,746 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively Additional Paid in Capital, Total Additional paid-in capital Retained Earnings (Accumulated Deficit), Total Accumulated deficit Stockholders Equity Attributable to Parent, Total Total stockholders’ equity Stockholders Equity [Abstract] Stockholders’ equity: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Fair Value Measurements Schedule Of Fair value Of Assumptuions Used [Table Text Block] Black-Scholes Inputs to Warrant Liability Valuation Tabular disclosure of assumptions used may change as the underlying sources of these assumptions and market conditions change during the period. Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis Disclosure Business and Basis Of Presentation Additional Information [Abstract] Disclosure - Business and Basis of Presentation - Additional Information [Abstract] Organization and Basis Of Presentation [Table] Organization And Basis Of Presentation [Table] Customer [Axis] Customer [Domain] Customer One [Member] Customer One Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Accounts Receivable [Member] Accounts Receivable Sales Revenue, Net [Member] Sales Revenue, Net Range [Axis] Concentration Risk, Percentage Concentration risk, percentage Other Comprehensive Income Loss [Table] Legal Entity [Axis] Entity [Domain] Other Comprehensive Income Loss [Line Items] Other Comprehensive Income Loss [Line Items] OtherComprehensiveIncomeLossLineItems Other Comprehensive Income (Loss), Net of Tax, Total Other comprehensive income (loss), net of tax Disclosure - Antidilutive Common Stock Equivalents Excluded From Calculation Of Diluted Net Income Per Common Share [Abstract] Disclosure - Antidilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Income Per Common Share [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Convertible Preferred Stock [Member] Convertible Preferred Stock Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Warrant [Member] Warrants Warrants Restricted Stock [Member] Unvested Restricted Stock Option Indexed to Issuers Equity, Type [Axis] Option Indexed to Issuers Equity, Type [Domain] Employee Stock Option [Member] Options Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Potentially dilutive common stock equivalents excluded from calculation of diluted net income per common share Determination of net loss per common share [Table] Determination of net loss per common share [Line Items] Net Income (Loss) Attributable to Parent, Total Net loss Net loss Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features Deemed dividends attributable to preferred stock in connection with embedded features. Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature Return of capital to common shareholders attributable from repurchase of preferred shares and related embedded beneficial conversion features. Net Income (Loss) Available to Common Stockholders, Basic Net loss applicable to common stockholders Earnings Per Share, Basic and Diluted, Total Net loss per common share applicable to common stockholders, basic and diluted Net loss per common share applicable to common stockholders, basic and diluted (See Note 3, Net Loss per Common Share) Inventory, Current [Table] Inventory [Line Items] Inventory Disclosure [Line Items] Inventory, Raw Materials, Net Of Reserves Purchased components Inventory, Finished Goods, Net Of Reserves Finished goods Disclosure Accrued Expenses [Abstract] Disclosure - Accrued Expenses [Abstract] Schedule Of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule Of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Technology Fees Technology fees The accrued technology fees as of the balance sheet date. Accrued Professional Fees Current Professional services Sales and Excise Tax Payable Current Sales taxes Accrued Consulting Fees Consulting fees The amount represents consulting fees which are accrued as of the balance sheet date. Accrued Personnel Related Obligations Personnel related obligations The amount represents accrued personnel related obligation as of the balance sheet date. Clinical Study Obligations Clinical study obligations Clinical study obligations Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, issued Preferred Stock Shares Outstanding Preferred stock, outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Disclosure Commitments and Contingencies Additional Information [Abstract] Disclosure - Commitments and Contingencies - Additional Information [Abstract] Commitments and Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Period [Axis] Period [Axis] Period [Domain] Period [Domain] Balance Sheet Location [Axis] Operating Leases Rent Expense Minimum Rentals Base rent, per month Fair Value Disclosures [Table] Investment Type [Axis] Common Stock warrants Fair Value Disclosure Common stock warrants liability Common stock warrants Common stock warrants fair value disclosure Disclosure Assets and Liabilities Measured At Fair Value On Recurring Basis [Abstract] Disclosure - Assets and Liabilities Measured at Fair Value on Recurring Basis [Abstract] Fair Value, by Balance Sheet Grouping [Table] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value Measurements Recurring [Member] Fair Value, Measurements, Recurring Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Assets, Fair Value Disclosure [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Assets, Fair Value Disclosure, Recurring Total Liabilities, Fair Value Disclosure [Abstract] Liabilities: Liabilities, Fair Value Disclosure, Recurring Total Black-Scholes Inputs to Warrant Liability Valuation [Abstract] Range [Domain] Asset Class [Axis] Asset Class [Domain] Two Thousand Fourteen Offering Warrants [Member] 2014 Offering Two Thousand Thirteen Offering Warrants [Member] 2013 Offering Share Price Stock Price Share price Fair Value Assumptions, Exercise Price Exercise price Fair Value Assumptions, Expected Volatility Rate Expected volatility Fair Value Assumptions, Risk Free Interest Rate Risk free interest rate Fair Value Assumptions, Expected Term Expected Term Summary of changes in the fair value [Table] Equity Components [Axis] Equity Component [Domain] Two Thousand And Fourteen Offering [Member] 2014 Offering Two Thousand And Thirteen Offering [Member] 2013 Offering Summary of changes in the fair value [Line Items] Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Balance Balance Fair Value Measurements With Unobservable Inputs Reconciliation Recurring Basis Liability Repurchase Of Warrants Repurchase of warrants in conjunction with public offering Amount of repurchase of warrants in conjunction with public offering of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in fair value of warrant liability Disclosure Credit Facility Additional Information [Abstract] Disclosure - Credit Facility - Additional Information [Abstract] Line of Credit Facility [Table] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Variable Rate [Axis] Variable Rate [Domain] Prime Rate [Member] Prime Rate Line Of Credit Facility [Line Items] Line of Credit Facility [Line Items] Line of Credit Facility, Maximum Borrowing Capacity Revolving credit facility, maximum borrowing capacity Line Of Credit Facility Expiration Date 1 Credit Facility expiration date Debt Instrument, Basis Spread on Variable Rate Interest rate over prime rate Restricted Cash Collateral Letters Of Credit Credit Facility limit restricted to support letter of credit Restricted Cash Collateral Letters of Credit Line of Credit Facility, Remaining Borrowing Capacity Line of credit facility, remaining borrowing capacity Disclosure Public Offering Of Common Stock and Warrants Additional Information [Abstract] Public Offering Of Common Stock and Warrants [Table] Subsidiary, Sale of Stock [Axis] Sale of Stock, Name of Transaction [Domain] Two Thousand And Fifteen Issuance [Member] 2015 Issuance Two Thousand And Fourteen Issuance [Member] 2014 Issuance EX-101.PRE 10 nuro-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(``!\5D=,.FCZM@$``!07```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RT[#,!!%?Z7*%C6N'=ZBW5"V@`0_8))I8S6.+=M]_3UV"@BJ@EJ@ MTMWDT3N>>Y-QSJ(WSVM+OK?23>N'61V"O6;,ES5IZ7-CJ8W*Q#@M0[QU4V9E M.9-38F(P.&>E:0.UH1]2CVQT\[`@YU1%O=N-D'H/,VEMHTH9E&G9HJVVNO;- M9*)*JDPYUW%)'J(UG40]ZSU*%^ZECBW8JF&=L#GR/.GL?PR]=20K7Q,%W>0^ MK!ORN_PWRKOSF"9RWH2#C-_>7>ZHZ6I\K>R;U=TJ=O'QMV$65;^7P_;"GY(I MG89FV^F7%>G^E\^R]1(7NAD[N51;!HNCC2F=::W?]W=`[T;/N=$1(')1#@.0H0'*<@N0X`\EQ#I+C`B3')4B.*Y`QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6:E((C-Z." MN[_8_`)02P,$%`````@``'Q61^,.F.&*`0``%A8``!H```!X;"]?P"(30`D/ MV:[:W+Z4144?'G41Z=N``&G\W_"3Y5T;\NV37%VLNS94=1]F[\VU#=OA_3ZK M8NRWQH2BDL:%AZZ7=OAZ[GSCXO#H2].[XN)*,9SG2^.G<[+#[N?LV?&TS_SQ M1-GLQ?E2XCY[Z_PE5"(QF/%&#\,"P^=;+_]9OCN?ZT(>N^*UD3;^46&^%LA, M.HC300P)LND@"PF:IX/FD*!%.F@!"5JF@Y:0H%4Z:`4)6J>#UI"@33IH`PFB M7)$QQR1I6&.T)H5KPGA-"MB$$9L4L@EC-BEH$T9M4M@FC-NDP$T8N4FAFS!V MDX(W8?1F16_&Z,V*W@S::VN;;8S>K.C-&+U9T9LQ>K.B-V/T9D5OQNC-BMZ, MT9L5O1FC-RMZ,T9OJ^AM,7I;16^+T=LJ>EO068EV6(+1VRIZ6XS>5M';8O2V M$[U#Y;R(MZO&ULO59+4]LP$/XKFEQ*#ZE#*)T.$SP3`DR9@9)I*)P7>8,UD257*P?H MK^]*3E('G$!Z:$[RZMO7MP]E8*AW-':V1.<5DG@JM*$C%AYW5@ M'C!K8E]?+KFX14=4G>I7?6S2A']#1( M5L)X;&*;9_4Y/3B,"#ZM(Y-59NF"MK6\@^1&>8UT/1V#\_^)BIC3DHB#PTXC M^Z4),329.#.>VU%IT`AJ,1#%YQ=H&B-CC9-E)CI['0G]L59EX M;M80"@D[%=?<;3&"=OOKX!%0+LZU?=P03$7*()$`SO$$2$6EL4-B`^!;=<*D M.@+,V>/UO$J:;T?2NDJS((A+CG% M_&/09T_A>U.@A?(U%0$ZLEQ$GD\C-WDYYUX4MZ`K%%<(5+F:R';KO!^4%^<@ ME>;6V%`+*V>YU1G/^P=Q]JO:!-Q:A_W#W0@6>S=PK]^BN48AM;?<5K[WO^[" MWM+1[HGW>^]L0-$5PXRKP4%">^)#+GTW4[KR06?)5BA/+$NKSBEZ=(4R=?(< MUCKC.Q8EAOAV4=@IJ`U[H`EL9KQ82ZTZ/ZP.Z_$17!92X$4C+A7"ON MP#E^E=J'MBH*<,^!+1G?,X1OV<9O*S.NY=#0_'5D]M\.U^\E,GZ M/[ST#U!+`P04````"```?%9'?G7[]CX!``!I`P``$0```&1O8U!R;W!S+V-O M&ULS9--3\,P#(;_"NJ]2]-I($5=#X`X,0F)(1"WD'A;6/.AQ%/7?T^6 M=2T#+KMQJVN_CU_'224<$];#D[<./"H(5WO=F,"$FV<;1,<("6(#FH=)K#`Q MN;)>+?S38)) M0:`!#08#H1-*LOK%;(UM345&?5U%QPT/N+!2K13(VVXL^YV*G1&\#D.3P;1=5-C`A;M-&IF6 MFSX32$(07CE4UER$2YAOX@0+NX]/$'@YJ!>FR[:%KK5>ACK=KS$ZO)RXLK7U MW3'U(SI[5?474$L#!!0````(``!\5D>97)PC$`8``)PG```3````>&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?= MTXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%, M4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SOX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38: MC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5` MY3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@` M`'Q61^`,5_)E`@``3`P```T```!X;"]S='EL97,N>&ULS5==:]LP%/TK0AFC MA1';"4G;U3:,0F"PE4'SL+='5T[[E' MTK6O$U9J3?'3`F,%5HSR*H(+IE"\Q0-10EYGHE%Y(AI:>R\*I28I15 M)HA1;^3[4X\APF$<\IK-F*I`*FJN(CAI(>#B'T2&(_A\]?E/+=3])^#&P9?! MP'^^OM_%K^S"-02.XWL6P6`Z@=[;28>^OY_8+.Z03X\E?YU]E_YF#WU?ZUYM MMT=J>TW9#O6=H?::RXO#7/#N#D?0`7%8O8`EHMH_,.ZIH$("I8M$:[`(1PP[ MCP=$22*)`7/$"%T[>&0`6U>-'R-<2)O;9=C-,_2[3+)((N@WO[>G2SIV.YCM M$4JWMZ>!."R14ECRF9Z`QIZO2[TY+CAV(JW?`>]"HG4PFO0"[*#S)D)F6+:9 M`[B!XI#B7.D`28J%&94HC72AE&#:R`@J!$?44&XB&D/3IIC2)_,4_\ZWN%+RD\IZ;.(NWV2..*"$5J22I.^_0[E.QV9-/N7EF4-3_G\'$X[]UL:^SSDS'/XK52VLWL M/"F]KV>#@VW@=EL9([7)F\JU'Z0#8?3@44%7AKM M2EF[9*?F_H^:JRU"X4I$7ZE.K`*IDP_OW6PC%3ZB=20LH*X_087SY%4E0H'S M-X7T6,R3,2W-%GLO;%-?-5*%Q60X209!;!_JO16Y*;`3>RBE^[K[(Q$%;J!1 M_H&\[3])LG&733B-\]BAQZ[A@>"$@]_(%'^!IG@P3`8TWMU)YM-?@\6]K MFEKJ;Z25B(VTSJ]#N.V7E=2RDC^"W[1RI=G^8ZS\8;0'ME+J,0\F0Y)\$4Z^225]-_G2?NL,$0R.`BE3?^O)Z';Y.Q+ M+!:Z$#?:DXI8Z:YXE)K@`WV\*MJ-[4S2@UT5:9HB-5\$QHRH2FQT)+4]&1*5$[`D[<&<>= M>,MLWQ[;?J*G8"'NT0H2JNA@K4O**I.X9!*7QQ(K_4(.$Z/(]WW'C-X=&RWR MW#98A"VI`[@V^VTB;E[#FI,TY"@-H^%7TG>E"`I+.BITME#G?8_2'I,1*&]! M6O$(JD'Q$<$UMJLOE^!XIA$^EQ:IYXA;R-LCQDTYD6D429,_ET85U&;^$#?_ M-@?VG,O5M+TWMP>,6%6!1$$44*/-<9 MYS>+\+L@[B\*J9IP\?RL6\"JQ8E+]=ILA.-KI)N*;J(NWQ1;'PDNQ;G.(ER? MAJF-DTMQQ+,(XCV8R$60O9Z?<:ZS"-?Q2!>^$<[AS:9R>XLY/EM1]QN$>QB4%!_GRQSJE#DL)*UPT)>R.^@K6@>UYQ MN$<1N-=-58']'NJ6ET!)E..>CR6Y\^S6QT=!*W:D(\ZQKMZ'9*`]#+OUTM]AX$EI<6'^DP7>>A.F4 M!M%&J26]^ZSO#+0S7*>\'VL__`=02P,$%`````@``'Q61U>3W?-6`@``]`<` M`!@```!X;"]W;W)K[UU1I-:/B`JVS_W[Y4(L3]$8%WY?G'.!`-E#VP2M"A/?9 M-AT_^I40_0$`7E2DQ?R%]J23?ZZ4M5C()KL!WC."2VUJ&X""(`$MKCL_SW3? M&\LS>A=-W9$WYO%[VV+V[T0:.AQ]Z$\=[_6M$JH#Y!F8?67=DH[7M/,8N1[] M5W@XPTA)M.)W309N?7LJ^`NE'ZKQLSSZ@8J!-*00:@@L7P]R)DVC1I+DO^.@ M3Z8RVM_3Z-]UNC+\"^;D3)L_=2DJ&6W@>R6YXGLCWNGP@XPYQ&K`@C9BQ6G-X".7,%1[7G[R,SRA.MB)Q`^(-0&S9=TZ` MK4C=@&0#D%CVO1-@*V#@)NPV"#O;#Y>(V"",I#/+',#8#4DW(*D-^;)3$@-9 M2%:VRGX#L;?]D7.J%I*5+-3IL,I0/Y\C),[)&C7=F&NZ3^.558'.VIU0B])T M[ZVE9F5W06 M->/BA+LT1N'^"PM8AVQ+V$U?/MPKZ+W3=YW5.U]PKT@?TD]YGO7X1GYA=JL[ M[EVHD$>]/I>OE`HB0PE>9$B5O(+G1D.N0GWN5*SF4C(-0?OICITO^OP_4$L# M!!0````(``!\5D='K;<.'@0``,P2```8````>&PO=V]R:W-H965T&ULC9A-C]LV$(;_BN%[(\[P0]3":Z!64;2'`D$.[5EK<]=&),N5M.OT MWY?ZL#,TADPNED6]0[XLOC7UN7]>'X?A\I1E_?[HFJK_ MU%[UYU[O5Y_2L\E5*. MDDGQ]\E=>_)_-9I_:=NOX\V?A^>U&#VXVNV'L8K*7SYIZK,FW_.]2Z?];[TH\MJDWV,=:S2'"2[`()IR@# MA;Y+,M_^W01R)N1L`FF\X>,E%Z_F>$GC\]!B/G=BEIPG20%@K#"#=Z(0;3=T4K!M-F@&1(QAD[5"= MR8L\9L+O MUB_*/\G.K=VB68"A#"A^#@8ZC6ASB#A*`14H467..Z*HS(W1FM65@<[ZQ:QE MQ%$*J4"9*GFF@@I&5*(U_,((A6B4S2.[#J3`"I2LDBDH!%BAA%4]8",@I5(1G@:PPT;66 MHBM0O"H>KT#!:3W&!4^T0*>ER"7A=6@IA5B@C%4/75^.+T#IJ92T4EE.6`9" M*T![[D<.9"G4(D7MXY2=-;M0HSE-&=.$3E)X18I7%5FFF,(K4KPJ_GB(%)N" MS6Q$$OI(014I5!^';YEZ2&$),F>A4@8J&QW@%$^1\E3Q[,(`D_[,B' M4IWG1NDB@@M,,14I4S6/,*2L_,4?^ZPV&GBN/FBU\L"3(K),,057I'#5/,@P M.+FJ0BC-;].!4$J_2T=',057I'#5/,TP@&OJ1!0JDRCF6^#.Y2+X>RQ\# M4`8OOHHE8*!YG!@9^>YPJ=[<7U7W=CKWJY=V&-IF^M[PVK:#\Q6)3SZ[1U<= M[C>U>QW&O_F8]OECRWPSM)?;MZ/[!ZSM_U!+`P04````"```?%9'4QAL]J," M```D"P``&````'AL+W=O^R>+" MAG=^H%1$'UW;\V5\$.(X3Q*^.=".\!D[TEX^V;&A(T(.AWW"CP,E6QW4M0E, M4YQTI.GCU4+/O0ZK!3N)MNGIZQ#Q4]>1X>\+;=EE&8/X.O'6[`]"322K17*+ MVS8=[7G#^FB@NV7\!]7(F_)IS6K/W=;,5!TJ9QM*4[EU?B2"KQ<`NT6":<22JYV">R9W;1%Q/#F:[Y,JXG#VO\GR1G%6>40*U MY,660)^B=A2?21)9_P8!?1#(0$`;`KLE2@-A)+V6I+,T!3Y5_5CEL&0!ELQF M*=PJN6')K"IYJG\^71W2.3PHP(-LGM++@^Q5>TG\"H'2G^[[Y_8X)"AZ@,$)4V M$?02E58AD!5E#C-O,VM;6((<%@C[@:H`4&4#95Z@:BI0-15(&?=#(O7P\SW. M'F3PNN4U`WC^-8X:[Z>@"+1AVIH,`S3++*]Q>4+&">#S+Q/`"3QP.D_(/('M MGACY>6Q;!"`MO>]&'9"Y/"'S!(Y[H@<90M8'\@D=MZVM0@!A_XHF."`(62#` M$[J-I['@"2PA`P3%A$[;S@90\<@`'=T]3&*=9XYD3W^28=_T/%HS(8]&^ARS M8TQ0F2B=R80'>62]#5JZ$^JV4)7,(SZ2W@_'J'U!+`P04````"``` M?%9'U1]@92\$``#M$```&````'AL+W=OJ_M$JHL_AU\.55WF M;7BLW]+F4OM\WQN51^$U5_'W:M\<0+5LD>W_(WXOV>W7]W8\:5#?AKBJ:_F^R>V_:JKR9+)(R M_SE\GL[]YW7XQ;+1C#;@HP&_&]S]T`9B-!"?!O*A@1P-Y/_UH$8#-?&0#MK[ MS&5YFZ^6=75-ZF&Y+WGW5L&S"FNS2YI^L!X6).2N":,?*ZV6Z4,&<&`UQ6TPIX5C7%%8AC$N%,BIO(';1FX=S8W!V M)#-.DMF),24DN:89QKCE2EEZ[3$GN!$XBY$Z^T"=Q>K(U5K;Z!W38;,94A[F ME##&TJ]VA($5RI'<-G*KC=5Z9N>Z!_(NRMIA/\)JH+?`)N:`,2!?ALQ% M)XXRS)+<%G-",\7DS,G;5?59@=V/GPK)3*Y'9@R).ZX%Z3>_#"/G"!52C&+CHA8UZ/N`'![0-?I M-42%.AQ[C"Z@$:>T5/1Z9!$GI!&6D:?;=N(X-%XP4P/A48L`N$>PDYC&%@]4 MM/\XZVH`V>3%9#ADP("@R"PFM0S]X/38'1N]F)0V'+Q\3BG9+MR4XG[!3G86 MP"A58V?LB6N2VTPY<"27Q1P\,4YRVRD'=D;AHX8&<$=#%ZBL<8[1A3\"M69-X`,9YU-_O^[O@Y_6IYR=_\GWG]=CHWR6O5AAMH?UT\5%7K M0^3L*2@X^GQ_?RC\H>V^FD[:)(ZO;D[4-M[F*CJ.1B M6_)?K+^X?!2UO3?MC^[B7)_\K,JZ>]E<^O[VG*;=X>*JHOO2W%SM_SDU;57T M_K(]I]VM=<5Q#*K*%!C3:557#1L\N-(=^J&)PG^]N]R5Y="2S_SWW.A'SB$0_UY:_W4LU]M_ M+3J7-^5?UV-_\6[9)CFZ4_%6]M^;^V]NKD$-#1Z:LAL_D\-;US?5$K))JN+G M]'VMQ^_[]$_&YC`Z`.8`>`0\\M`!8@X0'P%RK'1R-M;U2]$7NVW;W)-V&HQ; M,8PY?Q:^YPY)-]YLI^[RE77^[OLN$]OT?6AGEL`HV6,)?RA2W_@C`U`9YG!` MX4`ER+%"&SJ#H#*(J0:!:Y!TO*3BY10O<3P++9JIB$E2CY(G+4T&'"AA'@AE MI@R#2)^IE8H4=J3H>+U2D<;Q.C2JIHHT,LHULU90LCR0,0&*T6[,BAN#W1C2 MC4%I0&K)2--Y(&.94!GM)EMQDV$W&>DF0VD8:00K%,M,9-;9%1\6^3"6]&'Q M9!+2B(Q)TDX@Y$I)R2.S;B!;=-H-?W[TC8VT0.)D+HIC6%BR[_:S9BD+N%:* MK"H4@A]P'1EO3@)H\100B.[I6;-XLB`!:$^!4!N_*T8LD<1:+&%D64Y;$B%* M_)J@EV@H!$\G';&T!D&.*2AH9G!,-PD"3&3@L(Y;F_'8N)$07!QA"EIR./:S M9LHDF)7D@LX#62:YX)%MAJ]1E6.LTKS<X?J'3$C_S?O;1&1U"!*QJ/@+GWQ)GB])-&'@A!6@ZQK1;6"`DZ,$4C M$C#Z+("?_?0V$@JY54:)B*DU2(()3-&4!!/DXCJ++5TL''3Q)WQ8@R1D@:L( M)6&-DF"#)FA,`J8?^,D66R8VF,!2QBR)-4H*%ECZE&H^3`E&KDA\C`HD_FDV MR^#S(W:*#KJ5:\_C"X`N.31O=3\<+='=QTN&KS`FZ9UWR+[X?KNXXOBX*-VI'WZ:H4.G%P;31=_< MEO&PO=V]R M:W-H965T&UL?5/;;IPP$/T5RQ\0@W>3IBL6*9NJ2A\J17E( MG[TP@!5?J&V6]._C"Q`V0GW!,\,Y9\[X4HS:O-D.P*%W*90]XLZY_D"(K3J0 MS-[H'I3_TV@CF?.I:8GM#;`ZDJ0@-,ONB&1

.8QV%:/@_:SU M6TA^U4>_9E9>-3B#Z]= MY\UF&-70L$&X%ST^P33";1"LM+#QBZK!.BUG"D:2O:>5J[B.Z<]NIFT3Z$2@ M"^$^B\93HVCS!W.L+(P>D4E;V[-P@OF!^HVHD(U%DZ;W1JVO7LH\NR_()0A- M&!HQIRO,@B!>?6E!MUI,=+JBTVWZ;HN^2PYW5PZ_;POLMP3V26#_OQ$3YG2% MR;,O3":?\++H60N_F6FYLNBLG3_9>`R- MU@Z\B>SF%J/.OY\E$="X$'[SL4E7*B5.]_,#65YI^0%02P,$%`````@``'Q6 M1\K,W#JB`0``L0,``!@```!X;"]W;W)K<$SPSEG MSOA23MJ\VA[`H3Y#,WN@!E/_3:B.9\ZGIB!T,L":2I"`T MR^Z(9%SAJHRU9U.5>G2"*W@VR(Y2,O/O"$)/!YSC2^&%=[T+!5*59.$U7(*R M7"MDH#W@AWQ_W`5$!/SF,-E5C(+WD]:O(7EJ#C@+%D!`[8("\\L9'D&((.0; M_YTUWUL&XCJ^J/^(TWKW)V;A48L_O'&]-YMAU$#+1N%>]/03YA%N@V"MA8U? M5(_6:7FA8"396UJYBNN4_A3W,VV;0&<"70C?LF@\-8HVOS/'JM+H"9FTM0,+ M)YCOJ=^(&ME8-&EZ;]3ZZKG*\[PDYR`T8VC$'*\P"X)X]:4%W6HQT^F*3K?I MQ1:]2`Z+*X>?".RV!'9)8/?5B`ESO,84'YJ0U9Y*,%V\.A;5>E3QHJZJR^U\ MH/%,WN%5.;`.?C'3<67123M_LO$86JT=>!/9S2U&O7\_2R*@=2&\][%)5RHE M3@^7![*\TNH_4$L#!!0````(``!\5D>>N0TTH@$``+$#```8````>&PO=V]R M:W-H965T&UL?5/;;IPP$/T5RQ\0@Y=-HQ6+E$T5I0^5HCRT MSUX8P(HOU#9+^O?QA25LA?J"9X9SSISQI9RT>;<]@$,?4BA[Q+USPX$06_<@ MF;W3`RC_I]5&,N=3TQ$[&&!-)$E!:);=$\FXPE49:Z^F*O7H!%?P:I`=I63F M[PF$GHXXQ]?"&^]Z%PJD*LG":[@$9;E6R$![Q(_YX50$1`3\XC#958R"][/6 M[R'YT1QQ%BR`@-H%!>:7"SR!$$'(-_XS:WZU#,1U?%5_CM-Z]V=FX4F+W[QQ MO3>;8=1`RT;AWO3T`O,(^R!8:V'C%]6C=5I>*1A)]I%6KN(ZI3^[;*9M$^A, MH`OA(1)(:A1M?F>.5:71$S)I:P<63C`_4+\1-;*Q:-+TWJCUU4N5YT5)+D%H MQM"(.=U@%@3QZDL+NM5BIM,5G6[3=UOT77*XNW&XWQ8HM@2*)%#\;\2$.=UB M[O]I0E9[*L%T\>I85.M1Q8NZJBZW\Y'&,_F"5^7`.OC)3,>516?M_,G&8VBU M=N!-9'=[C'K_?I9$0.M"^,W')EVIE#@]7!_(\DJK3U!+`P04````"```?%9' M<[Q:S:(!``"O`P``&````'AL+W=O0/D_K3:2.9^:CMC!`&LB2`I"L^R& M2,85KLI8>S95J4>->[4"!52199 M\T,R`-?QA?TI3NO=GYB%!RW^\L;UWFR&40,M&X5[T=-/F$>X#H2U%C9^43U: MI^4%@I%D[VGE*JY3^K.C,VP;0&<`70!W632>A*+-1^9851H](9.V=F#A!/,] M]1M1(QN+)DWOC5I?/5?T1TG.@6=NH;'EN&[)EP[BR1<%NJ4PP^E:81N^VX+O MDL'=6CV_W28HM@B*1%!\,V%J.1:?-.Z^:)#5CDHP7;PX%M5Z5/&:KJK+W;R/ M1T@^VJMR8!W\9J;CRJ*3=OY&UL?5/;;IPP$/T5RQ\0@Y?TLF*1LJFJ]J%2E(?V MV0L#6+$9:ILE_?OZPA)2H;Y@>SCGS!G/N)S1O-@>P)%7K09[HKUSXY$Q6_>@ MA;W#$0;_IT6CA?-'TS$[&A!-)&G%>)9]8%K(@59EC#V9JL3)*3G`DR%VTEJ8 M/V=0.)]H3F^!9]GU+@185;*5UT@-@Y4X$`/MB3[DQW,1$!'P4\)L-WL2O%\0 M7\+A>W.B6;``"FH7%(1?KO`(2@4AG_CWHOF6,A"W^YOZUUBM=W\1%AY1_9*- MZ[W9C)(&6C$I]XSS-UA*N`^"-2H;OZ2>K$-]HU"BQ6M:Y1#7.?TY%`MMG\`7 M`E\)G[)H/"6*-K\()ZK2X$Q,NMI1A`[F1^XOHB8V!DVJWANU/GJM\OQSR:Y! M:,'PB#F_PZP(YM77%'POQ4+G&SK?IQ_VZ(?D\+#-SK-]@6)/H$@"Q?]*3)CS M.PS_MTBVN5,-IHNC8TF-TQ`'=1-=I_.!QYZ\P:MR%!W\$*:3@R47=+ZSL0TM MH@-O(KN[IZ3W[V<]*&A=V'[T>Y-&*AT&UL?5/; MCILP$/T5BP]8$X>T5420-EM5[4.EU3ZTSPX,8*WMH;8)V[^O+X0E*]07/#.< M<^:,+^6$YM7V`(Z\*:GM*>N=&XZ4VKH'Q>T##J#]GQ:-XLZGIJ-V,,";2%*2 MLCS_1!47.JO*6'LV58FCDT+#LR%V5(J;OV>0.)VR778KO(BN=Z%`JY(NO$8H MT%:@)@;:4_:X.YZ+@(B`7P(FNXI)\'Y!?`W)C^:4Y<$"2*A=4.!^N<(32!F$ M?.,_L^9[RT!48::/DHW0M.WV$>X1`$:Y0V M?DD]6H?J1LF(XF]I%3JN4_IS8#-MF\!F`EL(7_)H/#6*-K]RQZO2X$1,VMJ! MAQ/<'9G?B)K86#1I>F_4^NJUVC%6TFL0FC$L8LYWF`5!O?K2@FVUF.EL16?; M]/T6?9\<[N\<[K<%BBV!(@D4_QLQ8<[WF.)#$[K:4P6FBU?'DAI''2_JJKK< MSL=XB/0=7I4#[^`G-YW0EES0^9.-Q]`B.O`F\H=#1GK_?I9$0NM"^-G')EVI ME#@<;@]D>:75/U!+`P04````"```?%9'WY'PY:,!``"Q`P``&0```'AL+W=O M;0?@T*<4RAYPYUR_)\16 M'4AF;W0/RO]IM)',^=2TQ/8&6!U)4A":9;=$,JYP6<3:LRD+/3C!%3P;9`OWD/RI#S@+%D!`Y8("\\L9'D&((.0;?TR:WRT#<1E?U)_BM-[]B5EXU.*- MUZ[S9C.,:FC8(-R+'G_#-,(N"%9:V/A%U6"=EA<*1I)]II6KN([ISS:?:.L$ M.A'H3+C/HO'4*-K\Q1PK"Z-'9-+6]BRB2@\J7M1%=;Z=#S2>R3>\+'K6PE]F6JXL.FGG3S8> M0Z.U`V\BN]EAU/GW,R<"&A?".Q^;=*52XG1_>2#S*RV_`%!+`P04````"``` M?%9'=[.\TZ0!``"Q`P``&0```'AL+W=O`*\C M24G*\OP;55SHK"QB[<64!0Y."@TOAMA!*6[^'D'B>,@VV:7P*MK.A0(M"SKS M:J%`6X&:&&@.V<-F?]P%1`2\"1CM(B;!^PGQ/23/]2'+@P604+F@P/URAD>0 M,@CYQG\FS:^6@;B,+^H_X[3>_8E;>$3Y6]2N\V;SC-30\$&Z5QR?8!KA-@A6 M*&W\DFJP#M6%DA'%/](J=%S'](?=3;1U`IL(;";A"<,BYGB%F1'4J\\MV%J+B MU$5UOIT/+)[)%[PL>M["+VY:H2TYH?,G&X^A073@3>0WMQGI_/N9$PF-"^&= MCTVZ4BEQV%\>R/Q*RT]02P,$%`````@``'Q61\.MZE2B`0``L0,``!D```!X M;"]W;W)K&UL?5/+;J0P$/P5RQ\0@YEL5B,&*9,H MRAY6BG+8/7N@`2M^$-L,V;]?/QA"(I(+[FZJJJO]*"=M7FP/X-";%,H><._< ML"?$UCU(9J_T`,K_:;61S/G4=,0.!E@325(0FF4_B&1]"P52E63A-5R"LEPK9*`]X-M\?]P%1`3\X3#9 M58R"]Y/6+R'YU1QP%BR`@-H%!>:7,]R!$$'(-WZ=-=];!N(ZOJ@_Q&F]^Q.S M<*?%7]ZXWIO-,&J@9:-PSWIZA'F$ZR!8:V'C%]6C=5I>*!A)]I96KN(ZI3_% MS4S;)M"90!?"SRP:3XVBS7OF6%4:/2&3MG9@X03S/?4;42,;BR9-[XU:7SU7 M>9&7Y!R$9@R-F.,'S((@7GUI0;=:S'2ZHM-M>K%%+Y+#8MT]_T)@MR6P2P*[ M[T9,F.-'S._?SY((:%T(;WQLTI5*B=/#Y8$LK[3Z#U!+`P04```` M"```?%9'+X"VV]X!``!$!0``&0```'AL+W=ONZ95)H"+ M'*^\JF/0RX[W2$!]"IYVQW-F$!;PNX-);O;(Y'[A_,,*SD4WS!U&D MR`6?D)BO=B#F"^Z.D;Z($DD;%'/U.E&IH]=B%\+ MR&>QT*,-/?+38Q\]GC.,M^[AHU\@\0DDLT#BE)BX)LSL[-M%U8#Q%MDV^X$4^D`9^$=%TO407KG2SV@ MDP@?]#=K]4A;#Q1J9;8'O1=SE\\'Q8?;S%H'9_$?4$L#!!0````(``!\5D<2 M:XPDL0$``!8$```9````>&PO=V]R:W-H965TVB4I1%N_;`!:SX06TSI']?/Q@"%>T&VY?SNMBF MG)1^,SV`1>^"2W-.>FN'$\:F[D%0\Z`&D.Y-J[2@UBUUA\V@@3:!)#@F:?J( M!64RJ]%5J4;+F807C$0`_&$QF-4<^^U6I-[_XUIR3U$<`#K7U"M0--W@&SKV0,_XU M:WY8>N)Z?E?_$KIUZ:_4P+/B/UEC>Q1R3!.\4UQG&G[!#(3R$+XE(;@T2C$_$PMK4JM)J3CIQVHW\'L M1-R'J)$)11V[=T&-J]ZJ+#^4^.:%9@P)F,L&LR"P4U\LR)[%3"&UL;5/;;J0P#/V5*!_0 M0(9NVQ&#U.EJM?NP4M6']CD#!J+FPB9A:/^^N3"46?%";.-S?&PGY:3-N^T! M'/J00MD#[IT;]H38N@?)[(T>0/D_K3:2.>^:CMC!`&LB2`I"L^P'D8PK7)4Q M]FRJ4H].<`7/!ME12F8^CR#T=,`YO@1>>->[$"!5219[$91@VT;!3N14^_86[A-A#66MCX1?5HG987"$:2 M?:23JWA.Z<^.SK!M`)T!=`'<9U%X*A1E_F2.5:71$S)IM`,+&\SWU`^B1C8& M3>K>"[4^>J[RXKXDYT`TY]"8<[S*63*(9U]*T*T2,YRNX'0;OMN"[Y+"W;IZ M?K=-4&P1%(F@6-=_N.XPI1R+JRD\_%>#K$8JP73QYEA4ZU'%>[J*+I?S,>Z0 M?*=7Y<`Z^,M,QY5%)^W\8N,66JT=>!'9S2U&O7\^BR.@=<&\\[9)-RHY3@^7 M][$\TNH+4$L#!!0````(``!\5D?1;[]PL@$``!8$```9````>&PO=V]R:W-H M965TPZ$UP:4Y);^UPQ-C4/0AJ[M0` MTKUIE1;4NJ7NL!DTT":0!,6==;7\!5B1=>PP1(PY1$&MI3%#\-VML[\*F M"6J@I2.WSVKZ#G,+(6&MN`E/5(_&*G&C)$C0MS@R&<8IOCGD,VV?0&8"60A? MTA`\&H68C]32JM1J0CI^VH'Z'8!8&=^F)!]BQF.EG1R3X]WZ/G,6&^=B?IOL!A3^`0!0Z;%K-MBQ%SWF+^ MD;+XCTFQ%LB^[IIL,$7^P02O-DZ`[L+Y-*A6HPRW855=KL`]"1O_#J_*@7;P MD^J.28,NRKKC$_:Z5N12]NZ3+@D-K_?2SF^MX;N/"JN%V"Y=?0?47 M4$L#!!0````(``!\5D>.\"K9P0$``'L$```9````>&PO=V]R:W-H965T&5M9UP!EP5>>#43T&LF>Z2@.26/N^,Y=P@/^,U@TJL]F(Z_U-_=EW:]-?J(8GR?^PVG0V;)J@&AHZ MHB9;S+?_3/#J=@A0K1\"C2HY]G[D5M5ESA[] M=<2?\+(8:`N_J&I9K]%%&GM'_85JI#1@0Z1WMM7.?@F6`X?&N.V]W:LP'.%@ MY'`;]>5[4_X#4$L#!!0````(``!\5D<=,T!$0,``(\-```9````>&PO=V]R M:W-H965T=J:+=?=B93A^V MSU2C,@7BDEB[?[$!"7L)>*#0#CWW'.2W(3$5U9]\A.EPODN\I(OW),0Y[GG M\=V)%BE_8F=:RC<'5A6ID(_5T>/GBJ;[.JC(/>S[D5>D6>DNX[KMM5K&["+R MK*2OE<,O19%6?U%B]RVX2T[GH1J\):Q=XO;9P4M><9*IZ*'A?N,YB\X M4)`:\3NC5]ZY=Y3X#\8^U]^R;VN[4OY'RNF:Y>_97IRD6M]U]O207G+QQJX_J/80*L(=RWG][^PN7+"B M#7&=(OUNKEE97Z_-&S+387``U@'X%G#+`P=,=,#D'A!8`P(=$(S-$.J`<&R& M2`=$]X#(&D!T`.EE\)K>K<C MPV7KUQ)%?NQ]*2*-P35FU<5$$01)#!H(L343W3&>%'E3BB&E6@7N$&`HQ;J+ MB`BH\R')YC')UB`)(<@+-MQBV.T$BRT]%AH M='E@)@J;+@L[B:0]^8-@B05FR(DL%PO,D$,LE&TQB8J9P$K5##691+SL4LP$*<$W53A$:8Q6! MBUVK`H\P:X+(P*`B<)EI\QCK#!E8EA&XT+1N@U%N;96'C-(C&'*[[8&&\MA* M"ADU18(!"K`,6K=DE%NP$%H5T\=N5SU0"$\`$S10E,A65,BH&$)@"@Q6C.X2 M[(_I$@Q6C%:!T>,N27J@@>+&MK+"9L4,%#>V;SA+/6'U+]MI7:+Y&0'N"YIOFI'"G M7\;G]$A_I=4Q*[GSP83\@JT_-P^,"2I5^T^RDD_R='1[R.E!J%NBML_FO-`\ M"'9NCS^W,]CR'U!+`P04````"```?%9'Z$UE$L$!```]!```&0```'AL+W=O M M.-5/<@1A3UJI.#5VJSJB1P6T\23.2)HD>\+I('!9>-^;*@LY&38(>%-(3YQ3 M]?<,3,XGO,,WQ_O0]<8Y2%F0E=<,'(0>I$`*VA-^V1VKW"$\X/<`L][8R.5^ MD?+#;7XV)YRX%(!!;9P"MEML@E&#;1T8N9=SC]@*>'9"=:2:?]%]:2-Y#<*1IQ^A740?IW#R3Y;:'%" MNA#2E;#&B1.RA9#=";YU)&3FZ_I.#2T+)6>DPBQ&ZD:^.V:VY;6I"K$UHPJ<><'S`K@ECU-40:"['0TPT]&J#:(O:'>(0L%B$+160/ M161Q@3PFD`>!_$$@?TSR$,H(&.$Q20Q1Q1$A";(9"P?5^>NJ42TG85P?-M[U M1;RD;JS_^<_VI82+?97K&J+=O>=TP M:(TS#]96X7J'C9'C[;&N?XSR'U!+`P04````"```?%9'8K#GD>\"```4"P`` M&0```'AL+W=OVF<'!'AB6]06(?W[2KX0B5F(7[`EGSV[Y\BL=W;6S5M[4,I$ M'U59M_/X8,SQ(4G:S4%5>?M-'U5MG^QT4^7&+IM]TAX;E6^[H*I,"$(BJ?*B MCA>S;N^Y6U*E/L]C'(\;+\7^8-Q&LI@EE[AM4:FZ M+70=-6HWCQ_QPQH+!^D0OPMU;KW[R!7_JO6;6_S>``.@30SP!V M-X`-`6QJ!CX$\*L,2:^]?(P0$&05T%P0B2W@4@6!JA@R$"^<0`F6/D)(L(8O M2=8W2((R*50F[L)6$!P)8/W7O28NL-0)%*$&(*`2Q\H.2.I MY!!NY>-P1B7%",R\#C)S3B3+8(G\CD0>2$QA`G''9#'%9'FG`CG!9.E)387$ M%+1NZ<.X%)()T.&`C1`I,M!?'\:0X-ZY!N+2.^+20-R-\\GNV)M-L==UV)LE MN(=?&CR`ZO$]2#.,*.AQ@&29M%`"NAQ28BEQQD'*=8`DC`I*;PD%>^,H-.AJ MV8W3PF!C&]S&9)+=8-,9JZ!3[*:>8KA=!!#,609ZMPI@#('_BW7()3@F-X3= M:X8XZ(;9C<\&!IO-:"^?9"_8;L8JQ!1[A:\7982F"'Q)ER$RDU@R!OOL`X64 M,DO!B;%7"P(^IE4:J=<;?2 M*>N'MGYA]'&<02^#\.(_4$L#!!0````(``!\5D?L=7D\QP(``,<)```9```` M>&PO=V]R:W-H965T,T2>3FP)M23L21M_J?G>B:4NEEMT_DL>/EMG=JZ@0!0)*FK-IX,>MM MS]UB)DZJKEK^W$7RU#1E]V_):W&>QS"^&%ZJ_4$90[*8):/?MFIX*RO11AW? MS>,G.%WGANB!WQ4_2^<^,K6_"O%F%C^W\QB8$GC--\I$*/7EG1>\KDT@G?CO M$/.:TCBZ]Y?HWWNUNOK74O)"U'^JK3KH8D$<;?FN/-7J19Q_\$$"-@$WHI;] M;[0Y226:BTL<->6'O59M?SW;?Q@8W,(.:'!`H\.8)^R0#@[IU2&[ZY`-#ME7 M,^#!`=]D2*SV?N=6I2H7LTZ6>R(<0V_F!W+/?]5=ONJE=&K4/IP[4_"G1"*Z\+!1`LXZ*EJ7-1\I\PM M-&BVIBU3>C^_?I""%3>OL3V<,Z9,Y.QLY&+#]D`*/3):"<8' M1=L.W@22`V-$_#T"Y>,AV`2WP'M;-\H$<)[AF5>V##K9\@X)J`[!\V9_3@W" M`GZU,,K%'AGO%\X_S.%'>0A"8P$H%,HH$+U4]IB,O]3?W% M5JO=7XB$$Z>_VU(UVFP8H!(J,E#USL=7F$JP#@M.I?U%Q2`59S=*@!CY=&O; MV75T7[:[B>8G1!,AF@ES'C\AG@CQG9!\2T@F0O*%@%TIMA%GHDB>"3XBX?Z\ MGI@9V>P3W>H"21L4KK^Z%5)'K_EF]Y3AJQ&:,)'%'->8W8S!6G].$OF23`+1 M0D"/G2_):8W9^##G-2;R&XE]1A)7;;P2B/T"B4\@=@+)2B#Q"Z3?.$A7`NFZ MS-2URV$ZBXFCNXER!-A<^:'>-?I+F`X5* MF>VC<>]NJ3LHWM_>G/GAR_\!4$L#!!0````(``!\5D&PO=V]R:W-H965TZ^D`H6I[RHEZ$A,=S9M.2$ZT&_HW5ZVA/Q%%&\%^#V?=&U@4@3/MR)7I-S%_ITL)CK`53+DG:*]*"WZW1("3 M#]\.HVMG_R9)%UO8@!<#7@WQ8T.R&))/!NC)7%U?B29U)<4,I/\6$[&?/#XD M9N=:H-RD]-ME*E-F]E9CE%?P9H,6#7::EYTFI&AVBFR50`.P4N`01>(I\(ZB M"`G/#K`-&.VV[A2W>_W1^H,5TOT+6 M>ZS^!U!+`P04````"```?%9',$R-\9L!``"O`P``&0```'AL+W=OPZ%-P:;:XMW;8$&*:'@0U=VH` MZ78ZI06U+M5[8@8-M`TDP4F6)/=$4"9Q58;:JZY*=;2<27C5R!R%H/KK";@: MMSC%Y\(;V_?6%TA5DIG7,@'2,"61AFZ+']--G7M$`+PS&,U%C+SWG5('G_QM MMSCQ%H!#8[T"=:,%G`/%UAEA#U%6(]0X@S,+O(EESDT45VY2)=%LB7!%91(+\2N#%9Q#8B M1@;,_6I5%$NH^A*5W!@A%[,=Z![^4;UGTJ"=LNZ:PDP[I2PXG>1NC5'O7L^< M<.BL#PL7Z_A#Q<2JX?P\YC=:?0-02P,$%`````@``'Q61[7%/8+7`0``Y00` M`!D```!X;"]W;W)K&UL?51+;YPP$/XK%O?&K)=' MLF*1LJFJ]E`IRJ$]>V%X*#:FMEG2?U\_6`(2Y8+M\7R/,1YGHY#OJ@'0Z(.S M3IV#1NO^A+$J&N!4/8@>.K-3" MB4&SMH-7B=3`.95_+\#$>`X.P3WPUM:-M@&<9WC&E2V'3K6B0Q*J<_!\.%U2 MF^$2?K4PJL4<6>]7(=[MXD=Y#D)K`1@4VC)0,]S@!1BS1$;XS\3Y*6F!R_F= M_9NKUKB_4@4O@OUN2]T8LV&`2JCHP/2;&+_#5$)L"0O!E/NB8E!:\#LD0)Q^ M^+'MW#CZG22<8-L`,@'(#"#>N!=R-K]23?-,BA%)?[0]M7_P<"+F(`JD7%#Z MZHU19:*WG!R.&;Y9HBF'N)S+,N5P3Q M-D&T11!Y@FA%D*R+3+U+G]/Y(J/')_*?2N,=G7BEDZYU8J\3+W3";8ED1R)9 M23QN2B0+B2][M:0[0NE*Z&GSS-*=6O#B'G*0M6LWA0HQ=*ZY%]&YHY^)N\>? MZ7G6TQI^4EFWG4)7H4TWN*M;":'!6`@?3,V->7/F!8-*VVEJ#\.WH5]HT=\? ME?EER_\!4$L#!!0````(``!\5D=@72LG:@(``"\(```9````>&PO=V]R:W-H M965TW;U\ZI-C+A`I_^F?GL,6/*NY`?ZLRYCCZ[ME>;^*SUY35)U/[, M.Z9>Q(7W9N4H9,>T&>*].9VUG4BJ,EGL#DW'>]6(/I+\N(F_@-<:#))!\:OA M=^7T(PN_$^+##GX<-G%J&7C+]]JZ8*:Y\9JWK?5D(O^9G/Z/:0W=_NS]V[!= M@[]CBM>B_=T<]-G0IG%TX$=V;?6[N'_GTQZ(=;@7K1J^H_U5:='-)G'4L<^Q M;?JAO8\K>#8+&\#)`"X&`*\:H,D`/1@D(]FPKZ],LZJ4XA[),1D79G,.7I$Y MN7VDADDY'I?9F3*SMPK"M$QNUM&D@8-FZVE"BMI3D$62&("%`H8HT$@!/0H0 M=H!"#O#H`'D.'B#IN(U1TP\:3%+S"#_#ADQ,%.'`@+D!W)"$TA#N.0%1SBX>`@#G'B`,.3@B".*T,8IEF8)ENAR3P:$J3)G#`9A8^I MFF!<%:"(DB),0U=HJ$>3!6FH2X,)#B:T=E6(TNS)-13NAS2LQE/2C$)H;=^F+V>G9O-[+H.5';;O4'L'XGHT#+2[S\[S\ M1ZC^`5!+`P04````"```?%9'V^#XQB4"``"Q!@``&0```'AL+W=OBO.4+:"X*,%,0KC,%Q`ANLF*');>Q-%SB^*U@UY$T!>&,/B[Y90 MWFV"*+@5WNMSI4P!%CD<<,>:D4;6O`&"G#;!:[3>1[;%=ORJ22=':V#,'SC_ M,)L?QTT0&@^$DE(9"JPO5[(CE!HFK?RG)[UK&N!X?6/_9N-J^P$+5>^\^T[Z#)DA+#F5]A>4%ZDXNT$"P/"GN]:-O7;N#DI[F!\0 M]X!X``PZ?D#2`Y([8%XA[0'I@P)T4>Q![+'"12YX!X3[]UIL'I)HG>JC+H&T M1>'.5Q^%U-5K$2=A#J^&J.^);<]VW!.M5KZ>_:1GZ(#:P6`C]MGH)>(1?(%\ M"KMXXC3RNICT^%TD/A>I.XQD(O&$(/41)(X@G1`D?H)LQD$V(4BG(9$+Z7H: MUX.R,`S].HL9G<5$)_,3H)FDZ'^2+F<<+"<$"U_2W7*4%"79DYRK&9751`7Y M"!K4W/PZ:>1]QWH34?1UUFW?Y,(F"*T>'S\X>K$9$6<[(24H^:51Y@48 M58T#,7REBG]02P,$%`````@``'Q61\LL!2;Z`0`` M6`4``!D```!X;"]W;W)K&UL?53;CJ,@&'X5X@,, M*F@/L2;3-I/9BTTF<[%[32VM9D!#M=JPO1'Y_4X_`D4OY)>J*=7@ MF[-6;:):ZVX-H:IJRHEZ$1UMS9>3D)QH,Y5GJ#I)R=&1.(-I'.>0DZ:-RL+5 M/F19B(MF34L_)%`7SHG\NZ5,])LHB6Z%S^9<:UN`90%'WK'AM%6-:(&DITWT MFJSWN44XP*^&]FKR#FSV@Q!?=O+CN(EB&X$R6FFK0,QPI3O*F!4RQG\&S;NE M)4[?;^IOKEN3_D`4W0GVNSGJVH2-(W"D)W)A^E/T[W1H(;."E6#*/4%U45KP M&R4"G'S[L6G=V/LO^7*@A0GI0$A'PN@3)J"!@.X$_)2`!P)^($#?BEN(/=&D M+*3H@?0_KR-VCR1K;):Z`LH5I5]?LQ3*5*]EBI8%O%JA`9,ZS':*25:K$0.- M_FB2ADP&@71J$LP$\%<`/;2Q\ M&Q[3.LQR%2=Q%H+MI[`,Q0N$TG">[$F>;)8G"1EMLXG1"B._PLNC(F?XD M\MRT"AR$-L?#[>63$)J:(/&+"52;:VZ<,'K2]G5AD_J3[R=:=+=[;+Q,RW]0 M2P,$%`````@``'Q61]5N7=H>`P``\A```!D```!X;"]W;W)K&ULC9C?;ILP%,9?!?$`Q3[&(:F22&NF:;N85/5BNW83)T$%G&&G MZ=Y^F#\9KLS!-P7,=P[?.>;GXJQOJG[39RE-]%$6E=[$9V,NCTFB]V=9"OV@ M+K)J[AQ570K37-:G1%]J*0YM4%DD0,@B*45>Q=MU._9<;]?J:HJ\DL]UI*]E M*>J_3[)0MTU,XV'@)3^=C1U(MNOD'G?(2UGI7%51+8^;^`M]W+',2EK%KUS> M].@\LN9?E7JS%S\.FYA8#[*0>V-3B.;P+G>R*&RFYLE_^J3_GVD#Q^=#]F]M MN8W]5Z'E3A6_\X,Y-VY)'!WD45P+\Z)NWV5?`[<)]ZK0[=]H?]5&E4-(')7B MHSOF57N\=7>6I`_S!T`?`/<`FJ(!K`]@GP*2SEE;UU=AQ'9=JUM4=Y-Q$7;. MZ2-K.K>/=#M8=^UJ*M/-Z/L64K9.WFVB7@.MYLG1^!0[1\'ODJ0Q<'L M:.H]*+YM\Z1XB^ M=M2[P/1E41KRXE'OZC#4!2%UP<@N\5?DE[A&L%6&NLO,:B*%=UT8VI$&3;.7 MY,$%QQ:[H1T\=)IY\#1[5X>AKD70-&-$TVQ^A:'9_"S[):X/C&3JH,RG4F`L MTR"8`8,90F`&,MN."8EK!`,8@@`&#&`(`1CF`9Z0N$8P@,$!F-.)%!C`$`0P M8`!#",#`Y]OAE[A&,&@A"%K`H(4`:&$>V@F)ZP.#%EQH)_Z!`P8M!$'+,&A9 M"+1L'MH)B6L$@Y8%0C0;RR&?N:[_+*)%!B_+(A?AO'+ M0OAE\_Q.2%PC&+\LB%^&\-T]QW]+!QFO^03D:[TXLXR9^B/N65CEZ5 M:3:Z[:[TJ)2133KRT+3G+,7A?E'(H[&GF>U?MR7O+HRZ#+\PW'_FV/X#4$L# M!!0````(``!\5D>,#UD^E0(``)0*```9````>&PO=V]R:W-H965T/PO"`UYAO:DD8^N5!6 M8R&'[.KPEA%\UD%UY7BN&SDU+AL[3?3<*TL3>A-5V9!79O%;76/V[T@JVAUL M9(\3;^6U$&K"21/G$7#_8+V&8H4HHG?)>GXY-Y2\B=*W]7@ MY_E@N\J!5"07*@66ESO)2%6I3'+EOT/2SS55X/1^S/Y=;U?JGS`G&:W^E&=1 M2%O7ML[D@F^5>*/=#S+L(50)U^^N=SB>I+UKTON MC,O9>^J%0>+<5:*!\31SG#(((C*#B#X91QH\-#Q(8UC"FVJ`2QA$"*_@0RL$ M_49](WXA0;"2(#`21*8DZE_GL8<:#;F;[1:DLBF%-KL%F7!%)C1D8E@FG"SC M;=P`EEFD#)EH128R9&9[[IFCR>P@)C.8R(5%XA61V$B`0!&3\4`1D_%AD>V* MR-9($(`B)A."(B83P2*[%9&=D2`&14P&_'S9$F.(J%-ST40]G*38+:0`SZHQ M!7JF!`?JJQHTL.4B1."I-0IY:V48#S[>M,`@)%M`3)&UPPWY3Y2@"<4N^*%G MT,)1CM8.2A0\488F%,-U.(,6"A&M'90H?*(432@&H6P&+?U?U@Y*%#U1CC,( MKL=%J)=Q)DU`3=A5-T?&ULC99+;]LP#(#_BN'[:CW\#!P#;8=A.PPH>MC.:J(D1FTKDY2F^_?3RZZ" MR:XOMB63_$B*E%1?&7\5)TIE]-YW@]C&)RG/FR01NQ/MB;AC9SJH/P?&>R+5 MD!\3<>:4[(U2WR4(@#SI23O$36WFGGA3LXOLVH$^\4A<^I[POP^T8]=M#.-Q MXKD]GJ2>2)HZF?3V;4\'T;(AXO2PC>_AY@%66L1(_&KI57C?D7;^A;%7/?BQ MW\9`^T`[NI/:!%&O-_I(NTY;4N0_SN@'4ROZWZ/U;R9F!7#KYS*[?J8LATP9WK!/F&>TN0K)^5(FCGKS;=SN8]]7^*8%3"RL@ MIX`F!60=MR#CYEV9Z"6$&Z02L8N$F>0V>N6H4+-O#2KR.GG3 MAIP,,C(/O@R<)!)E?4*@$,*I(Q\!T[`!'#*`K8_XQL!2TT-;[HZGUN%8+NZFH'9JJ)9:D28KPG8[T6H]I852^N52IF5:S>4_V+,CJEJQ,3LART(H@_]M8XEWY/64 M'\W)+J(=NPSF(N'-3K>'>V2.S`_QICZ3(_U)^+$=1/3"I#IXS2EY8$Q2Y0BX M4\&?U/UF&G3T(/5GH;-B3WP[D.P\7F"F6U3S#U!+`P04````"```?%9''*D* M3/\!``#8!0``&0```'AL+W=O(^'. MMB/F$X9[K`^B0-(&A:M>&Y4Z>LWQ-LC\JR$:,-ABCE-,.")\S3Y*X"6)(1U/ M)<+-,D&T1!`YC]',XQT'FR6"C2/8S`CPO,C4N728UF'BP/R6A>(5H7@F%,V% M'.8XQ]PYCF1%))D1Q(O5)--J<))&=TXM7=%)9SK)HDXZU8E63FV[(K2=":7+ M!+N5"[+[S@4Q3_2N!;,YH=@N?KDOH-T7'7_R\AB(RC88B0I^:6T_FT3')O:( M[W/CHV\_P_4$L#!!0````(``!\5D>VY^0B;0<``.&PO=V]R M:W-H965TO_]M6,Y:-W51B]`S)%V5](YN]IX_E96O^KGHF@F?_:[0WTU M?6Z:E\O9K+Y_+O9Y?5&^%(?V/X]EM<^;]F/U-*M?JB)_.`[:[V8\2?1LGV\/ MT\7\^.Q;M9B7K\UN>RB^59/Z=;_/J_^R8E>^74W9='CP??OTW'0/9HOY[#3N M8;LO#O6V/$RJXO%J^H%=?K6V@QP1/[;%6^W]/>F<_UF6O[H/GQ^NIDGG0[$K M[IMNBKS]];NX+G:[;J;6\K]NTG>;W4#_[V'VFV.XK?L_\[JX+G?_;!^:Y];; M9#IY*![SUUWSO7Q;%2X&U4UX7^[JX\_)_6O=E/MAR'2RS__TO[>'X^^W_C\V M<<-OM]MSGM%ANVF_%H*\.&,V_'-3UDV'(6O>=LV'0V MWO59?^*/?/F8-_EB7I5ODZHG^4O>:0F[;$>UDT_JX].JYV%+F;I]^GO!TV0^ M^]W-Y##\B,E\#$M3#+/R,5ICD#68!D-L`$*_8V9M)*=P.!J.?(3SH)A/$,,QS`VTA6*6$"/0Y048#/$9SB(QS*V/T0;=I+.&[LY/L@&3 M*`SR!;J+8KY"C,:/@T"/@^A/MP`S&'P&B/&!OJ,6N( M"3#;4%8,F&%T-&T?M?'"22Z2,6][U#H*M0FC@,^6\MD"GT?,5KW/UK>#(=9G M$1L<`?Q,*3]3X"=Z=E=IV(L><7L6L?81RJ9&,90F^$0@G"[YA^/I_NL%I`)S MX(G120=C,=K!\&PT^,&!'Z.TR/H4_,6AG'Y;, MJM`^DU1E@*L,Y=F2^0QB057G)(DX(!%CJ'HYD+/$K>(\L)<<9]M@#+`M49BQ M&P=R:RB9\=?07VP(]`0->D1REP/N,AZ8@RP_>%3]PTG6#AP4#TQ@867-.3B"Y*](SE-J)7S^\K8@10N,SQ`FM0U$)4B2"P969N11 MVF^#8"`;)BQ4>0F2O@*F7KSV$G[F3263&H.M"1CTB,S0`HB!YQ&<@\S0(BI# M"Y+C0IT_%YE0D`S:%Q0/^!$`96(QT*<@"+I-"H:`@J%1#@L=)4V"5`L!U0*- M.Q.&6"!HC%0+`=4BM#2D6H@HM9"D6DB8[=$TDTF0[:52XJ^+I3L6`#G24O]D M1.)NH&4&ZPP_$T)@<,(5-&RLM0*7/@B44ICQV7,J0#M0'K7770@C8HKLLH,@9UQWNUK"4?I7#+T)UG23E M3X(2A^,ECO0%RR9$+2!)T9)`M#A:Y2RE+UHBY4R%KH"2U"T)=(OSP"*:N$4D M54L"U>)H0;64X,J3*J5U0-XD>>61L#W!,6.W,GCE`0VXN(N1(J52`:G$6WTK MY:N!071HZ,`1..@3*1J*+*V8Z_\J%K7WBJRL%*BL*;]DXD*F%@>N22#T MBE0K!=2*!RHT1597*JJZ4G1S%G9GT8;Q4OGR8E)JUTEY45!>#&8L4T!>J'N- M(N5%07D)4%GANC&LL(U:85(.%)`#'NA_^T27DN`?!80]<%(4-+AMC8ME)[XK MG80(Z,/681CTB)0$#>N(T4D<^O)`-T(%BR8%08-B0S/<$%`-$;C3:9+C&G`< M[T[<:K\B07/%70`"/2'K%0V4(I2N-:X4C@M:Q7!!TU^]Z(A4I'T!P&IL1P4* M!WTB=4*;B/R@_2J$)LW34/7Y]-P:T2UO)"KE+IGJCSB_OQL!FJ0QO)4ET`X@N`N6-(;_K,%'?=1B21@8F M<+3=DQD+8F:$E!@RU9N85&_\##ZN;WQ](X'P2UV2PA;6_ZBQS,)6"5796Y+$ M%I`8OT)F%C1-QXT9:(VDL87%/7Z'S"S\QC)4L5LRFUM8L>-->>NG:LED2Z#` MV;>D+%@H"X&S;\F$;:,2MB5Y;&$7,W!V1EW,@"$R"UMS7@V+ZNGXGF@]N2]?#TUGR'MZ>A?U`^_>>QL]S]CEDB'/ M5^SR%GN^9I=W_1NH[V87\Y?\J=CDU=/V4$]^EDU3[H]OS#V695.TT207[0H^ M%_G#Z<.N>&RZ/SN]K_KW4/L/3?ERY5ZK/;W;N_@?4$L#!!0````(``!\5D?7 M!QK($R8``.:P```4````>&PO6FV^> M/BW".[D.BD&VD2F\667Y.BCA:W[[M-CD,HB*.RG+=?)T-!S.GJZ#.'TBJC3^ M?27/LRHM?_5D/%X\^>[;(O[NV_*[YUE8K65:BK,T$B_2,BZWXB+E,>,L%:>B MN`MR67S[M/SNVZ?8A_LMQ>LL+>\*Z!/)J/WV6FX&8CSTQ&CH3]LO+\-R($9^ M]TL#CPW$[U[%J107I5P7_][;X=UV(]LO_>'I#^UG9]`ZHAXOD^"V_785)(4S MC)GCK=!Z;33R_[YSWZV1L791[`,&^"M0/L&UGEV6M9YO$G#[`=#GJ&.0*L^_W59=]2L_4:R.VZS,(/GK@FPA>755F408HC MMKL]"Y(@#26T!(8K@%?>7S\7QT)( MR$\@6@I8.\Z;E7>`]+`!I8/QK(2=W]WF9?Q)1NI=)V"7-%&2I;>GI<__B?1>KEU-A"(5&&`UP+LX*+37JTGCH:#X7#HPY;GW/R78CKT MX!'^KQ2<"*KR#KCB)QG]4OAC;[Z8>J/QDE:Y\/SIR)M/9KIM7!2X_\0>M7@0 M02E`!8":N@%"UNJ/6H$$4$^5%/!@_XJ-#,OXHTP<"78613%N(FP&,N1IG`+[ M;V+8G`Y2K-95`B(S0AJ+P]CA*][4HA.[>PF`H#^L[[5$F2+.0(R"B`$B!.X2 M]6[1]O;T>?:0/BVI>_PV0+J_DV4,ZN<$I/"1>-ICM;1HQZLI8F]+ATKV]F`B MV=LLZ]ULN@/@ULYI%?I<%O%MBC3J\CP\97$"(NQR M(W,2N#MTZ?A@P]/1M%M*%QFAX\B5-Z#?$@"S[[G8H'VB*!4)3@2;30+"`&5)F9E7EA#S MQ$U0Q"'O2)Q4*#V/KZ44I,#&GL"Q7^FQM5F(8SOT^%L9W]YA_P#D5P`+3"L2 M]*B1+9@:;-,Q_6[&("/P99+=[V`,:K.B-O9^HEI"+=-C#44_5H72YX`J,!TS M4.6`MU0C%Y[B9[(^JP+6"1MXT-#/)>CZ,.XTH$@ZG`(2]AA:BK2:E-5-6$4+ M,#(0"<,'68.UT?PY1C'.LL=N;=N,RGSJ7WO;T.LB_[V[LH](8M"ZQ;Z=?%N! M]`H09B#%E67&[P6I:_A](*WB%-3['I!P)A#(H9217@DH,#(+`$8V#!'!?88N M^)!J4=A>6RZG$QBT:5WN&L0L%R#Y&(,V$C?;3O"[.AY',LPE`'""8I4^"3+S M#G3W>OU"$"[@^*1ZDV1;B9@(80[0:PT6$=E-$M_NDA3&-*_` M.LAA8X%%V8[51"S.;G-)*R!IET=$S2(0:9:>MOTO1Q<]JXHXE05S[S,0XL03 M;]&I`93T^(HH87`WWF:@E1"6WYW=H-X.RW8TJ\=3VC^K<*(Y8%CF`J24#I)X ML,3G,@GN44'"NL%-I)X>D#>P4(8((Y[]ODJE\)?+V4"\J[MKPZ40]V#,D&I= MRP@M;E'*\"[-DNQV2_!MLC@M3[/5:8@SE<#_H$3NP#6ZD\D&C%C8#>T];NZV MH`;C`.R]&R``V+!UD*(.#>_R+`4%"8(W10<7T(#4ADP"%$HN22+E!I_A#N9% M$U:VGPKQ0R631/SI?]1_[UY3JR`,N1WNB6)7CR*B)+&`* M452H8$G7(`L@M*C\I6,:TERIO`V8-P\P.5J3R23JEW$(Y)%8#GQWGZHTJ,`G M1AFKW#^*XDK<8J,`QKD__=2#.:`T`<@+""08#&0.V9D9N1E)% M0`#`2-"/YVD"L,JR$II*--R`?G+6O5\5"TA\B01WH$M$#$#&TA#9!IPP9DF6 M7?B:EM,M6NRU*0;%]=1\%U@6.B(&VM(+I^<>[1>/(FKY`L1E.%J6/,HH`C.Q## MH7\Z'H^G_DG;&"#8"'@#S\"5N5V2UET^Z@^23T"HL.<1JP(M#3O1:B09J4[X M)X)78+=6\"F#Q;>%0&UH_F7XO:FCT"R\3>.?:#)RO4!=2QYAE24@RTF;PT9! MY\`2T&M9?H.T"8Y(@=0OT2E0+DD`W(<6*@L(H/ZX0&,[D@FTS%D+9R'9GQQ7 MSN/B`REZ=,+Q[0:M@8A%2R$Q$T:["`L/*C+Q!_C"H,BP[=;LFA@]H'0<3)\DJ$';].H34':`@3;$(`P&0$PC'`Z M6!YO(J*K0#DOT3%4YAP&O^,5V'@2H8ZP+?+H(%)O'1J0GD@!$QIUE(K.5 M@=-(,J%!%8(5A09^2@0=B.!C$"=D*G.+BQRJZ7;.;5V\-TE51&(O% M"&8U/^V*>1B"!UPHD MG*T!#OC+:1A8F!5D,DA$_M*[5J`P+ED?\3+1\$YP8*(\)-T8\!*RLP"=:/D8 MQUVC#+/CSXJ/"@Y+*6H?B.L[-2!!BG.[@#*_Q^C;2<\A;9B],BC$$6X"C$C? ME+2_P&PHK!AL^0EC*X1\O<0!>)Q,F05'JH'PUT&D+5"]?T@Y&!+E%=%,*/?( MV4+-,!Z*V5!TZH/'"UPM$<`O/ M&\[]KS,N16'G'N![#09N"SB-,LJDI(%*[7;"^BR#/^+XR07T>W(B?L1H"LJ. M_82)P![FM8G)E67UD-S]R6IR8 MJ08+K17F"!':H18C(IO66ERR'EGA^D!E@@$-^+O-@.Y0\F%HC6P63!`9/*!G MG6J)3)/EJ(<)RPJIC7GV*9"L'6`8 M`0:GL&!)W(_(P&Z;ZB9!BPF'13HE5Y`]#*0P[;;` M@*F&'&01FV((>Q!EF[*!?`P=W9+41=%PGZ']=$<*5L9D:JTJV@NPY'19`X^B M,"6#$./DH)D<.4#.B=Y%?$RHYJH&,J-9`J*PTP.V1%6,A(1(X+P?-FF:(K$) MBE'2H&!#!U.0[/=26`9(W*">Y*=V13ZDV3UO,D$")@G:\V"+V0@B6B3S,M-N M8%ID21R1^?S2"%([L9?K6*)>%R.5Q[HA:SERRO+.&XSYJB,Q:A?2_)-X0<4: MG-E\:.!Y-!#N=,9J_ORP6<,T`:RAKTY<#02FPW2<86O,SOEGQ!MY1=P$V#2M MTY5@L,ADY2#-Y'/?MO*Y3B5@D"/'<$-J\6"DC0>B=SJ*WH`AXN[^,]+.6A$3'Z@0RGO*T)&U#XN,R<;GGJ`$$J#&ZO9. M)/*6#=C.LB?/1(&L>)4]+8NN?).I%"*8\2$Q-\48-#[4YB)&"(`!J&C.S/^] M8$MLDHH5`27MF[)ISS3VP!PT91E05)1+$"P`"L\D&ST5%ZQW!;EZ()[),$`O MNLE`A66-U:LG_0"B1"N$#6>,,(J@JQYZ\4IAAF!-1@YO4F=3"F/5LA&7"IA) M:D&.>F%KIN/AR881]V3MD<@$BJE"&2DYW+/;)-)!'V2K_G2I+/;%;.[YXZF8SF=4+K@8 MC;SY;"DFPYDWG0R%R5+Z"V^Q6'K^<"PFWG(.WY8C<'R\^=SWEM.Q&'F3\XLA3`63PFR3B0!` MYW-ON0"O;#GVQC-?<.D0+)5""P#U'&`?>8LY3++TQO,Q@#T78V]*-9%+4K3/ MP#_"V`=T9`@P6"E>R@#\/TD*_MGY2Z_.N,+VW60JHD1HO-05'B;Q89[$]9!";BYJ4I=\X/CMHO1R$0JM$6G1DJM@+NV$0QAL>V5+M_47DUC#_[TU>?MV M"*37<+3PEL,Y?9U["W\$(FIY(KYR(2`,/AR,9B?\P5_R[(/A2'WP`;JO5/4G M8`G^>`SB=P)2=C&%]8,>6(*L7<)"IR"<9T-8Y&CF%,OK4QQ;.Y#Q4$O5.@K2 M4G*-B)LNG8EL$_U(3(=(EB/X-!HNO0D`^1(+4N^,FSV=+8&CAF(R'WICX,4C M4#O#.:QXAIUFL,8Y:)<+*WVV:@X`(N=H-@'.G!/2?I)YID)9&$"C+AH+5%B` M*2&@ZA@_#,= MB+TSMY:H*^1/K1``('\"W#/R-20D9`N)](MM@5>OS9=-L&7SE.*[QZKGB36P M2M0><;]>TGE7UP:MI$2JF?#)"^O3VSQ;2`+6S5B,YV"H^>(\`0H,*=Y91=M&0YALN)B*^82`?BDCJL26G\(8K?'@DQC- MO!$!#.R\%'R:R1\OO-ET)D;$Z'-B`7\,QM1L3)]',/UB[K)W^YS-N7W.YD&- MOT0^S`9B]]AUY<`K*F#LBLYJ)T52%3E%J3)@T^DI)=7K#+V.59PD-!"\UR%N$#&_S6Y`?WI@ MOA5%$-Y56'E8B&.$],]__"]^RZOY\Q__^X3#2/93DN^8*(F<>!I7`]V1Y4>& M"3@^6.,LB9D);>]XX$J#7MNVP#JLV4H424W:!MPE-)*08K3=6_AP%]D(PH MZA%7JQS\S/LL_\!;2M,0,]?G!#`P"[J.7$QGTL;360CX4S1J"#B^;PV_ MMI:&6PZ*I[&&DE:'!F")&:Z"(J`?8AR7PH^;2E>WH-5!U<]`Y#KWSLYZ\]1# M3WTZ2!S<&$X:IUC&6C\8B,OZI9H3I^,R>HP> M80OAFSDH;H%AS0QIB@HK0#)4*;LY,CKARCL*_.@24ZJ7([H(S;%4"E#6F]H$ MP1"1!<*H#8*[/5:L4X/-`'HFA-2$F[1[O(X3$)V=8'FM#G%J%F4H&8-Z:L'0 MF6%H4[L%*U;-`8`W5&"<9S>4AJ9U6HUL*B4@JQNTD$O.D>N0D:"C%*9^C/7V M9Z)W;--X@_8)""I85ME7BWL[2$UY4:2)5'ZHFY$(;[KZ`X.L;C/E2W>RFIT$ M9EF%K9S4L,(DFKK@D&THL,1!-0P0!B7MK([#$>YLU&U9M]45324;JRI(V"RY M-$`TR@FZ\\B&,A0&JM*.R=4J3);5%*HJJ2ML>YB4`7@ MG6PUJ:B<#@H9-#WQU@M,"FC.:LEE8IUZ.(KK*/7B6<__+@1'%PB.X+`)NHM# M.V6%QYE#K'I"AE6*-ZW1N1<6Y40;#+; M3\[X3@0^_V87BH/W2=&`X73<^@S^"/W#4"_5[;N[3PB#TT7RZ'G@S=> M#UX_T]/L:O.\%AU)$'[@6F%B7=J&0E4N(0N")JOR1J"B!D1E7U2DK1DC)>&% MS\;6`:3CPH3:3KP.&\0.-#:GPEBF16_=F\PI81SD&2[K]#J\RU"`K+-(`OMP M:C,N:JNB*8W!K>VMW;>UOEIOQQQ$W+6@N)$@R%09JR4J:1`L.E;Y=Y6OL-(! MVCABE!3-[E9QF%5FQ6,-Q'"P!"]NJF+IR\G8FXS&+5@OE,+,=/C?4-V6."K0 M*>T.'.N$P3-H6I] MK@*:18N2CF!-BP4&=0;#B9C#OV/Q"^$/ADOX,][F8KG&*GTN@!QW]QMBO\40 M.L"S$?P90;^%U<^:KSD*LY,.,P0=I5\8./!&8W#M1TL541I[LR&S]W@(#M9X M))K'^VH.ZJC]5C45YH3IL=K$$PK"FB\'GU[&8.ULA*!,3\3Q8K+P)LOE"88V M)W/,O4Q.[.5U;/F1F,W0+_01ES"0/YQ8LF2'''91Q6*X\?SK">`)IH$P:M[Z MW!;`^]H=)(+KK;4%;/VTEO:[VWTE45QBA5$CM/METM7=NJ\D7#MBG/\PLO69 M[8UV8L$.+]6'.7NP7G,H16*F@\^6T^YN_2W$M#]83HV8]@>^3V)ZBG\F(&YG M?6*Z[@=B>CJ8<[_11(GWJ>[G1!G!D@=#^B5'TYR3L<^QC/@+8HV+@6C-T*[@ MXI`^!0]?90$'P-6)F6U]JK<^ZM(H3\"A#\8\?9\C&E)7::KP:2.5C_%3G/DX M/A'^9$YA8XGK:@XDJ?Y9QG=LL[J"\(VO-Y8*R7V3[(W,1"I:1PY[O`*9 MKJHL+TKJA&>;.8M'7J?5A%YC/*0^N&55,/7`$":J=!AQ"`)%TL$?#@(I]=V' M2%92UKA\0`JKDTEGZKSL#MJBK7"HH^[8TB\-9G M8U?`!8>8(-X([Z%$*\E4;(YP?>KN2M_SU?O)<`%OU%E0Z[/"`>R,S;3Z?A)U MZQ7^2>.72V$ZWUO!!6!^V[/:K:U<: MQ;0E39M'\/^I:%Z14%_]P"=FJL(8=C/MLSZL\TF/4K`<6FH M$E94V&2G7(XSD^3CBX_4:381QGE8K3%,`4[X2>-&C[H&G0TC-1^2(,]HWN6VE.D;1$W6SF82'[ M:`%BCKPX+)P?>3-8BC^<\+O!1*=<&O>"X6%IVT%(,UTUC_==14P76UDV#*_. MZ"ON`RBRR4Q)=,=?/^`NKF-]T9=S1^-EE9O+O$[/4G'Y$W.UUH4ZX-IUFO(P%CILK,?KQQZO'WN\?NSQ^K'' MZ\<>KQ_[:UP_=ICN,M=RV3KU\;*RQ\O*'B\K>[RL[/&RLG_4R\H<=X?]M1=Z MKPYT;%J]'J]`^[]Z!9K[4P88@;-O!@/*3^%S^!#'>-\HCQ>O/5Z\]GCQVN/% M:_^/+U[KO]3K^!VY$$ZX_VV&!\78GCIOUE_HNZUPT`N^^:H>]C"1W73Q-M9< MSCU4YKXJ]YH*RO3885@N1/ND@@HF_=NJ'XFLN[FLF[L:MV]8A5YQKJF)2\S* M^-3`A,Q$5*HTKG,$[)O'"YN^ZH5-3@DJNHI5P@:D<_^=I^ZLXQ/?73]6UD.? M*`<>[X5ZO!?J0-0]W@OU>"_4X[U07^M>**H*ZC9+#K@,BNSMPN1UC)7QS=_N MFJ@'W\;4:Y7IGM;!,^`>3B2RFWX6=OT.Z@XUUSI$KW\0D$0]O`*QA64H&IUU M69%.<32O8K)O'6([5>L0_6MU><]/RNJ`0UA=22;E'W5#B/8B M%Q'1[V1RHH:BSMKZ&OQM[ZE1LLXK(R;(I
%+;EIX M/!W]1:>CG5K'AY^//?`'3?^B1WL?+V5X^*4,CT>A'W`4NA8S7L.*?*TO/`+D M7)F2*BH2_BJV9%&MUUAL@][$OB,2MNFGE5^=R[*37C>RO,VH_ M'.B-<4K=+_/;(-45R6<&NLL6=+][A1&7"\!"T3[K7_^(_57WC]B;]^=80=!^ M^QILTW6U%K][31AV1MXR'8.EMW8F"3SLGFG5WTWD\ M*A#X@\X1%I1,C1B?P67#KM!X/03+]8L^L:O&,7P^# M'@X-^%W#^+.NI^_N,RL]J?%QV.*FG?/TCK@?\''G@*-1)U;,G*+^*1'!(?N^B\H[W'*"IT4M9=9".\OI\.&]T- M=COSU['N#C:U8]W.\+MBWTU*3F.`1[?N/!I6SU8PGD%'$2O]UF_L`Q M^T+"7[`9?;^\L%/9[(Q;]MF@HG,J1]=SCAG\5-]UL50OYH M(LV.1,%PNA-/H#BR\Q2#U.!_2MF\,MVQE`?#I1MP&4S=`1LA;B?^04GY0BQ5 M/5/[_42]G_6\-Q'S]HO.N%(CCMN!I(7;A8+FSE/,+W2L?C1QIU0+6/0L0"-@ MVO/^NC,@[ERWI^X"2G:&P2TB[0L!=$_7BK\?8"FZMN?G!KL=$=NZN72OEG/% M+5>:MP?:M:HKB2?V^)PI]5J9.U?7*K#*%Z52DV`#;UTN;$\H/VUB%2:-.CCL M^R`=8#7MSW_V,[QE==]H20RVCUV1BW<;@8>"QZ(3OGT$-Y5Z]:'$61P(RR"F MXI7]RP/1M9;BJF,E%[8@X>NS-M2X2[`,!U.7"SM_[_L+[)O70=[OR7]?)?V6 MZ/=5:ARMG2^=86E.?[0K>C#M'K9UV2V:0?UWW>XB8PR9T"D%'6(T&:7FC9UI M?3N:(\W7FR3;2@HZH:/#\813OJW2KE3SQ!MS1=$975'D-2O9R`%]HVXMNC+E MPW_U"3T,(.&];NBY7M5GA_HD^5B7WOJ+SI2)WKK M<,UE74S9$TQ$HE#!Q'=9(QZF@XEG=C#Q)6Z_)94O&UUVZXQ%[PHG#U^A MY5:U02+*[9G+N;-U'UU;Z^)=/I0CT'`W5]3NZ;IW2=UT90O7!Z0^3&Q5[2C= MAU"OLST2A02U.%8W3-4W?N9TJIM.$G1=F`XL$O!1,YW&UL4$L!`A0#%`````@``'Q61WYU^_8^`0``:0,``!$``````````````(`! MP`<``&1O8U!R;W!S+V-O&UL4$L!`A0#%`````@``'Q61YE&PO M&PO=V]R:W-H965T&UL4$L!`A0#%`````@``'Q61T>MMPX>!```S!(``!@````````````` M`(`!F1@``'AL+W=OT<``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@``'Q61U`Q2*46!```D!$``!@``````````````(`!*R0``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@``'Q61YZY#32B`0`` ML0,``!@``````````````(`!*"P``'AL+W=O#" MDZ,!``"Q`P``&0``````````````@`'8+P``>&PO=V]R:W-H965TY"B2&H@$``+$#```9```````````` M``"``;(Q``!X;"]W;W)K&UL4$L!`A0#%`````@` M`'Q61]^1\.6C`0``L0,``!D``````````````(`!BS,``'AL+W=O&PO=V]R:W-H965TI4H@$``+$#```9``````````````"``4`W``!X;"]W M;W)K&UL4$L!`A0#%`````@``'Q61R^`MMO>`0`` M1`4``!D``````````````(`!&3D``'AL+W=O&PO=V]R:W-H965T; MT01>IP$``+`#```9``````````````"``18]``!X;"]W;W)K&UL4$L!`A0#%`````@``'Q61]%OOW"R`0``%@0``!D````````` M`````(`!]#X``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`A0#%`````@``'Q61^A-91+!`0``/00``!D``````````````(`!+48``'AL M+W=O\" M```4"P``&0``````````````@`$E2```>&PO=V]R:W-H965T&UL4$L!`A0#%`````@``'Q6 M1QSR+@/G`0``!`4``!D``````````````(`!24X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@``'Q61[7%/8+7`0``Y00` M`!D``````````````(`!1U0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@``'Q61\LL!2;Z`0``6`4``!D````````````` M`(`!4EL``'AL+W=O&PO=V]R:W-H965T M,#UD^E0(``)0*```9```` M``````````"``=A@``!X;"]W;W)K&UL4$L!`A0# M%`````@``'Q61TWH3(&/`@``40D``!D``````````````(`!I&,``'AL+W=O M&PO=V]R:W-H965TVY^0B;0<``.&UL4$L!`A0#%`````@``'Q61]<' M&L@3)@``YK```!0``````````````(`!1'```'AL+W-H87)E9%-T&UL4$L%!@`````L`"P`Y@L``(F6```````` ` end XML 12 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of changes in fair value of company's level 3 financial liabilities (Detail) - Warrants
9 Months Ended

Sep. 30, 2015

USD ($)

Summary of changes in the fair value [Line Items]

Balance $ 5,307,332

Repurchase of warrants in conjunction with public offering (943,423)

Change in fair value of warrant liability (3,473,804)

Balance 890,105

2014 Offering

Summary of changes in the fair value [Line Items]

Balance 4,233,729

Repurchase of warrants in conjunction with public offering (943,423)

Change in fair value of warrant liability (2,625,305)

Balance 665,001

2013 Offering

Summary of changes in the fair value [Line Items]

Balance 1,073,603

Repurchase of warrants in conjunction with public offering 0

Change in fair value of warrant liability (848,499)

Balance $ 225,104

X

- Definition
Amount of repurchase of warrants in conjunction with public offering of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
No definition available.
+ Details

Name: nuro_FairValueMeasurementsWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchaseOfWarrants

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: nuro_SummaryOfChangesInFairValueLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=nuro_TwoThousandAndFourteenOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=nuro_TwoThousandAndThirteenOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Detail) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Inventory Disclosure [Line Items]

Purchased components $ 502,952 $ 209,426

Finished goods 569,210 470,314

Inventories $ 1,072,162 $ 679,740

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_InventoryLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 15 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories
9 Months Ended

Sep. 30, 2015

Inventory Disclosure [Abstract]

Inventories

4.

Inventories

Inventories consist of the following:

September 30,
2015

December 31,
2014

Purchased components

$

502,952

$

209,426

Finished goods

569,210

470,314

$

1,072,162

$

679,740

Included in finished goods is $64,477 and zero of consigned inventory held by a third party as of September 30, 2015 and December 31, 2014, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 16 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies - Additional Information (Detail) - USD ($)
1 Months Ended 9 Months Ended

Sep. 30, 2014

Aug. 31, 2014

Sep. 30, 2015

Other Long Term Assets

Commitments and Contingencies Disclosure [Line Items]

Operating Leases, Rent Expense $ 275,000

5-year operating lease agreement

Commitments and Contingencies Disclosure [Line Items]

Base rent, per month $ 7,350

7-year operating lease agreement

Commitments and Contingencies Disclosure [Line Items]

Base rent, per month $ 37,792

X

- Definition
Commitments and Contingencies Disclosure [Line Items]
+ References
No definition available.
+ Details

Name: nuro_CommitmentsAndContingenciesDisclosureLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 25

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=7661868&loc=d3e34039-112682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

+ Details

Name: us-gaap_OperatingLeasesRentExpenseMinimumRentals

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: nuro_PeriodAxis=nuro_FiveYearOperatingLeaseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: nuro_PeriodAxis=nuro_SevenYearOperatingLeaseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 17 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Expenses (Detail) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Schedule of Accrued Liabilities [Line Items]

Technology fees $ 450,000 $ 450,000

Professional services 229,189 257,024

Sales taxes 122,901 34,206

Consulting fees 67,200 173,759

Personnel related obligations 64,543 37,761

Clinical study obligations 34,085 74,000

Federal excise tax 26,289 25,989

Other 138,656 212,137

Accrued expenses $ 1,132,863 $ 1,264,876

X

- Definition
The amount represents consulting fees which are accrued as of the balance sheet date.
+ References
No definition available.
+ Details

Name: nuro_AccruedConsultingFees

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount represents the accrued federal excise tax as of the balance sheet date.
+ References
No definition available.
+ Details

Name: nuro_AccruedFederalExciseTax

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount represents accrued personnel related obligation as of the balance sheet date.
+ References
No definition available.
+ Details

Name: nuro_AccruedPersonnelRelatedObligations

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Clinical study obligations
+ References
No definition available.
+ Details

Name: nuro_ClinicalStudyObligations

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Schedule of Accrued Liabilities [Line Items]
+ References
No definition available.
+ Details

Name: nuro_ScheduleOfAccruedLiabilitiesLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The accrued technology fees as of the balance sheet date.
+ References
No definition available.
+ Details

Name: nuro_TechnologyFees

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

+ Details

Name: us-gaap_SalesAndExciseTaxPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 18 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements - Additional Information (Detail) - USD ($)
1 Months Ended

May. 31, 2015

Sep. 30, 2015

Dec. 31, 2014

Fair Value Disclosures [Line Items]

Common stock warrants liability $ 890,105 $ 5,307,332

Warrants Fair Value Disclosure $ 943,423

Number Of Warrants Repurchased 1,571,744

X

- Definition
Common stock warrants fair value disclosure
+ References
No definition available.
+ Details

Name: nuro_CommonStockWarrantsFairValueDisclosure

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: nuro_FairValueDisclosuresLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of warrants repurchased during the reporting period.
+ References
No definition available.
+ Details

Name: nuro_NumberOfWarrantsRepurchased

Namespace Prefix: nuro_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of expense (income) related to fair value of warrant liability.
+ References
No definition available.
+ Details

Name: nuro_WarrantsFairValueDisclosure

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 19 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Assets:

Cash equivalents $ 5,028,053 $ 4,107,478

Total 5,028,053 4,107,478

Liabilities:

Common stock warrants 890,105 5,307,332

Total 890,105 5,307,332

Fair Value, Inputs, Level 1

Assets:

Total 5,028,053 4,107,478

Liabilities:

Total 0 0

Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring

Assets:

Cash equivalents 5,028,053 4,107,478

Liabilities:

Common stock warrants 0 0

Fair Value, Inputs, Level 2

Assets:

Total 0 0

Liabilities:

Total 0 0

Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring

Assets:

Cash equivalents 0 0

Liabilities:

Common stock warrants 0 0

Fair Value, Inputs, Level 3

Assets:

Total 0 0

Liabilities:

Total 890,105 5,307,332

Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring

Assets:

Cash equivalents 0 0

Liabilities:

Common stock warrants $ 890,105 $ 5,307,332

X

- Definition
Common stock warrants fair value disclosure
+ References
No definition available.
+ Details

Name: nuro_CommonStockWarrantsFairValueDisclosure

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureRecurring

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity.
+ References
No definition available.
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosureRecurring

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

Net Loss Per Common Share
9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Net Loss Per Common Share

3.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic net income per share. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period plus the dilutive effect of the weighted average number of outstanding instruments such as options, warrants, and restricted stock. Because the Company has reported a net loss for all periods presented, diluted loss per common share is the same as basic loss per common share, as the effect of utilizing the fully diluted share count would have reduced the net loss per common share. Therefore, in calculating net loss per share amounts, shares underlying the following potentially weighted average dilutive number of common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive for each of the periods presented:

Quarters Ended September 30,

Nine Months Ended September 30,

2015

2014

2015

2014

Options

867,135

576,746

822,769

406,540

Warrants

18,889,103

4,978,892

11,771,953

2,436,336

Unvested restricted stock

—

15,493

405

16,512

Convertible preferred stock

10,923,802

1,971,744

6,777,980

693,361

Total

30,680,040

7,542,875

19,373,107

3,552,749

The Beneficial Conversion Feature, or BCF, recorded in both the 2015 Offering and 2014 Offering was recognized as a deemed dividend attributable to the Preferred Stock and is reflected as an adjustment in the calculation of earnings per share. In May 2015, a BCF was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature, and is reflected as an adjustment in the calculation of earnings per share. See Note 9, Stockholders’ Equity, for further details.

Quarters Ended
September 30,

Nine months Ended
September 30,

2015

2014

2015

2014

Net loss

$

(3,203,778)

$

(1,461,713)

$

(6,478,212)

$

(4,857,021)

Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features

—

—

(4,140,446)

(2,955,668)

Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature

—

—

589,751

—

Net loss applicable to common stockholders

$

(3,203,778)

$

(1,461,713)

$

(10,028,907)

$

(7,812,689)

Net loss per common share applicable to common stockholders, basic and diluted

$

(0.26)

$

(0.19)

$

(1.02)

$

(1.18)

Weighted average number of common shares outstanding, basic and diluted

12,133,984

7,853,292

9,879,905

6,602,626

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 21 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

Black-Scholes Inputs to Warrant Liability Valuation (Detail) - $ / shares
9 Months Ended 12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

2014 Offering

Stock Price $ 0.88 $ 1.95

Exercise price $ 2.04 $ 2.04

Expected volatility 72.03% 71.11%

Risk free interest rate 1.09% 1.51%

Expected Term 3 years 9 months 4 years 6 months

Dividends 0.00% 0.00%

2013 Offering

Stock Price $ 0.88 $ 1.95

Exercise price $ 2.00 $ 2.00

Expected volatility 72.80% 75.71%

Risk free interest rate 0.82% 1.24%

Expected Term 2 years 8 months 3 years 5 months

Dividends 0.00% 0.00%

X

- Definition
Agreed upon price for the exchange of the underlying asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExpectedTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Risk-free interest rate assumption used in valuing an instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=nuro_TwoThousandFourteenOfferingWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=nuro_TwoThousandThirteenOfferingWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

Balance Sheets - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Current assets:

Cash and cash equivalents $ 9,116,806 $ 9,221,985

Accounts receivable, net 901,895 580,240

Inventories 1,072,162 679,740

Prepaid expenses and other current assets 878,533 608,160

Total current assets 11,969,396 11,090,125

Fixed assets, net 745,133 311,520

Other long-term assets 214,275 585

Total assets 12,928,804 11,402,230

Current liabilities:

Accounts payable 946,146 522,871

Accrued compensation 766,557 885,353

Accrued expenses 1,132,863 1,264,876

Current portion of deferred revenue 692,244 25,048

Total current liabilities 3,537,810 2,698,148

Deferred revenue, net of current portion 10,433 9,635

Common stock warrants 890,105 5,307,332

Total liabilities $ 4,438,348 $ 8,015,115

Commitments and contingencies (Note 6)

Stockholders’ equity:

Preferred stock value $ 0 $ 0

Common stock, $0.0001 par value; 50,000,000 shares authorized; 13,785,239 and 8,152,746 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively 1,379 815

Additional paid-in capital 169,345,497 157,764,598

Accumulated deficit (160,856,514) (154,378,302)

Total stockholders’ equity 8,490,456 3,387,115

Total liabilities and stockholders’ equity 12,928,804 11,402,230

Series A Convertible Preferred Stock

Stockholders’ equity:

Preferred stock value 0 4

Series B Convertible Preferred Stock

Stockholders’ equity:

Preferred stock value $ 94 $ 0

X

- Definition
Common stock warrants.
+ References
No definition available.
+ Details

Name: nuro_CommonStockWarrants

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesBConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 23 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business and Basis of Presentation
9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Business and Basis of Presentation

1.

Business and Basis of Presentation

Our Business-An Overview

NeuroMetrix, Inc., or the Company, a Delaware corporation, was founded in June 1996. The Company develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The Company markets Quell^® and SENSUS^® which are wearable therapeutic devices designed for relief of chronic, intractable pain. Quell was commercially launched in the United States during the second quarter of 2015. The Company also markets DPNCheck^®, which is a quantitative nerve conduction test that is used by physicians and health care professionals to evaluate systemic neuropathies such as diabetic peripheral neuropathy, or DPN. The Company’s historical neurodiagnostic business is based on the ADVANCE^TM System which is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures and which is primarily used in physician offices and clinics.

The accompanying financial statements have been prepared on a basis which assumes that the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The Company has suffered recurring losses from operations and negative cash flows from operating activities. The Company held cash and cash equivalents of $9.1 million as of September 30, 2015. The Company believes that these resources and the cash to be generated from expected product sales will be sufficient to meet its projected operating requirements into the second quarter of 2016. The Company continues to face significant challenges and uncertainties and, as a result, the Company’s available capital resources may be consumed more rapidly than currently expected due to (a) decreases in sales of the Company’s products and the uncertainty of future revenues from new products; (b) changes the Company may make to the business that affect ongoing operating expenses; (c) changes the Company may make in its business strategy; (d) regulatory developments affecting the Company’s existing products and delays in the FDA approval process for products under development; (e) changes the Company may make in its research and development spending plans; and (f) other items affecting the Company’s forecasted level of expenditures and use of cash resources. Accordingly, the Company will need to raise additional funds to support its operating and capital needs in the second quarter of 2016 and beyond. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company intends to obtain additional funding through public or private financing, collaborative arrangements with strategic partners, or through additional credit lines or other debt financing sources to increase the funds available to fund operations. However, the Company may not be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity or debt securities to raise additional funds, its existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of the Company’s existing stockholders. If the Company raises additional funds through collaboration, licensing or other similar arrangements, it may be necessary to relinquish valuable rights to its potential products or proprietary technologies, or grant licenses on terms that are not favorable to the Company. Without additional funds, the Company may be forced to delay, scale back or eliminate some of its sales and marketing efforts, research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue its operations. If any of these events occurs, the Company’s ability to achieve its development and commercialization goals would be adversely affected.

Unaudited Interim Financial Statements

The accompanying unaudited balance sheet as of September 30, 2015, unaudited statements of operations for the quarters and nine months ended September 30, 2015 and 2014 and the unaudited statements of cash flows for the nine months ended September 30, 2015 and 2014 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the financial statements include all normal and recurring adjustments considered necessary for a fair statement of the Company’s financial position and operating results. Operating results for the quarter ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other period. These financial statements and notes should be read in conjunction with the financial statements for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, or the SEC, on February 25, 2015 (File No. 001-33351), or the Company’s 2014 Form 10-K. The accompanying balance sheet as of December 31, 2014 has been derived from audited financial statements prepared at that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

Revenues

The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists, delivery has occurred and risk of loss has passed, the seller’s price to the buyer is fixed or determinable, and collection is reasonably assured.

Revenues associated with the Company’s medical devices and consumables, including single use nerve specific electrodes and other accessories are generally recognized upon shipment, assuming all other revenue criteria have been met. For the Company’s newest product, Quell, launched in June 2015, there was insufficient data available at September 30, 2015 to reasonably estimate product returns. Accordingly, approximately $680,000 of Quell revenue and approximately $425,000 of costs of Quell revenue have been deferred until sufficient product return history has been obtained or the right of return has lapsed. Deferred costs of Quell revenue have been recorded in prepaid expenses and other current assets on the balance sheet.

Revenue recognition involves judgments, including assessments of expected returns and expected customer relationship periods. The Company analyzes various factors, including a review of specific transactions, its historical returns, average customer relationship periods, customer usage, customer balances, and market and economic conditions. Changes in judgments or estimates on these factors could materially impact the timing and amount of revenues and costs recognized. Should market or economic conditions deteriorate, the Company’s actual return or bad debt experience could exceed its estimate.

Product sales are made with a specified right of return ranging from 30 to 60 days. Since the Company can reasonably estimate future returns for products other than Quell, it recognizes revenues associated with such product sales that contain a right of return upon shipment and at the same time it records a sales return reserve, which reduces revenue and accounts receivable by the amount of estimated returns.

One customer accounted for 11% and 16% of total revenues during the quarter and nine months ended September 30, 2015, respectively. Two customers accounted for a combined 51% of gross accounts receivables as of September 30, 2015. In comparison, during the quarter and nine months ended September 30, 2014, two customers accounted for a combined 31% and 22% of total revenue, respectively. At December 31, 2014, one customer accounted for 30% of accounts receivables.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.

Recent Accounting Pronouncements

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (ASU 2014-15). ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016, with early adoption permitted. We are currently evaluating the provisions of ASU 2014-15 and assessing the impact, if any, it may have on our financial position, results of operations or cash flows.

In May 2014, the FASB and the International Accounting Standards Board ("IASB") jointly issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance. The objective of ASU 2014-09 is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is effective for public entities for annual and interim periods beginning after December 15, 2017. An entity can elect to adopt ASU 2014-09 using one of two methods, either full retrospective adoption to each prior reporting period, or recognizing the cumulative effect of adoption at the date of initial application. The Company is in the process of evaluating the new standard and does not know the effect, if any, ASU 2014-09 will have on the Consolidated Financial Statements or which adoption method will be used.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stockholders' Equity - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended

May. 31, 2015

Mar. 31, 2015

Feb. 28, 2015

Oct. 31, 2014

Jul. 31, 2014

Jun. 30, 2014

Sep. 30, 2015

Jun. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Mar. 12, 2015

Feb. 25, 2014

Public Offering Of Common Stock and Warrants [Line Items]

Net proceed from offering common stock and warrants $ 13,316,324 $ 7,918,179

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 346,000 $ 346,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years 3 months 18 days

Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001 $ 0.001

Preferred Stock Shares Outstanding 0 0 0

Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features $ 0 $ 0 $ 589,751 $ 0

2014 Management Incentive Compensation

Public Offering Of Common Stock and Warrants [Line Items]

Closing Price Of Shares $ 1.69

2013 Management Incentive Compensation

Public Offering Of Common Stock and Warrants [Line Items]

Closing Price Of Shares $ 2.45

Series A-3 convertible Preferred Stock

Public Offering Of Common Stock and Warrants [Line Items]

Stock issued during period, shares, other 2,621,859

Share price $ 1,000

Stock Issued During Period, Shares, Conversion of Convertible Securities 1,285,225

Conversion of Stock, Shares Converted 2,417,859 204

Series A-4 convertible Preferred Stock

Public Offering Of Common Stock and Warrants [Line Items]

Stock issued during period, shares, other 4,022,357

Share price $ 1,000

Stock Issued During Period, Shares, Conversion of Convertible Securities 1,971,744

Stock Repurchased During Period, Value $ 3,200,000

Series B Preferred Stock

Public Offering Of Common Stock and Warrants [Line Items]

Conversion of Stock, Shares Converted 28,170 24,684

Preferred Stock Conversion Price Per Share $ 1.0101

Preferred Stock Shares Outstanding 94,146 94,146

Series A4 Preferred Stock

Public Offering Of Common Stock and Warrants [Line Items]

Conversion of Stock, Shares Converted 3,206,357 408 408

Preferred Stock, Redemption Price Per Share $ 1,000

Stock Repurchased During Period, Shares 3,206,357

Common Stock

Public Offering Of Common Stock and Warrants [Line Items]

Convertible Preferred Stock, Shares Issued upon Conversion 14,553,000 200,000 200,000 1,185,225 100,000 2,788,830 2,443,716 2,788,830

2014 Offering

Public Offering Of Common Stock and Warrants [Line Items]

Stock issued during period, shares, other 664,600

Share price $ 2.04

Gross proceeds from issuance or sale of equity $ 8,000,000

Class of warrant or right, Number of securities called by warrants or rights 3,921,569

Class of Warrant or Right, Exercise Price of Warrants or Rights $ 2.04

Debt Instrument, Convertible, Beneficial Conversion Feature $ 2,955,668

Preferred Stock, Par or Stated Value Per Share $ 1,000 $ 1,000

Warrants and Rights Outstanding $ 700,000 $ 700,000

Preferred Stock Conversion Price Per Share 2.04

Class of Warrant or Right, Outstanding 2,349,825 2,349,825

2014 Offering | Series A4 Preferred Stock

Public Offering Of Common Stock and Warrants [Line Items]

Net proceed from offering common stock and warrants $ 7,900,000

Proceeds used to repurchase outstanding preferred shares $ 3,200,000

2014 Offering | Warrants

Public Offering Of Common Stock and Warrants [Line Items]

Fair Value of Warrants $ 4,400,000 $ 4,400,000

Exercise price $ 2.04 $ 2.04

Expected volatility 67.48%

Risk free interest rate 1.64%

Share price $ 2.00 $ 2.00

2013 Offering

Public Offering Of Common Stock and Warrants [Line Items]

Warrants and Rights Outstanding $ 200,000 $ 200,000

Class of Warrant or Right, Outstanding 1,057,323 1,057,323

2015 Issuance | 2014 Management Incentive Compensation

Public Offering Of Common Stock and Warrants [Line Items]

Stock Issued During Period, Shares, New Issues 166,405

Stock Issued During Period, Value, New Issues $ 281,700

2014 Issuance | 2013 Management Incentive Compensation

Public Offering Of Common Stock and Warrants [Line Items]

Stock Issued During Period, Shares, New Issues 42,615

Stock Issued During Period, Value, New Issues $ 104,405

2015 Offering

Public Offering Of Common Stock and Warrants [Line Items]

Net proceed from offering common stock and warrants 10,100,000

Fair Value of Warrants $ 3,200,000 $ 3,200,000

Gross proceeds from issuance or sale of equity $ 14,700,000

Class of warrant or right, Number of securities called by warrants or rights 14,553,000

Class of Warrant or Right, Exercise Price of Warrants or Rights $ 1.25

Debt Instrument, Convertible, Beneficial Conversion Feature $ 4,140,446

2015 Offering | Series B Preferred Stock

Public Offering Of Common Stock and Warrants [Line Items]

Share price $ 100

Stock Issued During Period, Shares, New Issues 147,000

Preferred Stock, Par or Stated Value Per Share $ 100

X

- Definition
Closing price of shares
+ References
No definition available.
+ Details

Name: nuro_ClosingPriceOfShares

Namespace Prefix: nuro_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross Proceeds From Issuance Or Sale Of Equity
+ References
No definition available.
+ Details

Name: nuro_GrossProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Per share price represents the conversion price of preferred stock converted during the reporting period.
+ References
No definition available.
+ Details

Name: nuro_PreferredStockConversionPricePerShare

Namespace Prefix: nuro_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
It represents the amount used to repurchase outstanding preferred shares during the period.
+ References
No definition available.
+ Details

Name: nuro_ProceedsUsedToRepurchaseOutstandingPreferredShares

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: nuro_PublicOfferingOfCommonStockAndWarrantsLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Return of capital to common shareholders attributable from repurchase of preferred shares and related embedded beneficial conversion features.
+ References
No definition available.
+ Details

Name: nuro_ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

+ Details

Name: us-gaap_ConversionOfStockSharesConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued for each share of convertible preferred stock that is converted.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Beneficial Conversion Feature

-URI http://asc.fasb.org/extlink&oid=6505963

+ Details

Name: us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Agreed upon price for the exchange of the underlying asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Risk-free interest rate assumption used in valuing an instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

+ Details

Name: us-gaap_PreferredStockRedemptionPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-30)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockRepurchasedDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_StockRepurchasedDuringPeriodValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value portion of warrants not settleable in cash classified as equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_WarrantsNotSettleableInCashFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_PlanNameAxis=nuro_TwoThousandFourteenManagementIncentiveCompensationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=nuro_TwoThousandThirteenManagementIncentiveCompensationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesThreeConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesFourConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesA4PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=nuro_TwoThousandAndFourteenOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=nuro_TwoThousandAndThirteenOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=nuro_TwoThousandAndFifteenIssuanceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=nuro_TwoThousandAndFourteenIssuanceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=nuro_TwoThousandAndFifteenOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 25 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

Anti-dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Income Per Common Share (Detail) - shares
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Potentially dilutive common stock equivalents excluded from calculation of diluted net income per common share 30,680,040 7,542,875 19,373,107 3,552,749

Options

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Potentially dilutive common stock equivalents excluded from calculation of diluted net income per common share 867,135 576,746 822,769 406,540

Warrants

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Potentially dilutive common stock equivalents excluded from calculation of diluted net income per common share 18,889,103 4,978,892 11,771,953 2,436,336

Unvested Restricted Stock

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Potentially dilutive common stock equivalents excluded from calculation of diluted net income per common share 0 15,493 405 16,512

Convertible Preferred Stock

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Potentially dilutive common stock equivalents excluded from calculation of diluted net income per common share 10,923,802 1,971,744 6,777,980 693,361

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 26 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

Net Loss Per Common Share - Additional Information (Detail) - shares
1 Months Ended

May. 31, 2015

Feb. 28, 2015

Oct. 31, 2014

Series A4 Preferred Stock

Conversion of Stock [Line Items]

Conversion of Stock, Shares Converted 3,206,357 408 408

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ConversionOfStockLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

+ Details

Name: us-gaap_ConversionOfStockSharesConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesA4PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

Comprehensive Loss
9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Comprehensive Loss

2.

Comprehensive Loss

For the quarters and nine months ended September 30, 2015 and 2014, the Company had no components of other comprehensive income or loss other than net loss itself.

X

- Definition
The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Reclassification Adjustments

-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

Name: us-gaap_ComprehensiveIncomeNoteTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

Balance Sheets (Parenthetical) - $ / shares

Sep. 30, 2015

Dec. 31, 2014

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, issued 0 0

Preferred stock, outstanding 0 0

Common stock, par value $ 0.0001 $ 0.0001

Common stock, shares authorized 50,000,000 50,000,000

Common stock, shares issued 13,785,239 8,152,746

Common stock, shares outstanding 13,785,239 8,152,746

Series A Convertible Preferred Stock

Preferred stock, issued 0 3,614.357

Preferred stock, outstanding 0 3,614.357

Preferred Stock Shares Designated 11,083 11,083

Series B Convertible Preferred Stock

Preferred stock, issued 94,146 0

Preferred stock, outstanding 94,146 0

Preferred Stock Shares Designated 147,000 0

X

- Definition
It represents preferred stock shares designated.
+ References
No definition available.
+ Details

Name: nuro_PreferredStockSharesDesignated

Namespace Prefix: nuro_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=nuro_SeriesBConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Tables)
9 Months Ended

Sep. 30, 2015

Inventory Disclosure [Abstract]

Inventories

Inventories consist of the following:

September 30,
2015

December 31,
2014

Purchased components

$

502,952

$

209,426

Finished goods

569,210

470,314

$

1,072,162

$

679,740

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document And Entity Information - shares
9 Months Ended

Sep. 30, 2015

Oct. 21, 2015

Document Information [Line Items]

Document Type 10-Q

Amendment Flag false

Document Period End Date Sep. 30, 2015

Document Fiscal Year Focus 2015

Document Fiscal Period Focus Q3

Entity Registrant Name NeuroMetrix, Inc.

Entity Central Index Key 0001289850

Current Fiscal Year End Date --12-31

Entity Filer Category Smaller Reporting Company

Trading Symbol NURO

Entity Common Stock, Shares Outstanding 13,785,239

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Compensation and Expenses (Tables)
9 Months Ended

Sep. 30, 2015

Payables and Accruals [Abstract]

Accrued Liabilities Restructuring Actions

The following table provides a rollforward of the liability balance for severance obligations which was recorded as research and development expense in the Company’s Statement of Operations for the year ended December 31, 2014. The severance obligations were fully paid as of June 30, 2015.

September 30,
2015

Balance - beginning

$

148,921

Accrual for severance

—

Severance payments made

(148,921)

Balance - ending

$

—

Accrued Compensation and Expenses

Accrued expenses consist of the following:

September 30,
2015

December 31,
2014

Technology fees

$

450,000

$

450,000

Professional services

229,189

257,024

Sales taxes

122,901

34,206

Consulting fees

67,200

173,759

Personnel related obligations

64,543

37,761

Clinical study obligations

34,085

74,000

Federal excise tax

26,289

25,989

Other

138,656

212,137

$

1,132,863

$

1,264,876

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

+ Details

Name: us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Statements of Operations - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Revenues $ 2,054,432 $ 1,427,828 $ 4,562,379 $ 4,103,135

Cost of revenues 1,119,186 639,025 2,351,479 1,909,443

Gross profit 935,246 788,803 2,210,900 2,193,692

Operating expenses:

Research and development 940,794 945,349 2,825,589 3,273,900

Sales and marketing 1,965,627 537,785 5,183,595 1,678,665

General and administrative 1,386,170 1,310,012 4,157,082 3,605,047

Total operating expenses 4,292,591 2,793,146 12,166,266 8,557,612

Loss from operations (3,357,345) (2,004,343) (9,955,366) (6,363,920)

Interest income 1,761 1,336 3,350 3,362

Warrants offering costs 0 (23,256) 0 (50,874)

Change in fair value of warrant liability 151,806 564,550 3,473,804 1,554,411

Net loss $ (3,203,778) $ (1,461,713) $ (6,478,212) $ (4,857,021)

Net loss per common share applicable to common stockholders, basic and diluted (See Note 3, Net Loss per Common Share) $ (0.26) $ (0.19) $ (1.02) $ (1.18)

Weighted average number of common shares outstanding, basic and diluted 12,133,984 7,853,292 9,879,905 6,602,626

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of expense (income) related to adjustment to fair value of warrant liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section 25

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6939902&loc=d3e20148-110875

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_FairValueAdjustmentOfWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).
+ References
No definition available.
+ Details

Name: us-gaap_InterestAndOtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of other expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating expense recognized during the period. Such amounts may include: (a) unusual costs, (b) loss on foreign exchange transactions, (c) losses on securities (net of profits), and (d) miscellaneous other expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
No definition available.
+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 34 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements
9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

7.

Fair Value Measurements

The Fair Value Measurements and Disclosures Topic of the Codification defines fair value, establishes a framework for measuring fair value in applying generally accepted accounting principles, and expands disclosures about fair value measurements. This Codification topic identifies two kinds of inputs that are used to determine the fair value of assets and liabilities: observable and unobservable. Observable inputs are based on market data or independent sources while unobservable inputs are based on the Company’s own market assumptions. Once inputs have been characterized, this Codification topic requires companies to prioritize the inputs used to measure fair value into one of three broad levels. Fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values identified by Level 2 inputs utilize observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. Fair values identified by Level 3 inputs are unobservable data points and are used to measure fair value to the extent that observable inputs are not available. Unobservable inputs reflect the Company’s own assumptions about the assumptions that market participants would use at pricing the asset or liability.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis for the periods presented and indicates the fair value hierarchy of the valuation techniques it utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

Fair Value Measurements at September 30, 2015 Using

September 30, 2015

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Assets:

Cash equivalents

$

5,028,053

$

5,028,053

$

—

$

—

Total

$

5,028,053

$

5,028,053

$

—

—

Liabilities:

Common stock warrants

$

890,105

$

—

$

—

$

890,105

Total

$

890,105

$

—

$

—

$

890,105

Due to the lack of market quotes relating to our common stock warrants issued in the 2014 Offering and a 2013 financing (see Note 9), the fair value of the common stock warrants was determined at September 30, 2015 using the Black-Scholes model, which is based on Level 3 inputs. As of September 30, 2015, inputs used in the Black-Scholes model are presented below. The assumptions used may change as the underlying sources of these assumptions and market conditions change. Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $0.9 million at September 30, 2015. In May 2015, 1,571,744 warrants were repurchased by the Company. These warrants were adjusted to their fair value of $943,423 at the date of repurchase.

Black-Scholes Inputs to Warrant Liability Valuation at September 30, 2015

Warrants:

Stock Price

Exercise Price

Expected Volatility

Risk-Free Interest

Expected Term

Dividends

2014 Offering

$

0.88

$

2.04

72.03

%

1.09

%

3yr 9mo

none

2013 Offering

$

0.88

$

2.00

72.80

%

0.82

%

2yr 8mo

none

The following table provides a summary of changes in the fair value of the Company’s Level 3 financial liabilities between December 31, 2014 and September 30, 2015.

2014 Offering

2013 Offering

Total

Balance at December 31, 2014

$

4,233,729

$

1,073,603

$

5,307,332

Repurchase of warrants in conjunction with public offering

(943,423)

—

(943,423)

Change in fair value of warrant liability

(2,625,305)

(848,499)

(3,473,804)

Balance at September 30, 2015

$

665,001

$

225,104

$

890,105

Fair Value Measurements at December 31, 2014 Using

December 31,
2014

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Assets:

Cash equivalents

$

4,107,478

$

4,107,478

$

—

$

—

Total

$

4,107,478

$

4,107,478

$

—

$

—

Liabilities:

Common stock warrants

$

5,307,332

$

—

$

—

$

5,307,332

Total

$

5,307,332

$

—

$

—

$

5,307,332

Due to the lack of market quotes relating to our common stock warrants then outstanding, the fair value of the common stock warrants was determined at December 31, 2014 using the Black-Scholes model, which is based on Level 3 inputs. As of December 31, 2014, inputs used in the Black-Scholes model are presented below. The assumptions used may change as the underlying sources of these assumptions and market conditions change. Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $5.3 million at December 31, 2014.

Black-Scholes Inputs to Warrant Liability Valuation at December 31, 2014

Warrants:

Stock Price

Exercise Price

Expected Volatility

Risk-Free Interest

Expected Term

Dividends

2014 Offering

$

1.95

$

2.04

71.11

%

1.51

%

4yr 6mo

none

2013 Offering

$

1.95

$

2.00

75.71

%

1.24

%

3yr 5mo

none

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies
9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

6.

Commitments and Contingencies

Operating Lease

In August 2014, the Company entered into a 5-year operating lease agreement with one 5-year extension option for manufacturing and order fulfillment facilities in Woburn, Massachusetts (the “Woburn Lease”). The Woburn Lease commenced December 15, 2014 and has a monthly base rent of $7,350. In September 2014, the Company entered into a 7-year operating lease agreement with one 5-year extension option for its corporate office and product development activities in Waltham, Massachusetts (the “Waltham Lease”). The term of the Waltham Lease commenced on February 20, 2015 and includes fixed payment obligations that escalate over the initial lease term. Average monthly base rent under the 7-year lease is approximately $37,792. These payment obligations were accrued and recognized over the term of occupancy. Under the Waltham Lease, the landlord was responsible for making certain improvements to the leased space at an agreed upon cost to the landlord. Total costs for the landlord improvements exceeded the agreed upon cost by $275,000. The landlord billed that excess cost to the Company as additional rent, which has been included in other long term assets at September 30, 2015. This additional rent has been included in the net calculation of lease payments, so that rent expense is recognized on a straight-line basis over the term of occupancy.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

Determination of Net Loss Per Common Share (Detail) - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Determination of net loss per common share [Line Items]

Net loss $ (3,203,778) $ (1,461,713) $ (6,478,212) $ (4,857,021)

Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features 0 0 (4,140,446) (2,955,668)

Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature 0 0 589,751 0

Net loss applicable to common stockholders $ (3,203,778) $ (1,461,713) $ (10,028,907) $ (7,812,689)

Net loss per common share applicable to common stockholders, basic and diluted $ (0.26) $ (0.19) $ (1.02) $ (1.18)

Weighted average number of common shares outstanding, basic and diluted 12,133,984 7,853,292 9,879,905 6,602,626

X

- Definition
Deemed dividends attributable to preferred stock in connection with embedded features.
+ References
No definition available.
+ Details

Name: nuro_DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: nuro_DeterminationOfNetLossPerCommonShareLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Return of capital to common shareholders attributable from repurchase of preferred shares and related embedded beneficial conversion features.
+ References
No definition available.
+ Details

Name: nuro_ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256

+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 37 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements (Tables)
9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

Fair Value Measurements at September 30, 2015 Using

September 30, 2015

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Assets:

Cash equivalents

$

5,028,053

$

5,028,053

$

—

$

—

Total

$

5,028,053

$

5,028,053

$

—

—

Liabilities:

Common stock warrants

$

890,105

$

—

$

—

$

890,105

Total

$

890,105

$

—

$

—

$

890,105

Fair Value Measurements at December 31, 2014 Using

December 31,
2014

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant Other
Observable Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Assets:

Cash equivalents

$

4,107,478

$

4,107,478

$

—

$

—

Total

$

4,107,478

$

4,107,478

$

—

$

—

Liabilities:

Common stock warrants

$

5,307,332

$

—

$

—

$

5,307,332

Total

$

5,307,332

$

—

$

—

$

5,307,332

Black-Scholes Inputs to Warrant Liability Valuation

Based on the Black-Scholes model, the Company recorded a common stock warrants liability of $0.9 million at September 30, 2015. In May 2015, 1,571,744 warrants were repurchased by the Company. These warrants were adjusted to their fair value of $943,423 at the date of repurchase.

Black-Scholes Inputs to Warrant Liability Valuation at September 30, 2015

Warrants:

Stock Price

Exercise Price

Expected Volatility

Risk-Free Interest

Expected Term

Dividends

2014 Offering

$

0.88

$

2.04

72.03

%

1.09

%

3yr 9mo

none

2013 Offering

$

0.88

$

2.00

72.80

%

0.82

%

2yr 8mo

none

Black-Scholes Inputs to Warrant Liability Valuation at December 31, 2014

Warrants:

Stock Price

Exercise Price

Expected Volatility

Risk-Free Interest

Expected Term

Dividends

2014 Offering

$

1.95

$

2.04

71.11

%

1.51

%

4yr 6mo

none

2013 Offering

$

1.95

$

2.00

75.71

%

1.24

%

3yr 5mo

none

Fair Value, Liabilities Measured on Recurring Basis

The following table provides a summary of changes in the fair value of the Company’s Level 3 financial liabilities between December 31, 2014 and September 30, 2015.

2014 Offering

2013 Offering

Total

Balance at December 31, 2014

$

4,233,729

$

1,073,603

$

5,307,332

Repurchase of warrants in conjunction with public offering

(943,423)

—

(943,423)

Change in fair value of warrant liability

(2,625,305)

(848,499)

(3,473,804)

Balance at September 30, 2015

$

665,001

$

225,104

$

890,105

X

- Definition
Tabular disclosure of assumptions used may change as the underlying sources of these assumptions and market conditions change during the period.
+ References
No definition available.
+ Details

Name: nuro_ScheduleOfFairValueOfAssumptuionsUsedTableTextBlock

Namespace Prefix: nuro_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business and Basis of Presentation (Policies)
9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Our Business-An Overview

Our Business-An Overview

NeuroMetrix, Inc., or the Company, a Delaware corporation, was founded in June 1996. The Company develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The Company markets Quell^® and SENSUS^® which are wearable therapeutic devices designed for relief of chronic, intractable pain. Quell was commercially launched in the United States during the second quarter of 2015. The Company also markets DPNCheck^®, which is a quantitative nerve conduction test that is used by physicians and health care professionals to evaluate systemic neuropathies such as diabetic peripheral neuropathy, or DPN. The Company’s historical neurodiagnostic business is based on the ADVANCE^TM System which is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures and which is primarily used in physician offices and clinics.

The accompanying financial statements have been prepared on a basis which assumes that the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The Company has suffered recurring losses from operations and negative cash flows from operating activities. The Company held cash and cash equivalents of $9.1 million as of September 30, 2015. The Company believes that these resources and the cash to be generated from expected product sales will be sufficient to meet its projected operating requirements into the second quarter of 2016. The Company continues to face significant challenges and uncertainties and, as a result, the Company’s available capital resources may be consumed more rapidly than currently expected due to (a) decreases in sales of the Company’s products and the uncertainty of future revenues from new products; (b) changes the Company may make to the business that affect ongoing operating expenses; (c) changes the Company may make in its business strategy; (d) regulatory developments affecting the Company’s existing products and delays in the FDA approval process for products under development; (e) changes the Company may make in its research and development spending plans; and (f) other items affecting the Company’s forecasted level of expenditures and use of cash resources. Accordingly, the Company will need to raise additional funds to support its operating and capital needs in the second quarter of 2016 and beyond. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company intends to obtain additional funding through public or private financing, collaborative arrangements with strategic partners, or through additional credit lines or other debt financing sources to increase the funds available to fund operations. However, the Company may not be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity or debt securities to raise additional funds, its existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of the Company’s existing stockholders. If the Company raises additional funds through collaboration, licensing or other similar arrangements, it may be necessary to relinquish valuable rights to its potential products or proprietary technologies, or grant licenses on terms that are not favorable to the Company. Without additional funds, the Company may be forced to delay, scale back or eliminate some of its sales and marketing efforts, research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue its operations. If any of these events occurs, the Company’s ability to achieve its development and commercialization goals would be adversely affected.

Unaudited Interim Financial Statements

Unaudited Interim Financial Statements

The accompanying unaudited balance sheet as of September 30, 2015, unaudited statements of operations for the quarters and nine months ended September 30, 2015 and 2014 and the unaudited statements of cash flows for the nine months ended September 30, 2015 and 2014 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the financial statements include all normal and recurring adjustments considered necessary for a fair statement of the Company’s financial position and operating results. Operating results for the quarter ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other period. These financial statements and notes should be read in conjunction with the financial statements for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, or the SEC, on February 25, 2015 (File No. 001-33351), or the Company’s 2014 Form 10-K. The accompanying balance sheet as of December 31, 2014 has been derived from audited financial statements prepared at that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

Revenues

Revenues

The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists, delivery has occurred and risk of loss has passed, the seller’s price to the buyer is fixed or determinable, and collection is reasonably assured.

Revenues associated with the Company’s medical devices and consumables, including single use nerve specific electrodes and other accessories are generally recognized upon shipment, assuming all other revenue criteria have been met. For the Company’s newest product, Quell, launched in June 2015, there was insufficient data available at September 30, 2015 to reasonably estimate product returns. Accordingly, approximately $680,000 of Quell revenue and approximately $425,000 of costs of Quell revenue have been deferred until sufficient product return history has been obtained or the right of return has lapsed. Deferred costs of Quell revenue have been recorded in prepaid expenses and other current assets on the balance sheet.

Revenue recognition involves judgments, including assessments of expected returns and expected customer relationship periods. The Company analyzes various factors, including a review of specific transactions, its historical returns, average customer relationship periods, customer usage, customer balances, and market and economic conditions. Changes in judgments or estimates on these factors could materially impact the timing and amount of revenues and costs recognized. Should market or economic conditions deteriorate, the Company’s actual return or bad debt experience could exceed its estimate.

Product sales are made with a specified right of return ranging from 30 to 60 days. Since the Company can reasonably estimate future returns for products other than Quell, it recognizes revenues associated with such product sales that contain a right of return upon shipment and at the same time it records a sales return reserve, which reduces revenue and accounts receivable by the amount of estimated returns.

One customer accounted for 11% and 16% of total revenues during the quarter and nine months ended September 30, 2015, respectively. Two customers accounted for a combined 51% of gross accounts receivables as of September 30, 2015. In comparison, during the quarter and nine months ended September 30, 2014, two customers accounted for a combined 31% and 22% of total revenue, respectively. At December 31, 2014, one customer accounted for 30% of accounts receivables.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (ASU 2014-15). ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016, with early adoption permitted. We are currently evaluating the provisions of ASU 2014-15 and assessing the impact, if any, it may have on our financial position, results of operations or cash flows.

In May 2014, the FASB and the International Accounting Standards Board ("IASB") jointly issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance. The objective of ASU 2014-09 is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is effective for public entities for annual and interim periods beginning after December 15, 2017. An entity can elect to adopt ASU 2014-09 using one of two methods, either full retrospective adoption to each prior reporting period, or recognizing the cumulative effect of adoption at the date of initial application. The Company is in the process of evaluating the new standard and does not know the effect, if any, ASU 2014-09 will have on the Consolidated Financial Statements or which adoption method will be used.

X

- Definition
Business description and basis of presentation policy text block.
+ References
No definition available.
+ Details

Name: nuro_BusinessDescriptionAndBasisOfPresentationPolicyTextBlock

Namespace Prefix: nuro_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Interim disclosure policy text block.
+ References
No definition available.
+ Details

Name: nuro_InterimDisclosurePolicyTextBlock

Namespace Prefix: nuro_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

Credit Facility
9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Credit Facility

8. Credit Facility

The Company is party to a Loan and Security Agreement, or the Credit Facility, with a bank. As of September 30, 2015 the Credit Facility permitted the Company to borrow up to $2.5 million on a revolving basis. The Credit Facility was amended on January 23, 2015 and expires on January 15, 2016. Amounts borrowed under the Credit Facility will bear interest equal to the prime rate plus 0.5%. Any borrowings under the Credit Facility will be collateralized by the Company’s cash, accounts receivable, inventory, and equipment. The Credit Facility includes traditional lending and reporting covenants. As of September 30, 2015, the Company was in compliance with these covenants and had not borrowed any funds under the Credit Facility. However, $226,731 of the amount available under the Credit Facility is restricted to support letters of credit issued in favor of the Company’s landlords for its premises leased in September 2014 for its corporate offices. Consequently, the amount available for borrowing under the Credit Facility as of September 30, 2015 was $2.3 million.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stockholders' Equity
9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity

9.

Stockholders’ Equity

Public Offerings of Common Stock and Warrants

In May 2015, the Company completed an underwritten public offering (the “2015 Offering”) of (i) 147,000 shares of Series B Preferred Stock (the “Series B Preferred Stock”) at a price of $100 per share, and (ii) five year warrants to purchase up to 14,553,000 shares of common stock with an exercise price of $1.25 per share. The 2015 Offering resulted in approximately $14.7 million in gross proceeds, before deducting underwriting discounts and commission and expenses. In conjunction with the 2015 Offering, approximately $3.2 million of the proceeds were used to repurchase the outstanding Series A-4 preferred shares from the 2014 Offering (described below). Net proceeds from the 2015 Offering, after deducting underwriting discount and commissions and offering expenses and repurchase of outstanding Series A-4 preferred shares, were approximately $10.1 million.

Each share of Series B Preferred Stock had a stated value of $100 and is convertible at the option of the holder into the number of shares of common stock determined by dividing the stated value by the conversion price of $1.0101, which is subject to adjustment as provided in the Certificate of Designation for the Series B Preferred Stock. The Series B Preferred Stock has no dividend rights, liquidation preference or other preferences over common stock and has no voting rights except as provided in the Certificate of Designation for the Series B Preferred Stock and as required by law.

The Series B Preferred Stock is convertible into an aggregate of 14,553,000 shares of common stock. During the second quarter of 2015, 24,684 shares of the Series B Preferred Stock were converted into a total of 2,443,716 shares of common stock. During the third quarter of 2015, 28,170 shares of the Series B Preferred Stock were converted into a total of 2,788,830 shares of common stock. As of September 30, 2015, 94,146 shares of the Series B Preferred Stock were outstanding.

The terms and conditions of the Series B Preferred Stock were evaluated based on the guidance of the Derivatives and Hedging topic of the Codification to determine if the conversion feature was an embedded derivative requiring bifurcation. It was concluded that bifurcation was not required because the conversion feature was clearly and closely related to the Series B Preferred Stock. The conversion price at which shares of Series B Preferred Stock were convertible into shares of common stock was determined to be lower than the fair value of common stock at the date of entering into the agreement with the underwriter. This “in-the-money” beneficial conversion feature, or BCF, required separate recognition and measurement of its intrinsic value (i.e., the amount of the increase in value that holders of Series B Preferred Stock would realize upon conversion based on the value of the conversion shares on the date of the underwriting agreement). Because there was not a stated redemption date for the shares of Series B Preferred Stock, the BCF was recognized as a deemed dividend attributable to the Series B Preferred Stock and reflected as an adjustment in the calculation of earnings per share. The amount of the BCF totaled $4,140,446 for the 2015 Offering.

The Company determined that equity classification was appropriate for the warrants in the 2015 Offering following guidance in the Derivatives and Hedging topic of the Codification. In making this equity classification determination, the Company noted the warrants had no requirements to be settled in registered shares when exercised, and the Company is not required to pay cash in the event it does not make timely filings with the SEC. The fair value of the warrants issued in connection with the 2015 Offering was estimated to be $3.2 million on the offering date using utilizing quoted prices (unadjusted) in active markets. The relative fair value was recorded as equity.

In June 2014, the Company entered into a securities purchase agreement (the “2014 Offering”) for the issuance of (i) 664,600 shares of common stock at a price of $2.04 per share, (ii) 2,621.859 shares of Series A-3 Preferred Stock (the “Series A-3 Preferred Stock”) at a price of $1,000 per share, (iii) 4,022.357 shares of Series A-4 Preferred Stock (the “Series A-4 Preferred Stock,” and together with the Series A-3 Preferred Stock, the “Preferred Stock”) at a price of $1,000 per share, and (iv) five year warrants to purchase up to 3,921,569 shares of common stock with an exercise price of $2.04 per share. The 2014 Offering resulted in approximately $8.0 million in gross proceeds, before deducting expenses. Net proceeds from the 2014 Offering were approximately $7.9 million.

In the 2014 Offering, each share of Preferred Stock had a stated value of $1,000 and was convertible at the option of the holder into the number of shares of common stock determined by dividing the stated value by the conversion price of $2.04, which is subject to adjustment as provided in each applicable Certificate of Designation for the Preferred Stock. The Preferred Stock had no dividend rights, liquidation preference or other preferences over common stock and had no voting rights except as provided in each applicable Certificate of Designation for the Preferred Stock and as required by law. The 2014 Offering BCF measurement was limited by the transaction proceeds which had been allocated to the Preferred Stock. The BCF was recognized as a deemed dividend attributable to the Preferred Stock and reflected as an adjustment in the calculation of earnings per share in the quarter ended September 30, 2014. The amount of the BCF totaled $2,955,668 for the 2014 Offering.

The Series A-3 Preferred Stock was convertible into an aggregate of 1,285,225 shares of common stock and the Series A-4 Preferred Stock was convertible into an aggregate of 1,971,744 shares of common stock. During June 2014, 204 shares of the Series A-3 Preferred Stock were converted into a total of 100,000 shares of common stock. During July 2014, the remaining 2,417.859 shares of the Series A-3 Preferred Stock were converted into 1,185,225 shares of common stock. During October 2014, 408 shares of the Series A-4 Preferred Stock were converted into a total of 200,000 shares of common stock. During February 2015, 408 shares of the Series A-4 Preferred Stock were converted into a total of 200,000 shares of common stock. During May 2015, the remaining 3,206.357 shares of the Series A-4 Preferred Stock were repurchased by the Company at a price of $1,000 per share. Total consideration of $3.2 million for the repurchase of the Series A-4 convertible preferred stock and warrants was allocated to the convertible preferred stock and warrants based on their relative fair value. A BCF totalling $589,751 was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature. This BCF was reflected as an adjustment in the calculation of earnings per share in the quarter ended June 30, 2015.

The Company continues to revalue unexercised warrants from the 2014 Offering at each reporting period over the life of the warrants using the Black-Scholes model and the changes in the fair value of the warrants were recognized in the Company's statement of operations. The warrants issued in connection with the 2014 Offering were within the scope of the Derivatives and Hedging topic of the Codification. This Codification topic requires issuers to classify as liabilities (or assets under certain circumstances) financial instruments which require an issuer to settle in registered shares. As the warrants are required to be settled in registered shares when exercised, and since the Company is required to pay cash in the event it does not make timely filings with the SEC, the Company reflected the warrants as a liability in the balance sheet.

The fair value of the warrants issued in connection with the 2014 Offering was estimated to be $4.4 million on the offering date using a Black-Scholes model with the following assumptions: stock price of $2.00, exercise price of $2.04, expected volatility of 67.48%, risk free interest rate of 1.64%, expected term of five years, and no dividends. At September 30, 2015 2,349,825 warrants remain outstanding. They were revalued at September 30, 2015 in the amount of $0.7 million using the Black-Scholes model (see Note 7) and the liability was reflected in the September 30, 2015 balance sheet. The Company also continues to revalue warrants from its 2013 offering. At September 30, 2015, 1,057,323 warrants from its 2013 offering remain outstanding. They were revalued at September 30, 2015 in the amount of $0.2 million using the Black-Scholes model (see Note 7) and the liability was reflected in the September 30, 2015 balance sheet.

In 2015 and 2014, the Company issued shares of fully vested common stock in partial settlement of management incentive compensation. In March 2015, the Company issued an aggregate of 166,405 shares of fully vested common stock with a value of $281,700 in partial settlement of 2014 management incentive compensation. The shares issued reflected the $1.69 closing price of the Company’s common stock as reported on the NASDAQ Capital Market on March 12, 2015. The 2014 issuance to settle the 2013 management incentive compensation totaled 42,615 shares with a value of $104,405 reflecting the $2.45 NASDAQ Capital Market closing price on February 25, 2014.

Total compensation cost related to nonvested awards not yet recognized at September 30, 2015 was $346,000. The total compensation cost is expected to be recognized over a weighted-average period of 2.3 years.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

Net Loss Per Common Share (Tables)
9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Potentially Calculation of Diluted Net Income Per Common

the following potentially weighted average dilutive number of common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive for each of the periods presented:

Quarters Ended September 30,

Nine Months Ended September 30,

2015

2014

2015

2014

Options

867,135

576,746

822,769

406,540

Warrants

18,889,103

4,978,892

11,771,953

2,436,336

Unvested restricted stock

—

15,493

405

16,512

Convertible preferred stock

10,923,802

1,971,744

6,777,980

693,361

Total

30,680,040

7,542,875

19,373,107

3,552,749

Schedule of Earnings Per Share, Basic and Diluted

The Beneficial Conversion Feature, or BCF, recorded in both the 2015 Offering and 2014 Offering was recognized as a deemed dividend attributable to the Preferred Stock and is reflected as an adjustment in the calculation of earnings per share. In May 2015, a BCF was recognized as a return of capital from the preferred shareholders to the common shareholders attributable to the repurchase of 3,206.357 Series A-4 preferred stock and related beneficial embedded conversion feature, and is reflected as an adjustment in the calculation of earnings per share. See Note 9, Stockholders’ Equity, for further details.

Quarters Ended
September 30,

Nine months Ended
September 30,

2015

2014

2015

2014

Net loss

$

(3,203,778)

$

(1,461,713)

$

(6,478,212)

$

(4,857,021)

Deemed dividend attributable to preferred stockholders in connection with embedded beneficial conversion features

—

—

(4,140,446)

(2,955,668)

Return of capital to common shareholders attributable to the repurchase of the Series A-4 preferred shares and related embedded beneficial conversion feature

—

—

589,751

—

Net loss applicable to common stockholders

$

(3,203,778)

$

(1,461,713)

$

(10,028,907)

$

(7,812,689)

Net loss per common share applicable to common stockholders, basic and diluted

$

(0.26)

$

(0.19)

$

(1.02)

$

(1.18)

Weighted average number of common shares outstanding, basic and diluted

12,133,984

7,853,292

9,879,905

6,602,626

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

Credit Facility - Additional Information (Detail)
9 Months Ended

Sep. 30, 2015

USD ($)

Line of Credit Facility [Line Items]

Revolving credit facility, maximum borrowing capacity $ 2,500,000

Credit Facility expiration date Jan. 15, 2016

Credit Facility limit restricted to support letter of credit $ 226,731

Line of credit facility, remaining borrowing capacity $ 2,300,000

Prime Rate

Line of Credit Facility [Line Items]

Interest rate over prime rate 0.50%

X

- Definition
Restricted Cash Collateral Letters of Credit
+ References
No definition available.
+ Details

Name: nuro_RestrictedCashCollateralLettersOfCredit

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the credit facility terminates, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_PrimeRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

Comprehensive Loss - Additional Information (Detail) - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Other Comprehensive Income Loss [Line Items]

Other comprehensive income (loss), net of tax $ 0 $ 0

X

- Definition
OtherComprehensiveIncomeLossLineItems
+ References
No definition available.
+ Details

Name: nuro_OtherComprehensiveIncomeLossLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 44 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories - Additional Information (Detail) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Inventory [Line Items]

Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross $ 64,477 $ 0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_InventoryLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.2.Q2 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 45 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Statements of Cash Flows - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Cash flows from operating activities:

Net loss $ (6,478,212) $ (4,857,021)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation 160,993 103,250

Stock-based compensation 246,406 208,358

Warrant offering cost 0 50,874

Change in fair value of warrant liability (3,473,804) (1,554,411)

Changes in operating assets and liabilities:

Accounts receivable (321,655) (220,868)

Inventories (392,422) (67,200)

Prepaid expenses and other current and long-term assets (484,063) (26,476)

Accounts payable 423,275 199,818

Accrued expenses and compensation 30,948 841,317

Deferred revenue 667,994 (32,570)

Net cash used in operating activities (9,620,540) (5,354,929)

Cash flows from investing activities:

Purchases of fixed assets (594,606) (71,982)

Net cash used in investing activities (594,606) (71,982)

Cash flows from financing activities:

Net proceeds from issuance of stock and warrants 13,316,324 7,918,179

Repurchase of Series A-4 preferred stock and warrants (3,206,357) 0

Net cash provided by financing activities 10,109,967 7,918,179

Net (decrease) increase in cash and cash equivalents (105,179) 2,491,268

Cash and cash equivalents, beginning of period 9,221,985 9,195,753

Cash and cash equivalents, end of period 9,116,806 11,687,021

Supplemental disclosure of cash flow information:

Common stock issued to settle employee incentive compensation obligation 281,757 104,405

Warrants issued under Securities Purchase Agreement recorded as a non-current liability $ 0 $ 4,418,824

X

- Definition
Stock issuance to settle incentive compensation obligation
+ References
No definition available.
+ Details

Name: nuro_StockIssuanceSettleIncentiveCompensationObligation

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Supplemental warrant issued to placement agent and investors in private placement.
+ References
No definition available.
+ Details

Name: nuro_SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement

Namespace Prefix: nuro_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense (income) related to adjustment to fair value of warrant liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section 25

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6939902&loc=d3e20148-110875

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_FairValueAdjustmentOfWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of accrued expenses and other operating obligations not separately disclosed in the statement of cash flows.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_OtherNoncashIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to reacquire common and preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsForRepurchaseOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accrued Compensation and Expenses
9 Months Ended

Sep. 30, 2015

Payables and Accruals [Abstract]

Accrued Compensation and Expenses

5.

Accrued Compensation and Expenses

The following table provides a rollforward of the liability balance for severance obligations which was recorded as research and development expense in the Company’s Statement of Operations for the year ended December 31, 2014. The severance obligations were fully paid as of June 30, 2015.

September 30,
2015

Balance - beginning

$

148,921

Accrual for severance

—

Severance payments made

(148,921)

Balance - ending

$

—

Accrued expenses consist of the following:

September 30,
2015

December 31,
2014

Technology fees

$

450,000

$

450,000

Professional services

229,189

257,024

Sales taxes

122,901

34,206

Consulting fees

67,200

173,759

Personnel related obligations

64,543

37,761

Clinical study obligations

34,085

74,000

Federal excise tax

26,289

25,989

Other

138,656

212,137

$

1,132,863

$

1,264,876

X

- Definition
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

ZIP 47 0001144204-15-060400-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-15-060400-xbrl.zip M4$L#!!0````(`.![5D=0K!/?I9D``.&/"0`1`!P`;G5R;RTR,#$U,#DS,"YX M;6Q55`D``W0Y*59T.2E6=7@+``$$)0X```0Y`0``[%UK;^.XDOV^P/X'WWQ> M)R+U#KK[(DEW9H/;>=PD\[A8+`)%8F)-VY)'CW2RB_WO2\J63W/Y?Z-O=_>C\>CGSY^'#GY#E+SAT/9GH_$XE7-J MA5@&?L\?I[??1_`0+*^]/@93]YC\?X1A>^&Q%P?^YX-)%,V/CX[(*SV$?YFA M*'!?R3N/"`+)E'&K%@],7>]'Y@'RLD,_>,9W2O(1N?R(A:>WDZN.NWJ`OED[ M6EQ[H:]`H+.>6-R1/N"@>8!LTKVESYA'5F`'_A0=K6].'[?]V(N"MZRR0F0? M/OLO1\N+I#_DL03&,E@]%@4!@5/[*X5M`:SW+ML/B9Y!)Y!&0?"5V[^`%\H>CV:!Z4W(^O%#P0 MA^-GRYJOGGFRPL>D/Y<7"IK^.F6PYH_O%)7C*&"0!5\]P.-V-/I$Z'\<)L2^ M14^C9#@<1V]S]/D@=&?S*6%M\MLD0$^?#\BX'J=C]_`UQ"0[PB]:F(YT=OR MM]6OKD-^?W)1,$I@HTPS4Y6?7?SCX(N$QRTT3$.5/AWE'TY%'>5D91#,4>#Z M3AX!'LU!A(TL^I*260+I>];7TE=1S7&HA\RQ+*V%.\M':$B4\/2GI0Z7[V8J M5J44JPY1L6H3Q:K=*5:E%*L^R&#(BE6;*%;%=J@+Q>KOR!3H?3(%^CLR!?45 MVYTI.`FOO<$I=!&$1@6:2:^TI!F`U3(HXYC1#)#&$'2E&;AT&T.Q;I1FE#&` ME/WO2C/R\#0C=ZJ9P7G$#&>VMS-D6O'5G2$O26/P)Q99V_QPA]^.0CPO>4%! MY#Y.T0V>Q2`\\""HK.I%8;73\D-)Z]NN&/% MYQTA>B:@5O*6%QP,Y'4^=6TW6C1BY*1:^GRPG#\>,YI$YG''E;3SZ:A0WEH! M1T5`^^VB5H98$&2@!.G6'VU8D%/!$!9#>.KY"#9$4&1X%.G.BA1/OA_.XC#R M9RBX]A#-BDOK3S](KX5$=P]WUA2%M^@%>3&Z0A%]-]:DC1L<6"06NG7#'Z=O MI\BS)S,K&#B5^"U;D:Y(/>4<:@)FLU.6A-[HQ-UQM\]ID>+4LZ"\H'RKE._5 MHH!!Y:Z-54!P[KZ@?R$KN)Z317G7>_Z.K!"=/`:FW?'WW,/BWO%+O;ZVB" M@BOL5)+]&=%)&*(HI%WIJ34EFU'N)@A%WWT[\3O#Y%#JM4MN3R*ZU;5+/(SC M(!G#.(0AW8#'=LD+J7O/`_173'89#9N@U;2UIBM#_>W&>Y6TOG$SHS/?8:*' M,RR@&!;['!90#(M>#@M9#(M]#@M9#(M>#HL&0=3')C(W['FO3&D05WQLIG`C M@??*E`:N]F,SA>LKMF\_W>("MXSH_<=%>R# MT8*-_7#K>[9F>6.^U$)8R:0-EQ,U[`-;0Q^&*'D;*8B2)PI;0^^,*/SLB;`L M0[$L?9Y9\GDF#--0#%.?>99;&A,G$'JW;4:<0"AU\SM;,18G$'HW+,0)A'X. M"W$"H=^;+,6PV,NP$"<0!G0"86AQQ<=FRCY/(`S-U7YLINSS!,(^]FN+5.10 M4I%[)HK()0XEE[C;/=/*O2\LR[`M2QM?S"<,T%,,T")YE%]-N M`JSY6RR#9M-O5N!:C]/D]V&3:+,EZ95W`[M/97LG M[^+'T'5<*W@CQ4;?1W7J\B85;:TMTDV[.4Q&N>S5+>5=O;\ATJ=OAB6[I,30 M$$-C[Q7DR?@FN."J!T1=9#D*(D1!$D&0I(^.]?6X\\!.7D^Y-&7#:7LRUUI'9YJ6)L2P8$^B[2%+=J*TD`M@G)H7X7/-(^@MCQ+JNW+%72U"KVK+6E177H1A3#ZC M48GG14MCEY9G/2<==I%\TLI]0<37X6Y-OLA!O_=F:GE7UFS@ZQK-ADQ6S^T. MF:Q>RU;H*G646+!+1I!,>1F9G6=I/(!29H@!5"5EL[_Q4ZN?]N>!Y"8>2.YP M\@\?H%JZH>+#D7Z0-CJSVTN"8ZAVE260'W"D4G:479!E"`8IFTZ0L7/NBBQ- M*IZ5NV11D6=W]:&ZG6YVR^A=E'ZI4\!?,%HP>CN'OK<:-8+9@MDM,[O/6SL; M%[7\\`GGCU@A4JQ'#,;H[*;DFT9],%YK,U`4--E/JEMK\CWYCA94,_MT!*L& MQ*IL+-_E%IXU/1:+K_>3`*$SWWM!0>0^3I'8Q;&Q/EU%11^!*F20"*:PF%)! M0^^,*"4!C=C#TRG/ZNZ8>?\.M/=A6:M9X0'S>U"LVDV*52],L8KP;)#A63YW MJ?NKC:2"`WWF@-[1.0Y6T"X\SI`]3L]"7R!1V]>E ME=798GKXWKG5J\,0RAA(3;9R2]UM1:58)'Q7CWU7A@-M^BY(S9;@`S2V/C3V M#B@Q'(NBDJW'#69$<`R-KF9$:Q8)B]);BY+C0'[UYB$3.6&,OR(O1%8H$[X?'^\(N'%CTT/67Z@7I!>F[ M)'V3`E6[(#U5XFW+("?M]VL/O5?:=QEJM#H,-_IB6,3OJC);+C4J%M_ZO/BV MF_/28I6EOZLLN\F(L_)'(B,^W(QXWS)+Q=-K<39G,&=S!C&/S>8M+UW/G<4S MFD:WEO<\\`*'5!-6D3#=4)'/8U'">OT@E*`;*BC!W6DD8IU!QSI]VH)4PK-O ML_G4?T,HT=?U/%]]=_'+A>>@5^3<^Z1F-PK"Q6SU_FT^<`M5K77IW:6J$@1C M$*R@P.,);K'C3F-2W_@.V7'@1G@D?WNUI[&#G//`GY%$2!PE*;WKIV]6X.'0 M,KQ!P=W$"L@GS`M?,&PN=JJ4FL4E!6T?;E$8!:X=%?A:0=]]T;>P4P2-&306 MP6-I.E5$C5O/_7NZ\E+W=#7X%`/\9W M-'_W`V[P0V)<(8"*_*#/.;Z@N"XG<4*E_/OUM//XV3<;C"-MVX@+&X\6M#G*/ MO_IV3*Z1D'NTY.0M>BJ="Q\D\,XM_"+G`1Q\`=+XGY^.\F]*6T5^/\$_.N3" M^=1ZKBT"'GQYLJ8A6LC(O(L6D@J_20;:M\4@K"U,/LC,`TM?7"3YW`UM:_HO M9`7G^)>PMFQE(3LK-??2,TDJP=?_BD7R:5>2DO^EMC76_3LXH@`1[17 MUJR^JK6#+ULWQ9\A:LO7LQZQ M],6TY+,8^RFZ4YKRS#CX,DZ/G;->O-GL*@C-\Z=D/ZC?://AR-[.F^!6C M6S3WL0/VGDB,J\JZ"# MUR?#$T<27L<1.89+GLE*7I;-AZ!`(C@8$4N8W+CTJ2,'V2[60OCYX.+J'%LP M63=4*)L9$C"$IU!7L8P53DX\A_Q!LA'[?[.F,=I$7*8C M2"$F7IJ"B]5G`J`9DO;IJ);TEB"OJW=D(YWB^@C#_KJ,)"D["$$5A;1X93%@& M-BBRO(95070K:,N4:+*5*!E`D[9"VTR+4&*S"YB:*9N4K=L&0XEN(.!@D+!1 M@&I%##>!CR<^T=O-%,QD` M%4I-\953[\KW[+H$8YM["!2HJ]6(OY;>%N8R[?)K*Y'C`Z`)#4-2 M\B.DJM0R-;`-/P"*!*$L<:4N/>2-]4;<8VT+Q;;SIJ(!1=OTQUEI33&5:89M MS54(#1W4Q90NK]VB*8[ZG>^N]>A.DR1P797);*.N:YJJZFMX7,$M("U1I,PV M_0;VX:J\!5*L^2#>3I=L3P"`#`U-SO1UL<0MH)4IC^T$`-040]<:0/NZS`8O M:RG65AG;Y&MX,J)0MJI86E-,9;IBFW2H2HI1%](VK&(;=$QZW0"49>7WV38\ M8MMYJ)D&H+53FT`-P@:9;?6!I-#Q5ZF\+8"5*8MM^DU-5FO@6I1N7"2DFRYP(!3/XB2$Q!::K&U75I[* MMK=CH$F&JJF`BF_XTMO`6Z)3E6V7QT!5<*@A2W`;O`E7)_[466T>K*Y/MLTV M%%-25"J&W135!$R9LCA9%1G/ZNB1R@=#V?@3S]E&3VRKOID!X$G>'FF9$MEF M?S-K4!72=44#>\PFOH'GON]/-!A.=(!Z.C+5WR MLL+:EMN/,I#9+J13O]Y!:]A.2&F_-9L5H-ML#F=6T$%[-GJGS?9H;#=7CVS+ MV4_9IHC,AKTL"K;S4H`D`WJZE0JJ"8"Q08(SHU`UF(D?:P(H/!Z=!TG%TRK(!W#FA]'UT_)J?2)P?(HIF1@&'4)3TII`82B$/9^` M,H[]LE.*AE`JD(.S,"N;$E1;1,)0"F=*`8`)#*TBE%\"/PQO`O\I'^96(0K; M#D-@RII)T96251\&8V,3VWQ"2)8TI2UA\`FBL^VG;N"046X)!4,9G-TTL@KI M!1P&BEL4(BNPR<:5KY@[4S]9PUPNO=7FBLZ)]J$N9SJ)*;T-J`P5R^MX`DX.D:RY77\J:;#=DJ&JND;K MNFG-EMTQHDAIHXF2)H0M4$32!=>+8_ M0]]QN%F?3FQ7,M9D//NB=^`5"&V.BW&X@+,\89JJ*A=R:AMZTSJ!%D%FG'R1%AIG2)CZ(QC[+'WJ8OLW'*#)-]ZXOP9A\F"R/53\<:- M*G1C6_XQ4%5%`11(IO@VL#*4R78)8UG1Y>>:F&]0M$6#A=('`^B&#B`AQ0_,_*:@&$IBN,V-$4W(!U.-@;# M)QB0V(YBC`,VH`.Y13`LS;!]PUB&$IEF5P2S427#"EV;)&!(G0SD-&!1SD%0 M9^0IH)!H[1!0*#E`VL'-4JM6'3>]EZ-3W%6XJ5?%+1T"<\>X6?HVJN.&6F/< MOR/W>8)_/WG!4>4SNHK).NWU4_(H==IU>]K33JCD"*ZF25"CV](,7*=-9/08 MD/A--`W=-"6UETVL,)BJ'*0FIQXAO<+5PR:R>A'RFP@@CN--0VF[C4FH?>5[ M?BZ!T*`5;(],IP5*9&Z)C44BSE*2#.GM=BWCJS*.*^\:[@@;2W?L29PJ&;I2 M']]7-`_P:Y+"8"0A.B,U(?XG^6<#B)S5(@GW+Z5#ANSM8;)ZF;<'63)-N1', MU.TBA]34P/INJDC.3@+)D%4J0"P6NQ4XAOHXI[:AHBGT/*T:.!R&!PC?]!4M M_KSP-FL;U-%M(&7IEI-!-*$"86M0ET>TT\-8A4>U&VB;.S1-`69);J>0CN0<\>" MTWY:+7:4'H>KU`EL3VHH0`8ZIT4U`.ZHP8PNY!R_ER53X9&NU?;F3J'6[T'. M*?TQCBEUIF?)(6@+,JL/V-Y;TW23WMQ5&S(I\F2%DYO`)Q4EG=.W7W%T=>&M M.N@$PWA9')%.#JC$^+?E1=]K,(@X9_W'JJPJ)C0S>=4M`.ZDN:SNXZ2138WL M/)>Z:BZVGCY M1_-&E'0K"?_"3H899Q4TUSO;P=M)8UF]R%E&S7=CNZTMKD"X*'>:-\<-.I(S M?5=,'.127K@.F@Y:PN@E3H6',9!4D#EPTGI+JM>DE'/0V7&#"4Q5I\O[[+*. M9AEQ.$4D2.G/[#IS+=!)^8ODI!SYUHKEV>@.1=$4QQLVJ9C^@N@$S?7CU'UN MF+[B%*/`K%&456&0^H"Z:0]K%'`"`F@`G=2TVK(]^=RMC7MUL3S=.*%=O0Q& MJ=!MT;%XPO;DXY*<-A1S8$VS;M]`SVW?*4-)DNGX< M4WP;6!G*Y=3CD!JB+`EUSET/]T8'H1BG3`>0@&2:FLZ-Q2H"W$ES6;W&*:^: M'Q+MM';A&^+Y?/$E!FNZW*J6?/;,N??Q;,1.KIP\HV1:LHAL_2`D"4WLV2.T MNJ5!%W,7A=O$M\,VL_J9[;45!1@&,=A=M'R]=LA();'J2W,*F6B&)$F9I51F MPBB]3(X^IV7S<$,:E,8#F\5+3-L^!)L+08/;=N^`-/'L@/UC," M539#/)S%N&]F*+CV$%UZXM+ZTP_2:\F7K1Z(5PO3ZG@H\Y&\#12G;Z?(LR958+M]!&R8=+]Z`-@ZL-K9DV,MLU3UXL=TH6 M&>Y]JFC9LGA/LMNF_MX93B45S@92/J)N&L2P@9Q2*ISMN;MN4`5'QJG*@J>6 M$C1,2>]9BUA=Q-G.K1LD661NW:#$S7U%V$TY7Y,O47E.>!)%@?L81XL79*OI M7'AX:'J+[T7][D:3;]@>..1K@LB*\*!NL#V;4T\F#4):Q+CCMK-ZF5L8I]:'8>HJ$"KFJIA!8$Z1JSX1>+W-8_EMJEOKYR5^28"? M"G$P1VJ1A2AXJ5%!%'"*:ZD2=BE%G^4J%=T&V-)/>+$C7"B9"M1:`7M.JGE, MD/.+[SN-5YW;&-.N][S\J8: M^#BGXA7#I!M;EMY&@4_OY4/?\!QR[I[ M^MZ.Y3PN;MA6G+O^V.WUN<^TX!U;O7X5I6_HGE7B]1&&PAQ,[$/(/(]:S.-E MVP\IW%3^,%;3CH7UK]UWD2O1MN%TP,KZWK:+Y),^+)!QNF;=^8&Q2,+M6U#4 MAD98W9XRBN>;K'C9CBM:B:WUXG[82VALTXKB`AUT_&(>W$_=]-B]]G/'66GJ MAC97*M";DI)+&]Z[]S)7HG##^*->)U.^M-TJ>8G!WH._U`V]L+"GV5*I9.D1 M6]LN,/TTUX?>S^5?.W>JUPY MHG5#WOZ0FO3LL&5EEAX=OJ-^VREI68V=`)<=@=]L=E%A.S;%SS@1F;WM>DZ>PG M.%QFP>PK1/;J,8N<\XHAKX_FBRY'%#1VV MAIG>7V677A'(XR*?Q?<[C*?N!_.&TVHX'!=UCMP2:+XJ=&_@SUND&WZ/D_+" MV#Y5UZ6#QV\UBS(AIXSY'QV=EU$O@[FI]V,VK:!PO>62<^.^4=>FIUN.%[A; M6#D;FG_UE_,MQSH+45#TQ=>^.R?P?,UA<%&[_!5]H"C'8:A='. MAD9J2J-QV6T8+M>K/E7@DDO,@@MC"$J+I\Z&UG!+S+3YW=6NMBJ!E(-Z@\>V MD5#O(#1R4)<>M=D(>'=@[!R\I4L9RL.[:B#L/CI")]\N+U]ROF$J[AJ14=%R M6Z`6=/*]^U;$]YJ#OZ8I`>4"_,W!7],._@U](W9GXMB$23Q@U1S^:KEIW%N^ MOX9EUZ,%J*55M89!OKAQ61?)&8P6R[;[;S@-%+#`=P MJ.`1CJW#*[@;-GXB)N)ZT=L7FV=JWC\[]U,G\#3;`)OBQ@EH[>B6[$GDC12QOZMXQZH]ZX@@/B1#9L3V1OJDM;.7.D#=C>\E1HE.#:T`QW M,.@K2M'+%7MPS'$T<9.OWVU"OYH^#[LBFJH5A^18*?3O["'& MTJG]V\Q_:H*<66_ICGM=,,E"?]0AT-:&?3J*'"I7YWF^6[0G>C<-^#XF&Y1V MARO]%&KZH8V;\^9NZ(*=@;2LZSZ:31)=GT"4GY929H%IDVW5M)3^4!WVHAXK M:UY?.*O@BVOJI?6.O%".7E**Z7.0E9V_I%R.\E,8:,W[0Y,77?M`,ZX8FF3P MGN<%LSD=Z9B!I?O,^*=C`0L1MP!/;RNS*]S#3!OL?!.2'@([[!2ZS38"=3AT M5$@$F2;:>71T.3I&=6$#N[KJ@Q[PXT]=NO-=4OYKUN068Z3(Y>]0(I!_6&"MQ&0KUW_L6& M)ND'S\2LGK%S\);.M#E0)N8J)MS03CT.^QXZ%:Y=>L&&;NY'2"5LEQ:PH7M\ M\_#7L)-_0P_[?;AX[P2WE9)GRX230R?FU:T(;.B6?\24Q-J5@=)]4!H&^?YJ MP89*OHIH?ITSM3ASKT+?4;[C_TIGJGHY[N_K&BZ&ID+W3[[Q_][0[.T+[=T[ M]>_A1O_?4%6+B8XJB6"C#W#8']:&CBTAC=YFWW!_`S(.X!L^ M"%WT-Z.B4Y12LR4J/IHVNYV\%N2(DM6XG=`%9H+D<+7.R*O7G+GCP M3,/4W`4?:Q4_(H?$M'*T*K^A-\S@L1PFMDH/:"9N.F441RI/4&"P]/J MUOUJ/D[]*%WD#BT!WBE,LRPP)82F$ MO?_)7&QP12A.TFRB9ZB'15.OM&W1Z6_`TR;`,@?!WUS'\[8>I5RQM`OH:>'X17/A[B-ER.,CP3/:6I)4Y,5PQUBH_P'.@E\K!ZZ'X`+*)]+!2^8Y9J9'[#BB.GT>MUA;I#6MF#4@XF$ M&/;'1*;-?_G#MBI4X"\AB?);PR264Z![[G@SA#5=;-S$+80AI<]2H0IFMJ+DI*TW5C"/#\Z7;2 M9^_V&*G$+-KHX4GA(CH22^&BR$OT2;.U1\)^X83J]'._6)K]69L5&/?#$OIP M#ZRI_MYFTB[X[*;HLKM>M=D9G=%^5(/.7@F)-QCTE)WQ&38'=SPB8=*HBUB: M9'GG>Z>_TLE8#;S]DG9"Y[*7]%I?7OPNT'6_`X^MRC2N!KI!:2MH,"X!W88= M)PWOA$3+AB;H2J\,&V214@4FVR=4-C1J'ZG#$FZL]8A\/YM;SH(Q./.?3.SW M"W3[%FM[TLO][-#L9&92K$?;_`_U.8>7 MT_02^@JOV\&?/AR_^.U+YU_=3^KH.@'UL*O.XRSR9,#-=\SW+<9+TM")7"J1 M9Z<2U=7DMU]MWKKY)ZA?]7HY\WX[Z'"D;9>]\Q1\B&`&,&[,-59AT+<1M#]8-AK]%E7,="7(FP_J""6'9MITGYV-^& M(3S=WB`C@VM;<:F(1&NVOLIG'`KW><[>*[SLYK6A;!**;];@8/[42DTW8JAJ3[QH4[2+.&:[(X[ M:G\P;GSB0YUH*N_13'/PL3(?#B6U-T3_1\HQ,A^*@6]4V&K=9"PZXL?'RYJH MU,V2`[M4`L"2J-TN^:$XXS1U8JR9[WXD-MJ0E3KN]P>#E`M@%\BV4@33<>;4 MXQ/)GL/3L-!%4(_VT57*I`^`R=SIE(VF;02WWNR2WOXY%5VE3&)K3J8T)KED M&`>N*D!$IP0BU!QU'"&W9-TA53W+E`CG=Y1=$DUV!%]54G%+)=[^/<[H',`E MM-J>,MH;X#TI/P5Z!93?+[/)-8F`\H3?29T5G>^=T=Y)13DLE'`"-F#G4Z!7 ML/,ENC;6L//9^[XR@W&O^IH$T\*TW"IVO0K%<@4$->B5!\G-[FX8=]53>TJO M-ZA6K41B-GUJ%('MF@!J6#NS]26=<4VCA>[RT*N?GOG:-JV_OH#%P9;^6KFQ MT\^MH)3#+JQR4_>U5'9=_4K\E?+/U;-Z+CZN`G_JN%L%N;IJ"26EKRS9Q>M> MON]25R*XA'I1PU*Y4-X"HR4T@@T+Y*\LL[B2X9+<"DNY1;^BWNP__ MWWO^JC?W[__?_<6'S]?O\>7*9=^TWT@[+RU9V:^PM"J76<&2'O#3;>!*T;9? M7-G2[1.F-[-G6C-=47+U^05FH%F_I/#:?UY]_7"%0-B."[0:+#UKGC1Q`ML`@6W:TO\$-I/4\7AP M*=TGMX-X>6*6,_>D9Z:Y6'LDS9AAZIHE^4R?VH[E/"XD$"C2W#%M_\*97.CX M)I]YO@?KT'QIRJRY-(>7HA.;7SI=>.C^MCWI@9I_23,JX)/TJ>O8I@Y7F[!` M&^B128;IX1Q5P"W>ZEF,S?$[QS68ZV77.M/<'PS>\8^`61;NK!?,HYV=@)RZ MH,^O.98)?R%5#'N<*N!ZPBJ^Z>[]Y[MO=_L\Y7EJZE,)L1'C#I-HM3D+?``2 M,&OJ0$0&\\Q'&S9A`COG,LMD$\F91+B086]\%V0GW8^(N>3PT?[I8#%A\IMF M60O)T@);G_+=1`KX!D<%_$6'"[R&TC3H!P\GN1G2OP/-1>3#RU!,9W$))XH3 M(_3ZR^=W4Z;_V`,;/C$AU"N(@0/-#K.X7MR=?W/J\_OWI="Y/VG##G=$3!I-,+NSUTV9;:'>)Q; MF@\D-",ZPGO-X=SS`P-Q@[@U[2>-GL@LIONN,ULX MCT"UTP5B6F=`2.&%\5+F+J@@K@DT2-L%]!=O%[QY0F2.-^B6"23M769%<"R9 MJSHARQZ(VPA:)`)-USD9("--3!LP"YP'JPVU-R`)#=#VP!@@P&5S($[:>`UI M`-`4"@0LEV*A<$Q):NG9!*[6*<07,"1037IT0C539ZZ=PCEI73/<<7H0`[FA M6>9_2++C7FLT4X)+3/C2FVAZ]).5=)3F>Y)$&"/!P6D0?@ELB)AJ MR$L83P4PW;BGMN7`R^%H`<*1'*!!/L^6WF6S1\[SNN9-I8GE/&>O@[MQH4^T MNMS+F&7PVVC1^($E@VMPD7]"ZD%.BL@G<9&:H]::9%1YNNS>%$L%)HFFF(2%P',HPAS1P0]B"( M3`,$#2#6EI#D`##X,T:8`:P#ZWVIO4++B$:P$UUS!*(87+&2$-/)[B0@+?"^ M24")!RYL*R&%]LD&"&D^!F]!/_Y00O#[^/3@:A#`PZ"'79L MSNS)UB%,-BP?'JQO>#``B`00/]CSD9@>%W"K\0K6_!B`J'#<6)WCY,#?'&D% M14AA8(/2!1GL&*!/+F)I<7-])6ESN`!XD9\0GD=G4'P/ZIAN^M6P+%8.(K0\ ML9]^^-[X"9('N"$;'(2@[7&5[>7DE>10S14H/K,R\,$R&7`A$HZ%#\>-)K3# M21D?2E=P&KBX!&LA+\MQF\$S8;]=#?1723/BHW<"V""6@G,= ME''.N2GY1]*-LP(^(T9S,^V0L>T.#W\:`RG.`! MZ.W!"?S5#,GG^.("UQQ%7%(4'H&&`^<'0&7K5F#`O:A+&G\$7GC$$,G/L#`C ME`V/%B@D1$] MPG'AQ\NV'V4`QP+I0R81G$I4./(8PO%L@GX9\A&9)*X/(MH+[2O^[-1K==XY MV4+^PTLX'1H,$!Z_3XHD&RP<\$/"B2#G-)'(0A2X\%7J^+R4_NX\`X6Z\A*[ M(+9!3$8W>G@0,Z[D)F]&'$D^'($6WF3;2$$NZB83[A0+E+WZ??;/*>+XP7C#@AJ%Z2T;Z2]F6B^%BR>.B;CK:?%7!C-1+**'!7OQ-O)Q7,I:$ZX/B,,WXLB;E4!BPPGQX3F?`FXX3] MB)53X=*0CFU.%>%!Y3(BMA3).&D,7$HX.!R%R_*6YXD6H`'9JW,92>>)+'E@ M2<'AJ.D_<"D`W@S(%ZVX4"@@3/P8QZWDMBF=DQ-X%&)JY6&1*)5R@NV<;AIC MRUKP!<6Z5_I)R$=V^$9<.AY[II'1R&(!'\O/E(0G5@;"03QPB@/20Y4"+]&! MD+TUNE(BFC5]BOHE/3D#:*C0O547Y\QN)KKD`K,'VOYZ8/YGQYH6D,\OR ML!VZ_4CWX=]SI`W^=_Q\-_YDQ&[']$= M_7W<@Y;XN#NG[N3^9FN!06ZP<)>EFUAIB:,NWM8N[Z.[([9V9Q]]Q4L.E"#> MF@?-(B>5-T5+=I6%+:?N2.F;<&U*DD>^KU!-#MT.("/`>K3]*9SEY.]>?CI= MB(&[E/U7_+:T[R)\VW8O*'`2X;%"Y@3A@51/_#NP0^,+M$5SCB'MAG5=P"H"M3HLT0^)/-';3)M\@G0_D5\)WXG-,REC7.3KAJ+E!EZ*J M7/R#+KMR?5.'TT!5\!5?N6&)S[B[^'_+)M%BR1JPK$C1RB]@XC@^7,J\R&5! M;M]*L8#$9S&_V'"!8YD_PIF;=N@KF\5]!?FI7&CPI&$+/6<(3^(02YL_Z,P` M?0&A2[0Y7!NL4#/=Y+GK]-%D&7/',V,,IIT^:%D!2+?YK_(,LH9<0VTO6B9Z M=TT;0S]D*X7+BQ[+S3JNV,6^F.A="]#*I-!IX8L0>-2&2"F;4QEI M;,H6X9LXF@C%FT8J#0Z^01(`]/X!9B.A)*;HPJ?DUP;+S2^M%VUM3%U%FW%E MVP$\^BLC8Q[>&S',_R47V`3,C11WI4I^$8[W/[D31*(Z#XIAQ`&\N_?O9'H> M>W`#))-./\38RQMXJ/39N9041;WH=KM]]54^[I=9(P$3K^MR61872>!E=*## ME^06$##00.BKC*1D(9IC":>%(1T#?I*E!S`2#`>0D!<.1JR$U2,'6JOI;E)2 M\ZDK7[F?,M58-W3Y1-S\OB@U(SU/&I=#$ ML2R:"B:!=8K\JZ64OQGS7^-YYP5AM!4="6&L5K/33B#N@(*%&LR"*UT>>B-W M`8E6U#9,[P=%]QS/HU_G&`(TY-!U;%G,S44[L#E4'(]8H,\<#ZN?&#Q"QQKZ M?4"@@Q"20Z^"A=%@/%A-A%3S'/QU0>%,M\B%T-"]:Q^U18R-J';@@/73"D71 M<1]EZ$09)GS_,(J&^XDN13IQR:.)RCJC$`?/"?!`=\,87Q3\-\+[N7J&QRPL MPB7]Q66I`]A-VG`&$ MSCF9)\/(F>072F7B)B.^CE&J#-@UB8\.M!`MY6\'O:1``R8G:TSG\%)SAN[( MR"WH,C]P[7P@B")A/^E*N*G2F/1@I,B*HF3CTL#S/!THPBEN5HV+Z($66K0( MW?&X>9Q=3;*Q1IB,*J$:9Z4=IEF$AFDUBT3;Y#$>+IC(YJ#H$;PJN@$NM+2Y MAT(H9N[KZ'4;%X:4ZX9*/JFKIA&'7E.D'\::H]2*,)\GHS@W2P:V7-Q%$H4? M.?:38V$^Q1^!\1C%16(AAEOB>;&#)K8_0PZE38R_U,$6=V8DA+CK`B55:'?F M+`_@?GK!%X46LV\&RG*!*CAQ;'L].'H]GC*31CN2N6*A:L"40%' M.64]KEN1G/P<>'!UZN^0]L+,2!X/X;""L'*%<]3`R3L36A$-T/8E3BDQXT@T<#4]%#OGSV$QN]\9AC"&JS^/2D M=)4OF7PE5!%FFA%Y-",&0=;,R7#4=2FK#CT*59Y7W=Q1!8=ZI6=R[O&&M@!> MNS.1_M(Q3UVS"Y6).*N(2ZI,V@P_=RC1*51R3+_`W%C6"RGVG\T<(]\+6OR4 M+;&$_HS*QIF:L[FGS8C76?1N%Q,5PH=&>PO36IGQ]LBBV`EN"A`W=WM/3@R#L"(KJU$U.GLX&8\O10^/:5Y3@K MET-OO_*7G=GH6E_%J5F17BVFE64\%!%;&_W4I5W/^[:\6]<>=>\YHMUNF>D( M.`QLCYYWWSSL,QQKWMN[XLWE MJGCR53M)G)0[W\*^@/[*>_A;,/H:A>Y7!M=7+2>MT,<.LE#7X=<38B-/RE5D MH_,,`6Z-&R;6"T4YWYAW&Z.HS4=>5I[GI3T0_55,>6`AVPZFMA/"^8Y&-.%C%%A4%9G$_+>=%FWU28)U= M!8^P.Y&%A45+5W=O>0V#D=Z<.^R-@>/;I&]SDI689(-W7:#%BC":^,CKC/3] MEJU]H_(:S9;>8XES+E
!^ERFN^1L5U[SCQ36$5WJ/]/+J[EOT_E<@4I._ M5AU!W!=.2>K+[R]7W!-66R3)[>279DF*7B9+!X]9#KZDFZX>S+#<2(_*-[T0 MH1@T9KPORZ%5(M[(ON6Y5+P(F6)],`>3=LFE_,$#>K8H%-Y M5M1`YD<\TUP\R`V'SEF\'8Y_3'&7?F?DCTS5#/(R\T%M\TOT_"&UO, MQ)\`PSD.CM05RHZRM;#FI)"AWSI(AB]??(#[7KR2_L!V%=:BC`QX^0*(`6Z) M98$REN,H%6DRR,S8HR&L&GL7NV_HUNBF%Z_DI:)]K&=R"P)>,=^0GD@5A5Z` MR2+,P)LXD<.7<6E2T4,>`Y,2BCDK.@]_A.R7)F]EC*S)M5%)3U,S,GD!3(P'7C83NGKI96"E8X(!K_Z,LF*Y M0@]W48GJI1+BSFP+!J"I([D+WG^*9>" MI#/*I0SR`UX"9G.U_!FKN0$(C/LQD_S_DX#VPG>=R#V62#?L=:&1K]^DWB%9 M'9Q20J-=C"07"&A*V<:$H[#P>)(\,&>:;3"M)Q&D:042+D6#E(17;`WW9H".IJ)H#P0Y; M+41P<:3&]?.!%R8L5>77RSCU6FS';&NI%$Y!"@LD^9R%SZ`O).K2/B:.6HN) MP_?7O-GOKW]>OW^Z\7][1?Z0B+:B[_^RILY+?^0>D;T2_EC M,7S&Q_'ZXO64HHH.)1N!.(_WW^]__#NZN/%U<E76A=L%[C3R[://9<>^'<`^EEWA;Q(L=Y0VE>48[ M''^OOGF%F_W2?%5Q0+TW7$Z=Y`$F'EBFM-JW4AS!"@DMO^I5%V8`('V>9WE7 MW1M)S<,PQ]X%"`?W'+PT`7,3U#"IN.HYY!'R*`0N:.N@H@?SJC-Q`+URO]]= MAV&=LR]U<0@#`F@_\.FQ=2$+*'@%MK@JG:'!T$,05H36E\6K]BZ'V7,G%@=1 MHRM8`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`-[!%RKT%JXHF M*!<@G>*>;]_=R,DN>3Q=-!L>IZI)IF%<*NJX9/(FV;!H#VB/`_G2O&27P"ENX@DK*+^7S+L)>IFLWA9(A>=-VQJNO4G!DV"7&=(["HAVTEQ([,SZ! M&..O+J6W":V&I(FD'!MS;CROFS\NTJ,W$QG'#J"<'IIJ!4#)108NP$AL!LT' M!#\$?KJ%Z%I=/6M%!#)@U[".M8"9(<+'1BS'F'W#0'Q"[L MD-RR/MNDRTM\M(77;7VTD7MTIOW@FK+IK5AGW)Z%IY6E@R&8GV=D%XT>&]O) M3@+@DMUC?I1&`[:6Z?DLY;FD;)_(.VXD+9A3N1^9DQ#=^]J"I[*%\%-C6\P8 MBE,^>!M\D_I03TR+F#1ICO;^7=A8/'/$9'>`YVOQY'Z;K7,BTW8F1:4??@<-'/%"^U,O`YG*-&:]X/TC25,(1/!POO$'` M4P9!D<2E%A9:1#$BC7!E$#'J#M/+,@XI*XFYE^HJ'GO($^VE()#8*PXD1B($ MZ3;2>BN/+`X&/7E0,NY58V"PCOKC9:7BZJ);-O)9 M<.G!8I_+;J,LC`!D3U8Z'1R96@1DKSR02Y?*:168YV@_,G*OIOI+KL(0I_;4 M>QJ)01X_?CI&_+@KCSNJW!^,FQ0^7L-2@RYV/:*7JC@O/)0%)_?19&4I-%8 M*FV%]@NAHOYV&EBG>MK96(CN?9PW-?ELH@LWM"KO'=2WTY''_;X\&(Q6^G9Z MPK=ST(ARD>&0E]4'""K+G5%?[N23_5898:$O98U9<`P0QD-5'O96AIX+`[HI M<[K::&9>\2T,#Q9N_@&#X*I2T)-U(\:L="$C2'?-I&JRCMQ3ASGK>`=8*R8* MM3Q=QR#>ZKZ#(KH&NN@IHU)T4F3*I4N'!]V ML1.'0BQYC;3TW>G(J.D6^<,OI:M$^(=!LX![D23X]#6 MI(33H1_W/VR+TMA.-;=P'K?+N%L`]B&*T"5H=5S!R#6NW/^4$HY?=#,UE MF0CN+D%A;ZG;L>E5'!;.ANH2L9:%!05ZA.)%]+(&=^@_.5&U3]R^=\"X?>^R M5ZSKK(G;:X7B+QDR%R>!I+K\O0Y/]-I]K/GR9YE//)JXC/'V+#@3QJW%*W(YZ.7?'0.-OGO>@#*,5H;#&%*.:A2Z MA>-E*L[][O;&\BAOIL?LQ^VB3-HTLN,_+,\IUKJRFA8FC<*SNK'8 M6+'C%9OT8#+VAW*WTUVQY<5K:S8EK#!!CT`);3EVVZDG>@XKPF,4NI@2SIK9#.D.B*B:FJ3BP"[1##;2](L/VE@ MEQ>TDPA74*^K?3"0>\I*G^IJF,-!*O4$OCLC51[FW5`KL4PZ6PE4WR'+ZOU`W?D@5I,=[62EJKTE@D^I(-(ME>L MJO9R;RO>OQQY+(];[HE4VA4&7^B43I$LCOQ*ES;9Z*DD(:8]4T=-M/47S,^X M80L5#3RTJW5O]P9++G;.JOX*.##[/M;S'3YE/%XUN:.Z:4[!>9;#$8MM^#R.Y*I^.P/]CO-F]YHIOM/%%^I_LR9 M/H-7WJV=FAAR_^S<3YW``TWDRC9NS(G/F!UY(3*30X('SS1,D`IW())73@[I M=5*30[[=7:?'AEST7_S6[2CXOP0)V\%2V&SQ`QVI/!;VA8B/SQZYI>2G;)?% M0=AEL7?OP&>.A5XX-^5^"J;TNR0.L_<8E5ZWQ!B504<=]<_&IZJP[K[ZVZNB]JR6ZGVS10W;^1 MZRZ]50M:C+Z1"AJNKNNM&L[M31VF:_J88M?5-U*F+6OI1J5XS0-/YJ>7K>A% MNE4OU:W>*[T#!C-]"8B0'#4E5U%O$]02XZOX?_E/92DRUQHVI^S7-O^CCN$K M]]DX'_H&:*"$)GUT-%Y4?\=KYQ;2550P)T>SNW-[+D=6YX-F_Z#H9&'SD:); MD]$.&>\-:NJ.ZSK/88E0Q49ESJ9,Q8UH$+1C/5%3"6B$8TX!!SCV(Z[X#$?#'C3_-SBC>06B9YG**XI,>2IZ6*'?QDE_'^"6!L#=HN MI;_#I:"$R!6S4V<@#W.S1R,/71ABT)XTTR(U8O6F4K:!Y[MF9*I[P1Q1"=@% M\<`[<>C\GB0*/=&>''>=.]`";%DT[A@3X#".,G<9#KN`GQBEH<%3DHTAAU]T MI>ZX,1D[X``J<6@`40I-GY&((\>Z8BM?`NVH.;?5.DR6WP\J:N/8X'E8H MS7G=NL#^]O;1L$="PSXE#3O2T+;1>D%$.?8C_C7D#)1\L:SQ[C_08+>E(=U+ M1/C2IZ3VS-MYO4=7U[=6TFMUQ->ED:_8-CKR4Q),NE_95,U@$].&*Y(<+AF3 ML&#'3&^*J9'2Q`7%]=EQ?]!)Q2L3J?]-DO7%R\ZM!37#61ZK6CA_58YT7@V5 MD/1H.3Y*+_7X5#6DMSH+$]-NL"H3=:UG1_IAXG-IFM$\\*-95ZG.WDDON>7, MU>)QJJ\EYP'.3=(#Z;?`3KZXE&Z3'\-WXNOBW'7>T@5SRS0TBV!Y;(X&`;*I M$[@ZI5F:I/(XZY^T2G=QGN.WI++18&&\-Q$]B$8J48&H/M5P>!D0U'\PI=/? ME-S*IX29/"6&1D\!4O[#PIYH]/`(M>&&94D$OH_F7:&S47IP'5!*+5`P+5CC M37RIERN._HA72&K\#FJDP[9JH\,U-*(/'>=:\=V%[U*;FUU"3$RI)73R2UC> M)EY[3#WSHF7S!%`Y537%Q`:J$U"HH:B\;.%3,4X2W2PR^E;P5\%\:JU[)< M>KXSEUVDY^>G/H<8I:P*$($\*9X:`F)S/LVG'8Z"XH3#-`KK:>U4RYC>5IZD M22(O:2MD]GD\30-GB7.)F.QN$2VLF,$=LV!(JA3[3A\WW(F$`TIC)U)\_-$U->'L=?7I(N+)<"8?2G.F3VWSW\1]?B3"<@6'?GG!) ME3J[,HIV:6#+2="(M)9%C!P2%WFLX%CR@W!4[3-U#O7IWR;6LV#0.IG;&.D< MN)'HJ5C]!B'$DA5S&^XC69I9$'#]H>V);I.*[?[E%\1WO+O]^/'JRQTLDSRE M/O[:PG'),/[*S?XHTGJV6&"B?7_]_?\B6HGM.'76,0Z]?.+ MN.K^7Q\!%AOEMY7=(:HZ\O@<7MHBZ>W5N__[MZ^WWSY?OY;^]X3^M\2:&J:4'26<)'*4$@2*%%I)#6 M]PN6N#.E_(-L[`1I7\C83OXV;4J=1/2"YZF?==O&H1:>Z\+X)R]Z3<.S!8*5!BIS0@2M).$UL2$$I1)7EHTE?E M2;`C2%"0X'8DF**F=!`C_?UFNNNVB>X:J8_SK)$]4:'KC.V.BMX&;9R??Z]W MV.G#`C;2,NE^W"/RJ'5:"N)NTNX*X6[S[@K@% M<0OB;B=X@K@%<=>RO0VQK?8S,S?95MB_@XUDN[+U?7UA\]_B_)J^E$RT^&142#>^K+2&\J\57BI3^@=U75U='57,(M@ED8B2S"+8!;!+'L'18ZH;0MN:5504+"- M8)N&&:GUQA*/'S9N@C^B">"M8^2T_#D8^-4D11P0_D9F10CR%N0MR%N0MR!O M0=[M!4^0MR#OTS:SZHT%?DPU=SUGF[H)X.V2Q-``654A?(V418(\!7D*\FP\ M>((\!7DV&#Q!GH(\FVUHU%P;EIXR_QS._SUG\U(D5I]'8O5HK,BJLDO#/T'J M@M1;1>K'3\\0U"ZH75"[H'9![4*-.54[312'B:1DD<)_]%SD(PM$P2J"51J) MK$9JRH);!+;`)IU3-3F[NTZV0LN*7I/W`ZGQV.4U_=B0G<''8_7*\5C(] M+V`X(9>>U%'4GG0[F3":VTR#R?&[KC0Q;6KJ4QS8 M^Z#AM'3'SDU:OY2N/%S%\I/E>&RRE\!;\`Z:-)S,IGY@EO-\2?.TT^//Z2$S M;2'I4\U^Q-_H>8%M,-=:(`@>X!QG0W.4>-G;$;/A;NF.;9C\6_ZLRRHE0T8P M2&\CI*W$;VH0.`[P=EP#=VK%AL8SD!'(/U6Y;.5RG%WYS+0L&E=>1#0TU/L3 M;`;?YTHEJRKWAZH\[/6RZTF(&@=(NVP.FSTE[#XLTD@DRH'-SUX?#0L/&1C8 M)\M#E>)RW.O*O4XWNWZ-SWPW-)]>F`"0&V=]XC.CDW]"H1R^;ZR*"=)U3C0: MBZ&:58>A&H>"H9*>]J4.EA"2/8&6YLG%?_M.\OEW+D>3+Z)RET5VSJ^&)^H> M4WW/F@1W"XNU+EJ\22*%M+93&=4)44/;!%)MTPE1^]J9,STS4?J?#KIU2.,1!"3@%PRTGH&^FMZ/BQN79>95`X3, M\P7]"/HIC$`M"]U[YLX$N0AR*227:_/)-)AM[%+\=D)V8EN3:7>.71>X##+Q MLQ./8#<>O"-FWIP M%?L4-M=V[%WB?R>SLPWQ%5588%_L#.H>W1G4A#+[)H!79[^(4^@&<4QWCJ!1 M0:,E'3+*26YBBVCTX"S85F(==BY'ITFM1W.I"!X4/+BM4M-I_&ZVS"E2\Q&_ M<*71\;P>S67!5NS>,=T:3=BZ-<7UM13T+BVF^EKU2JKH:ZTBK:#$OYX^#%@S M/G$LRWFFDG8J6IV[#B:+>9(F><%LIKE4.\T+O[VH*GVYH#ZL)N:(''74X1LO M+GP/2_,U*Z['-N%1#\Q_9LR6KID>%DNK,B_OQ]KS@AKJ`]!2-2T93KPD.?," M481<7Z;CH'N*1_1YIO.N1L&&\@"4B`E.]G#6-P]RL?DE-K\K-O],-W_7MLC- M`[3M4=CJTD>*CO2WF@7J,<..-TNZ\+%LU2:$X)L`GLA?KC/)I"=WNEUYV&E^ M7I@@[RE#N=H\6T&H"F3=$8ZTNBE*D ML7Z-FS&B^S?IU&ICK]`_`EO'WF;P`'\JS8,'R]3A,I%DV`3P6CH2N-Z@X,NP M`>FKQF^?H$Z1-I("6LP!/#IX32+9QI"G$*C-T03K]5V^X\WE0?/+I@2$.F'2 M@/V<;8*C=J!M5I5O98-+CX.!(EG7D0<=-'W[1Y-V@L8%C==+XZ/>2.Z-QX+" M!86?*(6#OCKLRB.E=]8TWA"=M5[O92K>OIQE>LX6RW'G'VZ]Z><\__!PR"H0 MEH-!7U845;"*8!7!*ANJQ<`T5(_7I$^PBF"51B*K>5-U#\0J]&V#I^I&?Q"V MJ63H`4=LNE1L$RZ9X'S-JW_HF@M+6SB!_WIB_F3&FXU%._'SW?B3$0.0_N@F M'Z,5ATB-EK)SJ9;T8K4(J_8=4NYQ32I[K(\610VVGJ[5&2_B0;C0S-;`51[RF)CI]8IH7N&P&4*7FQJ:' MOD:E/ZF9KVIVYFNJ#/2;=_9E@/N[JAN'#''6G8$Z=L>R MP.8AXFQHH:[)@?$G,P,.!K:FCI>3#M--U>Z;SZECR3-_<%\+WW)Q$F1W0<# MT&7JO`0Y?HCGL?0)]I)ZO"1_J[N$3UNW+X)R]YU4#0:K.0'BLE,:T*T_!;&7 M(K;;!X^Y3^3Y28W&G`=9HLV38$>0H"#![4@P14W?;">ANM3WF^ENIVSG$SJ5 M&Y([4EV>4)$ZSL^_U\<*4C0A1Z@)X-40K&M`4<91JW=;M/N"N`5Q"^)N)WB" MN`5Q"^(6Q"V(NX6V575Y^46VU3O-FTKLWX'YI%D4)SO2AKK*J#.7>4$PV$\0NB%T0NR#V4R%VT:)'4+N@]O.B]H:8:?6& MP'9M2W\RQOAQ"]K:T.RV,05M1^YN?F1U5S"+8)9&(DLPBV`6P2Q[!T6.J&T+ M;A'.D9.RY^#@7^DOMF[P]_(9`A!WH*\ M!7D+\A;D+`)\A;D?=IF5KTAP(_A5`^3B5*X8X/7T@%$];9S;]'^"?(4 MY-G@_1/D*U"D3E=6TW4A8E\9)&/?/1\ MY*.+1,$L@ED:B:Q&:LN"6P2W-!)9@EL$MPAN$8I8=;;INL&P5(L+O;C3IXX%ZYLY!K-DZ7EJZE/)]*0' MS8-'P#MH!(C4E4R:#G(I77FXB*4'R^$%\`*XS[17O4+27";-7>;A5!!#>F"6 M\WPIW9+.7XB'&GL?>M]8%4.0:QS*TQ$# M9D]FGM5*%`S&Z8%5:G$(5EQO#02+?[;=Y+/OW-!G'P1E6XLLJ-J-3P%=A], M>]84N%MTIW5ASTT"*22UG2J"3H@:VB:/:INOAXI@;C9IBRA##&8\%N&\_\E< MW?28H!U!.]O3SISIF9G(_W30M4`*CR`@04";".BKZ?VXN'%99N(P0,@\7]"/ MH)_",,*RT+EG[DR0BR"70G*Y-I],@]G&+G5,)V0GM34G,Y!R":`=\1P_!G$VM7+<;_Q)"`H7%#XSA3>N51V<80+"F_2OAZNG4*; M27VH7JIJ:XAAF]W^L[[2%Q1>L=EYW`$S"U<:S)S&[^G!3^A3V%S; ML7<)$)W,SC;$F5)=*?$*;TGWZ-Z2)I03-P&\.BOC3Z'N_9C^#D&C@D9+>BR4 MQF^BH-&VV&OU$NNP?SD\FD56ZW8>S><@B+3Z4[]S-!]PXVBT$<'J33O67;A2 M_WAN@>8>@ZW8O6/:_4W8NK+%N]$?A!*J!GO`NCV7*J="!-%B7F/EV!N)KKFP MM(43^*\GYD]FO-E8@14_WXT_&=&G7],?W>1CM.*__!IX%X^:-G]]HYDN%J2P M:]/3+<<+7.;=LY_^6\O1?_SVW__UW_\E27^)+K[3I\P(+'8[B6^[\CSF>U>V MD9I1\HEI^!SCUO[*],!%]\%;S3.]>WQ]_'"LAO3ACZ]L\M<77Q3U._R_HZC] M>T<9?^\J]/F%9!I_?7&CZ;YI?._VQB]^"_&_B0MM, M(>W#@E?!ILJ#HFI7K&8-;.?!8^X3$9VA^9HT=TRL#)TX+I62:KAA$OP1EXK* M5*)JVKH5&$SR3)]7)WG2\Y3!$WWZMXFUI;YO,5D"Y&DVW!46M>+F/&'%Z>HW M7"XQ2`4X+XO-@HTHV*Y#%*&GBD7?2$O%I"OJ1PM*.3//65,%FBHDK;V>^A(P`U/%?`:LQM1YH^KX(>0S2"YZF3-HU5?-WSE! MN4>GW#LP6,T)$%>ZW\HMNBO2Q'8;NT.6.KBDKLJ38$>08./A;Q@)IJCI6\H) ME_Y^,]UU=Z:[TR"LYNCCF33#5!1A,S+(A;9.&^?G7]F^/7L"%T5#Z@"NI0)$ M0+\;])0ET"B'E2!N0=R"N,7V"N@%<9_Q]IXW](*XVV9;%1J:U=A6[S1O*K%_ M!^:39K'RP\OKV/"*H#RQ:$R"V`6Q"V*O8KZ\\/_)9D18C]%>`+\A;[*\`7Y'U&^WOFX`OR;IN956,L,-4Y3M3$ M-7T#3P^\EL@BL7_G"9X@SW;OWXF#)\BSW?MWXN`)\FR;H5%G;9@SFSDV+!Z[ M3S]KKJN)`K&6)AB+Q.IM8M:CL2*KRH$:_@E2%Z0N:@@$M0MJ%]0NJ%U0NU!C M3M).$\5AC0GKMBCG5J3PGY9`%*PB6*45K-((35EPB^`6P2V"6XY.%8);A!I6 MFUW:YL&X(>314O8<+UN,O&K?(>4>5]$(VRHFV-8[335%Q1]IOG1^H&IF4&K* M+9*>KIJ3(DHBJL)?/KZ_N<]\GQJJ6GX2:\$0U[2D7'YM*'GB'VJ?W]JX4>3# MU,#N2HHS&PVA`+#U`%:16]1L""L`<',PH=$HJ'M^ZS73\U,;U>S4QMYNXUL; MC=5#AT,:C0QQUIV!'-DT5ZY8#EC)W#B2!((66D0+93PCNY!*F^>WMGI?!.7N M2;F-F-_::@0+$JR0!*V#SF]M`E8;J9!;Y,O;$Q49?_C6J.AM4,>WF]]Z/."B M4,%*X*HV-8ZS=]L(ASJA#X-'K0&_:H>5(.XF[:X@[A;OOB!N0=R"N-L)GB!N M0=RU;&]#;*O]S,Q-MM6.\UN/!^5!I-EV7IJ&;?,>^87;P;U&TBUG]!T+&07B MK2>KRE#N#4>"V`6Q"V(7Q"Z(_42(?>LZ"D'M@MH%M;>:VAMBIM4;`MNF1/\D MC?&-O)TN1#K^YE;HC-I3YJW"2WU"[ZBNJZ.KNX)9!+,T$EF"602S"&;9.RAR M1&U;<(O@ED8B2W!+LVW3>D.(QX\6-\$-T03PUC'RND8=#<^%."#\C4R&$.0M MR%N0MR!O0=Z"O-L+GB!O0=ZG;6;5&P+<86SK2=K430!OE]R%!LBJ"N%KI"P2 MY"G(4Y!GX\$3Y"G(L\'@"?(4Y-EL0Z/FDK`]QK:>I'DI\JG/(Y^Z+W>5H=SM M=@2Q"V(_=6(_?H*&H'9![8+:!;4+:A>*S.G::J(N3.0CBWSDH^/3[QGOWTWUJ._N.W__ZO M__XO2?J+';A.T9-O)_#L8#;W`].QO6\>,[+W2[IC^_#'5S;YZXLOBOH=_M]1 MU/Z]HXR_=Q7Z_$(RC;^^N-%TWS2^=_O*B]_";8SPVLPYL9TJ!L4"RIDA.;;D M3YGTUM+T'Q>`9<>"^V:.P2R9?GCGS.::O9!"T(#4M6N+\+R9E( M)`TG@/$\`QK_I);W2_R+QZNZYA M75)7D7%`5_]2^F!+G[0%_2%+52Y$4N7^4)6'O5YV/3$.GIG+`%/SP-6GA-V' M11J)E]+]E'DL=[UF_!%X/ESL.WBQZ4H3(''I"6F\UVYU^EFUP]XQ%4: MFD\O3`"XS,JB6*Q51=:92;Y+HX13GKGT].""L;[A<\;J^H'`J2G"R3_$3+5/ M^DU!/MY^_'CA3/:,>S4U4*;X;%P>?9.<8.,*]+U&`]AL^#:'(_;&P%!)CV12 M!TOXR!X`2T._XK]])_G\.Q=CR1?1$;_(#F/5?!#6Q:-78_&=&N:D9&>O]H^_ M04; M()MCD\W[G\S538$RA&4LRWES)F>&??[3\<"I88TG:;C[\S)Y\S!;P#W?#6] M'Q\_<6>.Q)8CE&,1R;3Z9!K.-LK5) MIVD:5N,FJ)]8,F&W5#2M`A]!1U%[TNUDPC"<=!!BB$*#M4#82EE0'_!EP^MM M@CF,[2_'\=<*/.5R5+93MR#OIFRU(.^RY-VY5'K'.\K/A;P%;Q^;SH=`Z-U3 M)/0_GR)0S2)@P;W'YE[U4AF?(IWORKQ-WN$23H3NPI7&,T>HU:>WM;9C[QKC M.X5];5S^2#V>GVX#/#]50=CL9+7FV+Y'!:J-OAM!H()`-WM?E#9"VS`"%>QW M"/_)Z"1)]8C^DY.A4,%_AU!ERA9O-@K:DV2_$G9P9^%*HV.Z.`3[M=2'&BF?BA9DIK+FDL]8'6Q:GS7Q_LHB5-TNH2W#NDCS7J:)??:,A MK/CHJQS``V2`#L:9.M9^4^I8KYF>+V-5LV6L.R2UG!(%[AV':`6U9A2>(H&T M1R'K*5'#&@!/*V'](*6LAT:<()RC$TYEQ:R"=LZ0=JHL9Q4$='8$5&E%IZ"? MTZ.?&FLZ!;F]9U[D(.S4SE/(4-KB:[JOE` M[UI5,-ZAVYV@<$'A;:'PW:H[!84WG,)/&_H=$Q352U4]HOK:J"*QYF^R(/%= M])6^H/#6['$)L[NW<*7!+DF"XH1N_N;NED5X.CO;O!2$>KPE^]1"5K;;1T\: M;<4.5FDL'A6J5OH[!(T*&JVI(E+0Z+%IM.7@[>ASZ%\.CVF1U;>=.UMDC8;J M+(E4O>PT+AGZC&FT9'ND_E'=`H(%6VOW'WWKUI0/5C55D1X=C5-<7DR;BA3_ M\NNN\U:C>:W1,-CXQC*37_<8VJJV9&AK%3-;E\BI@F7NN:3[*9,FCF4YS["9 MG%REN>M@_I8G:1)0S$QS:2BL/M7L1_C2Y"-GLU-.4V-2.5^/.NKPC2=]9$_, MDKK2Q+0U6S4V[PZGD7J0ZZ;=)`&I/O6B&`#'==:+S3_^ MYG?%YI_IYM\[OF8U`!5'W.OF1&$K"D@7'>EO-0N4529I_K)F>D13_.@A^)8F M5X@$W]+.W9['[OB"S`69MX7,55D9=N7!+A-#IDW1V.M*)12I+%^9?/`U:>:1\[8Y[!-$;IJ=."QFND\5%O)/?&8T'AK=S@LT=`"0H'?778E4=*[ZQIO#DZ M:XW>RU2\?3GG\YPMEB;WD.S"RPPGH$32LXKBU(J7W;Q/@T%?5I0#E0X*5A&L MT@2\[%@0#J:A>M0N=H)5!*NT@E5&8P58Y:P5L%.97?B77_E'/1I:`Z%A2KW>M!T+!R$GX>MQ4*5M#"J'0OOG-G,]&<,%GAE&^\` M5%@RLW4X_:Y-3[< MR,/"2\\?8M5J=;N(0NVX`+#]%I0B:"J6SY#T+FM=H^HVM)E"K37V%71Z,/'3 M[9RY&NZ,]!&T;-[)Q2S@!+]'72],6_K=>0A<6/PG.`\U?1K`V0A\_!)7 M&K7/Z"AO^%4AX41?JV]>75+7CO2O<&#-X#4Z0!97+*K]5"^-J8;=/&8@"*;6 M0GK`6UQ:Y4^UV<;-X9>MVAT?3:FP,4KF MTM16P5IOV(,;8(.53ACNHD6:MFX%V("%7`/27%O0.IT'RWRD,=8>/%?S)>;I MFD4`/@%J\54FJ%'4985>A8NXE*[@1^V1%>Q^8!OA?2'6^6TFT,H<$/435#"? MP1V5DDAW*`_'G1R-`,K@Q46`/@-QP`[I;@"80.2X3'<>;?,_B,`([`C;CJX' M0%3ZXE+Z%L.603^G/0L>9`&32L_`%R[SYO`F[(D2LO,/I#N=N;X&]&#.L!\. MXT(\+P-CQ,HH9$"]PXT# M2)'$9.EY:NI3DC\/V.HG)&VD<0E."]@BR\'&0[B!&MH(7G$8&!=D+CV^^+FX M))OY$C"''EA$1T@6"5+G M`3UCZRBOQ<[![:RDO(UUI>M.`+=^T1;XZ"O.LRD_(SSS%K<\]57RV'>!BQNQ MAPTV4.JWP2JUJ$[%0@(&`1[&O$.7+5VWVLG>7/I])%D:+[_7J:O MWMICA"Y/_@E9);Q[V%_?E&^IGU_MK?F6&PH5QV'7!WY7!WC3P>-5,?-$#C) M*^Q4D`_1:`BK2/C8G,O;;!1L:-`5FPT)8D!XD<_4_94NWB*CM-F8.'!&\;+J MN"=PIFP%\DD3>$,%6KTI#5JQF94V.8^UZ:5#;*=J:<%H? M6HA5"',573).DF0;(JCJU<#N8B]#Y'"79IIQ-%'5A`-J5S.L8;M]>`2L$7?' MP4!1O6JH@96M5CU)"F^(9*M7!4ML2V8;1S0LFW"4;>3H=-W*\??Y"+;GEGAI MD&97I7DJ%+\-@<+#C#([VWA-:\*1490ZC`1BFHWMF9X?!1_C4.5KL;D'#,:- M.B(8MX7:U!^*8)P(QHE@G""&"!]1+DJ*%M0\+91MRM!L1!S1>&X<,L0YT!8` M*[2,SPO^U<9NNQ`@=EC`+RB\G?[NZB(;10?V/=.GMF,YCPMIPL(T^3.-;S0! MO%W(N>6)4EO)IEY?B:O9FKR/@DP%F9XWF3;D]*S7W/WB.A/F>;QDU6/NDZD? M[PQM0A"L">")A+V24JK3&+>O_13VZ+'!.R'95*_&KW8Z\KATDWY!KX)>CTNOW9[<40:-W\_3/TKK M-5#?.;876-1I[9CNW2:H3DT`[X3$4[VJ_F`(XNEH_C-!KH)GER'O6,F*36!7!MRL-9KM-XP@[EPKK*?NHEC([2?YZQ+-0&\ M$Y)0]:K^G8'<.5Z"DB!70:[;D6M?'I\WN3;D0*W74J4Q)^>L-AVUUUVS[(#* M>MTUVE)0NR-YT#]:NHB@>4'SA\\V5CNRVAV>,\TWY#2OUSQND2)^LKT>VS!G MH#&]'H\[B@!D8D<>#43X6#"+8):-S-(9].314.19QY^/T!>U/1-:JYVQFI_@ M>J=/F1%8[';RE7F^&X0CS>&97WDRVSL<7KS/B%:UEA&M1C-;G^;)K/IE5M+- M5HS`%",PMU\P/Q;$",SF.&[$"$S1:%5TW3U'IY48@=D*YYP8@5FK*2U&8#9$ ML-6KTH@1F`T$[X02@.J-&8I)2`T25&($9M/"(F($IAB!V6H*;XADJU<%$R,P MFQ+IW7J?SSG2>SAD"<5O^U!O2R.R6\9,5X=Q(#&+"IYCP**T8F"3`69-FT?13!<3/ALBW!J@DIX6OF(8L)G(\`3]"HF?+;L M5!43/MLMFYJ5#GL*&K^8\-D(\`2]B@F?[3I*ZS50Q83/1H%W0N*I7E5?3/AL M`GB"7,6$SY8=IV+"YZE)*Z'[BPF?@ES/F%S%A,^&G*TUFZIBPF=#P3LA256O M&2`F?#8!/$&N8L)GNPY6,>'S)"244/W%A$]!KN=,KF+"9S,.U'HM53'A4TP[ MK+R57Z,M!3'A4]#\N=&\F/#9E--<3/AL@'@30PN;TLI23/@4S"*8I7'($A,^ M-RL1I];V=5/?UM4=7S_83\SV'7<1S>7$#Q0%P]TE+' MQ/'D5(>C>NEO3-OTIJ`Y/#J.<7H%ML=WKC:,1!J'GS9FA9;10`9CN:.>7DWE M\0E&,-19,E1OJ,C=G<(VY\)0#5%GCNH):9'UTV#)>Y)9JQ5:CR*IM00R55D9 M=F1U(+PP@A,%)QZ3$P?#L3SLG=X0JGI4IUQJ^L2Q_>A%&:!_R:6R_B+_XF&6 M["]+D,;9YK_BPZ(_:GMPZY/IUZ?$YU/IWVNN#0OQOC#W;JJY>^7.]VK)G2_( M38XE%CTS+0N41`:$7X<2:?F'U#/28J/,ZN)G?'Q_DWUVN+YH+:4V/V=RY/G: M=^99,?Q'X/GF9%%DCH3IV5&V=EX8;[COV(?W8OB4*3+S8P MV$8AN@1M;4O_S'SIH^-Y$O""],Z9S1Q;(I[8&:(U@K&"9/_RU+K$AIFR@$XG MQD>MQ0E5K9=3-U_Q6\TS=3@[?LD=\"76D3PSU&W@(NV)N=HCD^P`[YFDT/,0(7_X/WPXM- MQ[B4OH'P]?`Y<*WOFCI^Y'?*DF;Y4R=XG`(K/FJ6M8#%>0&^TC;2CX4+8>&V MX_-:%SAM6.9W:>*XTCQPYXZ'ZX$%:I8>6!I-IWB(\6':L'!:&%_`I71M6H2' MIF!+FEN!1W\;N#+SB4F@Z3`]+NY9\YKT@TT;4!W,,&U#\@)]*FGPXCFU/)6E M9\UU-?A%)C2G=\6'0^Y2>LMT+/" MY0/^X'&8*63('`*X>B5>\?F>!AL"S^:;5'BIC+_CM0DF`#.6^9\(=9,`*2=Z M'7^\[@0@Z)Z=P#)@[8!&H)A`AY_QAI6[?2G=3X&V`"AXJVEGR"AS$W^)-L.W M`![#K0ULH$QK@5=7J8])&>F:*?&2YHX/Z#:)=Y9H(Z:A95K$G9;8OP/S2;.( M2IX!;NSC9P4&/&$":C>A*L8`W`2W&RE^27%39F;,BWA- M2#E,`](,*7N)@FHI7VO;`9$J37LC+96NK=`(ETK-,B5N:ZO44H5NM=>G+9EO MZTW`LAF"Q>;EY\ M@@EJ%]3>(FKO#P?RL%>V+$Q0^Q[[+:"O$/H=97NG(P\'92>Q"&IOSGZ?-_2[ M47M/&)TGMS;'/,A5#U=IGOXRT`$&R@F2/2[(]>3P$JAV7+5\2%"O`.[*05>7A4)7'?2%D!7CM(-F.W.L. MY&[WF.ZHHV]ISGX*\`[AOA9!>`%>.VA5'\Z\D@1[O!6[OK9(V!'LI?' M0U4>]@Z4WW[B5+\6O'.@^H,C8#>J'\C#X5`>CXZ92"2H7E#]@:E^W)6[`[4! M.!$F79V1J'O'UZQS-MP;4>Y0HG&K0%#E"-I-,G85>3!29.6\,XM/ERH$@FIA MFZ'<[W7DT5`$-8Y=?R&XYA@(VM'E,I:[PZZL*D/!-J=(%0)!]>AH] MLRYUK+=;=;Y!M[2TEL.T]*\`%/R[ZD;6[6N]71==W$]3'0W?,IM-3-W4+(D' MDSULSGO#-#_`ML6.*[U]=R-++M-Q+H.!?8SQ2=1D%QLK2;>3":.^T]C^&7OM M)-\\4YMGW7FTS?]@(V%/TB2#L1E\-K#S-8,[--]WS8>`=YSU'7KNESB2?4>= MA?'))CYJ8C'*S*7VOY)F8.MZ;$N-JRKH+\S"T0OI'MT?;.F3MJ"ER[`<`*YP MF2X#^&W>_'MN^H"=N(EQ*LZ.CYPZE@%8B]:>;EX<_50$H\OFX51T?$E7[BB# MRVY_2%0"VWEUT-@]/M@T;3AH>/]V\2[5^5J+MC3/KL^$P: MRWQC0O@X,8TZZO"-]/[?@>DO9.K'/`E<>+(+6^YKIN5=ULN!R^)OC5"N^-VB MKW(%&3&[-,KJ-R!^4"^$30?P$"UZN[NU988K'MQ?Z>HF-.85]'$D^LBV<)X5 MMG`6M-*2R)LX.DZQ2^B1)(>JMJQSK""4QA+*@7O,"DIH+"4(D=%X^)M!*&[1B,R+ZJ$O.P2\54!3>&_E-&_\_!*=U5UY.!R] M$D3=NOT51%U,U*K<&ZCR4.T*HF[?_@JB+B;J@=P;CN2.VA%$W;[]%41=3-0] M>=0?RDI'/6NB;H[Q5%%94-YX*HC)\[#WQNZZ?1U>N"5R,0LD)^-Z!,G]O0\ MP1,D>WI[>N+@E=)(U9XB]WJ#8VJD8@//$[P2]-F1Q_V^/!@>SX'"^3R%[.O#IG2_\PM'@.G5X.CH`6J[N" M[`79"[(7NRX04#/9]T=C>=@_9E\O0?."YH6H/V>#M*80'GZ.\A\E;3ZW3#TR M&B/#,EU&?,:^B28G1=?;3Z7!60RUXJ4M>9:"-01K-(\U&I&M*5A#L$8#64.1 MEX"+X0?-%$OE`O%5&&>*+;+_AB'[Y0S[N10G/,T1K#H+\SI`3LO_S$7.V1 M27:`+28IW39EG'J2$_B>#Y:G:3\VRPX]NMOBN&+BJ"X]@:'=\DS4CJQVN_)X M)`;DGB99"`S5PSA#>=3ORIVQ&*=^FE0A,%0/WXSET7`LCY5CSM03?"/XIFU\ M,Y`'2D<>=`;GS#=KQH,53J\AE%`<\P%G,[DT[25$$"WF-1\D0]=<6-H";,O7 M$_,G,]YLG!H3/]^-/QG1IU_3']WD8[3BO_P:>!>/FC9__3Z<(O2%N7=HWMZS MG_Y;R]%__/;?__7?_R5)?XDNO-.GS`@L=CNYLGV3C%WSB=TQ/7!-WV3>^Y^Z M%1C,N($-?>?,YH%/DXIN)RO?@$6D/OSQE4W^^N*+HGZ'_V-OYGM'&7_O*O3Y MA60:0$N:#J_\WAWT7_P6;EJ$Q:5974@)9<9\295.\"J8$%8P1ZSLVOC2L$9W MXEB6\XR3NN:.SP#QFF4MI.>\JR+:C@*?!;KL0F$Z;[-*I+@X5>Q&O"05-,TZ=1 MW3$\QW0,#XN./6Q4;+Q>XI\*=J0LKC>->^MTYM%0IEJ'8XD!51N/R(S8WZ41 M=J_;G/J?O8%I4BW3`28(#7>;,!7_V82906+/*]WS[-2H3X53H\3^-R"$(P1W M2P=S'&`&1[=EPUK$]A]X^P\\@D7LKV!OL?V"O4],!:LCH:A(*[N=HP=)S%)J M7U__\X:^1%"DLXR3T6`HJ]UCAA+%?@OH#T7M_>%`'O:.&0`\F_T6T%<(_8ZR MO=.1AX.QH/;6[?=Y0[\;M?>4@=SO*>=,[S?='*K>F; M=WK@[2:8U)$\&HUE5>D*DFW>GIXX>#N>I?)X"%0K4O,%>`<';T;K)*---O\IZ>.'@[:H1]N3<^IC9X.OLIP#N$^UH$X05X[:!5=2#WU6/Z MAHZ^G\TQ6VJ,M+RC$:D^5N6EYZL>V7`YNLEZF/T\VTEB=2)@1W&GR.-.5QXI MPAW>RET_>P3L2/;R>*C*PY[H:U8[>.=`]0='P&Y4/Y"'PZ$\'ATSD4A0O:#Z M`U/]N"MW!\<<$'QTFF^.25=C).K>\37KG`WW1I0[G%#;N!8A:#?)V%7DP4B1 ME?/.+#Y=JA`(JH5MAG*_UY%'0Q'4.';]A>":8R!H1Y?+6.X.N[*J#`7;G")5 M"`35HZ/)_7Y''O;.NM1Q36=?8__FGOP^5#^FR0(+.P9G_B"\-[I]J!46/66#(HR+TE]C+G M>4FSR!^!YYN3Q3(K^LZ\R"L3MI!50I_-:DF0Y\.X^RSO@+S,B_!Q`MNU0I+$ M;WO`#YU+>O%#O`2\,_YCLY@JP,!^"\I0HO31\;Q=%EBOH,GUH:ZB#74,?TZ2 M/A2"6CT,E?32OG%1)10=="&V MJ9+I?J0!S5Y(4PUNI]'4<\>FMMK.1`)(>8OL%)F$O;/A]33JFE_B3S6;.FO3 M=Z;O,6MRV>)38).,SLOT6\1"P4W(4Y^9?SNYUW[N(->'+Z3`-OD=W^ZN7T@& MTTU0&#R$]#XYEYJS;WV1J M&?Q^O])U)P#J_LIT9C[AQG\B]@@\?/[2X]\NWC);G\XT]\?53]/[?O_LO`/) M"ZMTO?2-G[0_'#?^!2_-866^WVD6 M`W0\,3M@@/:#H&.H;$)'MWYT%!+S<="A;D)'IW-(=*B=[UW^>5]^B8"^M=E6 M".FL08A*]+$;/MX&'AR1GG?-/-TUJ;/?E6V\U3S3NYU\X>,;Z#E[:./#;DMF M>NRIAD0S%,)VDH7*4Y$)D;(#LOX))?%+A%^']O[R#ZEGI%T9Y>R1\!D?W]]D MGYTS<78Q4@KLD:QQOZ2WKS12UFQZWO@N:3]D3)D"G\,.;]UD:J1T[:*K(Q?+ M+[D=^T7^Q<.]^B7REA0\-39.U)K-JLI1$0DATL1)]J"NG98^S3/#MK7V5PV? M(:D3XJ/6Z3,[+_A@='L;N%)$"A=7MG3[Q-PGDSUO;8NN=U]N@)ZN_>?5UP]7 MB*_('YGQ6F:^S#DNZ]OM)D.5^((^L\!U/C'?-7_*$M@OE[(4&N:A82U+FG3- M+.T9YTOICCMWN*(BTURI"2A7:*:;MO0_`=CNZG@\N)3N4W:Y`:JHYW!"C$J5OZU'5L4X>K35B@#?2(D[@\IGF(6[S5LQB; MXW=DN'O9M:+:Q^`=_PC@H,2=]8)YM+-(]1?T^37'\HN4!V;8XU0!UQ-6\4UW M[S_??;O;YRG/4U.?2HB-&'=HM,0(;!K;!H M4'DD]J19`0`M>0O/9S/`M8UL`C0X-0$37H#;`A@Q-2`_)#=@VCGNC)57%W_\^KS MN_>E$'G_*4-.=P1,&HU9Q]C=V<)Y!*J=+A#3.@-""B^,ES)WP39R3:!!VBZ@OWB[ MX,T3(G.\0;=,(&DOYYF+)?/1S]XU@A:)0--U3@;(2!/3!LP"Y\%J@=9F)-VF MVA-.\6,V%JC--9=OO(8T`&@*!8+G!;@HHO"T"_39!*Y&<\\$VQ\)5),>'7R5 MCA:F:Z=P3D;A#'><'L1`;H`U])]XV""\@X7"UH,OO8FF1S]90/6F1;$DOB<@ M0DR?+S\4')P&X9?`]8AT(G+.BHBIAKPTF3"76HGH@4L2!EVP\&R:@^@`#=*B M0O\P>^0\KVO>5)I8SG/V.K@;%_I$J\N]C%D&OXT6C1_2,QAAD7^J4E4:7ZH9 M94F:P>8@!C5ZU[);.[O:!Q3C3ZE-]G"+/$!HQ`I\0B1``?+J@4F/S$8,1/,C MV<\YH[8LP''(HK"+%MQ(%`)7(]:!NP!RO'W&<*2DCVSH_,%O2_#I(I9<%NTO M7+[R!,B=_!$EDD@%`H*[X)PRX<4@O.%X@C.'V8\A.`%2J`^G4T17,B=@`#JP M_(RK/R-#M2?-M.AHT[4YG`A6"DTS#1&)ZT"&,:29`\(>!)%I@*`ACS^2'``& M?\8(,X!U8+TOM5?HLG%)=4"ZY@@,!V86K23$=+(["4@+O&\2^`&^G[OF0KK% MJ'QTXQOIY<,KQ`LAQ<_H)?C/#UH8?A^?#D0=&A_SZ=B!`H/K,R\,$R&7`A$HZ%#\>-)K3#21D? M2NB:='$)UD)>EN,V@V?"?KL:Z*\2.FW"HW<"V""6@G,=E''.N2GY1]*-LP(^ M(T9S,^V0L>X'RB.;>4!P/T]N`$_FJ&I,-A@0M< M1GF%83RH9D8"XLBX?VD$E1]4L8 M,"N9X!L6(M%YP`OR^.5;[CK!XU2:!P\6:&1$CW!<^/&R[4>93V]](),(3B7J MY/L8PO%L@GX9\A&9)*X/(MH+[2O^[-1K0=3`9SA=;10S;DB'!@.$Q^^3(LD& M"P?\D'#B0XF))A)9B`(7ODH=GY?2WYUGH%!77F(7Q#:(R>A&#P]BQI7#NI8)2W!6_B;0+P6:'E"21@6@RECL=L$[<21;+CL75'0^%:+Z4/68P0M%X! MJX?$DJ(UA`B($A5WE/@1M7@F:!F:FZ%#Q%9T$MH,9:OF$G>BI6@#)D`HD;F# M6\C!)O)"=2`:<)U(8BZ5`0O,I\=$)KS).&$_8BOK<&E(QS:GBO"@9YH'VB*M#,@7[3B0J&` M,/%C'+>2VZ9T3D[@48BIE8=%HE3*";9SNFEZ'#@M*-:]TD]"/K+#-^+2\=@S MC8Q&%@OX6'ZF)#RQ,A`.XH%3')`>JA1XB0Z$[*W1E1+1K.E3U"_IR1E`0X6> M^P0B@^#104IGM*_;>!J">&L>-(N\.=X43;Y5IJB*WI8W\\&W;O:#`FX+RE_1NP@/I:!I/$>!6"JA5YAR/"&Y0 MHS"'W_$=*]RBL,XK$)=@U-(BS9#X$]76M,F)1H*4'##X3GR.:8-VR-UG).YO MT/>F*A?_H,NN7-_4X3A3%7S%5VZ!X3/N+O[?LNVP6%*;+2O22/(+F#B.#Y2YZQ2W9!ESQS-C#*:](VB"`$BW^:_R#+*&7$.U M*%HFND%-&V,D9%2$RXL>R^T?K@'%3HOH70M07Z30KKV&Q_$7J>&+$'A4&TA[ M01W926R^(GP31Q.A>-/H[`>;@T@`T/L'V%>$DIBB"Y^27QLL-[^T7K2U,745 M;<:5;0?PZ*^,K%YX;\0P_Y=\11/0RU/%V7R[*X2`(O MHP,]HR2W@("!!D*G7B0E"]$<2S@MC'T8\),L/8`V;3A8_Y$3#H;IZ9;CD9.B M#CEP69L6V)9SN'&:`^P89@O1?^,$FGCEZ>J`FG7%,#VQ-=I@<[>TE#(8.QB8 M[CS:YG^(XVD'I.$%85P/3=8P*@C6 M;,K=P%T=L%"P@.%*EP=YR#`EV83'M>G]H#@29MKCKW,,-AERZ*2T+.;F_.JF MGO)\+]`[B]+^)X8IT(6#'@:0B`\6DT/[U<*X(YY,)D*J>0[^NJ#`F5MDK#9T M[]I';1%C(ZH=.*'\](E<=%Y&N2!1+@/?/XS7X'ZB\XJ.+/*=H;;+R)G.H\\> M*#\838K"S$9X/]=O\)R"1;BD`+@L=8+%;&!(P1Q#UU-SSC5/BJR2(HG:,STF M8I1BKKB,RUB*@+/9,V8BA&X@F:==R)DT"TJ:X387OHY14@88!HDW"(YQ+>79 MA8.]0(4D=UY,Y_!2 M)YY$.,7-JG$1/5#CBA:A.QZW+[.K23;6B%K#HAYDI5US682&"1R+1%WCT00N MF$AIIS@%O"JZ`2ZTM+F'0BAF[NOH=1L7AI3KAEHRZ7NF$0?Y4J0?1C6C('Z8 M.9+1/)LE`ULN[B*)PH\<^\FQ,'+_1V`\1A[X6(CAEGA>[.&(#;B00VD3XR_U ML,``7?74>>!/PHO,HI6_.HL"H-D/;AC-D M=%+9$>,EY\*E=#<-'T@KQ7B6R&HS>+3D])5OF0R8U!%F&E&Y!*,&`19,R?#4=>E_"TTR:L\K[JY MHPH.]4K/Y-SC#6T!O'9G(OVEHVNZ9A@S]3AR6`AX:6RER.';-F`!<6%\4@&@];"3))G)\:;ET,@">O76)!E^L,DY#UJ"AQ[0W=&"Y?='0$2W=F+J=#80 M4YX>-A1/Y0H_5BZ'WG[E+WN#T3>]BE.7P^/585I9QD,1L9UM[+_INL_A0O\\ M^^E]I)X+M^Y!W+H\XA.G[*\(F:(JA?%?3/RI-MP=1HV\5/"6LLDQ^S:=Z9V8 M;:1?H8]M'@:]4^G+/,:)H3T6V6E>KA(A7WF0A+"X6X>`2CD^EN[A;\'`6!15 M71GW7+6:N8.QBCZ&R%:;8[ MU4&[&^TN8*,.`NFJZX.$S[!E@725,#+8LK:#ZI`*P8]^BIXA'U/M:*Z MN;I[R_.:C?3F@.2T#0VMT6]SDCV83X!W7:!M@3":^,CKC#3[EJV'H91[L*[? M8]EC+BTBR>I\ETFX_QLEW+_C"?>$5WJ/]/+J[EOT_E<@HI*_5HET[K6DQ-7E M]Y=+^`\SL).$5_(@LB0;*9.0@,<6!U_235`#*0^9')-! MJZV%>>B%#/W603)\^>(#W/?BE?0'EK!;BS(RX.4+(`:X)98%REB.XPFD&2`S M8]UV6$D2=QOBMT8WO7@E+Q7R4JO7@M!$S#>D=U&5D1=@6)\9>!,GLAC8%+N)&=%Y^&/D/W2Y*V,D36Y=B?IZ:JFV">8S4``4J=`Q`3A`YZ9F5@& M_.@@DP(EH]/.#.M>$H<#3Z4/G7+T,I=-,!3,*\*B!$"N(,.=W.>'/W$I%@9: MO+""DKZTN-[+HFPQGKR&*MK28@XLBX8@J2/Y2SY:BGJ3=$:YE$%^P,M";*[F M/F.%)P"!$1IFDJ=V$M!>^*X3.3(2Z8;U[QIY94WJ)Y#5:2G[+=K%2'*!@*;L M5$P-"8L1)\D##P_MFYGSJ!!YMZ`T>>SYA] MB^82P/H[)1KYF=9T\3O?+J[0ZGMGP:%:T)"M]^*W+]U_C3\E\&Y:;3GHL%#& M8U\H1RD#WI5W:]ZK_8$W[/FSLOA?#7N6^CPZS[ZEIT5^B8=%W6+])[_(^D([W;>[8_$)4 M\M=R`2:>.S8](0UU?,2\IZK4=W'_X@+(TTU8/5I%&N0/GV\`Z.%H-.HJF>Z2 MVX*1QT31?;>!3^=O:.*MA!IU0; MEIV'DJ[ZRN:!"[H?G.77Y-3[0EH/$4[N^.JGCJ]^2/,1O,CJ*Q&_"_3JZJ;$ M%_T7OW4[-*PB-05@$S#;0,]1MP7X5[W](>YLWF^`>M#M#\M!S8&(P+8#URDD MD&MJID5JX&:RKG2+NYL!5E5EU/W+KR46OQ><*1%>`YR]QL"Y+*8J!;1?`M#> MD-CVX#M:+:2#S9#N#61R/-%I'4TI*=4B/*6(7"WK81F(@P?/-$S-76`?[=40 M;Z=_E0MA>BV(QL;C0"U M?OA7S(U,#:EL-H8`1H*22FJB+3[!AN=^@@T/*W::`'^9.<\"/=NC1SD/_`CZ$.PC MV*=%[+._JL*]J'MB*C/E_M"F]I$QL;WL["L=>=SO-)X*!`\('JB+!SK* M6.YU!HVG@N/Q0$-4AZ-ZZ6],V_2F48W$L8BE-`J:(#"WUS9Y1CRXMB$\RQUE3N5_Q\+N=?*5&TZ7;:'R"+9L%LW1MVU?L:%-0RS;& MUAC*=5RFMN;552]2^UERD6,%%CG8;I$1UF^QY4V,^D_AC`#O+L`&-,R[LHU/ M#`/QMF%Z[!N.FG_'*9G:GZVI<M<4V--JQ^T`-^24AAKT75#&%2+9J#L+,6 M0J4FZ.YP6$Z`U9CO-1<[)'E1M20VI]'A8=Y1'CKNUE$$,`]\U'P(_/14]+AB6J&*8=PWSHB9G MX9/LU-#3J&V6KEEZ-"T66V>%7(,=O"0JS[Y,=;[K8_\X`*YPF='4$IS%.S>Q M!WK8M):Z#X>KHT>&0^VCM>O4["3[4Q&,;MRL`5_2E3O*X++;'TJ\2EVZNNBE M7Q2C(6H>^9!L&YXAAL&+WZ/]FT3[5R7J[AAV\/29-);YQH3PI9IB2KR7BTP] MWR:!2SW7#.9KIN5=UJL*;J-Y5OWN5(7?&VG-=,E,T=]2Q5ZF4G!ML5^J7K#V M,K\E*WB]);W2?;`R.)'*OBPVW9?S1!./>\["WLF5U6@(FP[@YEC?WBCH=-/5 M5?TE?/PC',2>X.4]3N[`*Z("JM7%>H(^3IX^/IMV2N'APUT$K6Q%*[N%:AN- M#'%T[`1@F3!`:R3'NKI=_+Q%!?<1$24(I0F$4C;31XB,4Z<$(3(:#W\S".7, M149SE,I,Q#\5R-^,#/*JK%,I/S-?LARO;*7"GM!%&0EU0-=2EJ\/^K(Y/ZT" MFC*.5B;OX.>7Z*SNRL/AZ)4@ZM;MKR#J8J)6Y=Y`E8=J5Q!U^_97$'4Q40_D MWG`D=]2.(.KV[:\@ZF*B[LFC_E!6.NI9$W5SC*="2W)_XZD@)A\V,__X_@9! M["Y-.+S`[_A#KC>DF>1R*Z),#3XUVL:42\<.1V!&Z16IE(OE3(MCVG<5;4"K MXB$"O+@X9+D09*W\#('NJP<"6I"L`$^0[`GOZ8F#5THC57N*W.L-CJF1B@T\ M3_!*T"?VENO+@\%1';9'W\#F6$PUA9OVLYB^+F6\X\SQG;+9\9OB/'8^3S&= MR%[.O#IG2_\PM+AE1%P@X,3574'V@NP%V8M=%PBHF>S[H[$\[*N"YMNXY6>/ M`"'J3\$@K2F$AY^C_$=)PPX(>F0T1H9ENHSXC'T334Z*3O.$D:$+RQ,V\,Y9':D0>C M\5FS1G/LS@/4W5$#JW08<[,A*DL/V%Z/PI0&;[!WSFZ*+27&$A/7ZKQJD2AM M$V)*R%+ELG/4?"?!%X(OFLD7ZE'5"\$7@B^:R!?JI2+*$$]T^P5?[,,7ZGDW M4FB..5IC&/1WAI2`_9>?F*L],LD.:-0#38](C%-/<@+?\[$]O/W8+#OTZ&Z+ MXXJ)H[KT!(9VRS-1.[+:[=3ORIUQV5F(@F_: M114"0_7PS5@>#K9T[-^. M`\R6YJ!AI"73*VZG?#//@[3N6,Z7.IC#6IV'-JP M<"`?+U>]<0(W]8QX#A4M(#VL[\[7?(;CD]Y9FN?=3NB"@N%]O=3<.&[@IT?' M??A\\^(W=3Q4A[U>"FE[09O'W94-*T$DFT^IJ][_Y#,N;X!!WCFS>>#3Y*?E M?;J:.4%^4EXQ"G.0]S=#WE4&(T7II:;G5;+80V*@E\)`?F;@8#,&AOU>9S3L MMQ@!62YZ/YM;SH(Q(N';.3XOS37\FP^VP4`&W3M$XZ['1X;=+^9%TR^'FY$X M&@S5[NG@\'?-=37;3^-MSY>_710_H`#=HQ+R:C0:C56E>S((_\H\WS5Q.-Z2 MF#\;$=]F.9G%>(5'+$U;WTBRRKC3'2F=%B,P<]!4+F=[BKH9B_WA8-@; MG`P.CRAG>TIG,[I[XR$(VM.AV0:(V9[2+2$L^KUQFP^W+-8K%;6[6#.MP=_F M,=D]I811HXZ[PZZJ#%N,@=5&34\I8=1T^_W.L#=N,0+J-6IZ2AFCIM,9#DX' MAT<];,L8->IPJ([[;93[Q0AOQ&E;PJ@!F7HR.*_RK%5+F#6#X7`X'K71+"P\ M::H7M&H)JP:.M'XK79#%.#RFH%5+6#6=7G?0[;;1BBS&=Q/DK%K&JAGTU3;: MDL58KU32EK!J!F.@6;4.]/WE?UU.^_AK1U&ZO^+/O^*%+\+K M?1"1?WT!F&4X\/S%;_3P7Y>>#M__Y5=\E/D:_TVK^/\!4$L#!!0````(`.![ M5D?LX_2Z00D``(]\```5`!P`;G5R;RTR,#$U,#DS,%]C86PN>&UL550)``-T M.2E6=#DI5G5X"P`!!"4.```$.0$``.U=46_CN!%^+]#_H/J>'_M-O> M1V`@2`2!-UEY`Q*16T'\;S*3][H'W8,3#W\YZK9'?M0^.NS^Y/WS\.?3'X]. MCX[_Y?WO^M/OWL7-K=?V'AX>#@+L(4IZ./#YW&NWU7-"RKY-B`0/@3%YUII% MT>*TTU'MEQ,1'G!QUSDZ/#SN9`U;CRU/EY)NM'XXSMIV.__X='7CSV!.VI3) MB##_64IU4R37/3DYZ23_Q::2GLI$_HK[)$I,58K+T[90?[6S9FWU4;M[U#[N M'BQET$(;>-X'P4,8P]1+`)Q&JP6!@@)Q?_B6FT:GFJMR_CRPW0#%!T#I&@2V7]CFK3*1+N(*)78CHG MH;+YS0P@DA7@Y.1V@&0`$8@Y90F)H^EGB*ZXE-<@^GP^Y^QF1@1@&T+#"C"K M=+H#'2[9/;"("PJR,M0"V1T@ZOF^B"&X6"Z`R1>@TLCO`-D-1AB8H\IR-!TM M5/!"BJJXH*Z#'6/K$SD;AOSAI=#6Y'>`K-"#*R#3R._6]U_F]6LH?!+Z<9@0 M>H7/W$`#RPA8`$&&1W53-5XED1R?$W)_H^]0S2%<;*J:=IU,%%,B)\EL$/U8 M"*2C%.53NS6P:YSUQ"9N(ORL2_QUB[#-*3AMT9'Q?)[TUJ8XEC+Y*5);;+?T M@=R(-Y;X:+Y0W1(,8US@=(JY%:96#T#O9A'^7A<#*D[T6*!^J/G]GH0J?O2B M/A%BA3G?WTD8@X$92WEG&,OY6IXX2W4<)A2G3AXCYC'X@/@G(6#PM1AA1K&F MT&?6HIBU(Q=8RR:D%>(UL+39K"FL;*(N9N'8!1:N!2P(S=).C`.C:`;"=I*R MDFX*9U;*%%/YHQM4-1-\A^.?R=T^ M<^:_:O"M=]``"NT4L0ZCJ&DG5]GLK^"IL/)10S6$<"X98@4%JG>/*%2*<,M3 M<&MK7>=$4M_@;I5[JF=8;<"T5<>)0?)"JO*C*:?87O+V[44)]LW<NYA,(<.P-@42Q@"+F M=O^(YI.^>YN4SYCMW3G,&/"I3"W=+6A$PB>U55B^F-^*2]1K1S41A>]^AAGS@ MM55W'5#'Y.$3DB^0;8EX1M,Q2!#WA4.XBK`#8ZV(#NU:@D$5AU?GGN`/*:-R M!L%'SH/J/)JDFT:D21?KBO6[QB[-%F#=!7"CE0-4&!PJ3\@&=(>)&`-&Q=@X"3PW<8""`L?) MF_X9K\-V[W.93#P)5--VYV:[9C"0`[V?HG;'@W*1U-]*L%_XYEI";?T?0W(@1AQE.N)7)-(:U$C?+C..VZE\N>CZ77L%I6?+CS M&@3E`1I?`)$P@,>?E8^\ZKJI;>-?X<.Z4.V#!N>K+Q(0W-.,^6N,QUMB7(`4R;Y9:@\[VN>__JQ;7:7Y1F?.3"P,YGSY>LNTWDHR+ M/S;B;Y9W._6+Z?_9B9&^K<'&F\85B"]\0_D=,+ZA=S'5?W64ZO3-C4%Z6K/P M#8Y*/F#7X3MR#CN#%'O-+XYZ31;BKLGJQ;/#D^P[\H4MW8MI/W$V+5`7G%Q1 M,J%A8HW,BY\,M?:_JDY1J>OWY3.53*-;ZW'3I[*P6'Z*R4+V'7G%ENX:VIU8 MX],81:5-US8MS:#PTN'.%,FNW"WO.>C>01HWQ8WN$F53AQP MB=T,EZUWM"L8H7R_H+YL5&.=(66$^7L()M8=.^`Y>PPFUF9P>,D:=?(!`JE> M5KR4,E;7G(W$#5II-,TNBM0'$0MA!UQ@-\.CX(Z.4N4=WF3,8M^0B_675,LY M-\N]7;K->ML?^/ZN9W:*+^"LXP+#K9+-ZBXSG,CO5D/0OSR? M;^6`CY>:<^/%];P"#H>E5#'U(@Q(F0!4F*V=12O8)-)L=7*X2%'SH%J5N5CZ M5,(M6:;K>^5$EDHVD9S\9AZIZ,@4_3>,FD6#28R]7WYGM MCK6'5/?5A.GU'Z-)2.^TI9BU9%,9,2JUES,"&GKZV(2BZ6ZB.%A9D*)OWS@J M]*J4[]+O?'P,(5#O"3V%RI)!L=V\<>;7:E*^<5[O6;>79/5E@DUBSU:G\JWL M.HK#VF^UW]S`*_J.$JT7E8O6,RSL=GM=V[BU)2+O]U:[K`X$JTH!RM&@5.!9 M!CJ:\)T%N:,?]I?;.U@15BKJ"Y5PF*B+^2+D*X`T0Z\TFBQD&T6?A3X.+\OL M;QG6?>8JYV=.;-#E3K64TZ43:!17.B4<_J:"'&2KV^X-,F[19_CZ)NZ;6P];H?C5J5JKJ1^L/SQ] M779BF#\`4$L#!!0````(`.![5D?I'C)S12P``/ZK`@`5`!P`;G5R;RTR,#$U M,#DS,%]D968N>&UL550)``-T.2E6=#DI5G5X"P`!!"4.```$.0$``.U]6U/C M2I;N^XF8_\#4/%-@;$.QH_>9<''I(8;"!+![GXZ)$PHA)5BS9I4SG@NZ776S(3*UO?7E=E\P__?O[-#YX(UD>I)X?7/J%_Y3YP1_Y MJOY![VOOZ_D!_'#2.QP'Q>')<6]X\%_'I[\,3GXYZ?_?@_]W_^/_'UP]/AT< M'OS\^?-K""T450M?@W1Z<'A(OQ-'R1_/?DX.0+`D__7+I"AFOQP=T?+OSUG\ M-CTZ.C_M'JX)?%B5_><^C1NF?_579WM'_^7'[&$S(U#^,DKSPDV!3BS;# MJM<[/S\_JOX*1?/HE[RJ?YL&?E&I2BK7`;<$_;_#5;%#^JO#WLEAO_?U/0_7 MTW=\>;AI( M$P*-3$F11>^4LB-:YDC^'' M01E7,HQ?+FDU$MZ1X@9FPBFY)]FRA8F?$6WHUB4QH"UHBF33*%E^%SY(.>H( M7*=1`QANDC=09II%)-<6E5'71!\,@JPDX=7[#/I]"ZDX]4W/J/?`0U),2!$% MOM9$)6C$S$PTC0JZL-"I\"*%892\PMX$.#(V)[7Z@`%LUWZ4_<6/2_*#^'F9 MD8401E#I-VVBI^7:WZ9U`Z@>R^G4S^;CEXN) M#V,`OKW1Y0M=N_UDGM^2-Q+WKV%"AS'BQS4*M'$:^IZ)609Z3@0])ZAT:VAB M46_3!'=T-P$])H1#&-U4F$*AV:X1)'"VK.:K\")"$)5Y^B$G6TZ%561_AJG`:-3\74-)IF3%`5H)P$7U_3MZ.01`"L M-Z`_T,ER<'C<6UH__PU^Y:V^7OLHX"(WL'[FJ]9C_YG$U3<]615OL%'5GL5^ M\I\W+,M%KHI[_8:X&VY'65-PZ%^KII==36M2?P':U16X_'"J)G^9@RSI;+$V M?3E(,]A#_OJE!\U47?F7`,[:T#.OXFI'!,.!O-(?-G^/TYR$OWXILI)T(^_% MSY\K393YX:OOSRB#PR,2%_GJ-]5R7:-R^6MOO6&[B/T<-FW5=GCT'K&ZH+2. M-^R?6Z15,"M*:5Z3UJ18$1*;Z1-7I-6%O&PLN@RV=@M[P\&Q19IX&X(-1XI: M9U/%P\/FJ/^!.?)V]F@VN6KN-:V2M0'&)FW/2]D3-"M9OF@1;VB3"-;&U-3B MM9*>K>WA?K0]`DE"*LUU[+]RU-THXYU^-'WOB,]6^.E^N_<]R:(4=KCA)0Q@ M23]OE/7./AH!7!AL(L[V2\1UE`=^_%?B9]?P&]DF?ZNT]^VCDL$`PJ;CFPLZ M%EU%G9!:><_F9G[Y.("X"248-K2-[_D\R%3&R5]7J]CTD%"P>'B]Y^N+@HLZPQ@8H7 M<5YQKW?RT1@10N&0TO$XKC=`KJ.89!<@T6N:B8='HZ37LVGWLC@X=E%P6.AX MX%9EX2GS:?#NXWSZG,8<_3?*>+W!1]/\KOP_IO+R<)C?!?95K,1^7!0TV MIJ**UPE!1:_WX0[7BJ`XE"WA`M2CIE_#FK>C&2;*8%WB4\+9+B@CL^)[Z3#> M@B`M0=0'$A`0&^;M.U(L<8N&G:":=XI@Y=(E4`K(CJ^F/7&KL/DYR"D@JE[, MP[!@Z1*S`\".HZ8]$;#/F?G1*JD5)H%Q,2%9`Z:`'X7:WJE#3T);VE1QV?'P M&-I_J.X[O%.''H?6,]X.`CM^GBXC*YW!86)^'_N+T'U866=TKRN>\D35O%.' MWH?V8TD"R(ZSR,Z4>)Q0PUM&P:>M`XW#HS=]2D5[=Y\"MY MIPYC1]LQ(F65!9%#HS/#R.KT>._/Z=%1_?SF<(C%>M&%2#QG$E.[."+&^4TB*16\<[0V"X M:CO\!)`XI#FSF%PN'4,/Y(TDI<)LR:[@G2$P9[6B2X"'PY4S>XC6R&+U/P3[ MR58<<;!P^'%F(]GJ2DJG:VX=[PR!';L9ZYC,*^J= M(3!*::E=B(2C;6=FBQHRM;G+.T-@5^HZ:54@.%0X,V4(;J@4N8WYM;PS!+8F M$P=>&48.D\X,%ZW,4`+5G'T2PX4$(H=&9X:+9I"6+'Z#4=H[0V"RD"B=:XAG M@N%0Y,Q>45MFI?$U6T6];PBL$:W(82+AA$F[,SZLKRN\]Z/P)KGP9U'ALW+4 M)#6\;P@,#ZUX$@'BT.7,[/!`+Y),2'CE9PDLKODH",II65F[X/@0!9%HZ9)7 M]KXA,$>T(E$1&X=/9Z:)7:Q:6P_O&P+31"N^.%@X_#@S3"=%/=)KSAL,7(:2TZ M+]]4I[IWOO8T]D/==) MCSS_?(FLYQ\FD563*8%[#VR7#(?[A;VSFV:$??GJ<$''2^$Y!KW>,P+8K[OTLGS$;A[$\5XZ>GWZFZXXA5O1N26_8 M1^";TM8T#PBR_-.+-`FJVQBI0`]1_L?W^7>2!).IG\F.0[*JT+5LFM7WN1M0 M@XHM1757ZI7,\LVXI"H`MFIM5]XLJ#&CRBH+)+9\5\NLXMI3V*97MM5PF`B[ MDQ#/73AE50`H`E>+VFCCN#F%R+#ES3[Z,ZLRP`$F_&B^]S7;&'"EO!:B2<=/K52WA#)Y81;BA5HORXXMLS7 M5OK'M8%H0X1T4^`LZO,'*'%:3J64-,H!)`3Q[3N=G6-WW94<6[+I#_]=C81Z M.8""(*A=E81=R;%ED>[G*K3>L4/23/CV6\#%EF*ZLP6]A^T1!?]*>B*"!=4` MJ$.3HE%>I2B1)Y\*&-PJZ0W./\E@9`+#EGBZ$O(BS3?WN"2A5H(CMRY`=I@W M9(-+"51S::L<#\M]EH9E4"S.W-'KI!B_/)"BS)(GDDUYSA9A)6\X<)A:8BRP M30&C.#UUC_&=%^ETEI$)/=N\D=LTSZV'=-*[KQI?O4E`FNK;M])@3I7*7J^- M^:"%N.(`3EE%$--1[*:Z$AF=6Q$7GH!-U0>0;LFK'U]5[_YPS'*,4@`621RF M&BU-0KF`K$1=ZKU$Q?4L;1?'_\5]!I"_0YNC:[,D.>XAJD1P+'CBJ= MJ0$#&"J+)8Q5EB&(7PDNVN>9_H37]B25#J67UL2N]1/0N$<[J66!V?+)NI9_?!*@/I3)76 M.79L#IY/EM`$F'#LV2V0A78OK_].G&)-0(W@R@G>T.$ZC.20D&4Y=5PGOL_9 M#4@64XM?!2T[-U3M?SFVKE!DV5YL<6DBB73ID%4%O#CBW*QSJM.5MO6#[6E% MN_T!U\8"<<>0;5237+H(JS4`X*W&%BIOS=29:L=T'2ZVY+D]U9]Q9M._U^@CN M#=Z'D\Z@NL0YAGN,!+@D!P8*O7*`>(7&?^=5YF!,", M.6ZYNP!8AL++Z"T*8<>5CPK84CW#M@_FRZ>TZ4^^22[2)"$!E>7WJ)A<@4I" MNEDD?E%FS/>F3'\"=.(Z@\G4GL*P3HQY2CG]9)%A-7Y9/D?RE-;@+N_7KX.@ M!X@',BNS8.+GI,KP6D*B%>AU]\M7<5=HOI.D>AC#CQ?Q#'3VDW4LES)Y0ZM7 MQNRO)[I7(C*G;F,2'KW!:7$Q*FNQY4N]T.S%0'6=DK?D]08.+R"UN)*I0D?F MO-WQ8%-)H8,OLP9$MD=Q34#KT,IDEF@EJ,B6N"+*V&61X`V-Q8";-C>.ID]WF!^/\P-L"!3<.35L"$ M@`T%D]^`?U\+4D/4P.IU*^U,?E2+,OO3@!M(@M7D-SA#;/)34SE:D]]ZU#[X M/W_`L3&#<^(BS_B!Y"1[$[YB+J\,V!'X^ELN*Q)4R%(ZUF)?@X+S"0G_G*:A M/I7\VEYOB.!]CI936`DL7WZ@]F"HZ04\U%$3>46CB*\ M)\I(,$G2.'V=7Q.^$[%9"B1T[6#NMCRPX"`[*2QAW6?I"\GS2B@JZX7T$EIQ M1:]WYMI]UIHZ'83(C@K5-:RC!+:J0923)__]WI_3]4Y.IZ0FH'7M'NG,IQ)$ MVT]B+F6_2),15-A\S"WL!E1JJ!65&`RO9#F:LA3;*_&R%B M8.9R@L6#Y9I`P["Y7,V:DA&R71SZC,.'ULP-"S8N=%FX],;0793R]5]<$7K< MAYW;=!!B2[1MPZ0(XH<=B8K@Q+FR>S09?_=C/PG(XX20(K_WJ8034M#)W$48 MR_H:.I%-F5_8ZWUS]]CG2AKIM;"-@M`=;-K!A($K/`5R3B4,N?'8B]%#UU5RE.@CF0;4&8(^&@%*]O:,.,F2)74W1E_EJ93%)L^CO MPO0.<47`BN"ZQBXLLA$AR\9BB5S=FJ3+W*(28$1P=V-WUNIHD*59L<2MY0)I MTE:K"6@=OC5JCKL=2-CNW*QE:[98!!5J`VR'ES>T8U(9%C9#?4UPC<5/4`M@ M(HBN;\T>&PXV>_R.P-)%CU/#ZYTCB)_OR%8="K9;*G>$55OL1-4`*(*@^HZ< M[>`Q=S4E]^GLW<7VDN31:^*S$[D5:GE#JWFI1JE0AH/FZD;:::*"`J/A4A=I M0H-T2!+0!P(LOY@M^/1EE%._1JEPCZ->*][@S)SU2>G3PEP)]19@`+NYRK&- M?AF#0A>I6[<8;WHC692&',?65@F`X?Q.^U::9\UH6ZB,>;.$>N8Z/7;*@%1N M+XIG:HFKR+K0QIQ.!E6)PVW45J?[\PU=1V_DKP2.HC`4?3JJ;HF?D]%K1JI) M2>Q\4*KL#8:NXW]WNRR#`PTP]EU";R1IS8I:;4#B^KUQ)5ITT"#S!-6#JF[I M9ZANQ1$EO"K>R3&.5,5N*[$:3&2N'Y:PTF`&?B5O<&K5E*(<>"(F09VX.BQD M?A\+U.'86-CC4+;U<.81JN*A[](D6`30CO*<%+GT)1=!+4"+P#XF&U%L#J6P ML'F#FJMW_@!"+^^G^`$ZGY93^AL_%K_"IM8$]'W7EWIW-SBT`XW-:[38JM%K M?:F02\$%%#/+@WIN/;A0J MOU)&6,D;]LSEP;*^)#2+:6.]VH6DFX"Y96A^^-XII-'APIY M?&#(T@+V0":N8YH-5O=G(ZXYY9>/<^>,J4;D'Y37!GTX#,OKL#[JP+-M-V[! MCDCFH=5US1XE4DRVW[M9W6"_$F3SY@DW?D10Q1O:?4+:&@]23&@NS*S,)W`J MJ^5I+\\^X:A8@Q\G#_2QTVSY%H'#>_[7(M6M1W_.TG)&KZ>)$OA=1._A6"6K M^96.A>N],%';##7L/8(DU*OC1A;]XZP'X)C"'78%V1+@+))H+?1-,BN+O$+? MDQH\!;4`+8*\DA9C5<(T#RFR\"*6O">M^#Q9HT206&Z5SP929"%&+'G[K?CL MKU$B2#:WRF<#*;:HH]KB4\-^G9&_E20)>-8`C=H`&\U%;P9WVV*XV**,6/U[ M+7:K_=56;8"-XZXX98K4=U),J-CRV/?",-I]LT6J95ME=PGQS$5K[7]17Y0% MU;V3/H)+#90'I<;IB`G47.:\HLZ+S`^$ET;+Z@)DAP^`[,-C MHZ@"<9:^@XLN_'Q"8VCAGZN_E=&;'Q/EB`7M-D`%".ZE5&2*3;,F5@[=SJQ@ M7.SK*:K-*%]7!M`(;D'L1+`J2`ZSSHQ9M5B)=G.X6@,`'I.)R\)$KJ,'3B
! M\NN"(\O`::5^7`;2-CQ\A."PZCQ8/96@[IYJU@&D-H],EN8K"1RL\5VKJQ<6 MV0+;*0*_)>ES3K(W"K[:@L&?4S@KQE&UZ:I#57=C&/XDZ-?J<:R-=XO5`R3= MQHI6L,:4?8Y>AVM!0=?]+,2Q<:P^3S_3ITE:YGX27J=E5A"2C%]>"!5_9=P0 MWSFGW`#@0F`1L#MI,*Q%FOJQ_:YX39RG2=2-;W$#@`?!(PTN^5;1#[(XN.J^ M[_LL"H0FC74A[V2(P(^N:=C8DAYMY!ITN7*Z\"9L-C!&Y1 M/<(40:&-36N(/2,!??8EC6%>H5;8!]"$-J&L1J`S(PA[,,$L'QW:X+2:_`]1 M_L=U1F`5*4A&\J(%P:PF0`&?8N#RL:$-0V-TSB>235N.6EH5`".(73`W5C>8 ML$6:B:2^C-ZBD"1AARFXW@0H`$&X@CE2=[&A>?;EL9Q._6P^?KF84"MO?I-L M;NIXN4BG,S^9+W,4UA$:-4>NP;L+!9*(?)K*=;V34W.7TP@^*+S04%8/>H?- MDQ[_7D-U#3(.:FJH/H/+J`>FYD1ZG$YLF^NU]Y;),CHXU>79/&OA=E.Z_O`N^MGQ5S-?BWT)/;+[]'K M=P$[DJBX]H-*9&.ODIE*K$VH[[$AHL@#J%3/._GF,,E_5S!9KB.WCG=R9G-! M$*8]*FB8/<8D:/!X!BW?AG^&)J5(PDB31BZ6CW4%_IG;#!VN%G>5O2OWQ[H" M_PQ)5DH'E:/UH;%&KL1IPZL".&V>7>U-2&K`D+G;F*LGW;QE4@.XK"K@Q?'R MHI@0=1)WP2'SO5DF$\?T:9M5M'?,/Y9P]*.71Q97;VHOVG)JP*;89GB0_1E6 MB`O93?(,6:6#D5L'$%J-.E$/[!(QH$Q:'12V1#G3M.&:/$WS)[UMV)D_YR]^ M%M'YA(:Y2Z;+[:(`S*95P_X\R0:$+9&N+J5TC.T6!E!6/:S*\ST`,55AK*NE428"&XMI,W)MCD,"%@2T]CS=H__/=H M6DZ_IUF6_HR2UPM_!G\IYIJ',UXSH`@$US(8-BYLD+[*2^GDJ!^OC+"-^.$[J4Y>(7=4F MO)-S!/=NM*98#Z:YZ\\YX3@/!$2):,XKO6O_(HUC^'CFQ[>D@'_S%41>1(UB M=0"#("-$FS-]B.9N*K4W!,I`<"&'T6E8!E9\V_D^$\3I MY>R3-(;OYXL<*&/A(IPYY+Y\CJ-@%$JZ&NM>=Y@Q-H_E_*3Q5BIFS(G:6/$$C.SM]NQSF\=&]>PZ;:K84^(6 M,&29X2TN=CZW&@3>YE[M_\*?SX!"AS/ZBV<%*GF[0R8,;C M-!6PPJ%2$1^R4)0]<(IKH-:@8E7U!E9O9]O[F.)C-!=:HC7]M6** M61=4@,#/:GSZ8X&TGF/+[#6M5BI656]P_@D'%0LCMH@3.Y<9]H]MTKG_\YT< M++;@%#/WY/6/K;J^#5UL6!'`9DX`"UOPBC'&D!W4C%,GC0AS9EEI=[5AOX<@ M^$`P4-CT,#!@BR"IS?922G;*`B0$\07:M'!P8'OS?O/`.[W=2-&*W2;`&@(0AU3B?U?D4J&6-SQ&\!RG&H'*<#BL MM3!J"`?8:*`_IMAU0&P$=D3M820"P^'`F9GB/O83:AV5;-;KQ6`*L'F4VOO^ M?!<;AR1GAHB5A-*=7K,@@+$:8ZV\%=_5L)B)NO@<+IQ9(3IP@6O'W9X4Z0;; MZ@/ M_9//%=D@@LEAT5E,@]E+HOHG2&(;1!0HLU8'Q>'-:>Z(4=YP3)>V")1.H^[, M"ED:$!+FUZ"#513B.%N$S2T\U:+CK;2RU^];-3\H/"1@()M5%R^'9&?VBA7( MN[1X)$41D\7C!_2F@O4S"9=13M-GRTQT?;U>0Z`,UX^<&"2_#79.1T#QR-_F M-7O8GT0YN<^B0.GA$5Y=@.PPW\$TW8IP.0P[B]Q@BSTC]&:2OZ2Q7RRNJ?`+ M?:I9C8`2',;C[X=S/FX.^T5I#I?H2$ER75Q>*QHL>)#W*/BXG8`2ZM#*`=VDA-4ZV*ET.R MLSM>*P%E:_2F$(!P_8*72=*V<''(:6&,XEC^_IRE>=[J;*13W>L/'`8D&[WK M1PLQASYG5JAE=,<2[3A[B%XGQ5U)U39^>:0/P@$G)+_PXYB$W^!P6W"4"L>:2QOE\\Y#L:@(1W2O;JCU0 MS2O";&7GNKTWV&Y;M;W^D.'L?][6JU9D#ELNWN$2+31V/18JIYUE][L M1-ONVJ0-@[*L)LBAZ!]:NN!Y<`[#$1T+A'E-6%R!_HCV#(EP.P\X"RZZFLSB=$YBALC?8 M\U9"?_=S$M8#:^\HB!Q`C'[Z69@_I07=`&W^?I'FQ5U:_)44#R1(7Y/H[YL+ MVED7?]CZIC>P^E#EGGN4935Q>J*["W]LP5VLS]=IMOP5+2>:N/8K")#Q":SB M+G7'ZEWY(W='F/G>$!W`X\AU_7ESXUG31JJZNLJC>T MFQ&(P)NU@Y;SYH,SLR/+.*;&KJ2F-_Q,D21*8#G( MZ@+DS^91D,/E,.SPYFV^V-RU6;TR@/Y$^32J>#DDF[NQZH$494:]4_XL*OSX M*5V"HC(L7\@<%446/9<%3?FAP8VU_T.5S&$9W?>[5R.F]RW%\L,\'7Y>7:\*F:#PCB[?"<[V770U?%'PK>.N5 M7]CKN]M]KZ7AO?'*+@@BVS2$,%]RE2F0-RGORHWG5=:Q/`=A&0V.I*([VP@:O%767ORFWE>56+FL9QQ4('E:-]2?6!O)%$'#:X*N+U M3Q'<"JRW*#1E1_;T*76-CE^6(@J#;VKE``F"ER#T6&``0/9BZ2H'["4J!$34 M2@$*AT:I=C3LB&_L15$S)"SW]LDK35Q/I`1:=#[F5`"."5V-;<2<#9>[U44/K%4D`90SRCL(IZ)@B MI#>HRNF3U`2X"%XI;<6A$C)S3Y-:6O-TUCJ`A.!:YU9D<;!@>Y!T+>9-$J13 M<@L;*!6"-J4!%H);FEMN0[9A8'M6='6_#0SYZOJ3A;P"@M@5`!R"IXGT.!(A MP?:6:"7@79JD6V->-)(X5;R^R]2BEL-)B`7;JZ&;^Z3"_R[S@J+! M142/[RY(Q6^5.@H[J*[*C=.?'S/JX)O#^QU;1AV3(XB5:'F^_(3C>FF1%Z4C\C9]%XHJ^C1TEIVELL`L*HI@TY'Y*%;6D M,`78^!SH%<'9VWYGLJ<[9"$GEV26D2"J-$,=A],T*Z*_5_\KZ%J"6H`2P6G= M'G_L_B)5"++0%?95)J+C*;,"8$,0\+!OLD6Z0!;@LG*]!(!^H0UUU]-.'4"( MP-N^;[8EZL`6&&/)??4-@1-_W\PKJ`1;-`UH(B,P,UV2Q;\U[,L\.H6-HWHC MH`0$@0/[[A>Z^L$6T[,K_R@(TA+4!\HCT9O$4JU2W>N?(PA3T"5*E6X>7GSA M0=N2WR3T@=,T$U^0+*P'4!'8A&Q1NP,46RS1KLCW&9GY47BYS'=>[DY6<5&C M/"?"A;]=@Z`0$5@$]T#Z7(E M8T)+G"[E[A5K``0[;OH/[?EO,.=1XW%U!_*V_4C0@72:`44@L+#J;2+T\7&( M=F8U92,808_.LCET5-G][TKU`3H"ZZD):IG`.)RZBW\L9[-%]ID?KU(;;Y*7 M-)LN0CCEQP+%%@#^AS-,:4'C,-O"8,FYXGW]0C'=6SZ2HH@)S!L@7/1&ZO&7 MX^N6%L;9L"2`BL"MI\=&DM!-N3KI:"Z,BC]H:L&5(UX:?T/O:#ZB^C M5U)9MA9&BC3+J7<>YIJ"K(MP^3;3/"@#@76H7/\LO*_SK_[,>WJ<#YY)#0!'WZ^)(4?Q2Z2UQ]`E5D9%-43&?0BV.HI@IQD M;^16(9U=I;HW:#/?&EI)@PD)2WK>;TBZ>6^!RIQ+L]_56P&P-N=D86J\.AF< ME547)IY,>BL#@)-KKUC3&_1M'H?T\N]UF65W$"7$5A+VV_/[!!_8@LW-,I?6 M`816ST'2!'\M)M@D2L!9N04`$7TX;@VPS2/:JP4:\BZ1JLZQR^*`#X&SJNMB MRT>&+*V?)6@5;NC'F]0630IWZ@-R!!XI&YQRH")+_F\X36H@5)U-M2J`#X&? MJ2N58G3"-/D]'C#O2$'SQ^Y)5GM^;A2&T4*RV@G4ZB=#$*S1D>#Y@/G/QK;J!T7A:`.2(_`=<@;`BP7@Q0,LH/7SMR] M>"MX\>N"A#V=C<=V74",(%C#T&Z$#4YXQ-KC)KV6M(UL:[Z2;*ZR)=\M[`V' MSE(XUM)PN+Q#_,^R_%Z^R_U8L\U/7:"5;<%$U MT*9-BY+6+ES`'L?Z(`6&;!_.$Y@:J:5[/GEEP&S5IJ2\3Y<3HT?H-D1D6_<] MT(IK:V^77[1>F>4;54NA?\#Q)HO\.*^B&UL550)``-T M.2E6=#DI5G5X"P`!!"4.```$.0$``-U]:V_EN-'F]P7V/W`GBV`&..Y[+CV3 MO"_<=GO66'!++$8RNM(YU(.KYDL?]]2>I&B2)9E'1(.A^2<=LL MJHI\JEA%%HM_^L^G;8(><%[$6?KG[]Z^>O,=PFF817%Z]^?O?KDY._KC=^@_ M_^.__[<__8^C(_0S3G$>E#A"M\_H-"B#FSP(OQ4-/7K[ZNVKCXC\\.[MT3HL MC]Z]>?L[].N;W__XX=V/[][_%_J_EU_^'_I\?8..T./CXZN(]%"R'EZ%V18= M'='O)''Z[38H,"*,I<6?O[LOR]V/KU_3]D^W>?(JR^]>OWOSYOWKIN%W5O_\^7B.KS'V^`H3HLR2,..BG8S1O?VX\>/K]E?2=,B_K%@ M]!=9&)1LJ+1$6D+^J^CIMD1_=71VW='[]^^>BJB[\@8(/2G/$OP%=X@QL"/ MY?,.__F[(M[N$LHX^]U]CC?C7"1Y_IK2OT[Q'9TL^H6/]`MO?T^_$OZUQ?! M+4Z^0[3E+U?G4H$^]OJJB5X3+FWQ>8GS.(L^I],8'E+;Y_RZ#/)R!N\\O4WN M;[(R2";QS5/:Y/@KGC;.'9W5\25&$T\;7XYR:8Y+D5OC015&,Z'_OB`\]+C# M3R5.(QPU_%%JA5UEG3-[S$PD[38+>QTFU#AG>5_>=)]G;"%Z\_']FTHB\IN_ MGV;A?HO3\C@EQJ&,R^?S=)/E6V;,?=;]WPUH&^D;^7NLYKC( M]GF(C62O1K7/4W!KPA-9\P@E7=IQ>O3+]7?_T9`A0H7\*@CQL."0_:J2J6[P.,[(@[\JCGH";/-L:CWG-2F8\,/QD05!5R\3D M*7#XZBY[>!WAF,CU]@/]@2+NP]&;M_6J_AORJY83CH&;X+;33PYFZN;6D*7A M6@JF'H)8:X?P@0Q]@QCXN)N"9!,4MXSU?7%T%P0[BI3?O<9)632_84:*@TS] MZ[^3];_$E*&3)"B*]>:ZS,)OQT]Q,8(;`(TU\$#X'R*(-4'9!K%&Q/J09A+H MS.:;!"VW6;N.VF;?!O+!"&K@;PB?0QO*&]*MQCA639P8Q)H[J1&D?_?#ZO'C M.&;IQ$$\U,P>D\]%])-G27`GF=I!&ZMS.^1O.+GMWQ%MX'9V1\>2GU[%0!Y: M<]NH^Y08$HT*#]HZT>4AOU*EKAH23SFB^U^>Z/?H:(\INF*H#XV(L[@(@^1O M.,C/R&_&?!=E:R>H$'F6XJ)JBFA;Q!K[@0S)J(]A0SGD=M!1P1..CUY[APCI M\ZW#2&U"O$/)R.C+<2(=^D,AI8K=K_!=3$/VM/P:;&4+RWA3J_B0<#N$1KWA MTK5#M*%;4*@&FL>#?I0/"X43@L4\2,[3"#_];_RLQ(+0U@$81'XE:*@;(M82 MD:8^X$$RVB(@E$-]*$2<[/.\MX2I/4]Y83` MQOVP9N,L3G!^0CYZE^5JHS%HZ@"?( MW@'-9?!,SX>*XS0Z#L-\'R2%X@091&7]D$8MPQ!F36M$!AXU[;TX*S:8D^&A M!WA"["&+\)'MT[*H66-LX>@B#F[C)"YCQNNZO,UNW>"G M\A-A\IL"C$M_R#I^%Q\I8>>__@"JO[!"]3<0U^.**03[#O]KU'UIA1I7_E?Z M-<0^=Z@3SI++$W(ZX;2HL@+H.'U^HO_&#C?!#JMG0P-S2"6S9Y/H M"AR7=">0\GN2D64YO<-IV&,6L/X9]F/=HIC**83L'3U#>Z\'SB)XM6Q.FMPA MSF?,K&-G3E5-\6QIY^3("Z]HAY5Q(UR`-?77/U<,_ M1!!D[%U!!V)@I12.P:.R00)ZO+&FZ=VTQV M6'&?)1'.B\__W),1_9J5$-NI(W1PDT,CR1!)/,%O?_/^XT^H(D.4SBO+"ILD M\9X$?(9<`\[,]AKTX0D,8;:-I^V!T4N;O92DO.[YJFL&!GXB.*V?V\7IW666 MQ'0_!6#N542NSM/&)9":4Q*[LK(QQ\*PRVC/[LWM1?8;<0]PU72&N+W:1G?6& MUAO$]X=^K7I$SLW[TN.PWN>HZ>[H.$5K\OV'&#\>2+JHO@G`N+,YS1$WS713 M_I9-<[9!.WZ:=]4LEW26;VF7KQR7+IBKZ;UR!LNH^0R[=9Z6.(^WW6H+M$]Z M.KMV""#'$(@U2<]7],JF3)#IES38DV@?1ZB1[BQ.@S2,@P2UU\`E>ZAV+,F, MB8JZB?+.*D#UJ*?]9DIDS^&]P@\XW>,K'&9W:0SS6@QHK;N_$'F&H*MI$$>T M0K5YL&5?6]6*"M$.XD2X0OY/2Z\1?-5I`J.0_)]I3W MB,2$[O!^RK4)`L7P-!0&=6 M!_B8_<.M0XR8<#94?X2Z-_QG4/<=U'P(450B[E/,)QI1&U8DT9<(Q\HP7F8E ML=QQD"3/Z"1(PGW2#M`I_2(9O*^85L,,LRUF0U5=7W1O5PZGE\)9W8&5TH4M M&[)&=U_#XS2J)YTI@IG!,NS1H54RE5UE>D0KLF)'-R';W6]4R)IA@1[*NQL+ MGPS')"606X<9&F#/!)RG#\3@9_FS40ZLDLJZ*JME$'?2Z]:^IL0"IF0(.O!\ MN%A;6N::^Y[FBXFN"X>KAU8ZJ8E<;U!+S%^B]G5M,):T(?#B?IDI'N5VW02, M+O3M"A/-WX7.&$/K%QDA4EZ!:0<4\.M0\JJ[@_Q]$Q?Z2F1(S4 M8RV<*O%(;0?4'X7CD(8I7JFJ$93E&CL!QPX>0UAOVCR%RZR(-<^VF)&[>R)! M+968XEN3T=6Q2]MH*+WRTTPF3OH<`7C6'`!2]I2+K*$[D,F>;^G@Y/S-%O7H M2O'A])T6_JV,TVP;Q$)&$W^!?Z2Q_?Y,@@]6_D"UB,+H[:^K0+D$:!&"JMH0_8$C7:&@1`UU M5>)BA=@KJR[/6&>+&=(?<$?JN&;4"Q%G)[P*;$^D%;K%=W%*3VK8O1O&RD'E M[%YNMBDE)K_5R&?5U34QE(+W:VXE[5>XI2F`A#42OGW%9;T\J9P>)9FSZK,2 M*:2U9+OV*YHITCI%'ACWJ2+EG$@I+MWK#@1ALDJM>G@Y.'LFK$`.FUDS=Z?+ M%9?2X^0:[\YA#N17>B@WGTLZ`H?FTLF!/(=3Z0F\`%*+5?MSO`OBJ"Y"W91> M[L5'"C4#4=NOX@^224ACK*B:>MQ<#?-!K.Y24>>)ANM2XTRVC,D6]N)X]WIC M@$?AY0)3,#K:S8+N8KG>O=+O6AUXY8*L"3J.&8/>H1R$9R^0>YEG)/PKGR_) MJ)9$IVCLM*,[Q&K_2TWF8$502B':RZKY"C&"ZIF&AL07G\U0IK/X"4>U`G@2 MDT"P)1IY*+#\\*&^DJ&8Y4;Q'7CE2?4D,W>F.G)?_2FE@)4P29;>'9$/;;U9 M6V8*?)0P)7+]A!]AL;]^B.^P #PIC_7=72 M`X`K0:-YR,UQH/IYNTNR9XSK/&TN95V/?0"M_>H-`'F$,@XUS5%S,:'W**,' MVY=3A&HN(83Z7!+[ZV)!YTL*&A<&WKE]KI@Z_TX+I@D0FW>V:$;M?MA M?REPKPQ:8&DL_YR3`4EY_:I"&+NJ]M<@SX-T=-]?WM1N$?UQ;L<>4R8K?W6! ML&GGL$R^$=<%X_KQL%R#"N'/8-MUL7L%JGOU[;60=N)6P?PIMXZ4SH/RR7&2 M>DR^>DH`%\D#F,+OC*J(/(@&%"=B8U&!-U=(C20Y$:,##RZ3ZN&D#Q-N\I8\6V<1JJ+;F2ROX54J4,8VM^W;JZ/\JW=WRK?<]> MZOS]#^[5!``QX1H>%%]6T_>J<(8Y7+K;UJ.M723FC?`\DH57QZ!5T,':N54$ M4\8K!_Y!SKCEY#H94D8RZ=0PL;L0U-&$MI2`T-2)R1]PJPRD/<`TG&6&YA7Z MGV]>O7GSYBW:!7D%[9_0[]ZLR*_H_U!!"_\2P[\O[[,\_A>.?D)OWZ_^\,?? MK=Z]_\C6@S^NWO[NW>H/'W[?M(V+@AZHL6L]^[(HR0^L1F&)K@FL\?86Y^C] MFQ6B"*DJ*>.P_NU;]ML/*T3ZV>&0EB5//'@=60;:L?5$CEB+I^=1Q`JQ!$/'BC-)/%X6:*JE7O%@4-/?!#1#'T^2R(RE?2F M4_FL4)^QQ@X*Y8UP+!;*ZQJAJA4Z+LL\OMV7K(9RF9'UQ9.C;I!$U<9MP37] M[6_^^.[M'WYB!75*#QPJ.93$(H!J'+F$/ZBXL9S(`W50%C(6U<*73=W)@O3U MP(.]73VH]`KA>F^W*U-^%L0Y"WSJ:RKJ(?J$I2EC?KZ*1-E\[O_D.RE+4?HF];^3SZP&'&;IN MN)IA\>21TX/HEOR=@<45:T;6S0A7ZPWA:[_=E7OZSL,O!>!=M^E=VAFFVH4?_Q7>%:%_>Z/B"XG]*@O#;$>F+?+9`Y^EN3^P><=_KO)76_#TS M75=7J']594Y7:XH"X8^]9Z;K)\FV@>6MIR<[M^D5+ MC8B0$-^MEDW';*&KM)LX3'SGB#NCX;H__'X(R(VP,$1'8X.4#0;I:.HP6?,- M%E6OGK=P`-V:84;6^5V0QO^J.A_E0_8REAFY75,`ETJHC\51*K1<^<26'5U> M2,;C:3):4T1#@/94;1(Z[3GC7X)_9/G)OBBS+?'D9*/\]"ETPVR/6Q\#;8DB.SQHWV53D%C'2DJ_N6`\>9U.NWP M#Y$#'/LY5POK;M;0<":(T MJ"7Q9IV$SI*8RVHR12Y1UW"E?^!52^H!Z@1IS%#GS6(+G2<][E23Y/)5+.F" MK2?QX#4LZ8(X\A*6X[5\&2'?>"/A M6S@]I^V:(B_L985#`Q]TN#.=??>05T)&R$/1X\7BY0%ZO*UQ8[DV]J\"IT7\@,_3,-OBBZPHU$=$ M>D++AT,`2<:?3>D1H8H*43)?SDJ@<]0_)3&;(%-;6^#PU5WV\#K",36S'^@/ M%%\?..M*?O7W"WP7))_3DJ:ICZ^EHZVL86><1Z'"#6V!JB;.EU7%L#8(T([I MH::[^IYT(T9L8G6B!]P)!>OK^76^A2(;27YZY<-XH.7@(D[Q>8FWTM*'0&)_ ME@5>(N.E@1(C1NWR@.,%BP=+AY@CGX[.XW5=4#;PVB[1-'NQE(HY$M2O-S?! MDR*F@I%;CZV`4AGHV?>4](=JERG;($+OP07\66*&/3'C6LRD$K,N-UP&3^[# M,1.(#L,R7C'_:`RW7`T\:ML""J]1B&Z.KS*[E&4"]BE(<#ZAA M`E$N$,<&S?*K&6'VI#8QEY7M89U1;KS+5WYIX[X9CGNVS+@[2("V9E`D:=*6 MK8F+V_"\B-?TX@B[3-(3BZPC^[(6JRGX0L1A@LCVWP[U(8?WX1<:*=6%^)ZF M=]\8ZG;W&4K4%DRB&EVKLNL]P@.5H_Z%?M MIU\==`R%Y"?)6N?ZY,(BHH14*EMP@F.Z?/!32U+&_(QS61`8S<_@DA3"KAZ(R1 MH9J.%BNK*>N:JRM$B;UQW4WF3C@Z,YXX?S"I=:FA'7B'2ZE[#46F-WZVV1R: MHM.MS_UYNTNR9XR9^:Y8U7H*"AKK*%3Q+^3AU6UK?Z'&H1\[E29R5'_VP!G6 M@F>H"T#DN-[K`&_?7"AR%Y?_A"=[)Y-&![J5.$A%X([-UN/'9A<'3RB$/35=\Q;>F)6HW8NQ3,=;>L/W<&:IZ?^EV:1V7`YED*H/O&!3 M)!VARZS$I.L@29Y1.U(A_P(]YG*;<,\ZA?W MO(7J:^#"YFE,_>;D@V*"K&VVS/HP'(NIH%D0D8?3TMA M2^%*TXX%L+K/WIDVC?TJ5SL*9WX!S^5[V<"02_5.X6H-V]JLK#O@<@HS+,*XNCSAYI@ZX40(1ABJ(R\?TYO%HM7+E&(2% M:I5R_,XR_GB+H]/X(8YP&A4\Y&ZR?I[:>7J2I2E]MCE+_QJ7]Y^WMSBB;A(. MRCV91?G2L.`G;"\<2XZ.N*S0WE';?5_A;S(AG?,\1=U'$/T*:CZ#FN\LK7$? MJV%*\1U]H_1&%?K8&[*H[AX%`Q.Y:T>,?Q^3OAT==@/W2`<.-P-WBU/V\&J0 MT#;$_A6TS>9`PVETD\;F4!:ZL50.8C-L M?H[[)N.\LUH!>#YI5'N%=P2Q]T&!66GUFFM*0!\VN,+L/>*&X4^M@IRT^J&S M^6YYLKM(.![_D??`"3MT7ZQFB*XD_'VUQBCV5ANVK]:Q53\LT*P^C#/V[$#- M6[?N=-RACKV#K48&Q1/\G!82/(;UM!`3RX>.S;0,S3!]>RWO)J9ZPPU=XYSN MBQX??>#M=#5/]`F,O)XGV#+GTF"4A6P#9*TPW59/X6>-W3BKVE$WJS M53%9;+8C&>QV21PVXO('0W4/GFUWP`&MW!`Q1;/%W*[A92/*#+$\]3UW58:7 MCM)^GI=6%B';2SB;K=6-+8`FB5<(5NVT&HCV$/Y8.U-1E^ MWL=1D(;"Z:%'8X"^O\88??$ MUTE)W\\G^YR>,>B*4TC:6[=',KZ'*&W;K5#=TOU9,6CLA_@!#+P#U*A.AU6- MW>%%==K;-O(FK=&0;:X&DA_'T7K`2''N_'BYY>0J>/Q"0L68"HE3`I]:N@0(_15H8RD:T6ZHZT]TB4] M[J3*!`7=,@5!PS#?X^CSTPZG!2X,RGC*")T5WY1*HBC=6!.AALJ_TI93I#HR ME\M%Z4@U]&0%'R&XFZ$:7*6ZZDL7<7`;)RQ?6YD3#2"TJQH02:2E#LFZT&"( M(_/A:?M98F43Q+*F&F#H]53#$'<'4@U59&Y"[(^*J$)@K9HXCN>7$4ZF+(<7 M;K8A.*Q\7E@$Z=;&5'6;81EN<'B?9DEV]WR&Y;E:PU9V=5W@<8B+K@&B+1QF M%)FPNCDEU9*,/,_,<,53,.5M3E^< M7LPUE:8G!8WXXU"FVU8OQH+P-?+H-!A/DY)^!C&!;X)GBZ#9^HCZY5% M2^GF.6JE+.,O.]-C\(J&OA:$:BH?-&:J1&7PY(.B`,$U^EPU%%DSG+1:(T^R MM-@G99S>J7PU26.[+IN,8]DRT#5T[<%!.>$F-)K_0D==+P^C:)[]CDZ?15 M2>E$>=6R2!VZAJJ]!\+1N==K,Z$Z89JL_.S@PIBHO)DTX_K?:/E.(>M+,`$` MU1NS!V"]FV$<3DB3.`R2ZW(?/0-,@KR]74.@X%M8#NNFB+7U1.>G\%\P_CU1 M\P,*8$T]=>#O*24,^?:BSOY]W1%&1^A8OT8DT>A5>Z.ZI7&YOS-#FEJ!FANN&G'<*9(,;&H% M4B/-K>*P"N:F2M,0>:$PK03:1:C6EHK`IT4'+$BM)[%"`M?*T0<41#'&T.16 M*=;[LBB#-(K3.T/-Z%%ZH1Y]68`+"D?DVXH"E:=6E4PGB6M]&<$:1&FD0+/Y M7FY[07I"T`.B=O!N+D0F<9^_JP;@=:PS2SS_HAP#!(K/Z!K"SXE>&00W2BJ7 M>@0(!/KZXU50,TD0?\,9`+84FN)+(".PI(UBI!3N-4/J]H]IQ>JPT_#3IP7+FA8EL8\N/'+I\Z1?W=T(]$-1>)H0Q8/NY$1/1.D/%+G$> M9Y'D.6ZAA5T5Z?$VDKA'_JA\--L.ON=R:0V;Y]G@DKZK/=+&!<"D MKV,WDZ=\_=HFR.9Q:AEHXT]Q:^;<7@C^J#>A+KH;>" M^R$VZJ:(M45-8^X3R@Z_0%#@I<7!%-KNN??(G3>+O? MTM\$B0I7\"ZLX\Q`.O%I])H45;2(-FV*WJ":'-7T;@_69DCYB1;ZKUYDHP5J MM\1GNW>O5*:@'"K9-$3.\!3.@CAGQW>=GZNNZ*,@L.M#J#@7*J*1MO61,M?: MD]A%.P6])1PX_G:K"A8L=KHAG]*LY&.-G=0,%#@>*Q%8-4*TE3?+MGRXQVKG MJ<9ZYOY0O5_]UR#/`Q(WC^!2M3<$H;:_+P22276\@AYK4C1JV)DI7M$7 M+ZDKYSP[J^2TK$"N-^H6G)H-11Y+-4*1!GE6]^?@!D/8FS.U%LM4`2T*S/8# MN2I17XA;1OX4'9Z&?KSY MQ#G!9/OC_XIQ3H;G_OD"/Y!15@>$T`YS''32!J3U*2]UXIR?L)H'KOL9), MDL=/)7EOKB2CV'(2JG(^X5F._[G':?@,CU/EU"Z#5(5,0[!Q35';UL<(53=/ MBO`4-DEN8].6L4D1J4#M11PJRJ0R=1(D>AV*2F8-$H`JI\SQ/DF[UPWW&Y3D M7J!Q1"K%9@A/R)V2>!673A6NIVO$N6AI_50R&1Q!VSQ*++IP.$9V[<_BE/PN MIN4X@Y*Q?1+L6#W."\!SWO.[=NBJ3!X-A>I*SG_:?E';,6IZ=OX>F96164F& M9C5W;-RXA/,T2>XO+J%&%A\W8@?8(UDPBMP3`UK[3QP!Y!&*XC.:U7B>W>%S M0("[`-,E^]&]VH%A)CQS9(8QB^4_@N*>7O`D__G\SWW\$"08G+HZH0_[A4$, MY!.2"0E1==67_L"12W3,:=&0N7+BCLJ]GAFC4B@?,@V2'BQ8K:L^9<7BB/U9 MLGB)C-8L;4QF1[4F"7:3E4'B7I'@,`.O6!*,V5,=+D=QFL,'[<"Z"H$E&Z*- M(_3=_UM"1@\\03,0#I5K"@)]43#(`@7NP3,54UETO8X=?KU:1,=>P+)EB$`S M]9JQ@$ENR'Q*@O!;$=X3"8OJ>/,F=F;WYLM4B84[Z[2? MH^NJH_J<'Y49JOMJ[V\\H[8W?VYGS)KVWDV,!>;JVLF_D^ MCT/4L;]Z=*@Z,J)#DR8=3B?I(BPX.$F"HH`GB0QI7*:&"/R/QJ6(M?`Q#61\ M_!7)'ZK!=X"@*KAL;I@-KY7]DF:W]%U[>HV'64/R9S)$Q`HR^\=+`\\36?R3 M[O"[_.@IX>^-F3PT?*3ZIS:Z#IRIC58RI=HTU)ZKC;&0!`SO/50;&`QE:F."07O.'BO;?YG' MH>KHF&]DW:'J<3A$"OLC8G]U>?BDYI&5N3DDC\`-1\!([N1'0[ILWQ90F(RNIMZ%93F:C3>B2?Z))$0KEA5!ZCK`=$N?%0QH*BM M2`]M2U\53@5/F.;IL>E6!:_BXMM9CO%Y2OP>7)03%'"\"R_43R(=5/DH.;WN MA5'3@:>Z!Y23R;.A\L2-/+E4'M?:IT(F1/?TL/1C\;O!^7;BDE>1>J%I`VF, MES=*YY]>::0"<.]:B\909K)RB1";L<-WO=]N@_QYO3FYI^>FQ7G:?EI9REU/ M9W<_#R"'$&U7)"C;H+`B(C88E?>8KX+KO`J@T2SU]KW,ILCB=E=S)XKFFY?/ M)]EVEZ7L^2SU";F&SOZFF$8.P32Q9JAKY\UY.6A&A-T?^'38P]:`%^VAMZ2] M=2S)^-9AR*,S9^70#\$#&/=ECJV.Q;,R\(F5@M;9895*'N4YU?'H$:_;>D=S MA//T6%>+-]G1%!!LBVG%\"C,1"MDM"ZU0BJ/5BO$$USOM`(LG*>GMEJ\*;0" M`K;#!$`7BFH:!K3>!$(7BJH/L&#HPH?*#L;3!HV*)'/FMKC27^/R7LB;*_J) MUZ4;UIBW*#EQQ[)MQ#_L>9^QN!SJ^'[&:O!M8U#[6/O MV-NM)&++2_">VX''LBZ;A5S<..)[0*WU]A5EEXTZ@SR1T#Q*=N\SJ7 M-ED?JZ%-\5U08JG![-H7M(,]C_NXOBUZ'Y2$J4V"PY*Y]J1'0OK;W[S_^%.!LL>4]-F<-J'@ M-MM7K;I?%HBXSM]PB7;$D8C#>,?D>/(_(/PE60G*>;+-^"ZEE,[,S52ZYF$BO>(:TZ0DU/J.L*<7UY]S;K8O(? M"2-P-'4,K#E8LX`O>5MU,NIM%GQ*B2/69U3W>*J"QD%1)SG_8AFGE*U00W`Z M3XD"3X98[0@T$V[AI,F"DI-X`29)[M,%3B.+*9Q[XHO3YVC*SP_D_V[( M]W3)FS(*^VF;4M[%,_&F)6)-$6WKC?G2S(&0K@F9`*<(TEHM!8T/*)+:*0F. MO+%.VKD`8,FM/?I+D,?4CZ,7BC2&2&QJ'3LCW`XATS1AE]N\,3FR81[B0SW& M;F"AM2YCC9U"0VI/!N#PQH[(AUL%$+>6XS*/MXP-;9E.H:5U<(B\#I'!6M2P M\.(E6Q.6W0-8`H8A>I5(V9>Z\.--MDGRC.VS M:>5Q'L+J'DDS@)I;O?D2/,7;_?93EN?98YS>G00[\I?RV5"-Y-UXH54**<%[ M*W4?J.T$-;WXIG,&TE[AARQYH,*$E;R;5MYM+>]M*V^HE->U3NJ0#%%1&(S= M:NSGIUVG6*;XMS]L$0Y8\<;W+<1"M4SY*4RD8O`OK6F8@G7!`3TA11[NJ MLX,K)!>XI,:SL0*R'"`PN=VL'[A4HFO54%:/@W:TJ";NUC-G MA9*GBS=2OQ2PEG M]9B&^-I00"^2"7S)[O(TY0H(*]EVFZ6L`OEQ&C67.&9F""_R$5>9P\N,D"*C MMOI`5]"#>ACL&Z@J!$]+?[3/-+R<5-L%D25)P5T<5C,T"L:+LDJA41=VM<%, M.N'4S`3@SA-VITYG#Z23Y])N4E,&]=ER`&+["(-( M)$"-A]>J2B(G_^1(/4J"@<^9`#_#"5NN0&*\H06VSHMB3VN4&-5''"=U6AY1 M(HV^.F)%B!I*_\K`046C$]Z*X545."745*41]3A;O%[H)'V0T/I0+W2"1C3U M0CU6":APK%ZHGSJAQ!N@7NA'\<6TNY4A;ZZ[(&+_"[CX?4_F146G* MMGN/2`J,H0.D0<6<(I\D9L3%#6F#3[*4C'09DS#QDI#@/,>1&K3&/5@N^&DB MF^!:,V)TC!@]XCI`;0]>P'\Y48_>T_)+,C%=ES4U!FJ_N.E$E,Y6+;H4S=(L M4`^/#*@+#P1AVS M+M>[)"XERCW:RO(Z.>1Q_/%MUL*Y*^VYF9]<7![_4!W&1O9/:LV-[`=43 MCNXED+9Y%SP+,8Z*,S("S9[J.J^.Y:H'RU3.%8#8P8UQ@$3BC>R*"%$D=%O_ M6=Z>\U>D*W23E4'B^H+Y;`EC3L*BEA#7$I8'E##"FSAE>50_[^.(Z*L!*UK2\>5J:G:$W/XX&*VYODOIQI(.`=LN\J0'U'5!*T/33E:( M>\^BZ\BE7LX6F9,HT[VC85,3IZ%VJ)5S(&OSU65B":G1P-'IGJX!567LZ_N` MX&9=WBO/:R'$#MY?!D@T'K565*@BJTO5KU!%N4*,UJU;,T.VN)(MJF3;U;(5 MM6R97#:K67)@-(K/3IM!<49`_W.>%<6DH,",W&X`#Y=JB"]&B5KG^:P7'JSK M\&#=A`?.+G/.%5#F30ZC`Y?7-]U.HK7-!T,-[&TZ3%(_B^E2]"6G]DV?=7X5 MW]V77_?T''&]N::/69#0$!N9') M%2-C-;=L&2T2,M&65"%/?/RO^)']27D9"=B!7[X^+]D4?Y_05RT\`+39%!HY MQY+YF^$@GY"0EGXDCT-Z8-C[>UZ_I*^!5-)&N&6#OJ"U4M7?I[AISO M&.?4D"LXM^;%J6#2<]GT&''LGWU^PGD8%[CF<&CW546R)O;GAR\&D-O``VMZ MJQ6,VQ+4.5W.70LH`$`.A=GLNRH)QR4]?L(IWL3T3=KJEP6Q6&K*Z5WF_G86@65.M">FV M(*8&\X".?=%6^$A,"?ZY98C6B./NL'1=>PM_0Y`8;1<8(L2>PIRG8;;%UR1@ M9H]#*VJF:2FL0US.NUB7E[9$;5,OZI$!IV"(,]#XVP/0%7[`J=JAZ9I8APC' MW<@S!>Q/A\V\!!U,`+AT#]/A1`]Q.3[+-DLF%.5Z4W.AVCOJMW-0*J'/IUAO MH"CIZEFW\`">4(YS;[`ZB@6Q0H(4"/90VQRL;T:KF(^VLH[8/H_2'`CRYP.# ME?:M`RN$V1W[LWN8CDS^$*32F;<'T?4.TZE+D'_#G":KMMD41/:WT%02B+5;6&.&J+:Y1RIB)DR0D)6/BK)M&KM7 M#3V@A"TY()HLNOLXI>^>$(Z.HVV-$LZE+X!29X`UK7'O@6=C+D3, M6KB'NQHXX@FI'C4633MEX6N69H.U1F7?I23VC;R<>\'2,[3S;1N/9FG0?ZQX M3_%=4.)(:^?A(G2ITUUME\*'_&D=B`2C#T*0/25H:S<<1__8%R7=GNIRM!6: MH*&SK@XZ.13%.CH*?=T.6ZIA*L[)/?D7JZZRH8(]-%5(FNN/21SET5) M/"GZV&A0Q"'=X(Z3/6FML!E3.[1?_6BJY,*R57>$ZI[X:]DL_1!QW:T0Z[`Z MS:FZ=)MTO?PP!/4PI.TP-"7:JM'(^-&X;4(0D':C('V==**<3]$U_K!]1M$79?8'<)ZF^@[B.>9.,<;*38*&V8[O-[ MCO1W2@V2>975H:#4.H4#V[$OG6Q9$#Y`-;F,)^S M;GL.-&I#_>(^@VXRU'X(41-5'U"P'7_RQ[[%^O2,F,$Z3T?ME2>&R<$PEAG* MVV%,R3`F=/S(;^G/(1W#?67H?35FAU38H6D[O+;:K&RP(Q,?,ZM+$P6V65[& M_QJMO-*[%:Z@!V_:[U"Y%\)9@]FLWP6CG1%=\%W>1;MP^J?SH]^ MILOI7C\!.!/+!0!!9C&NI>$VB;%Q=))MZ5Z\3E%D!/9C61GG0A1+&Q[=TI:( M;^H!_N$RT%N\M0PAU]2]&J@!)$3>`/38/P.E[D"UTL$/04=HG)V"CO$O/09E MOD^3]%*W_\&/HU"('&VI*?XHU+T::*$D.PK5X,CJE?L<$\T\Q=5_.>?N)-C% MQ%+";N&#.W%Q,1\NX^.6[T M(TPRA^U(Y8))F'6IFL=AF.U)M$9B-1P_T,2[4Z3Q]P2KZF+KJDH?-`D?IR2#7H^X;B!VKL M.:(#A49S54@G5OM7'W5F!%MZ99$"RZ667.9X%\31:?TZ>NVW-FFMQ\Q3,%(? M6(<>Z!50[G2VM!RHMR@/4WM95JRD]V$Z<(ETK MQJYJXJ.^23`']S5'`>=8B_(],;Y=*-WH>QM[<'_W3GWG#4PS`KU%UZ\#A*64`V0-)FN&2V/1>`;Z(H(`6@_4790' MJ,\-85.$T"]EU8O5\I^K^'>K?!*PZ;5+B;27DD>KT*VY';^PO-D1^"Z7+^OR M?OU!AD6;4.9>U9=1C&638CTS$G2WK3ADLKWQ!WPQ&N8C8V@\V@_XD&P/O"%V ML+$:IMO'[>!XE:&ZK!8!+5BQ6;3OQ8C-\GLR$J?N` M!N'9!FWB)WHCU),M;G.T#K5U*E1?RII_L+7^Q:WQ!UW;/0P,Y@U++S`86\?= M*_\RBK'L\NV9D3B+TR`-#Q@8&'_`%Z-A/C*&QJ/]P,L/#.:/U3`PV+2#\Q(" M@XE:!+0LLU3(?F!PEN57>%>[A.L-=8_*9T`L(*%SYO[+Y)!Z_!OZ_G-+07WA MBL8/SQXJ3E^":TPSM-#QT0>TRYM-_H*]3$B#F$=E52T7CKX2?3+?'@"]E[)2 M'VR%?G$K\T%79`_=^7G#PMSY'3S5?1CF677B=/ M@H3:LNH5U.$IIL(LF'5C__D^,RE''4NZ5+$?N!Y6]6.Z:.1(WH-BV3/%IBK] M?<2E&-0RDE@];$:$_8"[SMUK]Q1$"Z\,3H:SQ;OI^]TN876Z@J2ITW6>$O]Q M6]V@!Y1?@_9@__8Z6#;A*CA'V15E0QRQ)Y<0%Q(QBHLPR8I]SCSML(F`B8ZV M77D0\AIB5;@7/P6H$$U,]WG&].O-Q_=OF';1WW2O@M-2M=>X+!-,M)Y\/G[` M_,W\]6T2W\E*0DSNR9JV39=5_LP\[055W:"VGUYA"=3UY":H74[LD[I`*9,^ M9J_(TR.[HA(?;W=)]HSI>MF,`Y];BK*#C4,][U$6[K=-Y64+\Q\W\]^-P431 M;=BFF9K>V*A%U-R>U_!I7\0I+HI37(1YO*MK[=`RLL5Z<\E5ZK[!3^4GPL@W MA0,QI3/KOL0DB8<`;SI!7"_,_V7]T`*P?$_H5]H78ITYWFQ?5OI.XJPOL7L7 M8SJPA][&7%1;#-Z):U'Z0KI=F9`'N2/IO52%* MZY$BSI:.2N5>S:"0$R)J([S94Z'/09[&Z1V-[5GU+8CN*&BL*XV*_R&>FK9T MTZIZ8\`C_3`1A&Y,L8*O5)#:"6=$[O5#BZ>A8@#!9/.&5554X?FTW5J`*(6: MS,&]*J44LNH8SZAK[Y%R3)3&B],6")[$^U-0,%G<;PWO<;1/\'HCWI2\H?>G M(5IBTHG]75<3"84M@)J8QD)C-XM_93V@PZL4;/=UCJB->+U=+9:.[D(V@F0H8%L(>$[CN3("6Q7%-8-"@G58DCQ<*I(W1375@ER7B) MX;&EL:9QN1Y.D\;].@?#TVAU82"8[.G&%2[*?!^6>UJX^3B-KG!"C[&,'I8Q MZ,.ZQIC()R:4G$8 M$4%DE(9$Q).0`YAU48=''@!WPK3*0P?#.75D:RD[C+D"YP_X^"E6)4!K*=W: MU5%9U-;TAG!&;"=IZ@'\@!.CM):Z67$$LYH?*+;:YFX!U7&M1E'=[E!OB+/4 MR^LRR$N=*POD_E,=UAVA6WP7IW0/_J"\?TZUMVR,.@=NP+3A[4)NOW4 M'BD*(>JD@:"CVYP8FW$^,-CMRGH(.72KW"4+HZ%F:4Z%=*BQBQW[&( M,',&`8EDVNPAD@9\@]C\--L&L>IA2P6-=>RI^!<.?VAP*^R__%JU]P!CVKD8 M`@LX$3..8<_B!_PW''!EG^DUM^.['+,K.%_P]A;G(U`Q(;9[1`N52#CQI'F7 ME)"OALZN0+:TZ->*VE&"T"SQ?G?T3&7K"K(F3+:@(71\S&F$P]ZAYP00SKDM M1DLZ3U88*+7E6V%0F<;7*IVO:YI%L8% M_4R M_N$G5LI%5FW.IA)!X3?4)#/L^:-.@-PN>!?>J9?E$V7JS8-F3-"[IO'[.8^VQ=D6,_(S)<8IU^"-+AC<!"[+S@*!%H?]$([CNGGHKT7Y2\#]65T M]^8^7E1W#?MSIKNFGNW%$@T'K_DG1W$MIENCL#ZC;KDZ0$$V5\ MF^#+IO`S\P[83??BG%7,^F67I57#8KR0VJS>'%0QF2*S6/JC[06UW50>Y*HJ M=5"@JBNT)WVAKC/WWN2,61>KALR<\AGK%*TK$;/T*>K45C5[[W`:$B>WNY4N MY`$,5R?37NRN2<8RCE7`JSNH"N3R7?1J*5SH,COF;YZH+KK]^XD+NB7KD\36 MUMQIFMM;:>>HK>WUE5J]]88SB[75Q-%;[6JJI'6T=JKE&5\I"U95;*XH\D.AVE6&RW+6Y>^4&U?CK>WOU52P M$PS^[S2G\FM6_@V75SC,[M+X7SA2H.^`W[1?\^V`XR?4C&N*&-;]BG$2V-B\-]7IW; M-Z^2<\G+.5&//&+/DZ,`I5EZU.32-?DUBS_6:/2>@QU(U8\V[%I(!0Q2 M=+%=8++:W[1"*O M0^0V+5#=Q+TO(1G?X6*O'%S[:&!U>^HJ:02W7<(J`!\*6F>(4I`/G,4;>F"]WI#/Q^D=.*E#3NHL?T,AC3)5@WI9-2%J*#U+ MRC`0C4YX*X8_:18ZJ,DR*F`XLV=T&]^4[MK&=_=EL=Z711FPDC\*>ZLFLVYJ M-5)('7)6%8`1((["O=F%S,K0XL*GQ!ZZSH(X_TN0[/$Q\4JW[)&C@AX+A"6. M3F/Z@C%AEGBB"J3!N["..@/IA#O?A!0Q6L01KU!#CAIZ1#MPFYP^0\SFSQYX M,J90'*K7-!S.\&OZJ4C=`2T)WD+'W;"5G_/-N2'9D"J1T'#YI@>157E$4I(^LER M=K)>^S0!S!8+%&/Z`,ZG/H_:V[U**OL%B)4RB,47:&OT:9@R MZLGUWF6$<;]@`8`EE$2&HFI6'1+ZC>,/0,`#:&S7'%'R+\''\0?/T+ZH+*YW MR`&0&M00@>+)8A7*'B]7.,*5DZASUPSI[=>G!,JE<=IH7EM#"O/:K%9_-)D\ MH12D^%>?'7+1?L<02^*4QPCF/=D.&";(*@*QZ@31 M7NBI=-XJG>Y M#`>"#Z9\":&FZOX@GIJG^+.]1^F%*X@;J25VX4_J)9(Y8X@C]=?'/(Q\7OB= M0#"..*!&2)RM-)]F:8V>VH7:`&22!NPO0F\.)*`7B@,%Y(CFF*%QANHTAV+M M[GUWKTZF+TH2NTJBYEYZJLD=+G4$+MTZ,SF.*V\MVR!3R_`J)M3FF$&^F4 MA"Y]S;4+>I&)DJW\2F6"3I1P(]UHEF:LBE_W%,?MEXIN/V3LIJ^>Q.Z*J.9^ M")JJ-5JWJ"FXW5#))5D[+N(D.3K'K^`V];S.@@"@K;?:@Z'FL!Z([O5E&8'[ MRA^R-Y5'RGWX\W:R>ORUE3V1%\`&?$"V@9@0? M\BL=)_NB)"%_+G\H0=K2^H4-D=>Q^QEM*\WNI,W;#))1'EY>4`ZQJ?$H&8VHT/]`>*@0^=*R(`TFR@_T"=-TS$A]@I_TMP,+0!5N3>^('`\M6+J M9"UV1:3J_!07\5U*3TED/I..RN6ED!$9=+=!ZBJ,'8T_ET``TO23E887.YI$ MI+8'U]L7,,0I;F^HX38O+S+:A^5UD."BVBO<7.%RGZ?TU2ZY*BB)K&<[*B48 M2?"C[1$CJ/9^JS>(*0U[K,QQ*I^1-#?W&)7T@;6>.E02%DS"O)$P9_VX5P4` MX(9Y=U"T6SC1\T/M0ZH08F^@U9-(`3!OCH'A4P,%FFQ>9BSCZ_PN M2.L3YN,T^A04<;'>7%8K@G83R+P+NTN\F71"K6B.FI6N8/3T-(_OP8]'$!:4 M]-BEI"!?QQ-AK;D^$Y2TYPA-UE![Z]B7.(VW^ZTV=VG0SOKJ-.1S"*[Z[X?. MB%8:!$->W:^4HY,_7!05,V\1IL$3#*;]=O9A.N!3F/KJ[W[`%,:K!S`=FWP! MIO*9MP=3]O)XZS9^"<@\Q$%2L/*EU7.N7S#=+DVCN,"_T/*X)UE*MX@DU9@7 MZM>Z&LP=A_''Z=L.5ZCM&UL550)``-T.2E6=#DI5G5X"P`! M!"4.```$.0$``.U]67/<2)+F^YCM?^!JGB4Q+U(LZ]HQGC6TH9@TDM6U;6MC M,!`(DF@A@6P<%-EK^]_7`WD!F7$"@0P'NEY::A4\,C[_/"YW#X^__,?[+#QX M(TD:Q-&OGP9?#C\=D,B+_2!Z^?73[X]7G[]].OB/__4__NTO__/SYX/?2$02 M-R/^P=/'P86;N8^)Z_U(5_('@R^#+R<'\)?AX//4RSX/#P>3@_]S>/3+>/C+ M#SX?/#SY\\O/K20%2U\\>+9P>?/]'?"(/KQY*;D`#H6 MI;]^>LVR^2]?O]+OWY^2\$N9&WD:*-L.2&YRRY6:$J:;\.N%_0 M__=Y]=EG^D^?!\//H\&7]]3_!#HX./A+$H?DGCP?%!WX)?N8DU\_I<%L'M*. M%__VFI#G7S]%>1(7:CX\&1U2^7^_B+U\1J+L-/(OHRS(/JZCYSB9%;W^=$#; M_?W^NM+]B$`C,Y(EP3OEX2O]YJNXF:_0RX;]//6\)"?^>3R;DR@MVJ6_]4[_ M'TDU>BIKR$!?H>U9D%%UI-#T>0P*B5Y@F`1:'16V8J"75VZ0_-4-<_*=N&F> MD.*7-/K'D3>AOX3X07;E>D$(EJ2CLBU!`WUYR&+OQVL<^C!G7?XCU^L/2]A` MG\[R-(A(2LWBS$V#=/I\EY`4U%]8\UTGD=O0'Z.`'4VGUCR+8^_VEW4JVYMF89[>X*6S$QHMR0 MKO(/KX1HS8%;0:_MYR%Z'1/Y_DW-Z0&>OGNA;E/_"OH[;D;>GE8]&'Z M?$'%B`^SV#5LGF>D.H]I0V^])P:T!4V19!9$R]]E3N#:P'4:;6OM,F.]^DV; M7>6T.\R0-=LC,WI5;=!`W^_C,(1V?[J)/WV^"=RG8A.Z7"&NXN2!P+F7_ET; MA';+YO8;JQV!_IS$EC>]5M_!,(FR5Y(%GJNU!`H::?<$:&RUJ_4#;>WHS*#2 M;]J$I:9*`GHM-D_Z(:/8[)D9.2)UG'AQ( M27H=S7/80L=_N`E,'=EZ5J%]J+FKK-.ZB1-Z/INYRWK'"5Y#1CNV[F;OEZ%\<^Z72O)MW[:-7:D;>?8G(&_C12G?(>T8B.-BN.D3;:1BM*"(J\+MA[%5^*J2QG#B1 M0:?_XHA^X/0II5&L;-50Z#Z1L&C>499UAAL%J79UJ90BMI02[\M+_/;5)\%7 MZ/V8_H7"&'\^'"PC2_\._[3N2ZD+A=>-T7?1Y\ZHTMTRHZ=)M>MNXJT:A[_N MT%F-C"V_^#HO-O"?O=<@7%O",]!>0ZO+OL1JH/(4NA?/%PO+IX,X@07GUT^# M3P<`\9DDL);>+#3$A5#TOU!C,T:?W?2I:#5//[^X[IS2.OE*PBQ=_4MAIB5^ ME__LK&?W\]!-8>(LUL[3]R!ED"R5<2:C$YM1!5X;S,>P)))KT`EKN,I$G'%WQJH*%C:A MXPX0^@C-2@BDGS@3A(15*."3MNH_FZ0)8I).H?L^A7`5NB\]@/$EH,;D%ALWE"6(N%T?E>_(2 MT!-RE-VZ,]Z$ROK4&5@]--2CD`N$<]@_1,_?.>!/J./;)^__13Z$!&Y]ZPP& M7660A81#H0V'C2J%YWF25)8&\;Z&][DS&':/2"$8#I MXD0\&"M?.@.K7M0F0W$7!X<\S+Z7Q\2EUUP>/F9/<"T& M]B27>[1">V;\[G?N1Y&F#MTH.N>&J2``J"#E#$YLQ1"@*W$>T7RYHG=+99=R M6Z"[T^R5).5T%UB[PY@F.2T7\T=@]@PZ^4,`W^P/.4,4H0L9I^S810NJ,!2T MS$B2DAMK0UUT/<[".!=T9T.'PLC7:L<9-LP#:!FOREC7:\@96MT$UV>)$YG4 M!V]H]+Z1Y"FV.7[9UTL<6<(;?;`V@:H=4A@Y'PAE:C5\H*)@]7$1P M^C)0&!?S+0R6W5[<%)NPQE9=6EKD,$>:'I`^S+T M%&M-6!B.RZ,V[,!7O5`8BGPA9S36'X:N>O)$H)_?$BU^B0&T.4)9U1E8SXFI9@1XX0SG@V\[0_=O![RF9/E^F63!S M,R*ZNU']T!E9S9=KQ#`#B:$,<`P#^Y;\+&DEB2/XJ[=PDRT,67VB,443E&IF8/N#6#A%[7C1V"U9:6"I6G?C0BAX( MI)RQM1C!O# MNB?0F=S+92]^.[(^^=0=%)1.WZR36&*`& M?L?YAL)!+J54-HA-J0+%:L`)E3'0PNR5IOELGN6TV-[OJ<)1N6Y3SC<4CG9- M2VF$MD=1MC5PE6&ADVZITY[S#<6&H>9D4Q]R2S&Z?2>^5-Z*L))NMJR=!>-X M59CV+DX#25%"'7%G8C'U;-D]7H%"]H?.!,6!35FYO%2R'4Q_EB;R()=Z.L(@R#`,4-30XKK!VQ.BP4&2E":L\:<2N3!BU8+2%3EUPU7*TECEA< M;&\$%47Y'SL3%.=;_>6UB@!/U<,&B>P+'XY"\GKE0V=\A&LO7&6&32,+@J'* MA_83/!;@EC%193ZWOG]HT"O?\$?IG;[3[-Q- MDH\@>BD\):+ML(J\<(Q;Y+EWPI)%-E&.V3OLYZ`80J24[PF8-CB=8E=0>"J4*,]DF$L\'< M#58)/*MJ/!4%B?)GY-+.$0J_E2[EJLA,E7&T;PFJG&_I`(432WN6WL%@JJ)C M%F=N:'E$QW,X^'_[BO2#8@\SI>40\38O$G",<]V:UQ[`$DJG:D/8'KVBZ MNHTCK]%,OFG`.4*1KVMR,M\"9ZJ(I'V36,"33N3.$8H4H'HS>-%Y#F7:3B_[ M4W>U+B+C%5"Y#T6U"6>,8U^FY2W3`\>Q"VU'&@9_2PFYNC^-+^0%D`1LXW6\`Y1N%JK46V`!&'Z0[ZV[3&-,ON4>S?:_'+00L4A_"]^M\XN66EUT;^SZ93;0�V0'G66B%S0$B2=\*><8A2?4A%-$AI)C M!9UTC=5RDPK4>MP;UY@$),<(.ND:JZ8XR[+/&%\[QRB<8A+*N.$M)AP.P9WT MB)4V)M+#UU/>#!9`[-_"OHW-W'F0NZX%* MB83S#85SJQ;+(D@(B+\J57?J>?DL+_RX<$P,O$"T8,N%G6\H M'%ZU#$`1'<<6.NC\8KQ@HK-9<[ZA<'[5XIJ#AL-M!YU?LJUK@^P%YQLV5YB) MN#4?*LI7>A+X@LZ(H5Z="8XK;U/GHT8_!&=)..=J-AB[%2S,D/K=_7NAL96#,9020NS16A6_9Q& M1%R49.=#9W"(PGLI5CHKDLQ&8JA`12OU9!Y_QFL;%-.T^Z4SP?$2E39//"B& MJE#8W=_$D0U(+BT-N$<@&P_A2VN'>C%R)9Y-??`'BK"9N& M5O,M/*9J4UB=K@M,TK%:^LJ9X"BLND6&@+%ROTW5H;#K@@JB8);/I*Q5O@/\ M*)*F=RCA>)AV^VZJG(1E]^&[&G?E[P`_BA1I5>YV^VZJ[H-9OY%\2;@15#O5 M;0(TT>6X33VXQJI'6-_Q[*!M#H9`SL?NZIPEJ55&:*AY1XG3/^97T->:$O)(H#=[(39RFQE(JV\KVOHTS ME0?2Q8+.8&`P;Y*6!*PH\CH"!1?J%&=,R@2AFRC"0RK*9)VHU/#A28),B??E M)7[[ZI.`FNB8_H42/BY9)OR3W/`RRFC"-MM/S/@*P"(X(ZM14B63"P9/ M)J,JKLLD\;ZD@-I3-:?CSV%*8U/PCS#)"6 MKC27O&Z7[UZ80[M7('SNAAZ]_`B_/WV^H&+$!ZTL5'17*(ZV\`I$M7)-J+7> MJE\F:KT+8%W?;$T3FP>YRS`?Z!/*Q7VX"C08)'FVA+:Z'@N0"C#2MW*-_A"H MS/Z9>.\FPDDA:4&S>$X06*Y1#7`\+-H&V1RS$JL"STG%WIVK`8[W2"5,<4(K M'#A]N':E_PJMHB2H"(7[B$<>-XHF!]6CHT_#F?'L@]V`9.EH\5>!(12YS?M; M?%I7IMVK:6W:.;UU)%W,9**@)!2)FZW;@8[Y;:NG#P\\+RO+2A?&RG<`'T5Z MJ!I-;(H9@'KSV/,]@5-CX&6JNQ[F]Z`3%'FD34@6`#-TC\X^V=,"PW7DDW?B M/\;7:9JO@XJ/\..2;8N*.&@,13G>_>T_U+72AVMX,K32[81:`Z`P%/>RUSTX4HOBT*9_ MPAF,_L4\M68UUZ-7M)OIY71&+V.W9[&+]D'I*)S(9HVH%4,M*\S8&^%V@_$7 M!#HP"Z(EXEN2T;2#YG%U0^O^-@'R+%&>"+`V,I;RI*(U89ZH<@/0;11^,+%: M&4E/F@CQQ'M;SA@=V<]DTZ2F2BX7%)YX;&N9HR.K_BBNYG<)VNTVRLQ1%4,4 M[=SU&P%EV+^EU&C\U<7M01A[!\N`9BB2V$H5 MQ0M"9L2_"-X"'S:GZ6D&N\\GV%^#<3_&U5R`Z^@\CB+B41Q_!-GKY>R)^'17 M3MPL3YCON)G^"=`G@J2^IJ;2CE::QAI/%E86P0*6$?_1_".=BYM\T^?E>SF/ M<4E?RXM.92W0P]X]F>>)]^JFI+A)N-0)%:#5XY?/BJ_4<4:BXO45-URDLZ2@ M"9EMVNR3,T%0QLJ,,=M7HZ'(+`9/:F4%.7V#D_UB4BBE#2]U2N_8>JK+K+PE M9S"VZA=M<2%6!6\JYFO]69^=/!>*$0;6,IEBM>N*?0F?<%W*;TV#4]+G`/LVS-',C'_2A;BWU&@2](GB1QI01-=%! M>R5;]^RG9JH/664#D][JR:A&-0.3R>MI8;7%.B:[6<46``@H4M7%*F8/.1$B M/)YJ+#>3)B,4R>$BTM@T2R#A\6C;NV$TL>OS5F2*,XHY<%#ZPA](0O/"QXKW MA:0R`!5%RB2/!,8Q7PZG1W>$=F8K4:!#+@3Z09$1KS\)RS#UX:+,#L:%)VIY M+X[XDE*;8EE0$XH4`1F1BO2SX9F_ZK+G`\PUX(G`O&"&LW="677BHU0Y0'Y( M$4C!*7-L:U"MN[6LT"@[IC"_!P`HYDVICMFC1X`)SSFEY8R:,8H=JH`)A02: M,7=;VJL$FK'5+2E7\[($FC%WZ]FML@1K&U79:^Y^#(I`<7U&>:C)H!@Z3MA/ M-%\#O'=_?H>3#Q*6)?@0I$_8]@.KH(H M2%^)_UL<^_J&P)=V!A,4=UMJ6H(,&(H':0V;`L!4X1P^`QV@N`E2D]PU`E/7 MZ+>B[/8.C,CB7.9/D9.MC6'G3I$39#LCGHYU3I$3_A:I6]&NN_PI#+S?LR`L MKGNMT4H"7B(Q9X)LJMQECDVU'!2>8ZAYQI5J" MJD9<&U[5@YU&M]2UL!L"BV[IKLL$>S-NX^;.\K4"G``F[AUI$]^2Z6=,8X M`NO:K+*-0PEM'W;_=!N[I2OIII\K`VI!$2!68H]-O`1;'W;Y`NVH[/M5Q&%H MH0B"M#\;;$'NPXFA@G8)4]4>EI_#8$%Q$E0G3H'X"C9#&_DY'"%B_R%SD\Q^ M$=HMH*>>E^1N>.K_/4\SR6E021XTA\(1V(95<,#V*$AVYWY07"D<\BH*$'D' M.2*@&Q0^P::&(,;7-+16K0*`;GK07Q)0W'QI:4G@7H'1OK"\6!(NHS+C^WYU MCDYFQ+]\GY,HK9>#*W\KKOH;&B^\L06=P5&-[%K>!9--.=#%KZT\70$1OVDL M%81N(J@TH:;,Z@#0P8?'5=)R/NV1_3GT5IB[1&^Q-HCA<3: M(^N)M34F2Y%#05T8P-LO2U9KG.EB1)!ERV'YD7BO41S&+Q]7A%_$J?H58+)? M(TQ#^PSN6(!ZE`2[5,E=$C^3-"T`49S+P+E@BR\6=`;']LL7U29>!Z.A`[[] MM/@'-RQ"V)?O7I"21_<=#K=T5I.;@D02]&2_P$QC6U`"B>!-*L[LO41-\Q'R M,(.3JV@29WX,9V+[!Y=F<[D`EZ&S>RMU05?3$%@%K3T9+D,7TZ
"FT+R-2 M(`GHK7IES+$J!8FB=!B'XG/X)/#<\"'+_0\%8GG?PS1DOR)<,SK%T-JKT65N MH%X1Z!2<[U8KA61T;G\.UFHUD\+H=G91V, M/7J_J(85B)33X3E`$9ZQ5X'LWCU;YKX^O!*2I7>%6E])1IK M((*.!6YX%Z?%E3B%O%<5<6#OR-HI==4_:59KY4/H,HI\H9@P-LL\.#B#.D5]P65EL0#L M5[_6HD38F0Q0)(3P:&$%) M8K7\CYW!-Q3#N,9JNX7!?-E$"TF:%8N%T\@T*>#Z?W7#G*S*>HM2-I4:`(6A M&-T\*MG$ZV#KT2,V5=C+=WWR[#5.@G\*'Y00"X*>4%SV:6(#;$RF7IZQ[I-B M@;U.TUR;]840:`=%^6>#:@_\:<=J-*% MGB/A#$Y0W-ULR'09C+%($SZ6U99WD1BH",6MS(9\[R#BD(XAEYJU,;D@M%*0 MRW[B3T'*F>`HSJ]&HS(@#HL=JIA$+34HK@33_-'S.**9AR3R3-8JE=ZVT^V$ M^G6\NBW#(!T9&U""3FQZ*KRXI]X"=-Q^;H8I_3-&I:XF[,:?>3-L<8F6$T'> M^@)@6#WV9KG*+_<995CW*G@C?R-P M#)Z3Q*4F=D/RT(HS:OB"SGC M(Q2^'S%QZF2741F*Z%JENTBIOXTC;Y%'?9JF)$NY$[R"%*@&A?-'1AZ;AMKW<<-<2JU^45BSG!P:,Y9PO@A MH1.9*P#=0K'-DJN.Y2<1H^K#_2/ZJ,>B;"NM_RTY..]^#(JP?V26T,2>`WE8 M\)2!,T7JN9N1%YKZ49`B/3/)A9W)`$4V%(]"%<+YN'!ZKQDF+CTA"84`K/W8 MC];(5<5DMQ*]X,R[S-KXPTT2E]9.WH4B.NO*I4%I."G=(HASK%4%B,)YS:&Y M!K4[?-4OYN4D"$6=B]]&H!O1) M49GW*>^[TG?A,H5#<*E(Q_+$Z)]F:ZU-HWM"G:QPU#YSTZ"EBN#U^J)1.;S9 M#\"\>V)K+[ONW-E'V57^6Q+G<^BGK!J&BK@S'-JOV6F8+/8>6%T;>,ZV[=8Q M'PYQN2>DQ%2)Y4+"+*RC6M8P6FL(QV!!K;73W)(&5:&H!:#,JOKFDHG45"(8.JM(U[XS M]25$(.X,<;SZK$RLQJ&#"=54FABB729K>EV7*MZ4/74+T,+@NZFF0=6==DZ: MU4-_"I8L'/R,P)Q""J!4%I2%XH5I,Z2S#4I1"::*GV#8\)Z[Z2O-^H4_+O^1 M!V]N2)33#+3;`/6A\+DJ\LPV$DVT&(JFM#R]K%?R.O/+6AC4A<+'VL@X5&&: M*L)BWRI*P>1Z*X]:`Z`V7/[6%I8?'4UP#$C;'=O:1;SVDQ)'*)RN.J0Q$J)T MP'(XW^MKF/N8-%36$\460'$HG+'UK:068(ZE&'#)[OLIJ-#U?J3>*_P]7;B? M'^/E.%DIY(.JPG2=+ZW?E>7+U6H,B+26&U?W3:CAV'Z^6P-ELP<>"R.>++;Z M)-^[T8OL8M;Z&X"-PF7$(H--VU;7\>2M-61,ZE-L4A]_QH^O<9ZZD7\5 MYTE&2#1]AMX`UM594ERJ3KD!4`**8U2[)#..YYH:0I`C)[>5Q]>@F:V(&P!- MX,IPL6`K*AHRE$-GWYG3]+F[X1A%[HOZKH:'P5`>G-7M3%$S_BX)/.&Q?_V1 M,YR@2%#A4<(A<*O_O2ED5I[S\MDB]'#Y3A(O2*6D2F6=R2&*Z*T>UXJP^E2: MC`UY3CSZ2E,<`E_4"78/6M0V!U8C,(90>!E,V`4?7Y_>LF)AOP_2'U<)@3T0 M3&,DS6J8!ZL)4%Y/)@T^.E,99%A-8S4L'DDRJSEC4%%0%HH$#W/SQ`95GU+" M1(@O@K?`)Y'?8/$H-P'*P^71;&P2N^A,)8!9C\4^Y+.9FWQ,G\]?J:L^O8XV M-2.>S^/9W(T^EK>#UHDPI:AUSZIB3HZ-^68$BA46QY3)02=Q>6*XBF1X4]3` M]2$0NYY\:#II]D%'4AS1G%))G$@H!^JQ7UE8C4.)DX6/K@\QW2UTTM@/\WMG MB..1"07.V&0+4/4A"KQT_TI#]Y7O`#Z*E`L!-VPR&2A0O/:$,J)_9-5UTGB6 MEB#K5>F0/@3XCU`X8R16L^\`_Q'7AV.Y;&@IHGBZ&X!6CM=R90$Z"H],N]2* M0[42Y:"H=*)D'MLQ9QWS8,N"!E!X9RR;AT@Y*$J?Z+L51)%Z95G0@/TJTG4V M+YH(^UK!Y(\@>]T9,VEUT*35(5;)H%=R`)O\/:##?AUZ=;N1;&/,:\94#'M> M/`L+A_DD,SLC,>N`J(#G8-]4#]]4%.?-:/OX;6=R:/\A^[H&NF9KR,OH>^I79#%GRW,MEJ_#S:#VJ/\-<&0!B?P?5@`+VH)7`Q1/$;OE-#+M/92NR M4:60BP-/\+FUAS".K;IWN)K?)6BWVWV(&K/L5!)HY(F`4E#FJ@^G"' MF(7PAFY[$FFH4"8*2D*1`R8F49WX76Q]B#$_Y+!YI]5TL\LWHO1D,D?"&7Y# MD0E4:Z`+,=D-T+9&LW2`&1PZ:2":)/EUZ9FT6%@@1".5!3O\Y-6\CZ\]P""^QW]SV8Y;.S M.$GBGT'TR;Q07Y"F[CM(LR6E8K0B4/0`&UY]&Y=569!FJ M33C#$[0'=27ST`/:WB58`_&[>P(P`GI[ES[JT,TVC:0WW%CP&P(UHBBI8G3QD,$U]:3!MM7L M^YH\K>7_&H?0^W1Q=VY_^0=W^5,8>*M$]>)6_NIU@=/(7R7@- MC2Y)C+V6.DQ#B1#=O)$\.D011#5&M`AF=ZZ>7P7/%,1UFN;T342M`9&\]\E)AOD+,GI5HT,V5!>RA"Z<;G;19,0TD3^QO.M=9GEJ@S/NGE<&:A M[%-*13N%"4>'5HW!Z)E,#M14AD4/BA2.#E$$Q!5(8[,M0&4J+Z*#50I'`Q1Q M;`$Y;#89*/I4Q+LTHTD)W?D6U('"4Z)-*@<)CNP#PXMR4LS_,T%)=0#]3M`0%*6=RB"(\K4:_,B`.YSA<8XO>GX[UQS-; M!B"C<(9I#V$1'$ZR2">]7G>A&U'WH&1/7?X,IB[[E:4,;:-W<7'([98+:P5+ MNFNN?@@:0)&(N\N*F+UR[SG\[(&C`Y%H'C M8DZQ>#W,PR#C+,:,KT!/]BO(-5R+N;`X;%E.[]KTE+NZ,K\#3/93Z5EJ%K)1 M[CN'C\Y7I:E9?&@T[$]H5P210WNW*M28+48T&J)P00II4V:ZC(G#];YJUS2Z M\W0C>^9#LQEG-.K\.;<^;HXE[-E-9:KZ3>P1XJ=7H-M5LMHT621(+:*NHB.R M5!@4UI6XXA;)G&.U(F+.#1QM/YA/GH.HN+'W6Q[X]-HXQ=;`X#_O!=))X04KNDL#3?TJ^)`O* MLG^*,&@JBH`YUM'MYR4JD.>$EIOX:QP"DT7]`#?3-Q16(Z#`KMS:;6`Q?.0< MT^EDGAL+^WV0_KA*",RO,/61-*MA.*PF0'GVGQ]KV6SXN#E&T]$<.E`7W<<1 M_R*G>ER\X_/P"OI/I]FK.#XO%0:%=<4/HF0HJH@Y)J+MG41A(A2<;&^R^0@4 M8/]Q+).4;R'C4(OCUNEO29RFM4ZT.N+.:-P5YX>08GW,'/*UW9WV#R++I)>E MGJ;)??#RFMWF-!PV?7Z@+V3!H9NDYVX8$O_L8Z7/Y8&XV;^"N)CI1*=E:[8$^>W5( M;:`$CE%U*V^Q6F:WE$)_1B+R''B!&R[^,0685\3-Q%[X.LV!-GMUG*VO`XY% M==+GREE;"X=0@QU)5=X93;I2@*W)AH0%FF,KG72R"O=AF[%"5;L>3)M-?MUM MK;1A4+35ZXQ[W>XJ:H-C=MTJ!,B]*;90Q4)%O\_C:*,4T3Y*OS5G?-RK>:NV M"CCFU+%;TZ6A4T*]5`KQA9MPF2SHJ5>[(T7`',/H5N;KY6P>QA\$)M'D#4X2 M!=(S-R5^.5O^EB)/`?GI3S?QT\5W&R_"?ZG6B:W&]'@,%>A&)L M:H]C_]UZD[.ZF;ESDVE2U!99G,@`?:%*82JK2@/.^*17T5T=U!P[Z=9CG^MW M,")_X2*'X2@.49BN;C`*K/E M=]A#/<;W9)XGWBMLJ$ISV@:C,"BKWY(SL5L1T_!T40\^QRPZZ?UFAB#5-A`R M46>"X`9TV]':';P^A?LD@/F&$:W_,PBK-SMA[HP:*I7ER55$7-L8U\N7.YKTEF>T""M M.P\R-WR,EYJ@'5\^"WN:94GPE&?T$BA-OB[MJYZWME/T.$[H6\O^Y>R)^#[Q M!5DJW%VLS3XY$[N/^1C=#]M7),?HF_AM]_Y`\K+Z,^P4IW.2%&VG>B\AFYF7 MKR/H%%GW1_`$LD3"&4TF]A:796=X+QRS/X0NHWA[2:A1WOJP"P3/T\,I\;Z\ MQ&]??1)0$L?T+Y2[<8D[^"?GAKRXX664T0?"V>66&%\!6!35"ED45,GB=A[/ MP\*J3"T0<(LC;7\",*TN>%S-[Q*TV^U>O"&\,LX;0?TC_L>@"!RUK*1C3(:A M#X\"WY,W$HE3D5>?.*,C%-7Q>72PR:OVWM#[O?:OO-%TA.GS$IPPP:[T'>@` MQ<-#>@PR(!AZI-<^C:N+PL^!:%M<^@KPHZB8K4?A#@!#C^]F-$O'*H'+$U;T M0BO"1"D<.N6G'*X,Z`;7`T)*Y$K@&'J!U_Y8O0J/7/K.K$GLP214UU!9(A;$'E@"H!9>W2HE?$193K_4BF)GSI)A',4.DJO_W,30./.@Z" M,,_$5WK%DJ"H#CK-E$"9>JW77Y>^M_[>`:$IR\0_?8,5ZX6L2Q92%92R5M6- MHUZ#H%X47C<]FVF"M;U'@"VF-Q7O.X3Q3RO93>N.E/JAX/P7B0%51];\FW7S MG(Y1N#?D:I7$]DMH_F62G>R65A%14"6+V_E_@62G8ZON!Z[F=PG:[?:?R4Z@ M++M58]3'F`Q#'Y*=X(!%%X>[)'X+:#;X![UW>1VMO:&G7A:\+2IGQV#-44Z3 MV=7HUA[TV:5DWOQ3<4W@N3C"IY/+YQ/1Y[?@G# M#/D;!UU*+W=[<>0%(:E@?HP5-:PP^;3Q<\`)"N=*^Z;8GO9,Y;I9G\PN"/38 M"Q;<1_[I+$ZRX)_%_Q68I4`*](/"#=,>]VQ;DZJD-SES[%IKHBTT4P"T@B); M:M^&(M)&;S+K5E%,#_2VT*-Z''='!G2#PA^U;TN1**1Q1AZBB&!+L>!O*)QA M^[8;!:682N0K:]1V'`JTF1"85R_(XL^2_I9WS]5N*RLV`HI$D46T;^O2U9"Q MQ$+KB]HN\E//BW-0/*B=!&^2((N*N#,Z0>%;U"59U51XB!OG*"):RW917T=O MH/,X$;_L(90#-:'P'[9E&#M0&ZN1^UEZ2E+*@+A:^P[?6H`K=QJB7N'4N20_\# M]RD(%WN^Y?A8*[3TWW1-1Z-I4#4*/V&+EJ6M#6.9H0@-;S4KR\L;2&5!62@\ MAVV9#A.NJ;Q1^[;1+.[36J0>U(SB]N9>(K2-]60J]]1^$CM'&]?%TS$M)I!H M_@"H'843W$@"22WLG,1`[1OH&-((8+^Y]-B=>O_(@X2`A@!V]G$7NA&]XG<) M_UI47A`8EGHCH$`4GG"3YL`V.%V=<(Q*W1&.Z"383+NMS6"@:!2.\O:-SX2> M.`;9P7OX'&U2TNK)H_X(SMODIE=&&MA9UC63U^@HM(TW?Z*4! MR6GRX(9D^DRG_NQ#M*!*A4%A*-SP)NGG+*2*NN`83P=+#ZRV#L7;CYL"Y'*K M$DT`RI$X<'7VSCI(^0820?K-;"QG$X2I(/ M&!ZR%Y>4Y$%I*+SS)LR""8UC#]J>^/GB=9[,3;)_":M`X5UOQRJX#O&AMD-\ M8167D=W=S4,^GX>%GMQP=??^.GJ.D]F",(6:"&HM@/(ZZ-;6`L>Y,KW7RJF< MA[>*UYQ6I[L'DF4A@3408`5OI'P[8?H4!B^\:QXU6P+EH/!):W%9-8=&R#EF ML6?/,\\P2DI99HY3B/1%V[O0]1;O#KV0PJ.^<&_&24HSL&".S,CZ$ZZUF&D> M%(G"L]S8A$RJ@V-7V@YDZU6!SO(4YN*4YLW0\D=I\1;<^D=LE`=:9HO1EQ7C M,/`4K_!RA9SQ8&!K@5\I]X*D7A+,E[<6&7I^!/+.H",_!!#U&P/H*-QB,G+8 MRW]=O(:*$%D?F7192\@KK&RPQA55$*S4Z@*]+A^07#@9;^.,*%7K$@D"4V-K M)[&R7A?7=VC75(:@3!1@(3F5RY7/.8LI(>S+$+LE&1U8=R0I/9=J8YAM%[54 M&&`\$6#HV-;0VNZ3RICBR@`0%$<7L:+9PT@"JB_CIWSERLHSN8N?_[A8EVE5 MNGS*E7+&PT-;8X?1+97A(Q(#."CBZ%*-LP>1'-J^Q]%?OM*./KDI*73Z_P%0 M2P,$%`````@`X'M61U)UV&?Z#0``@9,``!$`'`!N=7)O+3(P,34P.3,P+GAS M9%54"0`#=#DI5G0Y*59U>`L``00E#@``!#D!``#M76UOX[@1_G[`_0?6!8KM M!\=QO'N]I)L[9/-R")!=!XFW=T51'&B)MHFC*1]))4Z+_O<.*(MP+?,KGI[VODZO^]SWT MXP_??O/Q3_T^^HEP(K`B/IH^H0NL\$1@[S>9R*/AP?#@&,'%T;`_]E3_Z'#X M`?WK\+N3]T?OX?NKR?H#YZ?'P\\$&#,AH.O&")^GU=C_069(F1 MPF).U!>$'*%/7+:6RBU.AD,M!PGH0B61`FZUH(#7(;EU!2-'YB&ZQ\.^Z-A(N(%(5?B*6NC M)-[!/'@8Q`^UV&A'+!0"NJ%-+GZJ!=]G!7U"BV7@04%QLO86Q>7UDP)[*'\@ M4A6+1,\*K.&8>K)8QCS2(L.LB*1>L0`\*"@.!*BG%9&%U)@G!;9(M1*62N!) M02T^60GBZ?%O[5_'`RP\$3`"",`!D/6*88Y5()ZNX/>F00+.PV6Q$E^)@48\ M@$)]*$4$];8CMU0H%@!/@M!'S'D`+@9@#C2 M%U_OKIW>P5AW$7BA]C1GW+_DBJJG:]`JEJ:N'J+00,X2F_H3!#Z944X-TN'A M$/QC(IZ^!%4HTH52RCX.=C5\^\VN^E`2?\Q_,-?`H01M1E8[CE@^+N*6W592 M5]+#S`N9M=)8;)"A(Z6R*4^?,-/.[GY!B)(1,=E;;B:.H/GOH:E(3$4LBR+A MKN6KMOPM!H>M%D110%-`0_:YFY.1DQ/T+J/KKQU'#HXVS2C'L_%*AW8`(!XF MEF=N;M[O<+-5@H(9VJKI6*G(RCF6BRL6/!:0LGWDYN2#DQ.M!1DU'28 M@[#S8`GV+@B7]('0/G;;EK^MDM+1@'2&CH:'#1\(4JWT2T1T'#+@-\O M8':.J"A^Y*;C^UTZ0(DA`8$:%.E!1E''BH.5:UBI>)D/C:?X#S,-7KI>%:_TIH*"GC9&9XN,M,K`VEU9G9)%'8\>6> M0)94F3@).#@/8-W-YX1[FS'C*N!F:E@PJ22J#$$991U+#I:N,!7_P"PDGPG6 MC6G:,.*G^)&;F:-=9K029+2@M)J.$]?($<2GZ@I[E%'U%`^6[#TW"Z/<^##2 M*!'O6M^Y>@R\WQ8!\XF0E[^'&P8*[KM9>+_+0EK#7_X\.OX[BO1T=#1>.-X& MC&YGE(IEW;1]J+^01.\2W5VZK/9B9H*G+"'05<#-6F[Y;UW8H'>1PHZJBBN< M-$'YVVY:Y'U\0A2FK$H"XQ)TD'^52$Q5B$AB\F_K2K[O1NZC*KB/4 M2G^7T;O?K,H5]2D+%;1G'&KJQ9E>CSU@IOWEY=ICH4_\ M*Q`^WX(*T7#Z"9Y-2*P1H10DE&!" M,P"%4JBTAXEQF>@Z0E807W<=L,+^)Z*(6%(>\UVX\$GWI1KEW=TBEQO*:-8< M.U9.';,-%[FELT=M*3?+N=R3G=1N(MF'[=1Z-DUG_K:;KUS2*;-.[HBH143I M8*M8UDU9+N.4IJP;5/MP>1)]BE>!N"YG)@NXEM=\%2HY"7[&`N(:M8EZ=`OG,^`-!-T] M()?',E7T[Z,Z4%0)4@&*JTF%99N*.M(K[7P)ETLLGL:S\P6&F13XVX[=F4Y! M8_XD;R"\9:,KRB'$I9BEQF"Z&SR/*G?'R&6RXDIU>.Y%U2+*T4Q[@X?(&\"# MJ&ZS_48BIA&@$9HE&!!+^92NT]3>K%8>'%8N[B8_E^#:V>+6107[N8+<9K=2 M9NN)N-G-I<-L6^(0[,D/FW($3_4GW:4_2Y8KI\PK,O84@L].> M/L.AGYS3\"L8?;!>LJ2(KL%Q`H+I(;OM%%>?BP!*@A41VMD.$O`] M-'A&PX"1NH9E26RG60Q/ZYH%(H2UUR(8`'4MVADSSVM7--[2IQW`K_1I".86 MF!4(A7CA*2NV8T.B`UIN`L^HO7`;&UL1Z( M1*X!B.)#62I6GPCH>C]4K=%YJHJE8E-IH>"`,"63._VMJEKV.TXX<0$J$(NO M^UL5C8`4G1Q3!4E:+OFQ-Y:BTV@J@4D+;G[UMVH:PO>Q1%4AI;5<;I4T0.@\G*I*3TED M]$4#G^$^/JE2@^Q*[JG/XD@7"654%`?K9-UW/MK-906$Y/-OQ=$>H*NC(S] MBZ>G"5FK3PS6SXG9T>EA)RJY7V3Z##/Y0K8WAV]ICVNN`.!RFS!HI]WE,"WV MI?:.QCENF>W!\)0H+)YJ&10M+%3>GJCH--K2<-KS3&*MNIF%:"V6Z=,?_9"1 M\2R5'CZ3,ERN5`CUR*^2^.:[A;:1V0BYS65M>D2#[P=:Y-.>QPQ+(XW%''/Z M'VQW%Z:U7[T9?'6R`$GAA5-RG6V0RI!MXSZ4*H#)>,S)9[*<$K'3]_U@B2E_ M79(+,-D(4PNSF77[X4*T85SO0FT?5>5@&YAY`Z-`5R3_^,%9$6:IAWJQ;QK: MZ,=>P5A;@U?8[M^Z050#]!YFMVA0U81K-1I^^1?T@?J$^_),@2734)G8(8#9 M8D8$A&"FYUWS[@C3^9L$ MP"?"R8SJ?0(`,#ZS_8]H^KHA^1_;+N5S2G:?;RMG`AO$TH5-+)G:W-(ZOUT! M;`,S6^2G*\*T&#DAWH('+)@_79%G&>!6JQ9W-.!)!MBT5&N3ZP^UZ%_M/;L-8.N73*J/N-01OG ME.8V./*$%H7;6ELW^]1!;3'\UD`[6]/7GVO`,)\N]8HZX#N&I5$Y@5^8/$X+ MDCM9.!;,FWSGEIWVA30.D-63[`5*VNQ-*QI0'HXW^YRCC2YV;U-L;^#J?.70 MGH9I"-L6%S\&DT402LS]JR`4BA!88L)"$\^XI^#%,IBO8W_YLK/\ZZ7V MS/8-85MSZ]H&3Q%?_\6C\X#IS(3`[(8H^%__.:68TE<+D&N^@*AL0&DON`VG MC'J)LTU[=2&_%W$I8;=;J M,O\T-+8K@:P.V&`YU2'DK`H\07^J7[8DO&HM[ MK-]2)G]VI+6;.2I;8'U9%4AHPEN(QZ!PM*U@TW6AWX(-YN;SQ(W5WT<5H7*- MO,3L>X@A]?K#@^?17K'-:?G;]UIM7E\UL<;]`O:*^#JZOEQ[5)()7K/K^!12DYFPMB2K5F?JR(TQH)/!#^%LRL"K1Z&OLSYGAN MRA0.@M98WAQZ]23W&VR+FM#W>9O>HNBD+EYK,G6UBFY@%HEX@_B2X9=@S M3\[FT:=KU^9;]$#(:PZ3Y@-69%.DQ<'+LUE89^'?\HR[!:4MK7!L_*7!2SFZ_3@E06/%0ZMO)-^)O9[=OF MJ+6)-4ZRWTK.8[_LSJ>W8F8Y4(N=+[N#YZ4FIB;;=HHV.K4H*"F!9S'J2ZC9 MW;Z9VXYL?\59QHK/'!,F7DZW:)I(#56G&CWSI!9%TSJ-34?8D9>_4 M31D^^W3HAY[2.2MY1^<+-9Y%W\I,B%AFK4J:^]5#&"?"QA]+M\A'U`*K#?XX MB,X2,;;_'U!+`0(>`Q0````(`.![5D=0K!/?I9D``.&/"0`1`!@```````$` M``"D@0````!N=7)O+3(P,34P.3,P+GAM;%54!0`#=#DI5G5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`.![5D?LX_2Z00D``(]\```5`!@```````$```"D M@?"9``!N=7)O+3(P,34P.3,P7V-A;"YX;6Q55`4``W0Y*59U>`L``00E#@`` M!#D!``!02P$"'@,4````"`#@>U9'Z1XR&UL550%``-T.2E6=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`X'M61WAUPLF;10``L-(#`!4`&````````0`` M`*2!%-```&YU`Q0````(`.![5D`L``00E M#@``!#D!``!02P$"'@,4````"`#@>U9'4G789_H-``"!DP``$0`8```````! M````I('41P$`;G5R;RTR,#$U,#DS,"YX`L``00E#@`` ;!#D!``!02P4&``````8`!@`:`@``&58!```` ` end XML 48 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

Rollforward of the Liability Balance for Severance (Detail)
9 Months Ended

Sep. 30, 2015

USD ($)

Restructuring Cost and Reserve [Line Items]

Balance - beginning $ 148,921

Accrual for severance 0

Severance payments made (148,921)

Balance - ending $ 0

X

- Definition
Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_PaymentsForRestructuring

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_RestructuringCostAndReserveLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringReserve

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of (expense) reversal of expense related to a previously accrued restructuring cost liability. Excludes adjustments for costs incurred, costs settled, and foreign currency translation adjustments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 40

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6394291&loc=d3e17658-110867

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringReserveAccrualAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 114 163 1 false 37 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.neurometrix.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Balance Sheets Sheet http://www.neurometrix.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 103 - Statement - Balance Sheets (Parenthetical) Sheet http://www.neurometrix.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 104 - Statement - Statements of Operations Sheet http://www.neurometrix.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 105 - Statement - Statements of Cash Flows Sheet http://www.neurometrix.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 5 false false R6.htm 106 - Disclosure - Business and Basis of Presentation Sheet http://www.neurometrix.com/role/BusinessAndBasisOfPresentation Business and Basis of Presentation Notes 6 false false R7.htm 107 - Disclosure - Comprehensive Loss Sheet http://www.neurometrix.com/role/ComprehensiveLoss Comprehensive Loss Notes 7 false false R8.htm 108 - Disclosure - Net Loss Per Common Share Sheet http://www.neurometrix.com/role/NetLossPerCommonShare Net Loss Per Common Share Notes 8 false false R9.htm 109 - Disclosure - Inventories Sheet http://www.neurometrix.com/role/Inventories Inventories Notes 9 false false R10.htm 110 - Disclosure - Accrued Compensation and Expenses Sheet http://www.neurometrix.com/role/AccruedCompensationAndExpenses Accrued Compensation and Expenses Notes 10 false false R11.htm 111 - Disclosure - Commitments and Contingencies Sheet http://www.neurometrix.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 112 - Disclosure - Fair Value Measurements Sheet http://www.neurometrix.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 113 - Disclosure - Credit Facility Sheet http://www.neurometrix.com/role/CreditFacility Credit Facility Notes 13 false false R14.htm 114 - Disclosure - Stockholders' Equity Sheet http://www.neurometrix.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 115 - Disclosure - Business and Basis of Presentation (Policies) Sheet http://www.neurometrix.com/role/BusinessAndBasisOfPresentationPolicies Business and Basis of Presentation (Policies) Policies 15 false false R16.htm 116 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://www.neurometrix.com/role/NetLossPerCommonShareTables Net Loss Per Common Share (Tables) Tables http://www.neurometrix.com/role/NetLossPerCommonShare 16 false false R17.htm 117 - Disclosure - Inventories (Tables) Sheet http://www.neurometrix.com/role/InventoriesTables Inventories (Tables) Tables http://www.neurometrix.com/role/Inventories 17 false false R18.htm 118 - Disclosure - Accrued Compensation and Expenses (Tables) Sheet http://www.neurometrix.com/role/AccruedCompensationAndExpensesTables Accrued Compensation and Expenses (Tables) Tables http://www.neurometrix.com/role/AccruedCompensationAndExpenses 18 false false R19.htm 119 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.neurometrix.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.neurometrix.com/role/FairValueMeasurements 19 false false R20.htm 120 - Disclosure - Business and Basis of Presentation - Additional Information (Detail) Sheet http://www.neurometrix.com/role/BusinessAndBasisOfPresentationAdditionalInformationDetail Business and Basis of Presentation - Additional Information (Detail) Details 20 false false R21.htm 121 - Disclosure - Comprehensive Loss - Additional Information (Detail) Sheet http://www.neurometrix.com/role/ComprehensiveLossAdditionalInformationDetail Comprehensive Loss - Additional Information (Detail) Details 21 false false R22.htm 122 - Disclosure - Anti-dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Income Per Common Share (Detail) Sheet http://www.neurometrix.com/role/AntidilutiveCommonStockEquivalentsExcludedFromCalculationOfDilutedNetIncomePerCommonShareDetail Anti-dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Income Per Common Share (Detail) Details 22 false false R23.htm 123 - Disclosure - Determination of Net Loss Per Common Share (Detail) Sheet http://www.neurometrix.com/role/DeterminationOfNetLossPerCommonShareDetail Determination of Net Loss Per Common Share (Detail) Details 23 false false R24.htm 124 - Disclosure - Net Loss Per Common Share - Additional Information (Detail) Sheet http://www.neurometrix.com/role/NetLossPerCommonShareAdditionalInformationDetail Net Loss Per Common Share - Additional Information (Detail) Details 24 false false R25.htm 125 - Disclosure - Inventories (Detail) Sheet http://www.neurometrix.com/role/InventoriesDetail Inventories (Detail) Details http://www.neurometrix.com/role/InventoriesTables 25 false false R26.htm 126 - Disclosure - Inventories - Additional Information (Detail) Sheet http://www.neurometrix.com/role/InventoriesAdditionalInformationDetail Inventories - Additional Information (Detail) Details 26 false false R27.htm 127 - Disclosure - Rollforward of the Liability Balance for Severance (Detail) Sheet http://www.neurometrix.com/role/RollforwardOfLiabilityBalanceForSeveranceDetail Rollforward of the Liability Balance for Severance (Detail) Details 27 false false R28.htm 128 - Disclosure - Accrued Expenses (Detail) Sheet http://www.neurometrix.com/role/AccruedExpensesDetail Accrued Expenses (Detail) Details 28 false false R29.htm 129 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.neurometrix.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 29 false false R30.htm 130 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.neurometrix.com/role/FairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 30 false false R31.htm 131 - Disclosure - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.neurometrix.com/role/AssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 31 false false R32.htm 132 - Disclosure - Black-Scholes Inputs to Warrant Liability Valuation (Detail) Sheet http://www.neurometrix.com/role/BlackscholesInputsToWarrantLiabilityValuationDetail Black-Scholes Inputs to Warrant Liability Valuation (Detail) Details 32 false false R33.htm 133 - Disclosure - Summary of changes in fair value of company's level 3 financial liabilities (Detail) Sheet http://www.neurometrix.com/role/SummaryOfChangesInFairValueOfCompanysLevel3FinancialLiabilitiesDetail Summary of changes in fair value of company's level 3 financial liabilities (Detail) Details 33 false false R34.htm 134 - Disclosure - Credit Facility - Additional Information (Detail) Sheet http://www.neurometrix.com/role/CreditFacilityAdditionalInformationDetail Credit Facility - Additional Information (Detail) Details 34 false false R35.htm 135 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.neurometrix.com/role/StockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 35 false false All Reports Book All Reports In ''Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Statements of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. nuro-20150930.xml nuro-20150930_cal.xml nuro-20150930_def.xml nuro-20150930_lab.xml nuro-20150930_pre.xml nuro-20150930.xsd true true XML 50 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business and Basis of Presentation - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Dec. 31, 2013

Organization And Basis Of Presentation [Line Items]

Cash and cash equivalents $ 9,116,806 $ 11,687,021 $ 9,116,806 $ 11,687,021 $ 9,221,985 $ 9,195,753

Deferred Revenue 680,000 680,000

Deferred Costs $ 425,000 $ 425,000

Minimum [Member]

Organization And Basis Of Presentation [Line Items]

Product Sales Right of Return Term 30 days

Maximum [Member]

Organization And Basis Of Presentation [Line Items]

Product Sales Right of Return Term 60 days

Customer One | Accounts Receivable

Organization And Basis Of Presentation [Line Items]

Concentration risk, percentage 30.00%

Customer One | Sales Revenue, Net

Organization And Basis Of Presentation [Line Items]

Concentration risk, percentage 11.00% 16.00%

Two Customers [Member] | Accounts Receivable

Organization And Basis Of Presentation [Line Items]

Concentration risk, percentage 51.00%

Two Customers [Member] | Sales Revenue, Net

Organization And Basis Of Presentation [Line Items]

Concentration risk, percentage 31.00% 22.00%

X

- Definition
Organization And Basis Of Presentation [Line Items]
+ References
No definition available.
+ Details

Name: nuro_OrganizationAndBasisOfPresentationLineItems

Namespace Prefix: nuro_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The term represents product sales right of return.
+ References
No definition available.
+ Details

Name: nuro_ProductSalesRightOfReturnTerm

Namespace Prefix: nuro_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying amount of deferred costs.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredCostsCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=nuro_CustomerOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=nuro_TwoCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

Summary of changes in fair value of company's level 3 financial liabilities (Detail) - Warrants	9 Months Ended
	Sep. 30, 2015 USD ($)
Summary of changes in the fair value [Line Items]
Balance	$ 5,307,332
Repurchase of warrants in conjunction with public offering	(943,423)
Change in fair value of warrant liability	(3,473,804)
Balance	890,105
2014 Offering
Summary of changes in the fair value [Line Items]
Balance	4,233,729
Repurchase of warrants in conjunction with public offering	(943,423)
Change in fair value of warrant liability	(2,625,305)
Balance	665,001
2013 Offering
Summary of changes in the fair value [Line Items]
Balance	1,073,603
Repurchase of warrants in conjunction with public offering	0
Change in fair value of warrant liability	(848,499)
Balance	$ 225,104

Inventories (Detail) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Inventory Disclosure [Line Items]
Purchased components	$ 502,952	$ 209,426
Finished goods	569,210	470,314
Inventories	$ 1,072,162	$ 679,740

Commitments and Contingencies - Additional Information (Detail) - USD ($)	1 Months Ended		9 Months Ended
	Sep. 30, 2014	Aug. 31, 2014	Sep. 30, 2015
Other Long Term Assets
Commitments and Contingencies Disclosure [Line Items]
Operating Leases, Rent Expense			$ 275,000
5-year operating lease agreement
Commitments and Contingencies Disclosure [Line Items]
Base rent, per month		$ 7,350
7-year operating lease agreement
Commitments and Contingencies Disclosure [Line Items]
Base rent, per month	$ 37,792

Accrued Expenses (Detail) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Schedule of Accrued Liabilities [Line Items]
Technology fees	$ 450,000	$ 450,000
Professional services	229,189	257,024
Sales taxes	122,901	34,206
Consulting fees	67,200	173,759
Personnel related obligations	64,543	37,761
Clinical study obligations	34,085	74,000
Federal excise tax	26,289	25,989
Other	138,656	212,137
Accrued expenses	$ 1,132,863	$ 1,264,876

Fair Value Measurements - Additional Information (Detail) - USD ($)	1 Months Ended
	May. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
Fair Value Disclosures [Line Items]
Common stock warrants liability		$ 890,105	$ 5,307,332
Warrants Fair Value Disclosure	$ 943,423
Number Of Warrants Repurchased	1,571,744

Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Assets:
Cash equivalents	$ 5,028,053	$ 4,107,478
Total	5,028,053	4,107,478
Liabilities:
Common stock warrants	890,105	5,307,332
Total	890,105	5,307,332
Fair Value, Inputs, Level 1
Assets:
Total	5,028,053	4,107,478
Liabilities:
Total	0	0
Fair Value, Inputs, Level 1 \| Fair Value, Measurements, Recurring
Assets:
Cash equivalents	5,028,053	4,107,478
Liabilities:
Common stock warrants	0	0
Fair Value, Inputs, Level 2
Assets:
Total	0	0
Liabilities:
Total	0	0
Fair Value, Inputs, Level 2 \| Fair Value, Measurements, Recurring
Assets:
Cash equivalents	0	0
Liabilities:
Common stock warrants	0	0
Fair Value, Inputs, Level 3
Assets:
Total	0	0
Liabilities:
Total	890,105	5,307,332
Fair Value, Inputs, Level 3 \| Fair Value, Measurements, Recurring
Assets:
Cash equivalents	0	0
Liabilities:
Common stock warrants	$ 890,105	$ 5,307,332

Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 9,116,806	$ 9,221,985
Accounts receivable, net	901,895	580,240
Inventories	1,072,162	679,740
Prepaid expenses and other current assets	878,533	608,160
Total current assets	11,969,396	11,090,125
Fixed assets, net	745,133	311,520
Other long-term assets	214,275	585
Total assets	12,928,804	11,402,230
Current liabilities:
Accounts payable	946,146	522,871
Accrued compensation	766,557	885,353
Accrued expenses	1,132,863	1,264,876
Current portion of deferred revenue	692,244	25,048
Total current liabilities	3,537,810	2,698,148
Deferred revenue, net of current portion	10,433	9,635
Common stock warrants	890,105	5,307,332
Total liabilities	$ 4,438,348	$ 8,015,115
Commitments and contingencies (Note 6)
Stockholders’ equity:
Preferred stock value	$ 0	$ 0
Common stock, $0.0001 par value; 50,000,000 shares authorized; 13,785,239 and 8,152,746 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	1,379	815
Additional paid-in capital	169,345,497	157,764,598
Accumulated deficit	(160,856,514)	(154,378,302)
Total stockholders’ equity	8,490,456	3,387,115
Total liabilities and stockholders’ equity	12,928,804	11,402,230
Series A Convertible Preferred Stock
Stockholders’ equity:
Preferred stock value	0	4
Series B Convertible Preferred Stock
Stockholders’ equity:
Preferred stock value	$ 94	$ 0

Stockholders' Equity - Additional Information (Detail) - USD ($)	1 Months Ended						3 Months Ended			9 Months Ended		12 Months Ended
	May. 31, 2015	Mar. 31, 2015	Feb. 28, 2015	Oct. 31, 2014	Jul. 31, 2014	Jun. 30, 2014	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Mar. 12, 2015	Feb. 25, 2014
Public Offering Of Common Stock and Warrants [Line Items]
Net proceed from offering common stock and warrants										$ 13,316,324	$ 7,918,179
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized							$ 346,000			$ 346,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition										2 years 3 months 18 days
Preferred Stock, Par or Stated Value Per Share							$ 0.001			$ 0.001		$ 0.001
Preferred Stock Shares Outstanding							0			0		0
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features							$ 0		$ 0	$ 589,751	$ 0
2014 Management Incentive Compensation
Public Offering Of Common Stock and Warrants [Line Items]
Closing Price Of Shares													$ 1.69
2013 Management Incentive Compensation
Public Offering Of Common Stock and Warrants [Line Items]
Closing Price Of Shares														$ 2.45
Series A-3 convertible Preferred Stock
Public Offering Of Common Stock and Warrants [Line Items]
Stock issued during period, shares, other						2,621,859
Share price						$ 1,000
Stock Issued During Period, Shares, Conversion of Convertible Securities							1,285,225
Conversion of Stock, Shares Converted					2,417,859	204
Series A-4 convertible Preferred Stock
Public Offering Of Common Stock and Warrants [Line Items]
Stock issued during period, shares, other						4,022,357
Share price						$ 1,000
Stock Issued During Period, Shares, Conversion of Convertible Securities							1,971,744
Stock Repurchased During Period, Value	$ 3,200,000
Series B Preferred Stock
Public Offering Of Common Stock and Warrants [Line Items]
Conversion of Stock, Shares Converted							28,170	24,684
Preferred Stock Conversion Price Per Share	$ 1.0101
Preferred Stock Shares Outstanding							94,146			94,146
Series A4 Preferred Stock
Public Offering Of Common Stock and Warrants [Line Items]
Conversion of Stock, Shares Converted	3,206,357		408	408
Preferred Stock, Redemption Price Per Share	$ 1,000
Stock Repurchased During Period, Shares	3,206,357
Common Stock
Public Offering Of Common Stock and Warrants [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion	14,553,000		200,000	200,000	1,185,225	100,000	2,788,830	2,443,716		2,788,830
2014 Offering
Public Offering Of Common Stock and Warrants [Line Items]
Stock issued during period, shares, other						664,600
Share price						$ 2.04
Gross proceeds from issuance or sale of equity						$ 8,000,000
Class of warrant or right, Number of securities called by warrants or rights						3,921,569
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 2.04
Debt Instrument, Convertible, Beneficial Conversion Feature						$ 2,955,668
Preferred Stock, Par or Stated Value Per Share									$ 1,000		$ 1,000
Warrants and Rights Outstanding							$ 700,000			$ 700,000
Preferred Stock Conversion Price Per Share									2.04
Class of Warrant or Right, Outstanding							2,349,825			2,349,825
2014 Offering \| Series A4 Preferred Stock
Public Offering Of Common Stock and Warrants [Line Items]
Net proceed from offering common stock and warrants						$ 7,900,000
Proceeds used to repurchase outstanding preferred shares	$ 3,200,000
2014 Offering \| Warrants
Public Offering Of Common Stock and Warrants [Line Items]
Fair Value of Warrants							$ 4,400,000			$ 4,400,000
Exercise price							$ 2.04			$ 2.04
Expected volatility										67.48%
Risk free interest rate										1.64%
Share price									$ 2.00		$ 2.00
2013 Offering
Public Offering Of Common Stock and Warrants [Line Items]
Warrants and Rights Outstanding							$ 200,000			$ 200,000
Class of Warrant or Right, Outstanding							1,057,323			1,057,323
2015 Issuance \| 2014 Management Incentive Compensation
Public Offering Of Common Stock and Warrants [Line Items]
Stock Issued During Period, Shares, New Issues		166,405
Stock Issued During Period, Value, New Issues		$ 281,700
2014 Issuance \| 2013 Management Incentive Compensation
Public Offering Of Common Stock and Warrants [Line Items]
Stock Issued During Period, Shares, New Issues												42,615
Stock Issued During Period, Value, New Issues												$ 104,405
2015 Offering
Public Offering Of Common Stock and Warrants [Line Items]
Net proceed from offering common stock and warrants	10,100,000
Fair Value of Warrants							$ 3,200,000			$ 3,200,000
Gross proceeds from issuance or sale of equity	$ 14,700,000
Class of warrant or right, Number of securities called by warrants or rights	14,553,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.25
Debt Instrument, Convertible, Beneficial Conversion Feature	$ 4,140,446
2015 Offering \| Series B Preferred Stock
Public Offering Of Common Stock and Warrants [Line Items]
Share price	$ 100
Stock Issued During Period, Shares, New Issues	147,000
Preferred Stock, Par or Stated Value Per Share	$ 100

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	13,785,239	8,152,746
Common stock, shares outstanding	13,785,239	8,152,746
Series A Convertible Preferred Stock
Preferred stock, issued	0	3,614.357
Preferred stock, outstanding	0	3,614.357
Preferred Stock Shares Designated	11,083	11,083
Series B Convertible Preferred Stock
Preferred stock, issued	94,146	0
Preferred stock, outstanding	94,146	0
Preferred Stock Shares Designated	147,000	0

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2015	Oct. 21, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Entity Registrant Name	NeuroMetrix, Inc.
Entity Central Index Key	0001289850
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	NURO
Entity Common Stock, Shares Outstanding		13,785,239

Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
Statements of Operations - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues	$ 2,054,432	$ 1,427,828	$ 4,562,379	$ 4,103,135
Cost of revenues	1,119,186	639,025	2,351,479	1,909,443
Gross profit	935,246	788,803	2,210,900	2,193,692
Operating expenses:
Research and development	940,794	945,349	2,825,589	3,273,900
Sales and marketing	1,965,627	537,785	5,183,595	1,678,665
General and administrative	1,386,170	1,310,012	4,157,082	3,605,047
Total operating expenses	4,292,591	2,793,146	12,166,266	8,557,612
Loss from operations	(3,357,345)	(2,004,343)	(9,955,366)	(6,363,920)
Interest income	1,761	1,336	3,350	3,362
Warrants offering costs	0	(23,256)	0	(50,874)
Change in fair value of warrant liability	151,806	564,550	3,473,804	1,554,411
Net loss	$ (3,203,778)	$ (1,461,713)	$ (6,478,212)	$ (4,857,021)
Net loss per common share applicable to common stockholders, basic and diluted (See Note 3, Net Loss per Common Share)	$ (0.26)	$ (0.19)	$ (1.02)	$ (1.18)
Weighted average number of common shares outstanding, basic and diluted	12,133,984	7,853,292	9,879,905	6,602,626

Credit Facility - Additional Information (Detail)	9 Months Ended
Credit Facility - Additional Information (Detail)	Sep. 30, 2015 USD ($)
Line of Credit Facility [Line Items]
Revolving credit facility, maximum borrowing capacity	$ 2,500,000
Credit Facility expiration date	Jan. 15, 2016
Credit Facility limit restricted to support letter of credit	$ 226,731
Line of credit facility, remaining borrowing capacity	$ 2,300,000
Prime Rate
Line of Credit Facility [Line Items]
Interest rate over prime rate	0.50%

Comprehensive Loss - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Other Comprehensive Income Loss [Line Items]
Other comprehensive income (loss), net of tax	$ 0	$ 0

Inventories - Additional Information (Detail) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Inventory [Line Items]
Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross	$ 64,477	$ 0

Statements of Cash Flows - USD ($)	9 Months Ended
Statements of Cash Flows - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (6,478,212)	$ (4,857,021)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	160,993	103,250
Stock-based compensation	246,406	208,358
Warrant offering cost	0	50,874
Change in fair value of warrant liability	(3,473,804)	(1,554,411)
Changes in operating assets and liabilities:
Accounts receivable	(321,655)	(220,868)
Inventories	(392,422)	(67,200)
Prepaid expenses and other current and long-term assets	(484,063)	(26,476)
Accounts payable	423,275	199,818
Accrued expenses and compensation	30,948	841,317
Deferred revenue	667,994	(32,570)
Net cash used in operating activities	(9,620,540)	(5,354,929)
Cash flows from investing activities:
Purchases of fixed assets	(594,606)	(71,982)
Net cash used in investing activities	(594,606)	(71,982)
Cash flows from financing activities:
Net proceeds from issuance of stock and warrants	13,316,324	7,918,179
Repurchase of Series A-4 preferred stock and warrants	(3,206,357)	0
Net cash provided by financing activities	10,109,967	7,918,179
Net (decrease) increase in cash and cash equivalents	(105,179)	2,491,268
Cash and cash equivalents, beginning of period	9,221,985	9,195,753
Cash and cash equivalents, end of period	9,116,806	11,687,021
Supplemental disclosure of cash flow information:
Common stock issued to settle employee incentive compensation obligation	281,757	104,405
Warrants issued under Securities Purchase Agreement recorded as a non-current liability	$ 0	$ 4,418,824

Rollforward of the Liability Balance for Severance (Detail)	9 Months Ended
	Sep. 30, 2015 USD ($)
Restructuring Cost and Reserve [Line Items]
Balance - beginning	$ 148,921
Accrual for severance	0
Severance payments made	(148,921)
Balance - ending	$ 0